Document

0000031791-18-000018.txt : 20181106 0000031791-18-000018.hdr.sgml : 20181106 20181106141918 ACCESSION NUMBER: 0000031791-18-000018 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 91 CONFORMED PERIOD OF REPORT: 20180930 FILED AS OF DATE: 20181106 DATE AS OF CHANGE: 20181106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PERKINELMER INC CENTRAL INDEX KEY: 0000031791 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 042052042 STATE OF INCORPORATION: MA FISCAL YEAR END: 0102 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-05075 FILM NUMBER: 181162531 BUSINESS ADDRESS: STREET 1: 940 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781 663 5776 MAIL ADDRESS: STREET 1: 940 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: EG&G INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: EDGERTON GERMESHAUSEN & GRIER INC DATE OF NAME CHANGE: 19670626 10-Q 1 pki-09302018x10qdocument.htm 10-Q Document

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________________________________

FORM 10-Q

_______________________________________

(Mark One)



ý	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2018



¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________ to ____________

Commission File Number 001-5075

_______________________________________

PerkinElmer, Inc.

(Exact name of Registrant as specified in its Charter)

_______________________________________



Massachusetts		04-2052042
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

940 Winter Street

Waltham, Massachusetts 02451

(Address of principal executive offices) (Zip code)

(781) 663-6900

(Registrant’s telephone number, including area code)

_______________________________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ý No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.



Large accelerated filer	ý	Accelerated filer	¨

Non-accelerated filer	¨	Smaller reporting company	¨
Emerging growth company	¨

If an emerging growth company, indicate by check mark whether the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No ý

As of November 1, 2018, there were outstanding 111,239,214 shares of common stock, $1 par value per share.

Table of Contents

TABLE OF CONTENTS



		Page
PART I. FINANCIAL INFORMATION

Item 1.	Unaudited Financial Statements	3
	Condensed Consolidated Statements of Operations	3
	Condensed Consolidated Statements of Comprehensive Income	4
	Condensed Consolidated Balance Sheets	5
	Condensed Consolidated Statements of Cash Flows	6
	Notes to Condensed Consolidated Financial Statements	7

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	44
	Overview	44
	Critical Accounting Policies and Estimates	45
	Consolidated Results of Continuing Operations	45
	Reporting Segment Results of Continuing Operations	51
	Liquidity and Capital Resources	53
	Dividends	57
	Contractual Obligations	57
	Effects of Recently Adopted and Issued Accounting Pronouncements	57

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	59

Item 4.	Controls and Procedures	60

PART II. OTHER INFORMATION

Item 1.	Legal Proceedings	61

Item 1A.	Risk Factors	61

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	68

Item 6.	Exhibits	69

Signatures		70

Table of Contents

PART I. FINANCIAL INFORMATION


Item 1.	Unaudited Financial Statements

PERKINELMER, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)



	Three Months Ended						Nine Months Ended
	September 30, 2018			October 1, 2017			September 30, 2018			October 1, 2017
	(In thousands, except per share data)
Product revenue	$	474,523		$	354,819		$	1,417,739		$	1,043,534
Service revenue	199,790			199,456			603,908			571,818
Total revenue	674,313			554,275			2,021,647			1,615,352
Cost of product revenue	213,672			165,015			663,651			501,079
Cost of service revenue	128,314			120,293			393,307			347,948
Total cost of revenue	341,986			285,308			1,056,958			849,027
Selling, general and administrative expenses	196,769			152,775			601,374			449,642
Research and development expenses	48,848			34,885			142,028			101,731
Restructuring and contract termination charges, net	6,508			3,269			13,086			12,920
Operating income from continuing operations	80,202			78,038			208,201			202,032
Interest and other expense, net	2,161			(27,016		)	29,947			(13,797		)
Income from continuing operations before income taxes	78,041			105,054			178,254			215,829
Provision for income taxes	2,596			8,508			12,101			20,495
Income from continuing operations	75,445			96,546			166,153			195,334
Income from discontinued operations before income taxes	—			—			—			650
(Loss) gain on disposition of discontinued operations before income taxes	(308		)	(206		)	(859		)	180,171
(Benefit from) provision for income taxes on discontinued operations and dispositions	(1,411		)	5,262			(1,341		)	42,405
Gain (loss) from discontinued operations and dispositions	1,103			(5,468		)	482			138,416
Net income	$	76,548		$	91,078		$	166,635		$	333,750
Basic earnings per share:
Income from continuing operations	$	0.68		$	0.88		$	1.50		$	1.78
Gain (loss) from discontinued operations and dispositions	0.01			(0.05		)	0.00			1.26
Net income	$	0.69		$	0.83		$	1.51		$	3.04
Diluted earnings per share:
Income from continuing operations	$	0.68		$	0.87		$	1.49		$	1.77
Gain (loss) from discontinued operations and dispositions	0.01			(0.05		)	0.00			1.25
Net income	$	0.69		$	0.82		$	1.49		$	3.02
Weighted average shares of common stock outstanding:
Basic	110,724			110,003			110,499			109,788
Diluted	111,747			110,993			111,510			110,653
Cash dividends declared per common share	$	0.07		$	0.07		$	0.21		$	0.21

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

PERKINELMER, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)



	Three Months Ended					Nine Months Ended
	September 30, 2018			October 1, 2017		September 30, 2018			October 1, 2017
	(In thousands)
Net income	$	76,548		$	91,078	$	166,635		$	333,750
Other comprehensive income:
Foreign currency translation adjustments	(30,105		)	9,805		(114,198		)	47,205
Unrealized gains on securities, net of tax	23			47		68			81
Other comprehensive (loss) income	(30,082		)	9,852		(114,130		)	47,286
Comprehensive income	$	46,466		$	100,930	$	52,505		$	381,036

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

PERKINELMER, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)



	September 30, 2018			December 31, 2017
	(In thousands, except share and per share data)
Current assets:
Cash and cash equivalents	$	149,513		$	202,134
Accounts receivable, net	551,385			552,304
Inventories	354,244			351,675
Other current assets	110,353			93,842
Total current assets	1,165,495			1,199,955
Property, plant and equipment:
At cost	724,053			630,919
Accumulated depreciation	(407,004		)	(332,853		)
Property, plant and equipment, net	317,049			298,066
Intangible assets, net	1,223,775			1,346,940
Goodwill	2,920,689			3,002,198
Other assets, net	235,347			244,304
Total assets	$	5,862,355		$	6,091,463
Current liabilities:
Current portion of long-term debt	$	20,072		$	217,306
Accounts payable	180,693			222,093
Accrued restructuring and contract termination charges	8,079			8,759
Accrued expenses and other current liabilities	475,743			500,642
Current liabilities of discontinued operations	2,165			2,102
Total current liabilities	686,752			950,902
Long-term debt	1,882,502			1,788,803
Long-term liabilities	720,632			848,570
Total liabilities	3,289,886			3,588,275
Commitments and contingencies (see Note 20)
Stockholders’ equity:
Preferred stock—$1 par value per share, authorized 1,000,000 shares; none issued or outstanding	—			—
Common stock—$1 par value per share, authorized 300,000,000 shares; issued and outstanding 111,087,000 shares and 110,361,000 shares at September 30, 2018 and at December 31, 2017, respectively	111,087			110,361
Capital in excess of par value	89,970			58,828
Retained earnings	2,532,060			2,380,517
Accumulated other comprehensive loss	(160,648		)	(46,518		)
Total stockholders’ equity	2,572,469			2,503,188
Total liabilities and stockholders’ equity	$	5,862,355		$	6,091,463

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

PERKINELMER, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)



	Nine Months Ended
	September 30, 2018			October 1, 2017
	(In thousands)
Operating activities:
Net income	$	166,635		$	333,750
Gain from discontinued operations and dispositions, net of income taxes	(482		)	(138,416		)
Income from continuing operations	166,153			195,334
Adjustments to reconcile income from continuing operations to net cash provided by continuing operations:
Stock-based compensation	23,275			16,179
Restructuring and contract termination charges, net	13,086			12,920
Depreciation and amortization	133,386			75,507
(Gain) loss on disposition of businesses and assets, net	(13,031		)	301
Gain on sale of investments, net	(557		)	—
Change in fair value of contingent consideration	10,804			1,560
Amortization of deferred debt financing costs and accretion of discount	2,454			1,936
Amortization of acquired inventory revaluation	18,160			4,240
Changes in assets and liabilities which provided (used) cash, excluding effects from companies acquired:
Accounts receivable, net	(12,670		)	10,971
Inventories	(41,313		)	(25,208		)
Accounts payable	(36,587		)	(12,459		)
Accrued expenses and other	(111,341		)	(116,118		)
Net cash provided by operating activities of continuing operations	151,819			165,163
Net cash used in operating activities of discontinued operations	(200		)	(4,806		)
Net cash provided by operating activities	151,619			160,357
Investing activities:
Capital expenditures	(60,443		)	(22,362		)
Settlement of cash flow hedges	—			60,420
Proceeds from disposition of businesses and assets	38,027			—
Purchases of investments	(5,500		)	—
Proceeds from surrender of life insurance policies	72			45
Activity related to acquisitions, net of cash and cash equivalents acquired	(44,057		)	(123,578		)
Net cash used in investing activities of continuing operations	(71,901		)	(85,475		)
Net cash provided by investing activities of discontinued operations	—			272,779
Net cash (used in) provided by investing activities	(71,901		)	187,304
Financing activities:
Payments on borrowings	(1,019,000		)	(146,965		)
Proceeds from borrowings	605,000			146,952
Proceeds from sale of senior debt	369,340			—
Payments of debt financing costs	(2,634		)	—
Settlement of cash flow hedges	(30,285		)	(11,539		)
Net payments on other credit facilities	(22,871		)	(872		)
Payments for acquisition-related contingent consideration	(12,800		)	(8,940		)
Proceeds from issuance of common stock under stock plans	19,484			14,004
Purchases of common stock	(4,974		)	(3,480		)
Dividends paid	(23,222		)	(23,077		)
Net cash used in financing activities of continuing operations	(121,962		)	(33,917		)
Net cash used in financing activities of discontinued operations	—			(533		)
Net cash used in financing activities	(121,962		)	(34,450		)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(7,410		)	19,945
Net (decrease) increase in cash, cash equivalents and restricted cash	(49,654		)	333,156
Cash, cash equivalents and restricted cash at beginning of period	202,371			376,568
Cash, cash equivalents and restricted cash at end of period	$	152,717		$	709,724

Supplemental disclosures of cash flow information
Reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets that sum to the total shown in the condensed consolidated statements of cash flows:
Cash and cash equivalents	149,513			709,488
Restricted cash included in other current assets	3,204			236
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows	$	152,717		$	709,724

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

PERKINELMER, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1: Basis of Presentation

The condensed consolidated financial statements included herein have been prepared by PerkinElmer, Inc. (the “Company”), in accordance with accounting principles generally accepted in the United States of America (the “U.S.” or the "United States") and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information in the footnote disclosures of the financial statements has been condensed or omitted where it substantially duplicates information provided in the Company’s latest audited consolidated financial statements, in accordance with the rules and regulations of the SEC. These condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes included in its Annual Report on Form 10-K for the fiscal year ended December 31, 2017, filed with the SEC (the “2017 Form 10-K”). The balance sheet amounts at December 31, 2017 in this report were derived from the Company’s audited 2017 consolidated financial statements included in the 2017 Form 10-K. The condensed consolidated financial statements reflect all adjustments that, in the opinion of management, are necessary to present fairly the Company’s financial position, results of operations and cash flows for the periods indicated. The preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts and classifications of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The results of operations for the three and nine months ended September 30, 2018 and October 1, 2017, respectively, are not necessarily indicative of the results for the entire fiscal year or any future period.

The Company’s fiscal year ends on the Sunday nearest December 31. The Company reports fiscal years under a 52/53 week format and as a result, certain fiscal years will contain 53 weeks. The fiscal year ending December 30, 2018 ("fiscal year 2018") will include 52 weeks, and the fiscal year ended December 31, 2017 ("fiscal year 2017") included 52 weeks.

Recently Adopted and Issued Accounting Pronouncements: From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (the "FASB") and are adopted by the Company as of the specified effective dates. Unless otherwise discussed, such pronouncements did not have or will not have a significant impact on the Company’s consolidated financial position, results of operations and cash flows or do not apply to the Company’s operations.

In August 2018, the FASB issued Accounting Standards Update No. 2018-15, Intangibles-Goodwill and Other- Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract ("ASU 2018-15"). ASU 2018-15 aligns the accounting for implementation costs incurred in a hosting arrangement that is a service contract with the guidance on capitalizing costs associated with developing or obtaining internal-use software (and hosting arrangements that include an internal use software license). Specifically, ASU 2018-15 amends Intangibles-Goodwill and Other (Topic 350) to include in its scope implementation costs incurred in a hosting arrangement that is a service contract and clarifies that a customer should apply Subtopic 350-40 to determine which implementation costs to capitalize as an asset related to the service contract and which costs to expense. The provisions of this guidance are to be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. ASU 2018-15 is effective for annual reporting periods beginning after December 15, 2019, and interim periods within those years with early adoption permitted. The Company is currently evaluating the requirements of this guidance and has not yet determined the impact of its adoption on the Company's consolidated financial position, results of operations and cash flows.

In August 2018, the FASB issued Accounting Standards Update No. 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans ("ASU 2018-14"). ASU 2018-14 adds, removes, and clarifies disclosure requirements related to defined benefit pension and other postretirement plans. ASU 2018-14 adds requirements for an entity to disclose the weighted-average interest crediting rates used in the entity’s cash balance pension plans and other similar plans; and an explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period. Further, ASU 2018-14 removes guidance that currently requires the following disclosures: the amounts in accumulated other comprehensive income expected to be recognized as part of net periodic benefit cost over the next year; the amount and timing of plan assets expected to be returned to the employer; information about (1) benefits covered by related-party insurance and annuity contracts and (2) significant transactions between the plan and related parties; and the effects of a one-percentage-point change on the assumed health care costs and the effect of this change in rates on service cost, interest cost, and the benefit obligation for postretirement health care benefits. ASU 2018-14 also clarifies the guidance in Compensation-Retirement Benefits (Topic 715-20-50-3) on defined benefit plans to require disclosure of (1) the projected benefit obligation ("PBO") and fair value of plan assets for pension plans with PBOs in excess of plan assets (the same disclosure with reference to the accumulated postretirement benefit

Table of Contents

obligation rather than the PBO is required for other postretirement benefit plans) and (2) the accumulated benefit obligation ("ABO") and fair value of plan assets for pension plans with ABOs in excess of plan assets. The provisions of this guidance are to be applied retrospectively to all periods presented upon their effective date. ASU 2018-14 is effective for annual reporting periods beginning after December 15, 2020, and interim periods within those years with early adoption permitted. The Company is currently evaluating the requirements of this guidance and has not yet determined the impact of its adoption on the Company's consolidated financial position, results of operations and cash flows.

In August 2018, the FASB issued Accounting Standards Update No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement ("ASU 2018-13"). ASU 2018-13 adds, removes, and modifies certain disclosures related to fair value measurements. ASU 2018-13 adds requirements for an entity to disclose the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period; and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. Further, ASU 2018-13 removes the requirement to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy; the policy for timing of transfers between levels; and the valuation processes for Level 3 fair value measurements. ASU 2018-13 also modifies existing disclosure requirements related to measurement uncertainty. The amendments regarding changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty are to be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments are to be applied retrospectively to all periods presented upon their effective date. ASU 2018-13 is effective for annual reporting periods beginning after December 15, 2019, and interim periods within those years. Early adoption is permitted for any removed or modified disclosures. The Company is currently evaluating the requirements of this guidance and has not yet determined the impact of its adoption on the Company's consolidated financial position, results of operations and cash flows.

In June 2018, the FASB issued Accounting Standards Update No. 2018-07, Compensation - Stock Compensation (Topic 718), Improvements to Nonemployee Share-Based Payment Accounting ("ASU 2018-07") which supersedes Subtopic 505-50, Equity - Equity-Based Payments to Non-employees, and expands the scope of Topic 718 (which currently only includes share-based payments to employees) to also include share-based payments issued to non-employees for goods and services, except for specific guidance on inputs to an option pricing model and the attribution of cost (that is, the period of time over which share-based payment awards vest and the pattern of cost recognition over that period). ASU 2018-07 specifies that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards, except for financing transactions, or awards issued to customers as part of a contract accounted for under Topic 606, Revenue from Contracts with Customers ("Topic 606"). The provisions of this guidance are to be applied using a modified retrospective approach, with a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year, for all (1) liability-classified non-employee awards that have not been settled as of the adoption date and (2) equity-classified non-employee awards for which a measurement date has not been established. ASU 2018-07 is effective for annual reporting periods beginning after December 15, 2018, and interim periods within those years. Early adoption is permitted, but no earlier than a company’s adoption date of Topic 606. The Company early adopted the provisions of this guidance effective July 2, 2018. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flow.

In March 2018, the FASB Issued Accounting Standards Update No. 2018-05, Income Taxes (Topic 740): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118 ("ASU 2018-05"). ASU 2018-05 was issued to incorporate into Topic 740 recent SEC guidance related to the income tax accounting implications of the Tax Cut and Jobs Act (the "Tax Act"). The SEC issued Staff Accounting Bulletin No. 118 ("SAB 118") to address concerns about reporting entities’ ability to timely comply with the accounting requirements to recognize all of the effects of the Tax Act in the period of enactment. SAB 118 permits companies to disclose that some or all of the income tax effects from the Tax Act are incomplete by the due date of the financial statements, and if possible, disclose a reasonable estimate of such tax effects. ASU 2018-05 is effective immediately. The Company is applying the guidance in ASU 2018-05 when accounting for the enactment date effects of the Tax Act. At September 30, 2018, the Company has not completed the accounting for all of the tax effects of the Tax Act; however, it has made a reasonable estimate of their effects based on currently available information. Management will continue to refine the calculations as additional guidance is available. These estimates may be affected as additional clarification and implementation guidance becomes available. These changes could be material to income tax expense (see Note 9, Income Taxes for further disclosures).

In February 2018, the FASB Issued Accounting Standards Update No. 2018-03, Technical Corrections and Improvements to Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities ("ASU 2018-03"). ASU 2018-03 was issued to clarify certain aspects of guidance concerning the recognition of financial assets and liabilities established in Accounting Standards Update No. 2016-01, Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities ("ASU 2016-01"). This

Table of Contents

includes treatment for discontinuations and adjustments for equity securities without a readily determinable market value, forward contracts and purchased options, presentation requirements for certain fair value option liabilities, fair value option liabilities denominated in a foreign currency, and transition guidance for equity securities without a readily determinable fair value. ASU 2018-03 is effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years beginning after June 15, 2018. Early adoption is permitted for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years, as long as the Company has adopted ASU 2016-01. The Company adopted the provisions of this guidance effective July 2, 2018. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows.

In February 2018, the FASB Issued Accounting Standards Update No. 2018-02, Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income ("ASU 2018-02"). ASU 2018-02 provides entities with an option to reclassify stranded tax effects within Accumulated Other Comprehensive Income ("AOCI") to retained earnings in each period in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Act (or portion thereof) is recorded. ASU 2018-02 requires entities to disclose a description of the accounting policy for releasing income tax effects from AOCI; whether they elect to reclassify the stranded income tax effects from the Tax Act; and information about the other income tax effects that are reclassified. ASU 2018-02 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted, and entities should apply the proposed amendments either in the period of adoption or retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Act is recognized. The Company is currently evaluating the requirements of this guidance and has not yet determined the impact of its adoption on the Company's consolidated financial position, results of operations and cash flows.

In August 2017, the FASB issued Accounting Standards Update No. 2017-12, Derivatives and Hedging (Topic 815), Targeted Improvements to Accounting for Hedging Activities ("ASU 2017-12"), which amends the hedge accounting recognition and presentation requirements in Topic 815. ASU 2017-12 makes targeted changes to the existing hedge accounting model to better align an entity’s financial reporting for hedging relationships with the entity’s risk management activities, and to reduce the complexity of, and simplify the application of, the hedge accounting model. Specifically, ASU 2017-12 expands the types of transactions eligible for hedge accounting, eliminates the requirement to separately measure and present hedge ineffectiveness, simplifies the way assessments of hedge ineffectiveness may be performed, relaxes the documentation requirements for entering into hedging positions, provides targeted improvements to fair value hedges of interest rate risk, and permits an entity to exclude the change in the fair value of cross-currency basis spreads in currency swaps from the assessment of hedge effectiveness. The standard also requires entities to provide new disclosures about the impact fair value and cash flow hedges have on their income statements and about cumulative basis adjustments arising from fair value hedges. The provisions of this guidance are to be applied using a modified retrospective approach to existing hedging relationships as of the adoption date. However, the transition provisions allow for certain elections at the date of adoption and entities may choose to apply any of the provided elections. ASU 2017-12 is effective for annual reporting periods beginning after December 15, 2018, and interim periods within those years. Early adoption is permitted, including adoption in any interim period. The Company early adopted the provisions of this guidance effective January 1, 2018. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows.

In May 2017, the FASB issued Accounting Standards Update No. 2017-09, Compensation - Stock Compensation (Topic 718), Scope of Modification Accounting ("ASU 2017-09"), which amends the scope of modification accounting for share-based payment arrangements. ASU 2017-09 provides guidance on the types of changes to the terms or conditions of share-based payment awards to which an entity would be required to apply modification accounting under Topic 718. Specifically, an entity would not apply modification accounting if the fair value, vesting conditions, and classification of the awards are the same immediately before and after the modification. If an entity modifies its awards and concludes that it is not required to apply modification accounting under the standard, it must still consider whether the modification affects its application of other guidance. Additionally, if a significant modification does not result in incremental compensation cost, entities are required to disclose the “lack of” incremental compensation cost resulting from such significant modification. The standard also removes the guidance in Topic 718 stating that modification accounting is not required when an entity adds an antidilution provision as long as that modification is not made in contemplation of an equity restructuring. The provisions of this guidance are to be applied on a prospective basis to awards modified on or after the effective date. ASU 2017-09 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years. Early adoption is permitted, including adoption in any interim period. The Company adopted ASU 2017-09 effective January 1, 2018. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows.

In March 2017, the FASB issued Accounting Standards Update No. 2017-07, Compensation - Retirement Benefits (Topic 715), Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost ("ASU 2017-07"), which amends the requirements in Topic 715 related to the income statement presentation of the components of net periodic benefit cost for an entity’s sponsored defined benefit pension and other postretirement plans. ASU 2017-07 requires entities to

Table of Contents

(1) disaggregate the current-service-cost component from the other components of net benefit cost (the “other components”) and present it with other current employee compensation costs in their income statements and (2) present the other components elsewhere in their income statements and outside of income from operations, and disclose the income statement lines that contain the other components if they are not presented on appropriately described separate lines. Additionally, the standard requires that only the service-cost component of net benefit cost is eligible for capitalization (e.g., as part of inventory or property, plant, and equipment). The change in income statement presentation requires retrospective application, while the change in capitalized benefit cost is to be applied prospectively. ASU 2017-07 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years, with early adoption permitted. The standard provides a practical expedient that permits entities to use the components of cost disclosed in prior years as a basis for the retrospective application of the new income statement presentation. Entities need to disclose the use of the practical expedient. The Company adopted ASU 2017-07 effective January 1, 2018 using a retrospective approach for each period presented. For the three and nine months ended October 1, 2017, $1.8 million and $5.4 million, respectively, of net periodic pension credit previously presented within operating income has been presented outside of operating income in the line item "Interest and other expense, net" in the condensed consolidated statement of operations due to the retrospective adoption of ASU 2017-07. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows, other than the impact discussed above.

In January 2017, the FASB issued Accounting Standards Update No. 2017-01, Business Combinations (Topic 805), Clarifying the Definition of a Business ("ASU 2017-01"), which amends Topic 805 to provide a screen to determine when a set of assets and liabilities is not a business. The screen requires that when substantially all of the fair value of the gross assets acquired (or disposed of) is concentrated in a single identifiable asset or a group of similar identifiable assets, the set is not a business. This screen reduces the number of transactions that need to be further evaluated. If the screen is not met, the standard (1) requires that to be considered a business, a set must include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create output and (2) removes the evaluation of whether a market participant could replace missing elements. The standard provides a framework to assist entities in evaluating whether both an input and a substantive process are present. The standard also provides a framework that includes two sets of criteria to consider that depend on whether a set has outputs and a more stringent criteria for sets without outputs. Lastly, the standard narrows the definition of the term "output" so that the term is consistent with how outputs are described in Topic 606, Revenue from Contracts with Customers. The provisions of this guidance are to be applied prospectively. ASU 2017-01 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years, with early adoption permitted in limited circumstances. The Company adopted ASU 2017-01 effective January 1, 2018. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows.

In November 2016, the FASB issued Accounting Standards Update No. 2016-18, Statement of Cash Flows (Topic 230), Restricted Cash ("ASU 2016-18"), which amends Topic 230 to add or clarify guidance on the classification and presentation of restricted cash in the statement of cash flows. The standard requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The provisions of this guidance are to be applied using a retrospective transition method to each period presented. ASU 2016-18 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years, with early adoption permitted. The Company adopted ASU 2016-18 effective January 1, 2018. For the nine months ended October 1, 2017, $17.2 million of changes in restricted cash balances that was previously presented within investing activities in the condensed consolidated statement of cash flows has been excluded from the cash flows used in investing activities and the effect of exchange rate changes increased by $0.2 million due to the retrospective adoption of ASU 2016-18. Restricted cash amounting to $17.3 million and $0.2 million at January 1, 2017 and October 1, 2017, respectively, have been included with the cash and cash equivalents when reconciling the beginning of period and end of period total amounts on the condensed consolidated statement of cash flows for the nine months ended October 1, 2017. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows, other than the impact discussed above.

In October 2016, the FASB issued Accounting Standards Update No. 2016-16, Income Taxes (Topic 740), Intra-entity Transfer of Assets Other than Inventory ("ASU 2016-16"). ASU 2016-16 removes the prohibition in Topic 740 against the immediate recognition of the current and deferred income tax effects of intra-entity transfers of assets other than inventory. The standard requires entities to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. The provisions of this guidance are to be applied on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. ASU 2016-16 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years, with early adoption permitted. The Company adopted ASU 2016-16 on January 1, 2018. The adoption of the standard resulted in a

Table of Contents

decrease in the retained earnings at January 1, 2018 of approximately $2.0 million with corresponding increase in deferred tax assets of $10.7 million and decrease in prepaid taxes of $12.8 million related to prior years’ intra-entity transfers of assets other than inventory. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows, other than the impact discussed above.

In June 2016, the FASB issued Accounting Standards Update No. 2016-13, Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments ("ASU 2016-13"). ASU 2016-13 changes how entities will measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. The standard requires entities to use the expected loss impairment model and will apply to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities, net investments in leases and off-balance sheet credit exposures. Entities are required to estimate the lifetime “expected credit loss” for each applicable financial asset and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The standard also amends the impairment model for available-for-sale (“AFS”) debt securities and requires entities to determine whether all or a portion of the unrealized loss on an AFS debt security is a credit loss. An entity will recognize an allowance for credit losses on an AFS debt security as a contra-account to the amortized cost basis rather than as a direct reduction of the amortized cost basis of the investment. The provisions of this guidance are to be applied using a modified-retrospective approach. A prospective transition approach is required for debt securities for which an other-than-temporary impairment had been recognized before the effective date. ASU 2016-13 is effective for annual reporting periods beginning after December 15, 2019, and interim periods within those years. Early adoption is permitted for annual periods beginning after December 15, 2018, and interim periods therein. The Company is currently evaluating the requirements of this guidance and has not yet determined the impact of its adoption on the Company's consolidated financial position, results of operations and cash flows.

In February 2016, the FASB issued Accounting Standards Update No. 2016-02, Leases ("ASU 2016-02"). ASU 2016-02 requires organizations that lease assets to recognize assets and liabilities on the balance sheet related to the rights and obligations created by those leases, regardless of whether they are classified as finance or operating leases. Consistent with current guidance, the recognition, measurement, and presentation of expenses and cash flows arising from a lease of assets will primarily depend on its classification as a finance or operating lease. ASU 2016-02 also requires new disclosures to help financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases. The provisions of this guidance are effective for annual periods beginning after December 15, 2018, and interim periods within those years, with early adoption permitted. ASU 2016-02 is to be applied using a modified retrospective approach. Subsequent to the issuance of ASU 2016-02, in July 2018, the FASB issued Accounting Standards Update No. 2018-10, Codification Improvements to Topic 842, Leases ("ASU 2018-10") and Accounting Standards Update No. 2018-11, Leases (Topic 842): Targeted Improvements ("ASU 2018-11"). The amendments in ASU 2018-10 clarify, correct or remove inconsistencies in the guidance provided under ASU 2016-02 related to sixteen specific issues identified. The amendments in ASU 2018-11 provide entities with an additional (and optional) transition method to adopt the new leases standard. Under the new transition method, an entity initially applies the new leases standard at the adoption date and recognizes a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. Consequently, an entity's reporting for the comparative periods presented in the financial statements in the period of adoption will continue to be in accordance with ASC 840, Leases ("ASC 840"). An entity that elects this additional (and optional) transition method must provide the required disclosures under ASC 840 for all periods that continue to be in accordance with ASC 840. ASU 2018-11 also provides lessors with a practical expedient, by class of underlying asset, to not separate nonlease components from the associated lease component and, instead, to account for those components as a single component if certain criteria are met. The effective date and transition requirements for these two standards are the same as the effective date and transition requirements of ASU 2016-02. The Company is in the process of completing its evaluation of the impact of the new leases standard upon adoption and has not yet determined the impact of adoption on its consolidated financial position, results of operations and cash flows. The Company intends to adopt the new leases standard using the optional transition method and will apply the new leases standard on December 31, 2018 (the first day of fiscal year 2019).

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers ("ASU 2014-09"). Under this new guidance, an entity should use a five-step process to recognize revenue, depicting the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard also requires new disclosures regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. Subsequent to the issuance of the standard, the FASB decided to defer the effective date for one year to annual reporting periods beginning after December 15, 2017, with early adoption permitted for annual reporting periods beginning after December 15, 2016. In November 2017, the FASB also issued Accounting Standards Update No. 2017-14, Income Statement-Reporting Comprehensive Income (Topic 220), Revenue Recognition (Topic 605), and Revenue from Contracts with Customers (Topic 606). ASU 2017-14 includes amendments to certain SEC paragraphs within the FASB Accounting Standards Codification ("Codification"). ASU 2017-14

Table of Contents

amends the Codification to incorporate SEC Staff Accounting Bulletin No. 116 and SEC Interpretive Release on Vaccines for Federal Government Stockpiles (SEC Release No. 33-10403) to align existing SEC staff guidance with Revenue from Contracts with Customers (Topic 606). In May 2016, the FASB also issued Accounting Standards Update No. 2016-12, Revenue from Contracts with Customers (Topic 606), Narrow-Scope Improvements and Practical Expedients ("ASU 2016-12"), which amended its revenue recognition guidance in ASU 2014-09 on transition, collectability, non-cash consideration, contract modifications and completed contracts at transition and the presentation of sales and other similar taxes collected from customers. In April 2016, the FASB also issued Accounting Standards Update No. 2016-10, Revenue from Contracts with Customers (Topic 606), Identifying Performance Obligations and Licensing ("ASU 2016-10"), which amended its revenue recognition guidance in ASU 2014-09 on identifying performance obligations to allow entities to disregard items that are immaterial in the context of the contract, clarify when a promised good or service is separately identifiable (i.e., distinct within the context of the contract) and allow an entity to elect to account for the cost of shipping and handling performed after control of a good has been transferred to the customer as a fulfillment cost (i.e., an expense). ASU 2016-10 also clarifies how an entity should evaluate the nature of its promise in granting a license of intellectual property ("IP") and requires entities to classify IP in one of two categories: functional IP or symbolic IP, which will determine whether it recognizes revenue over time or at a point in time. ASU 2016-10 also addresses how entities should consider license renewals and restrictions and apply the exception for sales- and usage-based royalties received in exchange for licenses of IP. In March 2016, the FASB also issued Accounting Standards Update No. 2016-08, Revenue from Contracts with Customers (Topic 606), Principal versus Agent Considerations (Reporting Revenue Gross versus Net) ("ASU 2016-08"), which amended the principal-versus-agent implementation guidance and illustrations in ASU 2014-09. ASU 2016-08 clarifies that an entity should evaluate when it is the principal or agent for each specified good or service promised in a contract with a customer. ASU 2017-14, ASU 2016-12, ASU 2016-10, ASU 2016-08 and ASU 2014-09 may be adopted either using a full retrospective approach or a modified retrospective approach. The Company adopted these standards beginning on January 1, 2018 using the modified retrospective approach only to contracts not completed as of January 1, 2018.

The most significant impact of the standards relates to the accounting for certain transactions with multiple elements or “bundled” arrangements. Specifically, for sales of software subscriptions or sales of licenses and maintenance, the Company will recognize the license revenue predominantly at the time of billing and delivery rather than recognizing the entire sales price ratably over the maintenance period, which is the Company's current practice. In addition, for certain sales of instruments that include customer-specified acceptance criteria, the Company will recognize revenue when the customer obtains control of the instrument which is typically upon delivery or when title has transferred to the customer, as the Company believes acceptance is perfunctory. The Company will also capitalize incremental commission fees as a result of obtaining contracts when these fees are recoverable and will amortize the assets based on the transfer of goods or services to which the assets relate which typically range from two to six years. The adoption of the standards resulted in an increase in retained earnings at January 1, 2018 of approximately $10.2 million for the cumulative effect of initially applying the standards as of that date. In addition, the adoption of the standards resulted primarily in a reduction in deferred revenue of approximately $11.5 million, mainly driven by the upfront recognition of license revenue and certain multi-year software subscriptions, and an increase in deferred income tax liability of approximately $3.0 million for the tax impact of the cumulative adjustments. The cumulative effect of recognizing instrument sales upon delivery or transfer of title and capitalizing the incremental commission fees were not material at January 1, 2018. The adoption of the standards had no impact to cash from or used in operating, investing, or financing activities in the Company's consolidated statement of cash flows at January 1, 2018. Refer to Note 3, Changes in Accounting Policies, for the impact of adoption of the standards on the Company's condensed consolidated financial statements for the quarter ended September 30, 2018. Also refer to Note 2, Revenue, for the disclosures required by the standards.

Note 2: Revenue

Significant accounting policy

The Company enters into contracts that can include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations. The Company recognizes revenue in an amount that reflects the consideration the Company expects to receive in exchange for the promised products or services when it satisfies a performance obligation by transferring control of those products or services to customers.

Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by the Company from a customer, are excluded from revenue.

The Company reports shipping and handling charges in revenue, to the extent these are billed to customers, and the associated costs in cost of product revenue.

Table of Contents

Nature of goods and services

The following is a description of principal activities - separated by reportable segments - from which the Company generates its revenue. For more detailed information about the reportable segments, see Note 12.

i. Discovery & Analytical Solutions

The Discovery & Analytical Solutions ("DAS") segment of the Company principally generates revenue from (a) sales of instruments, consumables and services in the applied markets, (b) sales of instruments, reagents, informatics, detection and imaging technologies, extended warranty, training and services in the life sciences market. Products and services may be sold separately or in bundled packages. The typical length of a contract for service is 12 to 36 months.

For bundled packages, the Company accounts for individual products and services separately if they are distinct - i.e. if a product or service is separately identifiable from other items in the bundled package and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The consideration (including any discounts) is allocated between separate products and services in a bundle based on their stand-alone selling prices. The stand-alone selling prices are determined based on the prices at which the Company separately sells the products, extended warranties, and services. For items that are not sold separately, the Company estimates stand-alone selling prices by reference to the amount charged for similar items on a stand-alone basis.

The Company sells products and services predominantly through its direct sales force. As a result, the use of distributors is generally limited to geographic regions where the Company has no direct sales force. The Company does not offer product return or exchange rights (other than those relating to defective goods under warranty) or price protection allowances to its customers, including distributors. Payment terms granted to distributors are the same as those granted to end-customers and payments are not dependent upon the distributor's receipt of payment from their end-user customers.

In instances where the timing of revenue recognition differs from the timing of invoicing, the Company determined that the contracts generally do not include a significant financing component. The primary purpose of its invoicing terms is to provide customers with simplified and predictable ways of purchasing products and services, rather than to receive financing from the customers or to provide customers with financing. Examples include invoicing at the beginning of a subscription term with revenue recognized ratably over the contract period, and multi-year software licenses or software subscriptions that are invoiced annually with revenue recognized upfront. In limited circumstances where the Company provides the customer with a significant benefit of financing, the Company uses the practical expedient and only adjusts the transaction price for the effects of the time value of money and only on contracts where the duration of financing is more than one year.

Table of Contents



Products and services	Nature, timing of satisfaction of performance obligations, and significant payment terms

Instruments	For instruments that include installation, and if the installation meets the criteria to be considered a separate performance obligation, product revenue is generally recognized upon delivery or when title has transferred to the customer, which is generally the point in time where control of the products has been transferred to customers, and installation revenue is recognized when the installation is complete. Certain of the Company's products require specialized installation and configuration at the customer's site. Revenue for these products is deferred until installation is complete and customer acceptance has been received. Payment terms and conditions vary, although terms generally include a requirement of payment within 30 to 60 days.
Consumables and reagents	The Company recognizes revenue from the sale of consumables and reagents upon delivery or when title has transferred to the customer, which is generally the point in time where control of the products has been transferred to customers. Payment terms and conditions vary, although terms generally include a requirement of payment within 30 days.
Software licenses and subscriptions	Customers may purchase perpetual or term licenses, or subscribe to licenses, which provide customers with the same functionality and differ mainly in the duration over which the customer benefits from the software. The Company sells its software subscriptions or software licenses with maintenance services and, in some cases, with consulting services. The Company recognizes revenue for the software upfront at the point in time when the software is made available to the customer. For maintenance and consulting services, revenue is recognized ratably over the period in which the services are provided. Payment terms and conditions vary by contract type, although terms generally include a requirement of payment within 30 to 60 days. Software subscriptions and maintenance service contracts are non-cancelable.
Cloud services	Cloud services, which allow customers to use hosted software over the contract period without taking possession of the software, are provided on either a subscription or consumption basis. Revenue related to cloud services provided on a subscription basis is recognized ratably over the contract period. Revenue related to cloud services provided on a consumption basis, such as the amount of storage used in a period, is recognized based on the customer utilization of such resources. Payment terms are generally net 30 days from signing of contract and contracts are non-cancelable.
Extended warranty	The Company recognizes revenue for extended warranties on a straight-line basis over the extended warranty period in service revenue. In the majority of countries in which the Company operates, the customary warranty period is one year and the extended warranty covers periods beyond year one. Customers typically pay for extended warranties on an annual basis over the term of the warranty. In general, customers can cancel the extended warranty at any time with 30 days notice without significant penalty.
Laboratory services and training	The Company's service offerings include service contracts, field service, including related time and materials, and training. The Company recognizes revenue as the services are performed. Revenue for the service contracts is recognized over the contract period or at a point in time when the service is billable based on time and materials. The Company recognizes revenue as training is provided in service revenue. Payment terms and conditions vary by contract type, although terms generally include a requirement of payment within 30 to 60 days. In general, customers can cancel the service contracts at any time with 30 to 90 days notice without significant penalty.

Table of Contents

ii. Diagnostics

The Diagnostics segment of the Company principally generates revenue from sales of instruments, solutions, consumables, reagents, extended warranty and services in the diagnostics market. Products and services may be sold separately or in bundled packages.

In instances where the timing of revenue recognition differs from the timing of invoicing, the Company determined that the contracts generally do not include a significant financing component. The primary purpose of its invoicing terms is to provide customers with simplified and predictable ways of purchasing products and services, rather than to receive financing from the customers or to provide customers with financing. Examples include invoicing at the beginning of a storage period with revenue recognized ratably over the contract period. In limited circumstances where the Company provides the customer with a significant benefit of financing, the Company uses the practical expedient and only adjusts the transaction price for the effects of the time value of money and only on contracts where the duration of financing is more than one year.

Table of Contents



Products and services	Nature, timing of satisfaction of performance obligations, and significant payment terms

Instruments	For instruments that include installation, and if the installation meets the criteria to be considered a separate performance obligation, product revenue is generally recognized upon delivery or when title has transferred to the customer, which is generally the point in time where control of the products has been transferred to customers, and installation revenue is recognized when the installation is complete. Certain of the Company's products require specialized installation and configuration at the customer's site. Revenue for these products is deferred until installation is complete and customer acceptance has been received. Payment terms and conditions vary, although terms generally include a requirement of payment within 30 to 60 days.
Consumables and reagents	The Company recognizes revenue from the sale of consumables and reagents upon delivery or when title has transferred to the customer, which is generally the point in time where control of the products has been transferred to customers. Payment terms and conditions vary, although terms generally include a requirement of payment within 30 days.
Solutions	When the Company sells the instrument and reagents that work only on those instruments to a customer or distributor, the Company considers the instrument and reagents as separate performance obligations. The Company recognizes revenue when an instrument is sold to the customer upon delivery or when title has transferred to the customer, which is generally the point in time where control of the products has been transferred to customers. Revenue from the sale of reagents is also recognized at the time of delivery or when title has transferred to the customer. Payment terms for instrument and reagent sales are usually net 30 days from invoice date. When the Company places the instrument at the customer's site and sells the reagents to a customer, the instrument and reagents are accounted for together as one performance obligation. The Company does not charge a fee for the use of the instrument and retains ownership of the placed instrument. The Company has a right to remove the instrument and replace it with another instrument at the customer's site at any time throughout the contract term. The Company recognizes revenue upon delivery of reagents, which is the point in time where the Company has performed its obligation to provide a screening solution to the customer. Payment terms are usually net 30 days from invoice date. Payment terms for certain contracts are based on equal installments over the duration of the contract.
Extended warranty	The Company recognizes revenue for extended warranties on a straight-line basis over the extended warranty period in service revenue. In the majority of countries in which the Company operates, the customary warranty period is one year and the extended warranty covers periods beyond year one. Customers typically pay for extended warranties on an annual basis over the term of the warranty. In general, customers can cancel the extended warranty at any time with 30 days notice without significant penalty.
Services	The Company's service offerings include cord blood processing and storage, and training. The Company recognizes revenue for the cord blood processing and training as the services are performed in service revenue. Revenue for the storage contracts are recognized over the contract period. Storage is typically for a period of 1, 20, or 25 years or lifetime. Lifetime storage is recognized over a certain period that is based on the life expectancy estimate from Social Security data. For cord blood processing, customers pay the processing fee in full at the point of sale. The processing fee is non-refundable unless the cord blood is non-viable for storage. For storage, customers are required to pay the storage fees in full upfront. Storage fees are refundable to the customer on a pro-rated basis if the contract is canceled.

Table of Contents

Disaggregation of revenue

In the following tables, revenue is disaggregated by primary geographical market, end-markets and timing of revenue recognition. The tables also include a reconciliation of the disaggregated revenue with the reportable segments revenue.



	Reportable Segments
	Three Months Ended
	September 30, 2018
	Discovery & Analytical Solutions		Diagnostics		Total
	(In thousands)
Primary geographical markets
Americas	$	169,366	$	95,607	$	264,973
Europe	110,747		68,480		179,227
Asia	126,053		104,060		230,113
	$	406,166	$	268,147	$	674,313

Primary end-markets
Diagnostics	$	—	$	268,147	$	268,147
Life sciences	222,191		—		222,191
Applied markets	183,975		—		183,975
	$	406,166	$	268,147	$	674,313

Timing of revenue recognition
Products and services transferred at a point in time	$	290,929	$	247,189	$	538,118
Services transferred over time	115,237		20,958		136,195
	$	406,166	$	268,147	$	674,313



	Reportable Segments
	Nine Months Ended
	September 30, 2018
	Discovery & Analytical Solutions		Diagnostics		Total
	(In thousands)
Primary geographical markets
Americas	$	497,833	$	282,536	$	780,369
Europe	357,766		205,892		563,658
Asia	377,720		299,900		677,620
	$	1,233,319	$	788,328	$	2,021,647

Primary end-markets
Diagnostics	$	—	$	788,328	$	788,328
Life sciences	675,807		—		675,807
Applied markets	557,512		—		557,512
	$	1,233,319	$	788,328	$	2,021,647

Timing of revenue recognition
Products and services transferred at a point in time	$	874,517	$	726,058	$	1,600,575
Services transferred over time	358,802		62,270		421,072
	$	1,233,319	$	788,328	$	2,021,647

Contract Balances

Table of Contents

customers. Contracts assets are generally classified as current assets and are included in "Accounts receivable, net" in the consolidated balance sheet. The balance of contract assets as of September 30, 2018 and as of the date of adoption of ASC 606 were $31.2 million and $22.7 million, respectively. The amount of unbilled receivables recognized at the beginning of the period that were transferred to trade receivables during the nine months ended September 30, 2018 was $21.1 million. The increase in unbilled receivables during the nine months ended September 30, 2018 as a result of recognition of revenue before billing to customers, excluding amounts transferred to trade receivables during the period, amounted to $29.5 million.

Contract liabilities: The contract liabilities primarily relate to the advance consideration received from customers for products and related installation for which transfer of control has not occurred at the balance sheet date. Contract liabilities are classified as either current in "Accounts payable" or long-term in "Long-term liabilities" in the consolidated balance sheet based on the timing of when the Company expects to recognize revenue. The balance of contract liabilities as of September 30, 2018 and as of the date of adoption of ASC 606 were $26.3 million and $29.0 million, respectively. The increase in contract liabilities during the nine months ended September 30, 2018 due to cash received, excluding amounts recognized as revenue during the period, was $17.6 million. The amount of revenue recognized during the nine months ended September 30, 2018 that was included in the contract liability balance at the beginning of the period was $20.4 million.

Contract costs: The Company recognizes the incremental costs of obtaining a contract with a customer as an asset if it expects the benefit of those costs to be longer than one year. The Company determined that certain sales incentive programs meet the requirements to be capitalized. Total capitalized costs to obtain a contract were immaterial during the period and are included in other current and long-term assets on the condensed consolidated balance sheet. The Company applies a practical expedient to expense costs as incurred for costs to obtain a contract with a customer when the amortization period would have been one year or less. These costs include the Company's internal sales force compensation program, as the Company determined that annual compensation is commensurate with annual sales activities.

Transaction price allocated to the remaining performance obligations

The Company applies the practical expedient in ASC 606-10-50-14 and does not disclose information about remaining performance obligations that have original expected durations of one year or less. The estimated revenue expected to be recognized beyond one year in the future related to performance obligations that are unsatisfied (or partially unsatisfied) at the end of the period are not material to the Company. Remaining performance obligations primarily include noncancelable purchase orders and noncancelable software subscriptions and cloud service contracts.

Note 3: Changes in Accounting Policies

Except for the changes below, the Company has consistently applied the accounting policies to all periods presented in these condensed consolidated financial statements.

The Company adopted ASC 606, Revenue from Contracts with Customers ("ASC 606"), with a date of the initial application of January 1, 2018. As a result, the Company has changed its accounting policy for revenue recognition as detailed below.

The Company applied ASC 606 using the modified retrospective method only to contracts that are not completed contracts as of January 1, 2018, and the cumulative effect of initially applying ASC 606 is recognized as an adjustment to the beginning retained earnings. Therefore, the comparative information has not been adjusted and continues to be reported under ASC 605. The details of the significant changes and quantitative impact of the changes are disclosed below.

A. Sales of software subscriptions or sales of licenses and maintenance in bundled arrangements

The Company previously recognized revenue from software licenses sold together with maintenance and/or consulting services upon shipment using the residual method, provided that the undelivered items in the arrangement have value to the customer on a stand-alone basis and vendor-specific objective evidence ("VSOE") of fair value can be determined. If VSOE of fair value for the undelivered elements cannot be established, the Company deferred all revenue from the arrangement until the earlier of the point at which such sufficient VSOE does exist or all elements of the arrangement have been delivered, or if the undelivered element is maintenance, then the Company recognized the entire fee ratably over the maintenance period. Under ASC 606, the total consideration in the contract is allocated to all products and services based on their stand-alone selling prices. The stand-alone selling prices are determined based on the list prices at which the Company sells the software license, software subscription, maintenance and/or consulting services. Accordingly, the Company now recognizes higher license revenue upfront and less service revenue over time.

B. Sales of instruments

Table of Contents

The Company previously recognized revenue from sale of instruments when persuasive evidence of an arrangement existed, delivery had occurred, the price to the buyer was fixed or determinable, and collectability was reasonably assured. For certain sales of instruments that included customer-specified acceptance criteria, the Company previously recognized revenue after the acceptance criteria had been met. Under ASC 606, revenue is recognized when the Company satisfies a performance obligation by transferring control of the product to a customer. Accordingly, the Company now recognizes product revenue upon delivery or when title has transferred to the customer, as the Company believes acceptance is perfunctory.

C. Sales commissions

The Company previously recognized commission fees related to sales of products and services as selling expenses when they were incurred. Under ASC 606, the Company capitalizes those commission fees as costs of obtaining a contract, when they are incremental and, if they are expected to be recovered, the Company amortizes them consistently with the pattern of transfer of the product or service to which the asset relates. If the expected amortization period is one year or less, the commission fee is expensed when incurred.

D. Impacts on financial statements

The following tables summarize the impacts of ASC 606 adoption on the Company's condensed consolidated financial statements for the quarter ended September 30, 2018.

Consolidated Balance Sheet



	As reported			Adjustments			Balances without adoption of ASC 606
	(In thousands)
Cash and cash equivalents	$	149,513		$	—		$	149,513
Accounts receivable, net	551,385			(11,554		)	539,831
Inventories	354,244			7,451			361,695
Other current assets	110,353			(522		)	109,831
Property, plant and equipment, net	317,049			—			317,049
Intangible assets, net	1,223,775			—			1,223,775
Goodwill	2,920,689			—			2,920,689
Other assets, net	235,347			—			235,347
Total assets	$	5,862,355		$	(4,625	)	$	5,857,730
Current portion of long-term debt	$	20,072		$	—		$	20,072
Accounts payable	180,693			—			180,693
Accrued restructuring and contract termination charges	8,079			—			8,079
Accrued expenses and other current liabilities	475,743			18,912			494,655
Current liabilities of discontinued operations	2,165			—			2,165
Long-term debt	1,882,502			—			1,882,502
Long-term liabilities	720,632			—			720,632
Total liabilities	3,289,886			18,912			3,308,798
Commitments and contingencies
Preferred stock	—			—			—
Common stock	111,087			—			111,087
Capital in excess of par value	89,970			—			89,970
Retained earnings	2,532,060			(23,537		)	2,508,523
Accumulated other comprehensive loss	(160,648		)	—			(160,648		)
Total stockholders’ equity	2,572,469			(23,537		)	2,548,932
Total liabilities and stockholders’ equity	$	5,862,355		$	(4,625	)	$	5,857,730

Table of Contents

Consolidated Statement of Operations



	Three Months Ended
	September 30, 2018
	As reported			Adjustments			Balances without adoption of ASC 606
	(In thousands)
Product revenue	$	474,523		$	(3,198	)	$	471,325
Service revenue	199,790			—			199,790
Total revenue	674,313			(3,198		)	671,115
Cost of product revenue	213,672			(98		)	213,574
Cost of service revenue	128,314			—			128,314
Total cost of revenue	341,986			(98		)	341,888
Selling, general and administrative expenses	196,769			47			196,816
Research and development expenses	48,848			—			48,848
Restructuring and contract termination charges, net	6,508			—			6,508
Operating income from continuing operations	80,202			(3,147		)	77,055
Interest and other expense, net	2,161			—			2,161
Income from continuing operations before income taxes	78,041			(3,147		)	74,894
Provision for income taxes	2,596			(814		)	1,782
Income from continuing operations	75,445			(2,333		)	73,112
Loss on disposition of discontinued operations before income taxes	(308		)	—			(308		)
Benefit from income taxes on discontinued operations and dispositions	(1,411		)	—			(1,411		)
Gain from discontinued operations and dispositions	1,103			—			1,103
Net income	$	76,548		$	(2,333	)	$	74,215

Table of Contents

Consolidated Statement of Operations



	Nine Months Ended
	September 30, 2018
	As reported			Adjustments			Balances without adoption of ASC 606
	(In thousands)
Product revenue	$	1,417,739		$	(25,562	)	$	1,392,177
Service revenue	603,908			—			603,908
Total revenue	2,021,647			(25,562		)	1,996,085
Cost of product revenue	663,651			(7,780		)	655,871
Cost of service revenue	393,307			—			393,307
Total cost of revenue	1,056,958			(7,780		)	1,049,178
Selling, general and administrative expenses	601,374			300			601,674
Research and development expenses	142,028			—			142,028
Restructuring and contract termination charges, net	13,086			—			13,086
Operating income from continuing operations	208,201			(18,082		)	190,119
Interest and other expense, net	29,947			—			29,947
Income from continuing operations before income taxes	178,254			(18,082		)	160,172
Provision for income taxes	12,101			(4,753		)	7,348
Income from continuing operations	166,153			(13,329		)	152,824
Loss on disposition of discontinued operations before income taxes	(859		)	—			(859		)
Benefit from income taxes on discontinued operations and dispositions	(1,341		)	—			(1,341		)
Gain from discontinued operations and dispositions	482			—			482
Net income	$	166,635		$	(13,329	)	$	153,306

The adoption of ASC 606 increased comprehensive income by $2.3 million and $13.3 million in the Company's condensed consolidated statement of comprehensive income for the three and nine months ended September 30, 2018, respectively. The adoption of ASC 606 had no impact on cash from or used in operating, investing, or financing activities in the Company's condensed consolidated statement of cash flows as of and for the nine months ended September 30, 2018.

Note 4: Business Combinations

Acquisitions in fiscal year 2018

During fiscal year 2018, the Company has completed the acquisition of three businesses for aggregate consideration of $55.4 million. The acquired businesses were Shanghai Spectrum Instruments Co., Ltd. ("SSI"), which was acquired for total consideration of $15.4 million in cash, RHS Limited ("RHS"), which was acquired for total consideration of $19.4 million in cash, and DNA Laboratories Sdn. Bhd. ("DNA Labs"), which was acquired for total consideration of $9.0 million in cash. The Company has an obligation to pay the former shareholders of SSI an additional consideration of $2.5 million in fiscal year 2019, which at closing had a present value of $2.4 million, and additional contingent consideration of up to $2.0 million, which at closing had an estimated fair value of $1.7 million. The Company has an obligation to pay the former shareholders of DNA Labs an additional cash consideration of $1.0 million and a working capital adjustment of up to $0.7 million in the fourth quarter of fiscal year 2018. The Company also has an obligation to pay the former shareholders of DNA Labs additional contingent consideration of up to $8.0 million, which at closing had an estimated fair value of $5.8 million. The excess of the purchase price over the fair value of the acquired businesses' net assets represents cost and revenue synergies specific to the Company, as well as non-capitalizable intangible assets, such as the employee workforce acquired, and has been allocated to goodwill, which is not tax deductible. The Company has reported the operations for SSI within the results of the Company's DAS segment and the other acquisitions within the results of the Company's Diagnostics segment from the acquisition dates. Identifiable definite-lived intangible assets, such as core technology, trade names and customer relationships, acquired as part of these acquisitions had a weighted average amortization period of 14.6 years.

Table of Contents

The total purchase price for the acquisitions in fiscal year 2018 has been allocated to the estimated fair values of assets acquired and liabilities assumed as follows:



	2018 Acquisitions
	(In thousands)
Fair value of business combination:
Cash payments	$	43,942
Other liability	3,354
Contingent consideration	7,500
Working capital and other adjustments	599
Less: cash acquired	(1,138		)
Total	$	54,257
Identifiable assets acquired and liabilities assumed:
Current assets	$	3,469
Property, plant and equipment	937
Other assets	430
Identifiable intangible assets:
Core technology	15,957
Trade names	1,010
Customer relationships	10,800
Goodwill	28,423
Deferred taxes	(2,524		)
Liabilities assumed	(4,037		)
Debt assumed	(208		)
Total	$	54,257

Subsequent to September 30, 2018, the Company completed the acquisition of Dani Analitica S.r.l. (“Dani”), a company based in Milan, Italy, for a total consideration of €43.1 million in cash, net of cash acquired, as of the closing date. The operations for this acquisition will be reported within the results of the Company's DAS segment from the acquisition date.

Acquisitions in fiscal year 2017

Acquisition of EUROIMMUN Medizinische Labordiagnostika AG. During fiscal year 2017, the Company completed the acquisition of 99.98% of the outstanding stock of EUROIMMUN Medizinische Labordiagnostika AG (“EUROIMMUN”) for aggregate consideration of €1.2 billion (equivalent to $1.4 billion at December 19, 2017, the time of closing). The purchase price was funded by borrowings from the Company's senior unsecured revolving credit facility and senior unsecured term loan credit facility of $710.0 million and $200.0 million, respectively, and available cash on hand of $503.8 million. EUROIMMUN is based in Lübeck, Germany, has approximately 2,400 employees, and is recognized as a global leader in autoimmune testing and an emerging force in infectious disease and allergy testing. The excess of the purchase price over the fair value of the acquired net assets represents cost and revenue synergies specific to the Company, as well as non-capitalizable intangible assets, such as the employee workforce acquired. As a result of the acquisition, the Company recorded goodwill of $581.2 million, which is not tax deductible, and intangible assets of $907.4 million. The Company has reported the operations for this acquisition within the results of the Company's Diagnostics segment from the acquisition date. Identifiable definite-lived intangible assets, such as core technology, trade names and customer relationships, acquired as part of this acquisition had a weighted average amortization period of 16.1 years.

Table of Contents

allocation shown below. The excess of the purchase prices over the fair values of the acquired businesses' net assets represents cost and revenue synergies specific to the Company, as well as non-capitalizable intangible assets, such as the employee workforces acquired, and has been allocated to goodwill, which is not tax deductible. The Company has reported the operations of Tulip within the results of the Company's Diagnostics segment and the other acquired business within the results of the Company's DAS segment from the acquisition date. Identifiable definite-lived intangible assets, such as core technology, trade names and customer relationships, acquired as part of these acquisitions had a weighted average amortization period of 11.8 years.

During the first quarter of fiscal year 2018, the Company paid the former shareholders of Tulip a portion of the additional consideration amounting to INR716.3 million (equivalent to $11.3 million). As of September 30, 2018, the Company may have to pay the former shareholders of Tulip additional consideration of up to INR803.6 million (currently equivalent to $11.1 million) in the first quarter of fiscal year 2019.

The total purchase price for the acquisitions in fiscal year 2017 has been allocated to the estimated fair values of assets acquired and liabilities assumed as follows:



	EUROIMMUN			Other Acquisitions
	(In thousands)
Fair value of business combination:
Cash payments	$	1,413,780		$	140,861
Other liability	—			1,273
Working capital and other adjustments	—			(93		)
Less: cash acquired	(25,018		)	(2,439		)
Total	$	1,388,762		$	139,602
Identifiable assets acquired and liabilities assumed:
Current assets	$	121,174		$	16,268
Property, plant and equipment	130,512			11,356
Other assets	49,679			1,691
Identifiable intangible assets:
Core technology	160,000			12,400
Trade names	36,000			3,000
Customer relationships	710,000			43,700
In-process research and development ("IPR&D")	1,400			—
Goodwill	581,172			75,250
Deferred taxes	(253,288		)	(15,735		)
Liabilities assumed	(86,530		)	(8,328		)
Debt assumed	(61,357		)	—
Total	$	1,388,762		$	139,602

EUROIMMUN's revenue and net loss for the period from the acquisition date to December 31, 2017 were $13.5 million and $1.0 million, respectively. The following unaudited pro forma information presents the combined financial results for the Company and EUROIMMUN as if the acquisition of EUROIMMUN had been completed at the beginning of fiscal year 2016:

Table of Contents



	Three Months Ended October 1, 2017		Nine Months Ended October 1, 2017
	(In thousands, except per share data)
Pro Forma Statement of Operations Information (Unaudited):
Revenue	$	640,154	$	1,846,233
Income from continuing operations	94,055		172,672
Basic earnings per share:
Income from continuing operations	$	0.86	$	1.57
Diluted earnings per share:
Income from continuing operations	$	0.85	$	1.56

The unaudited pro forma information for the three and nine months ended October 1, 2017 has been calculated after applying the Company's accounting policies and the impact of acquisition date fair value adjustments. These pro forma condensed consolidated financial results have been prepared for comparative purposes only and include certain adjustments, such as increased interest expense on debt obtained to finance the transaction and increased amortization for the acquired intangible assets recorded at fair value.

The pro forma information does not reflect the effect of costs or synergies that would have been expected to result from the integration of the acquisition. The pro forma information does not purport to be indicative of the results of operations that actually would have resulted had the combination occurred at the beginning of each period presented, or of future results of the consolidated entities.

The preliminary allocations of the purchase prices for acquisitions are based upon initial valuations. The Company's estimates and assumptions underlying the initial valuations are subject to the collection of information necessary to complete its valuations within the measurement periods, which are up to one year from the respective acquisition dates. The primary areas of the preliminary purchase price allocations that are not yet finalized relate to the fair value of certain tangible and intangible assets acquired and liabilities assumed, assets and liabilities related to income taxes and related valuation allowances, and residual goodwill. The Company expects to continue to obtain information to assist in determining the fair values of the net assets acquired at the acquisition dates during the measurement periods. During the measurement periods, the Company will adjust assets or liabilities if new information is obtained about facts and circumstances that existed as of the acquisition dates that, if known, would have resulted in the recognition of those assets and liabilities as of those dates. These adjustments will be made in the periods in which the amounts are determined and the cumulative effect of such adjustments will be calculated as if the adjustments had been completed as of the acquisition dates. All changes that do not qualify as adjustments made during the measurement periods are also included in current period earnings.

Allocations of the purchase price for acquisitions are based on estimates of the fair value of the net assets acquired and are subject to adjustment upon finalization of the purchase price allocations. The accounting for business combinations requires estimates and judgments as to expectations for future cash flows of the acquired business, and the allocation of those cash flows to identifiable intangible assets, in determining the estimated fair values for assets acquired and liabilities assumed. The fair values assigned to tangible and intangible assets acquired and liabilities assumed, including contingent consideration, are based on management’s estimates and assumptions, as well as other information compiled by management, including valuations that utilize customary valuation procedures and techniques. Contingent consideration is measured at fair value at the acquisition date, based on the probability that revenue thresholds or product development milestones will be achieved during the earnout period, with changes in the fair value after the acquisition date affecting earnings to the extent it is to be settled in cash. Increases or decreases in the fair value of contingent consideration liabilities primarily result from changes in the estimated probabilities of achieving revenue thresholds, changes in discount rates or product development milestones during the earnout period.

During the third quarter of fiscal year 2018, the Company obtained information relevant to determining the fair values of certain tangible and intangible assets acquired, and liabilities assumed, related to recent acquisitions and adjusted its purchase price allocation. Based on this information, for the EUROIMMUN acquisition, the Company recognized a decrease in deferred tax liabilities of $0.1 million, an increase in property and equipment of $0.5 million, a decrease in liabilities assumed of $1.2 million, a decrease in other assets of $0.3 million and a decrease in goodwill of $1.5 million during the third quarter of fiscal year 2018.

Table of Contents

obligations with an estimated fair value of $67.1 million, of which $61.3 million was recorded in accrued expenses and other current liabilities, and $5.8 million was recorded in long-term liabilities. As of December 31, 2017, the Company had recorded contingent consideration obligations with an estimated fair value of $65.3 million, of which $52.2 million was recorded in accrued expenses and other current liabilities, and $13.1 million was recorded in long-term liabilities. If the actual results differ from the estimates and judgments used in these fair values, the amounts recorded in the condensed consolidated financial statements could result in a possible impairment of the intangible assets and goodwill, require acceleration of the amortization expense of definite-lived intangible assets or the recognition of additional contingent consideration which would be recognized as a component of operating expenses from continuing operations.

Total acquisition and divestiture-related costs for the three and nine months ended September 30, 2018 were $1.7 million and $5.5 million, respectively. These amounts include $0.1 million and $1.0 million of net foreign exchange gain related to the foreign currency denominated stay bonus associated with the Tulip acquisition for the three and nine months ended September 30, 2018, respectively. Total acquisition and divestiture-related costs (income) for the three and nine months ended October 1, 2017 were $(30.8) million and $(30.1) million, respectively. These amounts include $36.3 million and $42.0 million of net foreign exchange gain related to the foreign currency forward contracts associated with the planned acquisition of EUROIMMUN for the three and nine months ended October 1, 2017, respectively. These acquisition and divestiture-related costs (income) were expensed as incurred and recorded in selling, general and administrative expenses and interest and other (income) expense, net in the Company's condensed consolidated statements of operations.

Note 5: Disposition of Businesses and Assets

As part of the Company’s continuing efforts to focus on higher growth opportunities, the Company has discontinued certain businesses. When the discontinued operations represented a strategic shift that will have a major effect on the Company's operations and financial statements, the Company has accounted for these businesses as discontinued operations and accordingly, has presented the results of operations and related cash flows as discontinued operations. Any business deemed to be a discontinued operation prior to the adoption of ASU 2014-08, Reporting Discontinued Operations and Disclosures of Disposals of Components of An Entity, continues to be reported as a discontinued operation, and the results of operations and related cash flows are presented as discontinued operations for all periods presented. Any remaining assets and liabilities of these businesses have been presented separately, and are reflected within assets and liabilities of discontinued operations in the accompanying condensed consolidated balance sheets as of September 30, 2018 and December 31, 2017.

During the third quarter of fiscal year 2018, the Company completed the sale of substantially all of the assets and liabilities related to its multispectral imaging business for aggregate consideration of $37.3 million, recognizing a pre-tax gain of $13.0 million. The pre-tax gain is included in interest and other expense, net in the consolidated statement of operations. The multispectral imaging business was a component of the Company's DAS segment. The divestiture of the multispectral imaging business has not been classified as a discontinued operation in this Form 10-Q because the disposition does not represent a strategic shift that will have a major effect on the Company's operations and financial statements.

On May 1, 2017 (the "Varex Closing Date"), the Company completed the sale of its Medical Imaging business to Varex Imaging Corporation ("Varex") pursuant to the terms of the Master Purchase and Sale Agreement, dated December 21, 2016 (the “Agreement”), by and between the Company and Varian Medical Systems, Inc. ("Varian") and the subsequent Assignment and Assumption Agreement, dated January 27, 2017, between Varian and Varex, pursuant to which Varian assigned its rights under the Agreement to Varex. On the Varex Closing Date, the Company received consideration of approximately $277.4 million for the sale of the Medical Imaging business. During fiscal year 2017, the Company paid Varex $4.2 million to settle a post-closing working capital adjustment. During fiscal year 2017, the Company recorded a pre-tax gain of $179.6 million and income tax expense of $43.1 million related to the sale of the Medical Imaging business in discontinued operations and dispositions. The corresponding tax liability was recorded within the other tax liabilities in the condensed consolidated balance sheet, and the Company expects to utilize tax attributes to minimize the tax liability. Following the closing, the Company provided certain customary transitional services during a period of up to 12 months. Commercial transactions between the parties following the closing of the transaction are not expected to be significant.

During fiscal year 2017, the Company sold Suzhou PerkinElmer Medical Laboratory Co., Ltd. for aggregate consideration of $2.3 million, recognizing a pre-tax loss of $1.1 million. The pre-tax loss recognized in fiscal year 2017 is included in interest and other expense, net in the consolidated statement of operations. Suzhou PerkinElmer Medical Laboratory Co., Ltd. was a component of the Company's Diagnostics segment. The divestiture of Suzhou PerkinElmer Medical Laboratory Co., Ltd. has not been classified as a discontinued operation in this Form 10-Q because the disposition does not represent a strategic shift that will have a major effect on the Company's operations and financial statements.

Table of Contents

The summary pre-tax operating results of the discontinued operations, were as follows for the three and nine months ended:



	Three Months Ended				Nine Months Ended
	September 30, 2018		October 1, 2017		September 30, 2018		October 1, 2017
	(In thousands)
Revenue	$	—	$	—	$	—	$	44,343
Cost of revenue	—		—		—		32,933
Selling, general and administrative expenses	—		—		—		5,869
Research and development expenses	—		—		—		4,891
(Loss) income from discontinued operations before income taxes	$	—	$	—	$	—	$	650

Note 6: Restructuring and Contract Termination Charges, Net

The Company has undertaken a series of restructuring actions related to the impact of acquisitions and divestitures, the alignment of the Company's operations with its growth strategy, the integration of its business units and its productivity initiatives. The current portion of restructuring and contract termination charges is recorded in accrued restructuring and contract termination charges and the long-term portion of restructuring and contract termination charges is recorded in long-term liabilities. The activities associated with these plans have been reported as restructuring and contract termination charges, net, as applicable, and are included as a component of income from continuing operations.

The Company implemented a restructuring plan in each of the first and third quarters of fiscal year 2018 consisting of workforce reductions principally intended to realign resources to emphasize growth initiatives (the "Q1 2018 Plan" and "Q3 2018 Plan", respectively). The Company implemented a restructuring plan in each of the fourth and third quarters of fiscal year 2017 consisting of workforce reductions principally intended to realign resources to emphasize growth initiatives (the "Q4 2017 Plan" and "Q3 2017 Plan", respectively). The Company implemented a restructuring plan in the first quarter of fiscal year 2017 consisting of workforce reductions and the closure of excess facility space principally intended to focus resources on higher growth end markets (the "Q1 2017 Plan"). Details of the plans initiated in previous years (the “Previous Plans”) are discussed more fully in Note 4 to the audited consolidated financial statements in the 2017 Form 10-K.

The following table summarizes the reductions in headcount, the initial restructuring or contract termination charges by reporting segment, and the dates by which payments were substantially completed, or the dates by which payments are expected to be substantially completed, for restructuring actions implemented during fiscal years 2018 and 2017 in continuing operations:



	Workforce Reductions					Closure of Excess Facility				Total		(Expected) Date Payments Substantially Completed by
	Headcount Reduction	Discovery & Analytical Solutions		Diagnostics		Discovery & Analytical Solutions		Diagnostics				Severance	Excess Facility
	Headcount Reduction	Discovery & Analytical Solutions		Diagnostics		Discovery & Analytical Solutions		Diagnostics				Severance	Excess Facility
	(In thousands, except headcount data)
Q3 2018 Plan	61	$	1,146	$	618	$	—	$	—	$	1,764	Q2 FY2019	—
Q1 2018 Plan	47	5,096		902		—		—		5,998		Q2 FY2019	—
Q4 2017 Plan	29	1,680		255		—		—		1,935		Q1 FY2019	—
Q3 2017 Plan	27	1,321		1,021		—		—		2,342		Q4 FY2018	—
Q1 2017 Plan	90	5,000		1,631		33		33		6,697		Q4 FY2018	Q4 FY2018

The Company does not currently expect to incur any future charges for these plans. The Company expects to make payments under the Previous Plans for remaining residual lease obligations, with terms varying in length, through fiscal year 2022.

In connection with the termination of various contractual commitments, the Company recorded additional pre-tax charges of $4.7 million and $5.0 million during the three and nine months ended September 30, 2018, respectively, in the DAS segment.

Table of Contents

At September 30, 2018, the Company had $9.4 million recorded for accrued restructuring and contract termination charges, of which $8.1 million was recorded in short-term accrued restructuring and contract termination charges and $1.3 million was recorded in long-term liabilities. At December 31, 2017, the Company had $14.0 million recorded for accrued restructuring and contract termination charges, of which $8.8 million was recorded in short-term accrued restructuring and contract termination charges, $2.3 million was recorded in long-term liabilities and $2.9 million was recorded in other reserves. The following table summarizes the Company's restructuring and contract termination accrual balances and related activity by restructuring plan, as well as contract termination accrual balances and related activity, during the nine months ended September 30, 2018:



	Balance at December 31, 2017		2018 Charges		2018 Changes in Estimates, Net		2018 Amounts Paid			Balance at September 30, 2018
	(In thousands)
Severance:
Q3 2018 Plan	$	—	$	1,764	$	—	$	—		$	1,764
Q1 2018 Plan	—		5,998		—		(4,273		)	1,725
Q4 2017 Plan	1,919		—		—		(1,538		)	381
Q3 2017 Plan	2,072		—		—		(868		)	1,204
Q1 2017 Plan	2,498		—		—		(1,174		)	1,324

Facility:
Q1 2017 Plan	33		—		—		(22		)	11

Previous Plans	4,399		—		353		(2,106		)	2,646
Restructuring	10,921		7,762		353		(9,981		)	9,055
Contract Termination	3,048		4,744		227		(7,653		)	366
Total Restructuring and Contract Termination	$	13,969	$	12,506	$	580	$	(17,634	)	$	9,421

Note 7: Interest and Other Expense, Net

Interest and other expense, net, consisted of the following:



	Three Months Ended						Nine Months Ended
	September 30, 2018			October 1, 2017			September 30, 2018			October 1, 2017
	(In thousands)
Interest income	$	(316	)	$	(802	)	$	(754	)	$	(1,512	)
Interest expense	16,684			10,974			50,745			32,510
(Gain) loss on disposition of businesses and assets, net (see Note 5)	(13,031		)	—			(13,031		)	301
Other income, net	(1,176		)	(37,188		)	(7,013		)	(45,096		)
Total interest and other expense (income), net	$	2,161		$	(27,016	)	$	29,947		$	(13,797	)

Foreign currency transaction losses (gains) were $4.3 million and $(8.8) million for the three and nine months ended September 30, 2018, respectively. Foreign currency transaction gains were $2.7 million and $5.4 million for the three and nine months ended October 1, 2017, respectively. Net (gains) losses from forward currency hedge contracts were $(2.5) million and $9.8 million for the three and nine months ended September 30, 2018, respectively. Net gains from forward currency hedge contracts were $32.7 million and $34.4 million for the three and nine months ended October 1, 2017, respectively. The other components of net periodic pension credit were $2.5 million and $7.5 million for the three and nine months ended September 30, 2018, respectively. The other components of net periodic pension credit were $1.8 million and $5.4 million for the three and nine months ended October 1, 2017, respectively. These amounts were included in other income, net.

Table of Contents

Note 8: Inventories

Inventories as of September 30, 2018 and December 31, 2017 consisted of the following:



	September 30, 2018		December 31, 2017
	(In thousands)
Raw materials	$	117,266	$	122,100
Work in progress	21,389		18,452
Finished goods	215,589		211,123
Total inventories	$	354,244	$	351,675

Note 9: Income Taxes

The Company regularly reviews its tax positions in each significant taxing jurisdiction in the process of evaluating its unrecognized tax benefits. The Company makes adjustments to its unrecognized tax benefits when: (i) facts and circumstances regarding a tax position change, causing a change in management’s judgment regarding that tax position; (ii) a tax position is effectively settled with a tax authority at a differing amount; and/or (iii) the statute of limitations expires regarding a tax position.

The total provision for income taxes included in the condensed consolidated statement of operations consisted of the following:



	Three Months Ended					Nine Months Ended
	September 30, 2018			October 1, 2017		September 30, 2018			October 1, 2017
	(In thousands)
Continuing operations	$	2,596		$	8,508	$	12,101		$	20,495
Discontinued operations	(1,411		)	5,262		(1,341		)	42,405
Total	$	1,185		$	13,770	$	10,760		$	62,900

At September 30, 2018, the Company had gross tax effected unrecognized tax benefits of $30.5 million, of which $28.8 million, if recognized, would affect the continuing operations effective tax rate. The remaining amount, if recognized, would affect discontinued operations.

The Company believes that it is reasonably possible that approximately $6.4 million of its uncertain tax positions at September 30, 2018, including accrued interest and penalties, and net of tax benefits, may be resolved over the next twelve months as a result of lapses in applicable statutes of limitations and potential settlements. Various tax years after 2010 remain open to examination by certain jurisdictions in which the Company has significant business operations, such as Finland, Germany, Italy, Netherlands, Singapore, the United Kingdom and the United States. The tax years under examination vary by jurisdiction.

Table of Contents

During the first nine months of fiscal years 2018 and 2017, the Company recorded net discrete income tax benefits of $7.1 million and $7.0 million, respectively. The discrete tax benefits in the first nine months of fiscal year 2018 include recognition of excess tax benefits on stock compensation of $5.4 million and tax benefits from the change in tax reform estimates of $5.4 million, offset by the tax expense of $7.1 million related to the sale of the multispectral imaging business. In the first nine months of 2017, discrete tax benefits include recognition of $3.6 million of excess tax benefits on stock compensation.

On December 22, 2017, the President of the United States signed the Tax Act, which makes broad and complex changes to the U.S. Internal Revenue Code. Changes include, but are not limited to: (1) the lowering of the U.S. corporate tax rate from 35% to 21%; (2) the transition of U.S. international taxation from a worldwide tax system to a modified territorial system with a one-time transition tax on the deemed repatriation of cumulative foreign earnings as of December 31, 2017; (3) a new provision designed to tax global intangible low-taxed income (GILTI); (4) the creation of the base erosion anti-abuse tax (BEAT), which is effectively a new minimum tax; (5) the deduction for foreign-derived intangible income (FDII); (6) a new limitation on deductible interest expense; (7) the repeal of the domestic production activity deduction; and (8) limitations on the deductibility of certain executive compensation.

The Company is applying the guidance in ASU 2018-05 (see Note 1, Basis of Presentation) when accounting for the enactment date effects of the Tax Act. At September 30, 2018, the Company has not completed the accounting for all of the tax effects of the Tax Act; however, it has made a reasonable estimate of their effects based on currently available information. As described below, the Company has made changes to certain aspects of the provision for the Tax Act. Management will continue to refine the calculations as additional guidance is available. These estimates may be affected as additional clarification and implementation guidance becomes available. These changes could be material to income tax expense.

Remeasurement: The Company remeasured its future tax benefits and liabilities at the enacted tax rate of 21% and provided a provisional amount of $21.5 million during fiscal year 2017. During the three and nine months ended September 30, 2018, the Company recognized a tax benefit of $1.8 million and $0.3 million, respectively, for the remeasurement of certain future tax liabilities and included these adjustments as a component of the provision for income tax from continuing operations.

One-Time Transition Tax: The Tax Act requires the Company to pay a one-time transition tax on the unremitted earnings of foreign subsidiaries. Based on available information, the Company estimated the tax on the deemed repatriation of foreign earnings and has recorded a tax expense of $85.0 million in continuing operations at December 31, 2017. During the three months ended September 30, 2018, the Company refined its calculations of the one-time transition tax based on newly issued guidance from the Internal Revenue Service and recorded a tax benefit of $5.1 million in continuing operations.

GILTI, FDII, and other provisions: For fiscal year beginning in 2018, the Company is subject to several provisions of the Tax Act including computations under GILTI, FDII, and other provisions. Management has made a reasonable estimate of the impact of each provision of the Tax Act on the Company's effective tax rate for the nine months ended September 30, 2018. Management will continue to refine the provisional estimates for the computations of the GILTI, FDII, and other provisions as additional clarification and implementation guidance becomes available.

Under U.S. GAAP, the Company is allowed to set an accounting policy on GILTI. The choice is either to (1) treat taxes due on future U.S. inclusions in taxable income related to GILTI as a current-period expense when incurred (the “period cost method”), or (2) factor such amounts into the measurement of deferred taxes (the “deferred method”). At September 30, 2018, the Company is still evaluating the GILTI provisions and the analysis of future taxable income that is subject to GILTI, thus, the Company has not recorded any potential deferred tax effects related to the GILTI in the financial statements and has not made a policy decision regarding whether to record deferred taxes on GILTI or use the period cost method.

Note 10: Debt

Senior Unsecured Revolving Credit Facility. The Company's senior unsecured revolving credit facility provides for $1.0 billion of revolving loans and has an initial maturity of August 11, 2021. As of September 30, 2018, undrawn letters of credit in the aggregate amount of $11.4 million were treated as issued and outstanding when calculating the borrowing availability under the senior unsecured revolving credit facility. As of September 30, 2018, the Company had $577.6 million available for additional borrowing under the facility. The Company uses the senior unsecured revolving credit facility for general corporate purposes, which may include working capital, refinancing existing indebtedness, capital expenditures, share repurchases, acquisitions and strategic alliances. The interest rates under the senior unsecured revolving credit facility are based on the Eurocurrency rate or the base rate at the time of borrowing, plus a margin. The base rate is the higher of (i) the rate of interest in effect for such day as publicly announced from time to time by JP Morgan Chase Bank, N.A. as its "prime rate," (ii) the Federal Funds rate plus 50 basis points or (iii) an adjusted one-month Libor plus 1.00%. The Eurocurrency margin as of

Table of Contents

September 30, 2018 was 110 basis points. The weighted average Eurocurrency interest rate as of September 30, 2018 was 2.19%, resulting in a weighted average effective Eurocurrency rate, including the margin, of 3.29%, which was the interest applicable to the borrowings outstanding under the Eurocurrency rate as of September 30, 2018. As of September 30, 2018, the senior unsecured revolving credit facility had outstanding borrowings of $411.0 million, and $2.6 million of unamortized debt issuance costs. As of December 31, 2017, the senior unsecured revolving credit facility had outstanding borrowings of $625.0 million, and $3.3 million of unamortized debt issuance costs. The credit agreement for the facility contains affirmative, negative and financial covenants and events of default. The financial covenants include a debt-to-capital ratio that remains applicable for so long as the Company's debt is rated as investment grade. In the event that the Company's debt is not rated as investment grade, the debt-to-capital ratio covenant is replaced with a maximum consolidated leverage ratio covenant and a minimum consolidated interest coverage ratio covenant.

Senior Unsecured Term Loan Credit Facility. The Company entered into a senior unsecured term loan credit facility on August 11, 2017 that provided for $200.0 million of term loans and had an initial maturity of twelve months from December 19, 2017, the date of the initial draw. The Company utilized the senior unsecured term loan facility for the acquisition of EUROIMMUN. The interest rates under the senior unsecured term loan credit facility were based on the Eurocurrency rate or the base rate at the time of the borrowing, plus a margin. The base rate is the higher of (i) the rate of interest in effect for such day as publicly announced from time to time by JP Morgan Chase Bank, N.A. as its "prime rate," (ii) the Federal Funds rate plus 50 basis points or (iii) an adjusted one-month Libor plus 1.00%. In April 2018, the Company paid in full the outstanding balance of $200.0 million on the Company’s senior unsecured term loan credit facility, from the proceeds of the 0.6% senior unsecured notes due in 2021 that were issued in April 2018.

5% Senior Unsecured Notes due in 2021. On October 25, 2011, the Company issued $500.0 million aggregate principal amount of senior unsecured notes due in 2021 (the “November 2021 Notes”) in a registered public offering and received $493.6 million of net proceeds from the issuance. The November 2021 Notes were issued at 99.4% of the principal amount, which resulted in a discount of $3.1 million. As of September 30, 2018, the November 2021 Notes had an aggregate carrying value of $497.2 million, net of $1.2 million of unamortized original issue discount and $1.7 million of unamortized debt issuance costs. As of December 31, 2017, the November 2021 Notes had an aggregate carrying value of $496.6 million, net of $1.4 million of unamortized original issue discount and $2.0 million of unamortized debt issuance costs. The November 2021 Notes mature in November 2021 and bear interest at an annual rate of 5%. Interest on the November 2021 Notes is payable semi-annually on May 15th and November 15th each year. Prior to August 15, 2021 (three months prior to their maturity date), the Company may redeem the November 2021 Notes in whole or in part, at its option, at a redemption price equal to the greater of (i) 100% of the principal amount of the November 2021 Notes to be redeemed, plus accrued and unpaid interest, or (ii) the sum of the present values of the remaining scheduled payments of principal and interest in respect to the November 2021 Notes being redeemed, discounted on a semi-annual basis, at the Treasury Rate plus 45 basis points, plus accrued and unpaid interest. At any time on or after August 15, 2021 (three months prior to their maturity date), the Company may redeem the November 2021 Notes, at its option, at a redemption price equal to 100% of the principal amount of the November 2021 Notes to be redeemed plus accrued and unpaid interest. Upon a change of control (as defined in the indenture governing the November 2021 Notes) and a contemporaneous downgrade of the November 2021 Notes below investment grade, each holder of November 2021 Notes will have the right to require the Company to repurchase such holder's November 2021 Notes for 101% of their principal amount, plus accrued and unpaid interest.

1.875% Senior Unsecured Notes due 2026. On July 19, 2016, the Company issued €500.0 million aggregate principal amount of senior unsecured notes due in 2026 (the “2026 Notes”) in a registered public offering and received approximately €492.3 million of net proceeds from the issuance. The 2026 Notes were issued at 99.118% of the principal amount, which resulted in a discount of €4.4 million. The 2026 Notes mature in July 2026 and bear interest at an annual rate of 1.875%. Interest on the 2026 Notes is payable annually on July 19th each year. The proceeds from the 2026 Notes were used to pay in full the outstanding balance of the Company's previous senior unsecured revolving credit facility. As of September 30, 2018, the 2026 Notes had an aggregate carrying value of $572.3 million, net of $4.2 million of unamortized original issue discount and $3.9 million of unamortized debt issuance costs. As of December 31, 2017, the 2026 Notes had an aggregate carrying value of $591.7 million, net of $4.7 million of unamortized original issue discount and $4.3 million of unamortized debt issuance costs.

Prior to April 19, 2026 (three months prior to their maturity date), the Company may redeem the 2026 Notes in whole at any time or in part from time to time, at its option, at a redemption price equal to the greater of (i) 100% of the principal amount of the 2026 Notes to be redeemed, or (ii) the sum of the present values of the remaining scheduled payments of principal and interest in respect to the 2026 Notes being redeemed, discounted on an annual basis, at the applicable Comparable Government Bond Rate (as defined in the indenture governing the 2026 Notes) plus 35 basis points; plus, in each case, accrued and unpaid interest. In addition, at any time on or after April 19, 2026 (three months prior to their maturity date), the Company may redeem the 2026 Notes, at its option, at a redemption price equal to 100% of the principal amount of the 2026 Notes due to be redeemed plus accrued and unpaid interest.

Table of Contents

Upon a change of control (as defined in the indenture governing the 2026 Notes) and a contemporaneous downgrade of the 2026 Notes below investment grade, the Company will, in certain circumstances, make an offer to purchase the 2026 Notes at a price equal to 101% of their principal amount plus any accrued and unpaid interest.

0.6% Senior Unsecured Notes due in 2021. On April 11, 2018, the Company issued €300.0 million aggregate principal amount of senior unsecured notes due in 2021 (the “April 2021 Notes”) in a registered public offering and received approximately €298.7 million of net proceeds from the issuance. The April 2021 Notes were issued at 99.95% of the principal amount, which resulted in a discount of €0.2 million. As of September 30, 2018, the April 2021 Notes had an aggregate carrying value of $345.8 million, net of $0.2 million of unamortized original issue discount and $2.3 million of unamortized debt issuance costs. The April 2021 Notes mature in April 2021 and bear interest at an annual rate of 0.6%. Interest on the April 2021 Notes is payable annually on April 9th each year. The proceeds from the April 2021 Notes were used to pay in full the outstanding balance of the Company’s senior unsecured term loan credit facility, and a portion of the outstanding senior unsecured revolving credit facility, and in each case the borrowings were incurred to pay a portion of the purchase price for the Company's acquisition of EUROIMMUN, which closed in December 19, 2017. Prior to the maturity date of the April 2021 Notes, the Company may redeem them in whole at any time or in part from time to time, at its option, at a redemption price equal to the greater of (i) 100% of the principal amount of the April 2021 Notes to be redeemed, or (ii) the sum of the present values of the remaining scheduled payments of principal and interest in respect to the April 2021 Notes being redeemed, discounted on an annual basis, at the applicable Comparable Government Bond Rate (as defined in the indenture governing the April 2021 Notes) plus 15 basis points; plus, in each case, accrued and unpaid interest. Upon a change of control (as defined in the indenture governing the April 2021 Notes) and a contemporaneous downgrade of the April 2021 Notes below investment grade, the Company will, in certain circumstances, make an offer to purchase the April 2021 Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest.

Other Debt Facilities. The Company's other debt facilities include Euro-denominated bank loans with an aggregate carrying value of $35.3 million (or €30.4 million) and $57.2 million (or €47.6 million) as of September 30, 2018 and December 31, 2017, respectively. These bank loans are primarily utilized for financing fixed assets and are repaid in monthly or quarterly installments with maturity dates extending to 2031. Of these bank loans, loans in the aggregate amount of $35.1 million bear fixed interest rates between 1.1% and 5.5% and a loan in the amount of $0.2 million bears a variable interest rate based on the Euribor rate plus a margin of 1.5%. An aggregate amount of $5.4 million of the bank loans are secured by mortgages on real property and the remaining $29.9 million are unsecured. Certain credit agreements for the unsecured bank loans include financial covenants which are based on an equity ratio or an equity ratio and minimum interest coverage ratio.

In addition, the Company has other unsecured revolving credit facilities and a secured bank loan in the amount of $8.1 million and $0.2 million, respectively, as of September 30, 2018. The unsecured revolving debt facilities bear fixed interest rates between 0.05% and 2.30%. The secured bank loan of $0.2 million bears a fixed annual interest rate of 1.95% and is repaid in monthly installments until 2027.

Financing Lease Obligations. In fiscal year 2012, the Company entered into agreements with the lessors of certain buildings that the Company is currently occupying and leasing to expand those buildings. The Company provided a portion of the funds needed for the construction of the additions to the buildings, and as a result the Company was considered the owner of the buildings during the construction period. At the end of the construction period, the Company was not reimbursed by the lessors for all of the construction costs. The Company is therefore deemed to have continuing involvement and the leases qualify as financing leases under sale-leaseback accounting guidance, representing debt obligations for the Company and non-cash investing and financing activities. As a result, the Company capitalized $29.3 million in property, plant and equipment, net, representing the fair value of the buildings with a corresponding increase to debt. The Company has also capitalized $11.5 million in additional construction costs necessary to complete the renovations to the buildings, which were funded by the lessors, with a corresponding increase to debt. At September 30, 2018, the Company had $34.9 million recorded for these financing lease obligations, of which $1.5 million was recorded as short-term debt and $33.4 million was recorded as long-term debt. At December 31, 2017, the Company had $35.9 million recorded for these financing lease obligations, of which $1.4 million was recorded as short-term debt and $34.5 million was recorded as long-term debt. The buildings are being depreciated on a straight-line basis over the terms of the leases to their estimated residual values, which will equal the remaining financing obligation at the end of the lease term. At the end of the lease term, the remaining balances in property, plant and equipment, net and debt will be reversed against each other.

Note 11: Earnings Per Share

Table of Contents

primarily shares issuable upon the exercise of stock options using the treasury stock method. The following table reconciles the number of shares utilized in the earnings per share calculations:



	Three Months Ended		Nine Months Ended
	September 30, 2018	October 1, 2017	September 30, 2018	October 1, 2017
	(In thousands)
Number of common shares—basic	110,724	110,003	110,499	109,788
Effect of dilutive securities:
Stock options	791	735	813	669
Restricted stock awards	232	255	198	196
Number of common shares—diluted	111,747	110,993	111,510	110,653
Number of potentially dilutive securities excluded from calculation due to antidilutive impact	358	14	346	377

Antidilutive securities include outstanding stock options with exercise prices and average unrecognized compensation cost in excess of the average fair market value of common stock for the related period. Antidilutive options were excluded from the calculation of diluted net income per share and could become dilutive in the future.

Note 12: Industry Segment Information

The Company discloses information about its operating segments based on the way that management organizes the segments within the Company for making operating decisions and assessing financial performance. The Company evaluates the performance of its operating segments based on revenue and operating income. Intersegment revenue and transfers are not significant. The accounting policies of the operating segments are the same as those described in Note 1 to the audited consolidated financial statements in the 2017 Form 10-K.

The principal products and services of the Company's two operating segments are:


•	Discovery & Analytical Solutions. Provides products and services targeted towards the life sciences and applied markets.


•	Diagnostics. Develops diagnostics, tools and applications focused on clinically-oriented customers, especially within the reproductive health, emerging market diagnostics and applied genomics markets. The Diagnostics segment serves the diagnostics market.

The Company has included the expenses for its corporate headquarters, such as legal, tax, audit, human resources, information technology, and other management and compliance costs, as well as the activity related to the mark-to-market adjustment on postretirement benefit plans, as “Corporate” below. The Company has a process to allocate and recharge expenses to the reportable segments when these costs are administered or paid by the corporate headquarters based on the extent to which the segment benefited from the expenses. These amounts have been calculated in a consistent manner and are included in the Company’s calculations of segment results to internally plan and assess the performance of each segment for all purposes, including determining the compensation of the business leaders for each of the Company’s operating segments.

Table of Contents

Revenue and operating income (loss) from continuing operations by operating segment are shown in the table below:



	Three Months Ended						Nine Months Ended
	September 30, 2018			October 1, 2017			September 30, 2018			October 1, 2017
	(In thousands)
Discovery & Analytical Solutions
Product revenue	$	247,250		$	222,618		$	748,270		$	665,068
Service revenue	158,916			162,764			485,049			465,202
Total revenue	406,166			385,382			1,233,319			1,130,270
Operating income from continuing operations	48,381			47,258			149,243			128,604
Diagnostics
Product revenue	227,273			132,201			669,469			378,466
Service revenue	40,874			36,692			118,859			106,616
Total revenue	268,147			168,893			788,328			485,082
Operating income from continuing operations	47,411			43,361			104,585			113,024
Corporate
Operating loss from continuing operations	(15,590		)	(12,581		)	(45,627		)	(39,596		)
Continuing Operations
Product revenue	474,523			354,819			1,417,739			1,043,534
Service revenue	199,790			199,456			603,908			571,818
Total revenue	674,313			554,275			2,021,647			1,615,352
Operating income from continuing operations	80,202			78,038			208,201			202,032
Interest and other expense (income), net (see Note 7)	2,161			(27,016		)	29,947			(13,797		)
Income from continuing operations before income taxes	$	78,041		$	105,054		$	178,254		$	215,829

Note 13: Stockholders’ Equity

Comprehensive Income:

The components of accumulated other comprehensive loss consisted of the following:



	September 30, 2018			December 31, 2017
	(In thousands)
Foreign currency translation adjustments	$	(160,780	)	$	(46,582	)
Unrecognized prior service costs, net of income taxes	322			322
Unrealized net losses on securities, net of income taxes	(190		)	(258		)
Accumulated other comprehensive loss	$	(160,648	)	$	(46,518	)

Stock Repurchases:

On July 27, 2016, the Board of Directors (the "Board") authorized the Company to repurchase up to 8.0 million shares of common stock under a stock repurchase program (the "Repurchase Program"). On July 23, 2018, the Board authorized the Company to immediately terminate the Repurchase Program and further authorized the Company to repurchase shares of common stock for an aggregate amount up to $250.0 million under a new stock repurchase program (the "New Repurchase Program"). The New Repurchase Program will expire on July 23, 2020 unless terminated earlier by the Board and may be suspended or discontinued at any time. During the nine months ended September 30, 2018, the Company had no stock repurchases under either the Repurchase Program or the New Repurchase Program. No shares remain available for repurchase under the Repurchase Program due to its cancellation. As of September 30, 2018, $250.0 million remained available for aggregate repurchases of shares under the New Repurchase Program.

Table of Contents

pursuant to the Company's equity incentive plans. During the three months ended September 30, 2018, the Company repurchased 3,807 shares of common stock for this purpose at an aggregate cost of $0.3 million. During the nine months ended September 30, 2018, the Company repurchased 63,506 shares of common stock for this purpose at an aggregate cost of $5.0 million. The repurchased shares have been reflected as additional authorized but unissued shares, with the payments reflected in common stock and capital in excess of par value.

Dividends:

The Board declared a regular quarterly cash dividend of $0.07 per share for the first three quarters of fiscal year 2018 and in each quarter of fiscal year 2017. At September 30, 2018, the Company has accrued $7.8 million for dividends declared on July 23, 2018 for the third quarter of fiscal year 2018 that will be payable on November 9, 2018. On October 24, 2018, the Company announced that the Board had declared a quarterly dividend of $0.07 per share for the fourth quarter of fiscal year 2018 that will be payable on February 8, 2019. In the future, the Board may determine to reduce or eliminate the Company’s common stock dividend in order to fund investments for growth, repurchase shares or conserve capital resources.

Note 14: Stock Plans

In addition to the Company's Employee Stock Purchase Plan, the Company utilizes one stock-based compensation plan, the 2009 Incentive Plan (the “2009 Plan”). Under the 2009 Plan, 10.0 million shares of the Company's common stock are authorized for stock option grants, restricted stock awards, performance restricted stock units, performance units and stock awards as part of the Company’s compensation programs. In addition to shares of the Company’s common stock originally authorized for issuance under the 2009 Plan, the 2009 Plan includes shares of the Company’s common stock previously granted under the Amended and Restated 2001 Incentive Plan and the 2005 Incentive Plan that were canceled or forfeited without the shares being issued.

The following table summarizes total pre-tax compensation expense recognized related to the Company’s stock option grants, restricted stock awards, performance restricted stock units, performance units and stock awards, included in the Company’s condensed consolidated statements of operations for the three and nine months ended September 30, 2018 and October 1, 2017:



	Three Months Ended				Nine Months Ended
	September 30, 2018		October 1, 2017		September 30, 2018		October 1, 2017
	(In thousands)
Cost of revenue	$	430	$	357	$	1,093	$	898
Research and development expenses	335		373		1,029		1,077
Selling, general and administrative expenses	10,362		3,682		21,153		14,204
Total stock-based compensation expense	$	11,127	$	4,412	$	23,275	$	16,179

The total income tax benefit recognized in the condensed consolidated statements of operations for stock-based compensation was $6.1 million and $10.6 million for the three and nine months ended September 30, 2018, respectively. The total income tax benefit recognized in the condensed consolidated statements of operations for stock-based compensation was $1.9 million and $9.9 million for the three and nine months ended October 1, 2017, respectively. Stock-based compensation costs capitalized as part of inventory were $0.4 million as of each of September 30, 2018 and October 1, 2017.

Stock Options: The fair value of each option grant is estimated using the Black-Scholes option pricing model. The Company’s weighted-average assumptions used in the Black-Scholes option pricing model were as follows:



	Three and Nine Months Ended
	September 30, 2018		October 1, 2017
Risk-free interest rate	2.9	%	1.5	%
Expected dividend yield	0.4	%	0.4	%
Expected term	5 years		5 years
Expected stock volatility	20.7	%	22.4	%

Table of Contents

The following table summarizes stock option activity for the nine months ended September 30, 2018:



	Number of Shares		Weighted- Average Exercise Price		Weighted-Average Remaining Contractual Term	Total Intrinsic Value
	(In thousands)				(In years)	(In millions)
Outstanding at December 31, 2017	2,154		$	42.77
Granted	363		77.81
Exercised	(554	)	35.19
Forfeited	(43	)	51.62
Outstanding at September 30, 2018	1,920		$	51.38	4.3	$	88.1
Exercisable at September 30, 2018	1,113		$	43.10	3.2	$	60.3

The weighted-average per-share grant-date fair value of options granted during the three and nine months ended September 30, 2018 was $18.65 and $17.56, respectively. The weighted-average per-share grant-date fair value of options granted during the three and nine months ended October 1, 2017 was $14.32 and $11.79, respectively. The total intrinsic value of options exercised during the three and nine months ended September 30, 2018 was $18.9 million and $25.3 million, respectively. The total intrinsic value of options exercised during the three and nine months ended October 1, 2017 was $0.7 million and $12.8 million, respectively. Cash received from option exercises for the nine months ended September 30, 2018 and October 1, 2017 was $19.5 million and $14.0 million, respectively.

The total compensation expense recognized related to the Company’s outstanding options was $1.4 million and $4.0 million for the three and nine months ended September 30, 2018, respectively, and $1.1 million and $3.5 million for the three and nine months ended October 1, 2017, respectively.

There was $8.0 million of total unrecognized compensation cost related to nonvested stock options granted as of September 30, 2018. This cost is expected to be recognized over a weighted-average period of 2.0 years.

Restricted Stock Awards: The following table summarizes restricted stock award activity for the nine months ended September 30, 2018:



	Number of Shares		Weighted- Average Grant- Date Fair Value
	(In thousands)
Nonvested at December 31, 2017	496		$	50.30
Granted	206		75.78
Vested	(200	)	50.18
Forfeited	(32	)	53.67
Nonvested at September 30, 2018	470		$	61.38

The fair value of restricted stock awards vested during the three and nine months ended September 30, 2018 was $1.1 million and $10.0 million, respectively. The fair value of restricted stock awards vested during the three and nine months ended October 1, 2017 was $0.5 million and $9.8 million, respectively. The total compensation expense recognized related to the Company’s outstanding restricted stock awards was $3.0 million and $8.7 million for the three and nine months ended September 30, 2018, respectively, and $2.3 million and $7.8 million for the three and nine months ended October 1, 2017, respectively.

As of September 30, 2018, there was $18.9 million of total unrecognized compensation cost related to nonvested restricted stock awards. This cost is expected to be recognized over a weighted-average period of 1.5 years.

Table of Contents

stock units outstanding. The total compensation expense recognized related to the performance restricted stock units was $1.3 million and $2.2 million for the three and nine months ended September 30, 2018, respectively, and $0.2 million and $0.6 million for the three and nine months ended October 1, 2017, respectively.

Performance Units: As part of the Company's executive compensation program, the Company granted 37,281 performance units during the nine months ended September 30, 2018. The weighted-average per-share grant-date fair value of performance units granted during the nine months ended September 30, 2018 was $73.23. During the nine months ended September 30, 2018, no performance units were forfeited. As of September 30, 2018, there were 201,762 performance units outstanding and subject to forfeiture, with a corresponding liability of $13.9 million recorded in accrued expenses and other current liabilities. The total compensation expense recognized related to performance units was $5.3 million and $7.6 million for the three and nine months ended September 30, 2018, respectively, and $0.8 million and $3.6 million for the three and nine months ended October 1, 2017, respectively.

Stock Awards: The Company’s stock award program provides an annual equity award to non-employee directors. The Company granted 1,386 shares to each non-employee member of the Board during the nine months ended September 30, 2018. The weighted-average per-share grant-date fair value of the stock awards granted during the nine months ended September 30, 2018 was $72.17. The total compensation expense recognized related to the stock awards was $0.8 million and $0.7 million for the nine months ended September 30, 2018 and October 1, 2017, respectively.

Employee Stock Purchase Plan: During the nine months ended September 30, 2018, the Company issued 21,321 shares of common stock under the Company's Employee Stock Purchase Plan at a weighted-average price of $69.57 per share. During the nine months ended October 1, 2017, the Company issued 18,483 shares of common stock under the Company's Employee Stock Purchase Plan at a weighted-average price of $64.73 per share. At September 30, 2018, an aggregate of 0.8 million shares of the Company’s common stock remained available for sale to employees out of the 5.0 million shares authorized by shareholders for issuance under this plan.

Note 15: Goodwill and Intangible Assets, Net

The Company tests goodwill and non-amortizing intangible assets at least annually for possible impairment. Accordingly, the Company completes the annual testing of impairment for goodwill and non-amortizing intangible assets on the later of January 1 or the first day of each fiscal year. In addition to its annual test, the Company regularly evaluates whether events or circumstances have occurred that may indicate a potential impairment of goodwill or non-amortizing intangible assets.

The process of testing goodwill for impairment involves the determination of the fair value of the applicable reporting units. The test consists of the comparison of the fair value to the carrying value of the reporting unit to determine if the carrying value exceeds the fair value. If the carrying value of the reporting unit exceeds its fair value, an impairment loss in an amount equal to that excess is recognized up to the amount of goodwill. The Company performed its annual impairment testing for its reporting units as of January 1, 2018, its annual impairment testing date for fiscal year 2018. The Company concluded that there was no goodwill impairment, and the fair value exceeded the carrying value by more than 20.0% for each reporting unit, except for the Company's Informatics reporting unit which had a fair value that was less than 20% but more than 10% of its carrying value. The range of the long-term terminal growth rates for the Company’s reporting units was 3.0% to 5.00% for the fiscal year 2018 impairment analysis. The range for the discount rates for the reporting units was 9.0% to 15.0%. Keeping all other variables constant, a 10.0% change in any one of these input assumptions for the various reporting units, except for the Informatics reporting unit, would still allow the Company to conclude that there was no impairment of goodwill. As of January 1, 2018, the Company's Informatics reporting unit, which had a goodwill balance of $217.2 million, was at increased risk of an impairment charge given its ongoing weakness due to a highly competitive industry. Despite the increased risk associated with this reporting unit, the Company does not currently expect a significant change in the key estimates or assumptions driving the fair value of this reporting unit that would lead to a material impairment charge.

The Company has consistently employed the income approach to estimate the current fair value when testing for impairment of goodwill. A number of significant assumptions and estimates are involved in the application of the income approach to forecast operating cash flows, including markets and market share, sales volumes and prices, costs to produce, tax rates, capital spending, discount rates and working capital changes. Cash flow forecasts are based on approved business unit operating plans for the early years’ cash flows and historical relationships in later years. The income approach is sensitive to changes in long-term terminal growth rates and the discount rates. The long-term terminal growth rates are consistent with the Company’s historical long-term terminal growth rates, as the current economic trends are not expected to affect the long-term terminal growth rates of the Company. The Company corroborates the income approach with a market approach.

Table of Contents

amortizing intangible asset with its carrying amount. If the carrying amount of a non-amortizing intangible asset exceeds its fair value, an impairment loss in an amount equal to that excess is recognized. In addition, the Company evaluates the remaining useful lives of its non-amortizing intangible assets at least annually to determine whether events or circumstances continue to support an indefinite useful life. If events or circumstances indicate that the useful lives of non-amortizing intangible assets are no longer indefinite, the assets will be tested for impairment. These intangible assets will then be amortized prospectively over their estimated remaining useful lives and accounted for in the same manner as other intangible assets that are subject to amortization. The Company performed its annual impairment testing as of January 1, 2018, and concluded that there was no impairment of non-amortizing intangible assets. An assessment of the recoverability of amortizing intangible assets takes place when events have occurred that may give rise to an impairment. No such events occurred during the first nine months of fiscal year 2018.

The changes in the carrying amount of goodwill for the nine months ended September 30, 2018 were as follows:



	Discovery & Analytical Solutions			Diagnostics			Consolidated
	(In thousands)
Balance at December 31, 2017	$	1,344,235		$	1,657,963		$	3,002,198
Foreign currency translation	(26,167		)	(31,613		)	(57,780		)
Acquisitions and other	(7,980		)	(15,749		)	(23,729		)
Balance at September 30, 2018	$	1,310,088		$	1,610,601		$	2,920,689

Identifiable intangible asset balances at September 30, 2018 and December 31, 2017 by category were as follows:



	September 30, 2018			December 31, 2017
	(In thousands)
Patents	$	42,951		$	39,959
Less: Accumulated amortization	(37,046		)	(35,085		)
Net patents	5,905			4,874
Trade names and trademarks	78,628			80,974
Less: Accumulated amortization	(32,251		)	(28,250		)
Net trade names and trademarks	46,377			52,724
Licenses	52,261			53,300
Less: Accumulated amortization	(44,889		)	(42,635		)
Net licenses	7,372			10,665
Core technology	476,403			471,740
Less: Accumulated amortization	(272,475		)	(244,916		)
Net core technology	203,928			226,824
Customer relationships	1,108,220			1,141,511
Less: Accumulated amortization	(290,616		)	(242,840		)
Net customer relationships	817,604			898,671
IPR&D	81,813			88,025
Less: Accumulated amortization	(9,808		)	(5,427		)
Net IPR&D	72,005			82,598
Net amortizable intangible assets	1,153,191			1,276,356
Non-amortizing intangible asset:
Trade name	70,584			70,584
Total	$	1,223,775		$	1,346,940

Table of Contents

next five years is $37.6 million for the remainder of fiscal year 2018, $148.3 million for fiscal year 2019, $150.4 million for fiscal year 2020, $135.2 million for fiscal year 2021, and $123.8 million for fiscal year 2022.

Note 16: Warranty Reserves

The Company provides warranty protection for certain products usually for a period of one year beyond the date of sale. The majority of costs associated with warranty obligations include the replacement of parts and the time for service personnel to respond to repair and replacement requests. A warranty reserve is recorded based upon historical results, supplemented by management’s expectations of future costs. Warranty reserves are included in “Accrued expenses and other current liabilities” on the condensed consolidated balance sheets.

A summary of warranty reserve activity for the three and nine months ended September 30, 2018 and October 1, 2017 is as follows:



	Three Months Ended						Nine Months Ended
	September 30, 2018			October 1, 2017			September 30, 2018			October 1, 2017
	(In thousands)
Balance at beginning of period	$	8,943		$	9,088		$	9,050		$	9,012
Provision charged to income	3,327			3,326			10,012			9,706
Payments	(3,547		)	(3,488		)	(10,514		)	(10,625		)
Adjustments to previously provided warranties, net	(226		)	(730		)	110			(215		)
Foreign currency translation and acquisitions	(49		)	117			(210		)	435
Balance at end of period	$	8,448		$	8,313		$	8,448		$	8,313

Note 17: Employee Postretirement Benefit Plans

The following table summarizes the components of net periodic pension credit for the Company’s various defined benefit employee pension and postretirement plans for the three and nine months ended September 30, 2018 and October 1, 2017:



	Defined Benefit Pension Benefits						Postretirement Medical Benefits
	Three Months Ended
	September 30, 2018			October 1, 2017			September 30, 2018			October 1, 2017
	(In thousands)
Service and administrative costs	$	1,712		$	1,231		$	27		$	23
Interest cost	4,051			4,160			30			32
Expected return on plan assets	(7,270		)	(6,568		)	(314		)	(279		)
Amortization of prior service costs	(41		)	(49		)	—			—
Net periodic pension credit	$	(1,548	)	$	(1,226	)	$	(257	)	$	(224	)

	Defined Benefit Pension Benefits						Postretirement Medical Benefits
	Nine Months Ended
	September 30, 2018			October 1, 2017			September 30, 2018			October 1, 2017
	(In thousands)
Service and administrative costs	$	5,180		$	3,667		$	80		$	69
Interest cost	12,212			12,420			90			94
Expected return on plan assets	(21,926		)	(19,609		)	(941		)	(836		)
Amortization of prior service costs	(123		)	(144		)	—			—
Net periodic benefit credit	$	(4,657	)	$	(3,666	)	$	(771	)	$	(673	)

Table of Contents

September 30, 2018, the Company contributed $15.0 million to its defined benefit pension plan in the United States for the plan year 2017.

The Company recognizes actuarial gains and losses, unless an interim remeasurement is required, in the fourth quarter of the year in which the gains and losses occur, in accordance with the Company's accounting method for defined benefit pension plans and other postretirement benefits as described in Note 1 of the Company's audited consolidated financial statements and notes included in its 2017 Form 10-K. Such adjustments for gains and losses are primarily driven by events and circumstances beyond the Company's control, including changes in interest rates, the performance of the financial markets and mortality assumptions. As discussed in Note 1, Basis of Presentation, the Company adopted ASU 2017-17 on January 1, 2018. Actuarial gains and losses are now recognized in the line item "Interest and other expense, net" in the condensed consolidated statement of operations. Actuarial gains and losses were presented within operating income prior to the adoption. As such, prior year amounts, including other components of periodic pension cost, have been reclassified to "Interest and other expense, net" in the condensed consolidated statement of operations due to the retrospective adoption of ASU 2017-17.

Note 18: Derivatives and Hedging Activities

The Company uses derivative instruments as part of its risk management strategy only, and includes derivatives utilized as economic hedges that are not designated as hedging instruments. By nature, all financial instruments involve market and credit risks. The Company enters into derivative instruments with major investment grade financial institutions and has policies to monitor the credit risk of those counterparties. The Company does not enter into derivative contracts for trading or other speculative purposes, nor does the Company use leveraged financial instruments. Approximately 70% of the Company’s business is conducted outside of the United States, generally in foreign currencies. As a result, fluctuations in foreign currency exchange rates can increase the costs of financing, investing and operating the business.

In the ordinary course of business, the Company enters into foreign exchange contracts for periods consistent with its committed exposures to mitigate the effect of foreign currency movements on transactions denominated in foreign currencies. The intent of these economic hedges is to offset gains and losses that occur on the underlying exposures from these currencies, with gains and losses resulting from the forward currency contracts that hedge these exposures. Transactions covered by hedge contracts include intercompany and third-party receivables and payables. The contracts are primarily in European and Asian currencies, have maturities that do not exceed 12 months, have no cash requirements until maturity, and are recorded at fair value on the Company’s condensed consolidated balance sheets. The unrealized gains and losses on the Company’s foreign currency contracts are recognized immediately in interest and other expense, net. The cash flows related to the settlement of these hedges are included in cash flows from operating activities within the Company’s condensed consolidated statement of cash flows.

Principal hedged currencies include the British Pound, Euro, Swedish Krona, Japanese Yen and Singapore Dollar. The Company held forward foreign exchange contracts, designated as economic hedges, with U.S. dollar equivalent notional amounts totaling $180.4 million, $212.1 million and $140.0 million at September 30, 2018, December 31, 2017 and October 1, 2017, respectively, and the fair value of these foreign currency derivative contracts was insignificant. The gains and losses realized on these foreign currency derivative contracts are not material. The duration of these contracts was generally 30 days or less during each of the nine months ended September 30, 2018 and October 1, 2017.

In addition, in connection with certain intercompany loan agreements utilized to finance its acquisitions and stock repurchase program, the Company enters into forward foreign exchange contracts intended to hedge movements in foreign exchange rates prior to settlement of such intercompany loans denominated in foreign currencies. The Company records these hedges at fair value on the Company’s condensed consolidated balance sheets. The unrealized gains and losses on these hedges, as well as the gains and losses associated with the remeasurement of the intercompany loans, are recognized immediately in interest and other expense, net. The cash flows related to the settlement of these hedges are included in cash flows from financing activities within the Company’s condensed consolidated statement of cash flows.

The outstanding forward exchange contracts designated as economic hedges, which were intended to hedge movements in foreign exchange rates prior to the settlement of certain intercompany loan agreements, included combined Euro notional amounts of €48.7 million and combined U.S. Dollar notional amounts of $28.0 million as of September 30, 2018, combined Euro notional amounts of €57.2 million and combined U.S. Dollar notional amounts of $1.3 billion as of December 31, 2017, and combined Euro notional amounts of €19.0 million and combined U.S. Dollar notional amounts of $12.3 million as of October 1, 2017. The net gains and losses on these derivatives, combined with the gains and losses on the remeasurement of the hedged intercompany loans were not material for each of the three and nine months ended September 30, 2018 and October 1, 2017. The Company paid $30.3 million and $11.5 million during the nine months ended September 30, 2018 and October 1, 2017, respectively, from the settlement of these hedges.

Table of Contents

In April 2018, the Company entered into a series of foreign currency forward contracts with a notional amount of €298.7 million to hedge its investments in certain foreign subsidiaries. Realized and unrealized translation adjustments from these hedges were included in the foreign currency translation component of accumulated other comprehensive income ("AOCI"), which offsets translation adjustments on the underlying net assets of foreign subsidiaries. The cumulative translation gains or losses will remain in AOCI until the foreign subsidiaries are liquidated or sold. The foreign currency forward contracts were settled during the second quarter of 2018 and the Company recorded a net realized foreign exchange loss in AOCI of $2.6 million for the nine months ended September 30, 2018.

During fiscal year 2016, the Company designated the 2026 Notes to hedge its investments in certain foreign subsidiaries. In January 2018, the Company removed the hedging relationship of its 2026 Notes and investments in certain foreign subsidiaries and recognized $2.1 million of unrealized foreign exchange gain in AOCI. In April 2018, the Company designated a portion of the 2026 Notes to hedge its investments in certain foreign subsidiaries. Unrealized translation adjustments from a portion of the 2026 Notes were included in the foreign currency translation component of AOCI, which offsets translation adjustments on the underlying net assets of foreign subsidiaries. The cumulative translation gains or losses will remain in AOCI until the foreign subsidiaries are liquidated or sold. As of September 30, 2018, the total notional amount of the 2026 Notes that was designated to hedge investments in foreign subsidiaries was €135.1 million. The unrealized foreign exchange gain recorded in AOCI related to the net investment hedge was $0.8 million and $7.7 million for the three and nine months ended September 30, 2018, respectively.

In April 2018, the Company designated the April 2021 Notes with a notional amount of €298.7 million to hedge its investments in certain foreign subsidiaries. Unrealized translation adjustments from the April 2021 Notes were included in the foreign currency translation component of AOCI, which offsets translation adjustments on the underlying net assets of foreign subsidiaries. The cumulative translation gains or losses will remain in AOCI until the foreign subsidiaries are liquidated or sold. As of September 30, 2018, the total notional amount of the April 2021 Notes that was designated to hedge investments in foreign subsidiaries was €298.7 million. The unrealized foreign exchange gain recorded in AOCI related to the net investment hedge was $1.8 million and $22.6 million for the three and nine months ended September 30, 2018, respectively.

The Company does not expect any material net pre-tax gains or losses to be reclassified from accumulated other comprehensive loss into interest and other expense, net within the next twelve months.

Note 19: Fair Value Measurements

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash equivalents, derivatives, marketable securities and accounts receivable. The Company believes it had no significant concentrations of credit risk as of September 30, 2018.

The Company uses the market approach technique to value its financial instruments and there were no changes in valuation techniques during the nine months ended September 30, 2018. The Company’s financial assets and liabilities carried at fair value are primarily comprised of marketable securities, derivative contracts used to hedge the Company’s currency risk, and acquisition-related contingent consideration. The Company has not elected to measure any additional financial instruments or other items at fair value.

Valuation Hierarchy: The following summarizes the three levels of inputs required to measure fair value. For Level 1 inputs, the Company utilizes quoted market prices as these instruments have active markets. For Level 2 inputs, the Company utilizes quoted market prices in markets that are not active, broker or dealer quotations, or utilizes alternative pricing sources with reasonable levels of price transparency. For Level 3 inputs, the Company utilizes unobservable inputs based on the best information available, including estimates by management primarily based on information provided by third-party fund managers, independent brokerage firms and insurance companies. A financial asset’s or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement. In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible.

Table of Contents

The following tables show the assets and liabilities carried at fair value measured on a recurring basis as of September 30, 2018 and December 31, 2017 classified in one of the three classifications described above:



				Fair Value Measurements at September 30, 2018 Using:
	Total Carrying Value at September 30, 2018			Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)
	(In thousands)
Marketable securities	$	2,405		$	2,405	$	—		$	—
Foreign exchange derivative assets	1,273			—		1,273			—
Foreign exchange derivative liabilities	(4,694		)	—		(4,694		)	—
Contingent consideration	(67,126		)	—		—			(67,126		)



				Fair Value Measurements at December 31, 2017 Using:
	Total Carrying Value at December 31, 2017			Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)
	(In thousands)
Marketable securities	$	2,208		$	2,208	$	—		$	—
Foreign exchange derivative assets	1,431			—		1,431			—
Foreign exchange derivative liabilities	(23,638		)	—		(23,638		)	—
Contingent consideration	(65,328		)	—		—			(65,328		)

Level 1 and Level 2 Valuation Techniques: The Company’s Level 1 and Level 2 assets and liabilities are comprised of investments in equity and fixed-income securities as well as derivative contracts. For financial assets and liabilities that utilize Level 1 and Level 2 inputs, the Company utilizes both direct and indirect observable price quotes, including common stock price quotes, foreign exchange forward prices and bank price quotes. Below is a summary of valuation techniques for Level 1 and Level 2 financial assets and liabilities.

Marketable securities: Include equity and fixed-income securities measured at fair value using the quoted market prices in active markets at the reporting date.

Foreign exchange derivative assets and liabilities: Include foreign exchange derivative contracts that are valued using quoted forward foreign exchange prices at the reporting date. The Company’s foreign exchange derivative contracts are subject to master netting arrangements that allow the Company and its counterparties to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled under these arrangements have been presented in the Company's condensed consolidated balance sheet on a net basis and are recorded in other assets. As of both September 30, 2018 and December 31, 2017, none of the master netting arrangements involved collateral.

Level 3 Valuation Techniques: The Company’s Level 3 liabilities are comprised of contingent consideration related to acquisitions. For liabilities that utilize Level 3 inputs, the Company uses significant unobservable inputs. Below is a summary of valuation techniques for Level 3 liabilities.

Contingent consideration: Contingent consideration is measured at fair value at the acquisition date using projected milestone dates, discount rates, probabilities of success and projected revenues (for revenue-based considerations). Projected risk-adjusted contingent payments are discounted back to the current period using a discounted cash flow model.

During fiscal year 2015, the Company acquired certain assets and assumed certain liabilities from Vanadis Diagnostics AB ("Vanadis"). Under the terms of the acquisition, the initial purchase consideration was $32.0 million, net of cash and the Company will be obligated to make potential future milestone payments, based on completion of a proof of concept, regulatory approvals and product sales, of up to $93.0 million ranging from 2016 to 2019. The fair value of the contingent consideration as of the acquisition date was estimated at $56.9 million. During the third quarter of fiscal year 2018, the Company updated the fair value of the contingent consideration and recorded a liability of $59.6 million as of September 30, 2018. The key assumptions used to determine the fair value of the contingent consideration as of September 30, 2018 included projected milestone dates of 2018 to 2019, discount rates ranging from 3.4% to 6.5%, conditional probabilities of success of each individual milestone ranging from 95% to 98% and cumulative probabilities of success for each individual milestone ranging from 84.0% to 98%. A significant delay in the product development (including projected regulatory milestone) achievement

Table of Contents

date in isolation could result in a significantly lower fair value measurement; a significant acceleration in the product development (including projected regulatory milestone) achievement date in isolation would not have a material impact on the fair value measurement; a significant change in the discount rate in isolation would not have a material impact on the fair value measurement; and a significant change in the probabilities of success in isolation could result in a significant change in fair value measurement.

During the third quarter of fiscal year 2018, the Company recorded a contingent consideration obligation relating to its acquisition of DNA Labs with an estimated fair value of $5.8 million and the Company paid $16.5 million of contingent consideration to the former shareholders of Vanadis, of which $12.8 million was included in financing activities and $3.7 million was included in operating activities in the condensed consolidated statement of cash flows.

The fair values of contingent consideration are calculated on a quarterly basis based on a collaborative effort of the Company’s regulatory, research and development, operations, finance and accounting groups, as appropriate. Potential valuation adjustments are made as additional information becomes available, including the progress towards achieving proof of concept, regulatory approvals and revenue targets as compared to initial projections, the impact of market competition and market landscape shifts from non-invasive prenatal testing products, with the impact of such adjustments being recorded in the Company's consolidated statements of operations.

As of September 30, 2018, the Company may have to pay contingent consideration related to acquisitions with open contingency periods of up to $76.5 million. The expected maximum earnout period for the acquisitions with open contingency periods does not exceed 2.0 years from September 30, 2018, and the remaining weighted average expected earnout period at September 30, 2018 was 0.6 years.

A reconciliation of the beginning and ending Level 3 net liabilities for contingent consideration is as follows:



	Three Months Ended						Nine Months Ended
	September 30, 2018			October 1, 2017			September 30, 2018			October 1, 2017
	(In thousands)
Balance at beginning of period	$	(74,093	)	$	(64,076	)	$	(65,328	)	$	(63,201	)
Additions	(5,800		)	—			(7,500		)	—
Amounts paid and foreign currency translation	16,507			—			16,507			34
Change in fair value (included within selling, general and administrative expenses)	(3,740		)	(651		)	(10,805		)	(1,560		)
Balance at end of period	$	(67,126	)	$	(64,727	)	$	(67,126	)	$	(64,727	)

The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses approximate fair value due to the short-term maturities of these assets and liabilities. If measured at fair value, cash and cash equivalents would be classified as Level 1.

As of September 30, 2018, the Company’s senior unsecured revolving credit facility, which provides for $1.0 billion of revolving loans, had a carrying value of $408.4 million, net of $2.6 million of unamortized debt issuance costs. As of December 31, 2017, the Company’s senior unsecured revolving credit facility had a carrying value of $621.7 million, net of $3.3 million of unamortized debt issuance costs. The interest rate on the Company’s senior unsecured revolving credit facility is reset at least monthly to correspond to variable rates that reflect currently available terms and conditions for similar debt. The Company had no change in credit standing during the first nine months of fiscal year 2018. Consequently, the carrying value approximates fair value and were classified as Level 2.

The Company's November 2021 Notes, with a face value of $500.0 million, had an aggregate carrying value of $497.2 million, net of $1.2 million of unamortized original issue discount and $1.7 million of unamortized debt issuance costs as of September 30, 2018. The November 2021 Notes had an aggregate carrying value of $496.6 million, net of $1.4 million of unamortized original issue discount and $2.0 million of unamortized debt issuance costs as of December 31, 2017. The November 2021 Notes had a fair value of $515.6 million and $536.6 million as of September 30, 2018 and December 31, 2017, respectively. The fair value of the November 2021 Notes is estimated using market quotes from brokers and is based on current rates offered for similar debt.

Table of Contents

€502.9 million and €508.9 million as of September 30, 2018 and December 31, 2017, respectively. The fair value of the 2026 Notes is estimated using market quotes from brokers and is based on current rates offered for similar debt.

The Company's April 2021 Notes, with a face value of €300.0 million, had an aggregate carrying value of $345.8 million, net of $0.2 million of unamortized original issue discount and $2.3 million of unamortized debt issuance costs as of September 30, 2018. The April 2021 Notes had a fair value of €301.2 million as of September 30, 2018. The fair value of the April 2021 Notes is estimated using market quotes from brokers and is based on current rates offered for similar debt.

The Company's financing lease obligations had an aggregate carrying value of $34.9 million and $35.9 million as of September 30, 2018 and December 31, 2017, respectively. The carrying values of the Company's financing lease obligations approximated their fair value as there has been minimal change in the Company's incremental borrowing rate.

As of September 30, 2018, the November 2021 Notes, 2026 Notes, April 2021 Notes and financing lease obligations were classified as Level 2.

The Company’s other debt facilities that were assumed from the EUROIMMUN acquisition had an aggregate carrying value of $43.5 million and $60.2 million as of September 30, 2018 and December 31, 2017, respectively. As of September 30, 2018, these consisted of bank loans in the aggregate amount of $43.3 million bearing fixed interest rates between 0.05% and 5.5% and a bank loan in the amount of $0.2 million bearing a variable interest rate based on the Euribor rate plus a margin of 1.5%. The Company had no change in credit standing during the first nine months of fiscal year 2018. Consequently, the carrying value approximates fair value and were classified as Level 2.

As of September 30, 2018, there has not been any significant impact to the fair value of the Company’s derivative liabilities due to credit risk. Similarly, there has not been any significant adverse impact to the Company’s derivative assets based on the evaluation of its counterparties’ credit risks.

Note 20: Contingencies

The Company is conducting a number of environmental investigations and remedial actions at current and former locations of the Company and, along with other companies, has been named a potentially responsible party (“PRP”) for certain waste disposal sites. The Company accrues for environmental issues in the accounting period that the Company’s responsibility is established and when the cost can be reasonably estimated. The Company has accrued $8.5 million and $9.4 million as of September 30, 2018 and December 31, 2017, respectively, which represents its management’s estimate of the cost of the remediation of known environmental matters, and does not include any potential liability for related personal injury or property damage claims. These amounts were included in accrued expenses and other current liabilities. The Company's environmental accrual is not discounted and does not reflect the recovery of any material amounts through insurance or indemnification arrangements. The cost estimates are subject to a number of variables, including the stage of the environmental investigations, the magnitude of the possible contamination, the nature of the potential remedies, possible joint and several liability, the time period over which remediation may occur, and the possible effects of changing laws and regulations. For sites where the Company has been named a PRP, management does not currently anticipate any additional liability to result from the inability of other significant named parties to contribute. The Company expects that the majority of such accrued amounts could be paid out over a period of up to ten years. As assessment and remediation activities progress at each individual site, these liabilities are reviewed and adjusted to reflect additional information as it becomes available. There have been no environmental problems to date that have had, or are expected to have, a material adverse effect on the Company’s condensed consolidated financial statements. While it is possible that a loss exceeding the amounts recorded in the condensed consolidated financial statements may be incurred, the potential exposure is not expected to be materially different from those amounts recorded.

The Company is subject to various claims, legal proceedings and investigations covering a wide range of matters that arise in the ordinary course of its business activities. Although the Company has established accruals for potential losses that it believes are probable and reasonably estimable, in the opinion of the Company’s management, based on its review of the information available at this time, the total cost of resolving these contingencies at September 30, 2018 would not have a material adverse effect on the Company’s condensed consolidated financial statements. However, each of these matters is subject to uncertainties, and it is possible that some of these matters may be resolved unfavorably to the Company.

Table of Contents


Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations

This quarterly report on Form 10-Q, including the following management’s discussion and analysis, contains forward-looking information that you should read in conjunction with the condensed consolidated financial statements and notes to the condensed consolidated financial statements that we have included elsewhere in this report. For this purpose, any statements contained in this report that are not statements of historical fact may be deemed to be forward-looking statements. Words such as “believes,” “plans,” “anticipates,” “intends,” “expects,” “will” and similar expressions are intended to identify forward-looking statements. Our actual results may differ materially from the plans, intentions or expectations we disclose in the forward-looking statements we make. We have included important factors below under the heading “Risk Factors” in Part II, Item 1A. that we believe could cause actual results to differ materially from the forward-looking statements we make. We are not obligated to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

Overview

We are a leading provider of products, services and solutions for the diagnostics, life sciences and applied markets. Through our advanced technologies and differentiated solutions, we address critical issues that help to improve lives and the world around us.

The principal products and services of our two operating segments are:


•	Discovery & Analytical Solutions. Provides products and services targeted towards the life sciences and applied markets.


•	Diagnostics. Develops diagnostics, tools and applications focused on clinically-oriented customers, especially within the reproductive health, emerging market diagnostics and applied genomics markets. The Diagnostics segment serves the diagnostics market.

Overview of the Third Quarter of Fiscal Year 2018

Our fiscal year ends on the Sunday nearest December 31. We report fiscal years under a 52/53 week format and as a result, certain fiscal years will contain 53 weeks. The fiscal year ending December 30, 2018 ("fiscal year 2018") will include 52 weeks, and the fiscal year ended December 31, 2017 ("fiscal year 2017") included 52 weeks.

Our overall revenue in the third quarter of fiscal year 2018 was $674.3 million and increased $120.0 million, or 22%, as compared to the third quarter of fiscal year 2017, reflecting an increase of $20.8 million, or 5%, in our Discovery & Analytical Solutions segment revenue and an increase of $99.3 million, or 59%, in our Diagnostics segment revenue. The increase in our Discovery & Analytical Solutions segment revenue for the third quarter of fiscal year 2018 was primarily due to an increase in our applied markets revenue, as well as an increase in our life sciences market revenue. The increase in our Diagnostics segment revenue for the third quarter of fiscal year 2018 was primarily due to our acquisition of EUROIMMUN, which contributed $90.2 million in revenues during the third quarter of fiscal year 2018, as well as strong performance of our reproductive health, genomics and immuno-diagnostics solutions.

In our Discovery & Analytical Solutions segment, we had an increase in revenue for the third quarter of fiscal year 2018 as compared to the third quarter of fiscal year 2017. During the third quarter of fiscal year 2018, revenue increased in our applied markets primarily driven by strength in sales of industrial, environmental and food offerings. In addition, the increase in our life sciences market revenue was driven by strength in drug discovery sales and increased demand for our OneSource laboratory service business.

In our Diagnostics segment, we experienced growth from our acquisition of EUROIMMUN and continued expansion in our reproductive health, applied genomics and immuno-diagnostics solutions, particularly in the Americas and emerging markets, such as China and India.

Our consolidated gross margins increased 76 basis points in the third quarter of fiscal year 2018, as compared to the third quarter of fiscal year 2017, primarily due to strong volume leverage and benefits from our initiatives to improve our supply chain. Our consolidated operating margins decreased 219 basis points in the third quarter of fiscal year 2018, as compared to the third quarter of fiscal year 2017, primarily due to increased costs related to amortization of acquired intangible assets and investments in new product development, which were partially offset by lower costs as a result of our cost containment and productivity initiatives.

We continue to believe that we are well positioned to take advantage of the spending trends in our end markets and to promote efficiencies in markets where current conditions may increase demand for certain services. Overall, we believe that

Table of Contents

our strategic focus on diagnostics and discovery and analytical solutions markets, coupled with our deep portfolio of technologies and applications, leading market positions, global scale and financial strength will provide us with a foundation for growth.

Critical Accounting Policies and Estimates

The preparation of condensed consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to revenue recognition, warranty costs, bad debts, inventories, accounting for business combinations and dispositions, long-lived assets, income taxes, restructuring, pensions and other postretirement benefits, contingencies and litigation. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

Critical accounting policies are those policies that affect our more significant judgments and estimates used in the preparation of our condensed consolidated financial statements. We believe our critical accounting policies include our policies regarding revenue recognition, warranty costs, allowances for doubtful accounts, inventory valuation, business combinations, value of long-lived assets, including goodwill and other intangibles, employee compensation and benefits, restructuring activities, gains or losses on dispositions and income taxes.

We adopted Accounting Standards Codification 606, Revenue from Contracts with Customers ("ASC 606") on January 1, 2018. As a result, we changed our accounting policy for revenue recognition as detailed in Note 3, Changes in Accounting Policies, in the Notes to Condensed Consolidated Financial Statements. For a more detailed discussion of our critical accounting policies and estimates, other than the changes in revenue recognition, refer to the Notes to our audited consolidated financial statements and Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 (our “2017 Form 10-K”), as filed with the Securities and Exchange Commission (the "SEC"). There have been no significant changes in our critical accounting policies and estimates during the nine months ended September 30, 2018, other than the changes in revenue recognition mentioned above.

Consolidated Results of Continuing Operations

Revenue

Revenue for the three months ended September 30, 2018 was $674.3 million, as compared to $554.3 million for the three months ended October 1, 2017, an increase of $120.0 million, or 22%, which includes an approximate 16% increase in revenue attributable to acquisitions and divestitures and a 2% decrease in revenue attributable to unfavorable changes in foreign exchange rates. The analysis in the remainder of this paragraph compares segment revenue for the three months ended September 30, 2018 as compared to the three months ended October 1, 2017 and includes the effect of foreign exchange rate fluctuations, acquisitions and divestitures. Our Discovery & Analytical Solutions segment revenue was $406.2 million for the three months ended September 30, 2018, as compared to $385.4 million for the three months ended October 1, 2017, an increase of $20.8 million, or 5%, primarily due to an increase of $8.5 million from our applied markets revenue, and an increase of $12.3 million from our life sciences market revenue. Our Diagnostics segment revenue was $268.1 million for the three months ended September 30, 2018, as compared to $168.9 million for the three months ended October 1, 2017, an increase of $99.3 million, or 59%, primarily due to our acquisition of EUROIMMUN, which contributed $90.2 million in revenues during the third quarter of fiscal year 2018, and continued expansion in our reproductive health, genetic testing and immuno-diagnostics solutions. As a result of adjustments to deferred revenue related to certain acquisitions required by business combination accounting rules, we did not recognize $0.2 million of revenue for each of the three months ended September 30, 2018 and October 1, 2017 that otherwise would have been recorded by the acquired businesses during each of the respective periods.

Revenue for the nine months ended September 30, 2018 was $2,021.6 million, as compared to $1,615.4 million for the nine months ended October 1, 2017, an increase of $406.3 million, or 25%, which includes an approximate 15% increase in revenue attributable to acquisitions and divestitures and a 2% increase in revenue attributable to favorable changes in foreign exchange rates. The analysis in the remainder of this paragraph compares segment revenue for the nine months ended September 30, 2018 as compared to the nine months ended October 1, 2017 and includes the effect of foreign exchange rate fluctuations, acquisitions and divestitures. Our Discovery & Analytical Solutions segment revenue was $1,233.3 million for the nine months ended September 30, 2018, as compared to $1,130.3 million for the nine months ended October 1, 2017, an increase of $103.0 million, or 9%, primarily due to an increase of $63.2 million from our life sciences market revenue and an

Table of Contents

increase of $39.8 million from our applied markets revenue. Our Diagnostics segment revenue was $788.3 million for the nine months ended September 30, 2018, as compared to $485.1 million for the nine months ended October 1, 2017, an increase of $303.2 million, or 63%, primarily due to our acquisition of EUROIMMUN, which contributed $262.4 million in revenues during the nine months ended September 30, 2018, and continued expansion in our reproductive health, genetic testing and infectious disease screening solutions. As a result of adjustments to deferred revenue related to certain acquisitions required by business combination accounting rules, we did not recognize $0.6 million of revenue for each of the nine months ended September 30, 2018 and October 1, 2017 that otherwise would have been recorded by the acquired businesses during each of the respective periods.

Cost of Revenue

Cost of revenue for the three months ended September 30, 2018 was $342.0 million, as compared to $285.3 million for the three months ended October 1, 2017, an increase of $56.7 million, or 20%. As a percentage of revenue, cost of revenue decreased to 50.7% for the three months ended September 30, 2018, from 51.5% for the three months ended October 1, 2017, resulting in an increase in gross margin of 76 basis points to 49.3% for the three months ended September 30, 2018, from 48.5% for the three months ended October 1, 2017. Amortization of intangible assets increased and was $11.6 million for the three months ended September 30, 2018, as compared to $7.1 million for the three months ended October 1, 2017. Stock-based compensation expense was $0.4 million for the three months ended September 30, 2018, as compared to $0.4 million for the three months ended October 1, 2017. In addition to the above items, the overall increase in gross margin was primarily due to strong volume leverage and benefits from our initiatives to improve our supply chain.

Cost of revenue for the nine months ended September 30, 2018 was $1,057.0 million, as compared to $849.0 million for the nine months ended October 1, 2017, an increase of $207.9 million, or 24%. As a percentage of revenue, cost of revenue decreased to 52.2% for the nine months ended September 30, 2018, from 52.6% for the nine months ended October 1, 2017, resulting in an increase in gross margin of 28 basis points to 47.7% for the nine months ended September 30, 2018, from 47.4% for the nine months ended October 1, 2017. Amortization of intangible assets increased and was $34.8 million for the nine months ended September 30, 2018, as compared to $21.3 million for the nine months ended October 1, 2017. Stock-based compensation expense was $1.1 million for the nine months ended September 30, 2018, as compared to $0.9 million for the nine months ended October 1, 2017. The amortization of purchase accounting adjustments to record the inventory from certain acquisitions added an incremental expense of $18.2 million for the nine months ended September 30, 2018 as compared to $4.2 million for the nine months ended October 1, 2017. In addition to the above items, the overall increase in gross margin was primarily the result of a favorable shift in product mix and benefits from our initiatives to improve our supply chain.

Selling, General and Administrative Expenses

Selling, general and administrative expenses for the three months ended September 30, 2018 were $196.8 million, as compared to $152.8 million for the three months ended October 1, 2017, an increase of $44.0 million, or 29%. As a percentage of revenue, selling, general and administrative expenses increased and were 29.2% for the three months ended September 30, 2018, as compared to 27.6% for the three months ended October 1, 2017. Amortization of intangible assets increased and was $20.0 million for the three months ended September 30, 2018, as compared to $10.5 million for the three months ended October 1, 2017. Stock-based compensation expense was $10.4 million for the three months ended September 30, 2018 as compared to $3.7 million for the three months ended October 1, 2017. Other purchase accounting adjustments added an incremental expense of $3.8 million for the three months ended September 30, 2018, as compared to $0.7 million for the three months ended October 1, 2017. Acquisition and divestiture-related expenses added an incremental expense of $1.7 million for the three months ended September 30, 2018, as compared to $5.4 million for the three months ended October 1, 2017. Legal costs for significant litigation matters were $1.0 million for the three months ended September 30, 2018, as compared to zero for the three months ended October 1, 2017. In addition to the above items, the increase in selling, general and administrative expenses was primarily due to our acquisition of EUROIMMUN, which was partially offset by lower costs as a result of cost containment and productivity initiatives.

Selling, general and administrative expenses for the nine months ended September 30, 2018 were $601.4 million, as compared to $449.6 million for the nine months ended October 1, 2017, an increase of $151.7 million, or 34%. As a percentage of revenue, selling, general and administrative expenses increased and were 29.7% for the nine months ended September 30, 2018, as compared to 27.8% for the nine months ended October 1, 2017. Amortization of intangible assets increased and was $62.0 million for the nine months ended September 30, 2018, as compared to $30.7 million for the nine months ended October 1, 2017. Stock-based compensation expense was $21.2 million for the nine months ended September 30, 2018 as compared to $14.2 million for the nine months ended October 1, 2017. Other purchase accounting adjustments added an incremental expense of $10.9 million for the nine months ended September 30, 2018, as compared to $1.6 million for the nine months ended October 1, 2017. Acquisition and divestiture-related expenses added an incremental expense of $5.9 million for the nine months ended September 30, 2018, as compared to $11.7 million for the nine months ended October 1, 2017. Legal

Table of Contents

costs for significant litigation matters were $5.3 million for the nine months ended September 30, 2018, as compared to zero for the nine months ended October 1, 2017. In addition to the above items, the increase in selling, general and administrative expenses was primarily due to our acquisition of EUROIMMUN, which was partially offset by lower costs as a result of cost containment and productivity initiatives.

Research and Development Expenses

Research and development expenses for the three months ended September 30, 2018 were $48.8 million, as compared to $34.9 million for the three months ended October 1, 2017, an increase of $14.0 million, or 40%. As a percentage of revenue, research and development expenses increased and were 7.2% for the three months ended September 30, 2018, as compared to 6.3% for the three months ended October 1, 2017. Amortization of intangible assets was $3.7 million for the three months ended September 30, 2018, as compared to $0.1 million for the three months ended October 1, 2017. Stock-based compensation expense was $0.3 million for each of the three months ended September 30, 2018 and October 1, 2017. The increase in research and development expenses was primarily the result of investments in new product development and our acquisition of EUROIMMUN, which was partially offset by lower costs as a result of cost containment and productivity initiatives.

Research and development expenses for the nine months ended September 30, 2018 were $142.0 million, as compared to $101.7 million for the nine months ended October 1, 2017, an increase of $40.3 million, or 40%. As a percentage of revenue, research and development expenses increased and were 7.0% for the nine months ended September 30, 2018, as compared to 6.3% for the nine months ended October 1, 2017. Amortization of intangible assets was $3.8 million for the nine months ended September 30, 2018, as compared to $0.2 million for the nine months ended October 1, 2017. Stock-based compensation expense was $1.0 million for each of the nine months ended September 30, 2018 and October 1, 2017. The increase in research and development expenses was primarily the result of investments in new product development and our acquisition of EUROIMMUN, which was partially offset by lower costs as a result of cost containment and productivity initiatives.

Restructuring and Contract Termination Charges, Net

We have undertaken a series of restructuring actions related to the impact of acquisitions and divestitures, the alignment of our operations with our growth strategy, the integration of our business units and our productivity initiatives. The current portion of restructuring and contract termination charges is recorded in accrued restructuring and contract termination charges and the long-term portion of restructuring and contract termination charges is recorded in long-term liabilities. The activities associated with these plans have been reported as restructuring and contract termination charges, net, as applicable, and are included as a component of income from continuing operations.

We implemented a restructuring plan in each of the first and third quarters of fiscal year 2018 consisting of workforce reductions principally intended to realign resources to emphasize growth initiatives (the "Q1 2018 Plan" and "Q3 2018 Plan", respectively). We implemented a restructuring plan in each of the fourth and third quarters of fiscal year 2017 consisting of workforce reductions principally intended to realign resources to emphasize growth initiatives (the "Q4 2017 Plan and "Q3 2017 Plan", respectively). We implemented a restructuring plan in the first quarter of fiscal year 2017 consisting of workforce reductions and the closure of excess facility space principally intended to focus resources on higher growth end markets (the "Q1 2017 Plan"). Details of the plans initiated in previous years (the “Previous Plans”) are discussed more fully in Note 4 to the audited consolidated financial statements in our 2017 Form 10-K.

Table of Contents

The following table summarizes the reductions in headcount, the initial restructuring or contract termination charges by operating segment, and the dates by which payments were substantially completed, or the dates by which payments are expected to be substantially completed, for restructuring actions implemented during fiscal years 2018 and 2017 in continuing operations:



	Workforce Reductions					Closure of Excess Facility				Total		(Expected) Date Payments Substantially Completed by
	Headcount Reduction	Discovery & Analytical Solutions		Diagnostics		Discovery & Analytical Solutions		Diagnostics				Severance	Excess Facility
	Headcount Reduction	Discovery & Analytical Solutions		Diagnostics		Discovery & Analytical Solutions		Diagnostics				Severance	Excess Facility
	(In thousands, except headcount data)
Q3 2018 Plan	61	$	1,146	$	618	$	—	$	—	$	1,764	Q2 FY2019	—
Q1 2018 Plan	47	5,096		902		—		—		5,998		Q2 FY2019	—
Q4 2017 Plan	29	1,680		255		—		—		1,935		Q1 FY2019	—
Q3 2017 Plan	27	1,321		1,021		—		—		2,342		Q4 FY2018	—
Q1 2017 Plan	90	5,000		1,631		33		33		6,697		Q4 FY2018	Q4 FY2018

We do not currently expect to incur any future charges for these plans. We expect to make payments under the Previous Plans for remaining residual lease obligations, with terms varying in length, through fiscal year 2022.

In connection with the termination of various contractual commitments, we recorded additional pre-tax charges of $4.7 million and $5.0 million during the three and nine months ended September 30, 2018, respectively, in the DAS segment.

At September 30, 2018, we had $9.4 million recorded for accrued restructuring and contract termination charges, of which $8.1 million was recorded in short-term accrued restructuring and contract termination charges and $1.3 million was recorded in long-term liabilities. At December 31, 2017, we had $14.0 million recorded for accrued restructuring and contract termination charges, of which $8.8 million was recorded in short-term accrued restructuring and contract termination charges, $2.3 million was recorded in long-term liabilities and $2.9 million was recorded in other reserves. The following table summarizes our restructuring and contract termination accrual balances and related activity by restructuring plan, as well as contract termination accrual balances and related activity, during the nine months ended September 30, 2018:



	Balance at December 31, 2017		2018 Charges		2018 Changes in Estimates, Net		2018 Amounts Paid			Balance at September 30, 2018
	(In thousands)
Severance:
Q3 2018 Plan	$	—	$	1,764	$	—	$	—		$	1,764
Q1 2018 Plan	—		5,998		—		(4,273		)	1,725
Q4 2017 Plan	1,919		—		—		(1,538		)	381
Q3 2017 Plan	2,072		—		—		(868		)	1,204
Q1 2017 Plan	2,498		—		—		(1,174		)	1,324

Facility:
Q1 2017 Plan	33		—		—		(22		)	11

Previous Plans	4,399		—		353		(2,106		)	2,646
Restructuring	10,921		7,762		353		(9,981		)	9,055
Contract Termination	3,048		4,744		227		(7,653		)	366
Total Restructuring and Contract Termination	$	13,969	$	12,506	$	580	$	(17,634	)	$	9,421

Table of Contents

Interest and Other Expense, Net

Interest and other expense, net, consisted of the following:



	Three Months Ended						Nine Months Ended
	September 30, 2018			October 1, 2017			September 30, 2018			October 1, 2017
	(In thousands)
Interest income	$	(316	)	$	(802	)	$	(754	)	$	(1,512	)
Interest expense	16,684			10,974			50,745			32,510
(Gain) loss on disposition of businesses and assets, net	(13,031		)	—			(13,031		)	301
Other income, net	(1,176		)	(37,188		)	(7,013		)	(45,096		)
Total interest and other expense, net	$	2,161		$	(27,016	)	$	29,947		$	(13,797	)

Interest and other expense, net, for the three months ended September 30, 2018 was an expense of $2.2 million, as compared to income of $27.0 million for the three months ended October 1, 2017, an increase in expense of $29.2 million. The increase in interest and other expense, net, for the three months ended September 30, 2018, as compared to the three months ended October 1, 2017, was primarily due to a one-time foreign exchange gain of $36.3 million recorded for the three months ended October 1, 2017, related to the remeasurement and settlement of the EUROIMMUN acquisition-related hedges, and an increase in interest expense by $5.7 million primarily due to higher outstanding bank debt balances as well as the new April 2021 Notes related to financing of the EUROIMMUN acquisition. This increase was partially offset by a gain of $13.0 million recorded for the three months ended September 30, 2018 due to the sale of the multispectral imaging business discussed below.

Interest and other expense, net, for the nine months ended September 30, 2018 was an expense of $29.9 million, as compared to income of $13.8 million for the nine months ended October 1, 2017, an increase in expense of $43.7 million. The increase in interest and other expense, net, for the nine months ended September 30, 2018, as compared to the nine months ended October 1, 2017, was primarily due to a one-time foreign exchange gain of $42.6 million recorded for the nine months ended October 1, 2017, related to the remeasurement and settlement of the EUROIMMUN acquisition-related hedges, and an increase in interest expense by $18.2 million primarily due to higher outstanding bank debt balances as well as the new April 2021 Notes related to financing of the EUROIMMUN acquisition. This increase was partially offset by a gain of $13.3 million for the nine months ended September 30, 2018 primarily due to the sale of the multispectral imaging business. A more complete discussion of our liquidity is set forth below under the heading “Liquidity and Capital Resources.”

Provision for Income Taxes

For the three months ended September 30, 2018, the provision for income taxes from continuing operations was $2.6 million, as compared to $8.5 million for the three months ended October 1, 2017. For the nine months ended September 30, 2018, the provision for income taxes from continuing operations was $12.1 million, as compared to $20.5 million for the nine months ended October 1, 2017.

On December 22, 2017, the President of the United States signed into law tax reform legislation, known as the Tax Cuts and Jobs Act (the "Tax Act"), which makes broad and complex changes to the U.S. Internal Revenue Code. Changes include, but are not limited to: (1) the lowering of the U.S. corporate tax rate from 35% to 21%; (2) the transition of U.S. international taxation from a worldwide tax system to a modified territorial system with a one-time transition tax on the deemed repatriation of cumulative foreign earnings as of December 31, 2017; (3) a new provision designed to tax global intangible low-taxed income (GILTI); (4) the creation of the base erosion anti-abuse tax (BEAT), which is effectively a new minimum tax; (5) the deduction for foreign-derived intangible income (FDII); (6) a new limitation on deductible interest expense; (7) the repeal of the domestic production activity deduction; and (8) limitations on the deductibility of certain executive compensation. Based on available information, we have performed a preliminary analysis of the impacts of the Tax Act, and the details are discussed more fully in Note 9, Income Taxes, in the Notes to Condensed Consolidated Financial Statements.

The effective tax rate from continuing operations was 3.3% and 6.8% for the three and nine months ended September 30, 2018, respectively, as compared to 8.1% and 9.5% for the three and nine months ended October 1, 2017, respectively. The lower effective tax rate during the three months ended September 30, 2018, as compared to the three months ended October 1, 2017, was due to certain higher tax rate jurisdictions projected to have lower income in fiscal year 2018 as compared to fiscal year 2017, and higher tax benefits related to discrete items, which were $5.5 million in the three months ended September 30, 2018, as compared to $2.2 million in the three months ended October 1, 2017. The lower effective tax rate during the nine months ended September 30, 2018, as compared to the nine months ended October 1, 2017, was due to lower projected income in certain higher tax rate jurisdictions in fiscal year 2018 as compared to fiscal year 2017.

Table of Contents

Disposition of Businesses and Assets

As part of our continuing efforts to focus on higher growth opportunities, we have discontinued certain businesses. When the discontinued operations represented a strategic shift that will have a major effect on our operations and financial statements, we accounted for these businesses as discontinued operations, and accordingly, have presented the results of operations and related cash flows as discontinued operations. Any business deemed to be a discontinued operation prior to the adoption of ASU 2014-08, Reporting Discontinued Operations and Disclosures of Disposals of Components of An Entity, continues to be reported as a discontinued operation, and the results of operations and related cash flows are presented as discontinued operations for all periods presented. Any remaining assets and liabilities of these businesses have been presented separately, and are reflected within assets and liabilities of discontinued operations in the accompanying condensed consolidated balance sheets as of September 30, 2018 and December 31, 2017.

During the third quarter of fiscal year 2018, we completed the sale of substantially all of the assets and liabilities related to our multispectral imaging business for aggregate consideration of $37.3 million, recognizing a pre-tax gain of $13.0 million. The pre-tax gain is included in interest and other expense, net in the consolidated statement of operations. The multispectral imaging business was a component of our DAS segment. The divestiture of the multispectral imaging business has not been classified as a discontinued operation in this Form 10-Q because the disposition does not represent a strategic shift that will have a major effect on our operations and financial statements.

On May 1, 2017 (the "Varex Closing Date"), we completed the sale of our Medical Imaging business to Varex Imaging Corporation ("Varex") pursuant to the terms of the Master Purchase and Sale Agreement, dated December 21, 2016 (the “Agreement”), by and between us and Varian Medical Systems, Inc. ("Varian") and the subsequent Assignment and Assumption Agreement, dated January 27, 2017, between Varian and Varex, pursuant to which Varian assigned its rights under the Agreement to Varex. On the Varex Closing Date, we received consideration of approximately $277.4 million for the sale of the Medical Imaging business. During fiscal year 2017, we paid Varex $4.2 million to settle a post-closing working capital adjustment. During fiscal year 2017, we recorded a pre-tax gain of $179.6 million and income tax expense of $43.1 million related to the sale of the Medical Imaging business in discontinued operations and dispositions. The corresponding tax liability was recorded within the other tax liabilities in our condensed consolidated balance sheet, and we expect to utilize tax attributes to minimize the tax liability.

Following the closing, we provided certain customary transitional services during a period of up to 12 months. Commercial transactions between the parties following the closing of the transaction are not expected to be significant.

During fiscal year 2017, we sold Suzhou PerkinElmer Medical Laboratory Co., Ltd. for aggregate consideration of $2.3 million, recognizing a pre-tax loss of $1.1 million. The pre-tax loss recognized in fiscal year 2017 is included in interest and other expense, net in our condensed consolidated statement of operations. Suzhou PerkinElmer Medical Laboratory Co., Ltd. was a component of our Diagnostics segment. The divestiture of Suzhou PerkinElmer Medical Laboratory Co., Ltd. has not been classified as a discontinued operation in this Form 10-Q because the disposition does not represent a strategic shift that will have a major effect on our operations and financial statements.

The summary pre-tax operating results of the discontinued operations, were as follows for the three and nine months ended:



	September 30, 2018		October 1, 2017		September 30, 2018		October 1, 2017
	(In thousands)
Revenue	$	—	$	—	$	—	$	44,343
Cost of revenue	—		—		—		32,933
Selling, general and administrative expenses	—		—		—		5,869
Research and development expenses	—		—		—		4,891
Income from discontinued operations before income taxes	$	—	$	—	$	—	$	650

Contingencies, Including Tax Matters

We are conducting a number of environmental investigations and remedial actions at our current and former locations and, along with other companies, have been named a potentially responsible party (“PRP”) for certain waste disposal sites. We accrue for environmental issues in the accounting period that our responsibility is established and when the cost can be reasonably estimated. We have accrued $8.5 million and $9.4 million as of September 30, 2018 and December 31, 2017, respectively, which represents our management’s estimate of the cost of the remediation of known environmental matters, and

Table of Contents

does not include any potential liability for related personal injury or property damage claims. These amounts were included in accrued expenses and other current liabilities. Our environmental accrual is not discounted and does not reflect the recovery of any material amounts through insurance or indemnification arrangements. The cost estimates are subject to a number of variables, including the stage of the environmental investigations, the magnitude of the possible contamination, the nature of the potential remedies, possible joint and several liability, the time period over which remediation may occur, and the possible effects of changing laws and regulations. For sites where we have been named a PRP, our management does not currently anticipate any additional liability to result from the inability of other significant named parties to contribute. We expect that the majority of such accrued amounts could be paid out over a period of up to ten years. As assessment and remediation activities progress at each individual site, these liabilities are reviewed and adjusted to reflect additional information as it becomes available. There have been no environmental problems to date that have had, or are expected to have, a material adverse effect on our condensed consolidated financial statements. While it is possible that a loss exceeding the amounts recorded in the condensed consolidated financial statements may be incurred, the potential exposure is not expected to be materially different from those amounts recorded.

Various tax years after 2010 remain open to examination by certain jurisdictions in which we have significant business operations, such as Finland, Germany, Italy, Netherlands, Singapore, the United Kingdom and the United States. The tax years under examination vary by jurisdiction. We regularly review our tax positions in each significant taxing jurisdiction in the process of evaluating our unrecognized tax benefits. We make adjustments to our unrecognized tax benefits when: (i) facts and circumstances regarding a tax position change, causing a change in management’s judgment regarding that tax position; (ii) a tax position is effectively settled with a tax authority; and/or (iii) the statute of limitations expires regarding a tax position.

We are subject to various claims, legal proceedings and investigations covering a wide range of matters that arise in the ordinary course of our business activities. Although we have established accruals for potential losses that we believe are probable and reasonably estimable, in our opinion, based on our review of the information available at this time, the total cost of resolving these contingencies at September 30, 2018 would not have a material adverse effect on our condensed consolidated financial statements. However, each of these matters is subject to uncertainties, and it is possible that some of these matters may be resolved unfavorably to us.

Reporting Segment Results of Continuing Operations

Discovery & Analytical Solutions

Revenue for the three months ended September 30, 2018 was $406.2 million, as compared to $385.4 million for the three months ended October 1, 2017, an increase of $20.8 million, or 5%, which includes an approximate 1% decrease in revenue attributable to unfavorable changes in foreign exchange rates. The analysis in the remainder of this paragraph compares selected revenue by end-markets for the three months ended September 30, 2018, as compared to the three months ended October 1, 2017, and includes the effect of foreign exchange fluctuations. The increase in revenue in our Discovery & Analytical Solutions segment was a result of an increase in our applied markets revenue of $8.5 million and an increase of $12.3 million in our life sciences market revenue. The increase in our applied markets revenue was driven by strength in sales of industrial, environmental and food offerings. The increase in our life sciences market revenue was driven by strength in our drug discovery sales and increased demand for our OneSource laboratory service business.

Revenue for the nine months ended September 30, 2018 was $1,233.3 million, as compared to $1,130.3 million for the nine months ended October 1, 2017, an increase of $103.0 million, or 9%, which includes an approximate 2% increase in revenue attributable to favorable changes in foreign exchange rates. The analysis in the remainder of this paragraph compares selected revenue by end-markets for the nine months ended September 30, 2018, as compared to the nine months ended October 1, 2017, and includes the effect of foreign exchange fluctuations. The increase in revenue in our Discovery & Analytical Solutions segment was a result of an increase of $63.2 million in our life sciences market revenue and an increase in applied markets revenue of $39.8 million. The increase in our life sciences market revenue was driven by strength in our drug discovery sales, a strong performance in our Informatics business and increased demand for our OneSource laboratory service business. In our applied markets, we experienced higher growth in our industrial, environmental and food offerings.

Operating income from continuing operations for the three months ended September 30, 2018 was $48.4 million, as compared to $47.3 million for the three months ended October 1, 2017, an increase of $1.1 million, or 2%. Amortization of intangible assets was $11.4 million for the three months ended September 30, 2018, as compared to $12.8 million for the three months ended October 1, 2017. Restructuring and contract termination charges, net, were $5.9 million for the three months ended September 30, 2018, as compared to $1.7 million for the three months ended October 1, 2017. Acquisition and divestiture-related expenses, contingent consideration and other costs added an incremental expense of $1.8 million for the three months ended September 30, 2018. Legal costs for significant litigation matters were $0.6 million for the three months ended September 30, 2018, as compared to zero for the three months ended October 1, 2017. In addition to the factors noted

Table of Contents

above, operating income increased for the three months ended September 30, 2018, as compared to the three months ended October 1, 2017, as we continued to realize the benefits from our cost containment initiatives partially offset by higher costs in research and development expenses.

Operating income from continuing operations for the nine months ended September 30, 2018 was $149.2 million, as compared to $128.6 million for the nine months ended October 1, 2017, an increase of $20.6 million, or 16%. Amortization of intangible assets was $34.6 million for the nine months ended September 30, 2018, as compared to $37.5 million for the nine months ended October 1, 2017. Restructuring and contract termination charges, net, were $11.6 million for the nine months ended September 30, 2018, as compared to $9.7 million for the nine months ended October 1, 2017. Acquisition and divestiture-related expenses, contingent consideration and other costs added an incremental expense of $1.9 million for the nine months ended September 30, 2018, as compared to $0.4 million for the nine months ended October 1, 2017. Legal costs for significant litigation matters were $5.1 million for the nine months ended September 30, 2018, as compared to zero for the nine months ended October 1, 2017. In addition to the factors noted above, operating income increased for the nine months ended September 30, 2018, as compared to the nine months ended October 1, 2017, as we continued to realize the benefits from our cost containment initiatives partially offset by higher costs in research and development expenses.

Diagnostics

Revenue for the three months ended September 30, 2018 was $268.1 million, as compared to $168.9 million for the three months ended October 1, 2017, an increase of $99.3 million, or 59%, which includes an approximate 53% increase in revenue attributable to acquisitions and divestitures and a 2% decrease in revenue attributable to unfavorable changes in foreign exchange rates. As a result of adjustments to deferred revenue related to certain acquisitions required by business combination accounting rules, we did not recognize $0.2 million of revenue in our Diagnostics segment for each of the three months ended September 30, 2018 and October 1, 2017 that otherwise would have been recorded by the acquired businesses during each of the respective periods. In our diagnostics market, we experienced growth from our acquisition of EUROIMMUN, which contributed $90.2 million in revenues during the three months ended September 30, 2018, and continued expansion of our reproductive health, applied genomics and immuno-diagnostics solutions, particularly in the Americas and emerging markets, such as China and India.

Revenue for the nine months ended September 30, 2018 was $788.3 million, as compared to $485.1 million for the nine months ended October 1, 2017, an increase of $303.2 million, or 63%, which includes an approximate 52% increase in revenue attributable to acquisitions and divestitures and a 2% increase in revenue attributable to favorable changes in foreign exchange rates. As a result of adjustments to deferred revenue related to certain acquisitions required by business combination accounting rules, we did not recognize $0.6 million of revenue in our Diagnostics segment for each of the nine months ended September 30, 2018 and October 1, 2017 that otherwise would have been recorded by the acquired businesses during each of the respective periods. In our diagnostics market, we experienced growth from our acquisition of EUROIMMUN, which contributed $262.4 million in revenues during the nine months ended September 30, 2018, and continued expansion of our reproductive health, applied genomics and immuno-diagnostics solutions in key regions outside the United States, particularly in Europe and emerging markets, such as China and India.

Operating income from continuing operations for the three months ended September 30, 2018 was $47.4 million, as compared to $43.4 million for the three months ended October 1, 2017, an increase of $4.1 million, or 9%. Amortization of intangible assets increased and was $23.9 million for the three months ended September 30, 2018, as compared to $4.9 million for the three months ended October 1, 2017. Acquisition and divestiture-related expenses, contingent consideration and other costs added an incremental expense of $3.9 million for the three months ended September 30, 2018, as compared to $6.3 million for the three months ended October 1, 2017. Restructuring and contract termination charges, net, were $0.6 million for the three months ended September 30, 2018, as compared to $1.5 million for the three months ended October 1, 2017. Legal costs for significant litigation matters were $0.4 million for the three months ended September 30, 2018, as compared to zero for the three months ended October 1, 2017. In addition to the factors noted above, operating income increased for the three months ended September 30, 2018, as compared to the three months ended October 1, 2017, primarily the result of a favorable shift in product mix, higher sales volume, strong reproductive health sales and benefits from our initiatives to improve our supply chain.

Operating income from continuing operations for the nine months ended September 30, 2018 was $104.6 million, as compared to $113.0 million for the nine months ended October 1, 2017, a decrease of $8.4 million, or 7%. Amortization of intangible assets increased and was $66.1 million for the nine months ended September 30, 2018, as compared to $14.8 million for the nine months ended October 1, 2017. Acquisition and divestiture-related expenses, contingent consideration and other costs added an incremental expense of $15.5 million for the nine months ended September 30, 2018, as compared to $13.5 million for the nine months ended October 1, 2017. The amortization of purchase accounting adjustments to record the inventory from certain acquisitions was $18.2 million for the nine months ended September 30, 2018, as compared to $4.2

Table of Contents

million for the nine months ended October 1, 2017. Restructuring and contract termination charges, net, were $1.5 million for the nine months ended September 30, 2018, as compared to $3.2 million for the nine months ended October 1, 2017. Legal costs, net of reversals, for significant litigation matters were $0.2 million for the nine months ended September 30, 2018, as compared to zero for the nine months ended October 1, 2017. In addition to the factors noted above, operating income decreased for the nine months ended September 30, 2018, as compared to the nine months ended October 1, 2017, primarily the result of an unfavorable shift in product mix partially offset by higher sales volume, strong reproductive health sales and benefits from our initiatives to improve our supply chain.

Liquidity and Capital Resources

We require cash to pay our operating expenses, make capital expenditures, make strategic acquisitions, service our debt and other long-term liabilities, repurchase shares of our common stock and pay dividends on our common stock. Our principal sources of funds are from our operations and the capital markets, particularly the debt markets. We anticipate that our internal operations will generate sufficient cash to fund our operating expenses, capital expenditures, smaller acquisitions, interest payments on our debt and dividends on our common stock. However, we expect to use external sources to satisfy the balance of our debt when due and fund any larger acquisitions and other long-term liabilities, such as contributions to our postretirement benefit plans.

Principal factors that could affect the availability of our internally generated funds include:


•	changes in sales due to weakness in markets in which we sell our products and services, and


•	changes in our working capital requirements.

Principal factors that could affect our ability to obtain cash from external sources include:


•	financial covenants contained in the financial instruments controlling our borrowings that limit our total borrowing capacity,


•	increases in interest rates applicable to our outstanding variable rate debt,


•	a ratings downgrade that could limit the amount we can borrow under our senior unsecured revolving credit facility and our overall access to the corporate debt market,


•	increases in interest rates or credit spreads, as well as limitations on the availability of credit, that affect our ability to borrow under future potential facilities on a secured or unsecured basis,


•	a decrease in the market price for our common stock, and


•	volatility in the public debt and equity markets.

At September 30, 2018, we had cash and cash equivalents of $149.5 million, of which $135.6 million was held by our non-U.S. subsidiaries, and we had $577.6 million of additional borrowing capacity available under our senior unsecured revolving credit facility. We had no other liquid investments at September 30, 2018.

We utilize a variety of tax planning and financing strategies to ensure that our worldwide cash is available in the locations in which it is needed. The Tax Act requires us to pay a one-time transition tax on the unremitted earnings of foreign subsidiaries. Based on available information, we estimated the tax on the deemed repatriation of our foreign earnings and have recorded a tax expense of $85.0 million in continuing operations at December 31, 2017. During the three months ended September 30, 2018, we refined our calculations of the one-time transition tax based on newly issued guidance from the Internal Revenue Service. As a result, we recorded a benefit of $5.1 million in continuing operations related to the one-time transition tax. No additional income taxes have been provided for any remaining undistributed foreign earnings not subject to the transition tax, or any additional outside basis difference inherent in these entities, as these amounts continue to be indefinitely reinvested in foreign operations.

On July 27, 2016, our Board of Directors (our "Board") authorized us to repurchase up to 8.0 million shares of common stock under a stock repurchase program (the "Repurchase Program"). On July 23, 2018, our Board authorized us to immediately terminate the Repurchase Program and further authorized us to repurchase shares of common stock for an aggregate amount up to $250.0 million under a new stock repurchase program (the "New Repurchase Program"). The New Repurchase Program will expire on July 23, 2020 unless terminated earlier by our Board and may be suspended or discontinued at any time. During the nine months ended September 30, 2018, we had no stock repurchases under the Repurchase Program and New Repurchase Program. No shares remain available for repurchase under the Repurchase Program due to its cancellation. As of September 30, 2018, $250.0 million remained available for aggregate repurchases of shares under the New Repurchase Program.

Table of Contents

In addition, our Board has authorized us to repurchase shares of common stock to satisfy minimum statutory tax withholding obligations in connection with the vesting of restricted stock awards and restricted stock unit awards granted pursuant to our equity incentive plans and to satisfy obligations related to the exercise of stock options made pursuant to our equity incentive plans. During the three months ended September 30, 2018, we repurchased 3,807 shares of common stock for this purpose at an aggregate cost of $0.3 million. During the nine months ended September 30, 2018, we repurchased 63,506 shares of common stock for this purpose at an aggregate cost of $5.0 million.

The repurchased shares have been reflected as additional authorized but unissued shares, with the payments reflected in common stock and capital in excess of par value. Any repurchased shares will be available for use in connection with corporate programs. If we continue to repurchase shares, the New Repurchase Program will be funded using our existing financial resources, including cash and cash equivalents, and our senior unsecured revolving credit facility.

Distressed global financial markets could adversely impact general economic conditions by reducing liquidity and credit availability, creating increased volatility in security prices, widening credit spreads and decreasing valuations of certain investments. The widening of credit spreads may create a less favorable environment for certain of our businesses and may affect the fair value of financial instruments that we issue or hold. Increases in credit spreads, as well as limitations on the availability of credit at rates we consider to be reasonable, could affect our ability to borrow under future potential facilities on a secured or unsecured basis, which may adversely affect our liquidity and results of operations. In difficult global financial markets, we may be forced to fund our operations at a higher cost, or we may be unable to raise as much funding as we need to support our business activities.

During the first nine months of fiscal year 2018, we contributed $6.4 million, in the aggregate, to our defined benefit pension plans outside of the United States, and expect to contribute an additional $2.3 million by the end of fiscal year 2018. During the nine months ended September 30, 2018, we contributed $15.0 million to our defined benefit pension plan in the United States for plan year 2017. We could potentially have to make additional contributions in future periods for all pension plans. We expect to use existing cash and external sources to satisfy future contributions to our pension plans.

Our pension plans have not experienced a material impact on liquidity or counterparty exposure due to the volatility and uncertainty in the credit markets. We recognize actuarial gains and losses in other income or expense in the fourth quarter of the year in which the gains and losses occur, unless there is an interim remeasurement required for one of our plans. It is difficult to reliably predict the magnitude of such adjustments for gains and losses in fiscal year 2018. These adjustments are primarily driven by events and circumstances beyond our control, including changes in interest rates, the performance of the financial markets and mortality assumptions. To the extent the discount rates decrease or the value of our pension and postretirement investments decrease, a loss will be recorded in fiscal year 2018. Conversely, to the extent the discount rates increase or the value of our pension and postretirement investments increase more than expected, a gain will be recorded in fiscal year 2018.

Cash Flows

Operating Activities. Net cash provided by continuing operations was $151.8 million for the nine months ended September 30, 2018, as compared to net cash provided by continuing operations of $165.2 million for the nine months ended October 1, 2017, a decrease in cash provided by operating activities of $13.3 million. The cash provided by operating activities for the nine months ended September 30, 2018 was principally a result of a net cash decrease in accrued expenses, other assets and liabilities and other items of $90.7 million and a net cash decrease in working capital of $90.6 million. These items were partially offset by income from continuing operations of $166.2 million, adjusted for non-cash charges, including depreciation and amortization of $133.4 million, stock-based compensation expense of $23.3 million, restructuring and contract termination charges, net of $13.1 million and change in fair value of contingent consideration of $10.8 million, as well as a gain on disposition of businesses and assets, net of $13.0 million and a gain on sales of investments, net of $0.6 million. Contributing to the net cash decrease in working capital for the nine months ended September 30, 2018, excluding the effect of foreign exchange rate fluctuations, was a decrease in accounts payable of $36.6 million, an increase in accounts receivable of $12.7 million and an increase in inventory of $41.3 million. The decrease in accounts payable was primarily a result of the timing of disbursements during the first nine months of fiscal year 2018. The increase in accounts receivable was a result of higher sales volume during the first nine months of fiscal year 2018. The increase in inventory was primarily a result of expanding the amount of inventory held at sales locations within our Discovery & Analytical Solutions and Diagnostics segments to improve responsiveness to customer requirements and to facilitate the introduction of new products. Changes in accrued expenses, other assets and liabilities and other items decreased cash provided by operating activities by $90.7 million for the nine months ended September 30, 2018, as compared to $109.6 million for the nine months ended October 1, 2017. These changes primarily related to the timing of payments for pensions, taxes, restructuring, and salary and benefits.

Investing Activities. Net cash used in the investing activities of our continuing operations was $71.9 million for the nine months ended September 30, 2018, as compared to $85.5 million for the nine months ended October 1, 2017, a decrease of $13.6 million. For the nine months ended September 30, 2018, the net cash used in investing activities of our continuing

Table of Contents

operations was principally a result of capital expenditures of $60.4 million, cash used for acquisitions of $44.1 million, and purchases of investments of $5.5 million. These items were partially offset by $38.0 million in proceeds from disposition of investments and $0.1 million in proceeds from the surrender of life insurance policies. Net cash used for capital expenditures was $22.4 million for the nine months ended October 1, 2017. The capital expenditures in each period were primarily for manufacturing and other capital equipment purchases. In addition, during the nine months ended October 1, 2017, we used $123.6 million in cash for acquisitions and investments, which was partially offset by $60.4 million in proceeds from settlement of acquisition-related foreign currency forward contracts.

Financing Activities. Net cash used in financing activities of continuing operations was $122.0 million for the nine months ended September 30, 2018, as compared to net cash used in financing activities of continuing operations of $33.9 million for the nine months ended October 1, 2017, an increase in cash used in financing activities of continuing operations of $88.0 million. During the nine months ended September 30, 2018, we paid $30.3 million as compared to $11.5 million for settlement of forward foreign exchange contracts for the nine months ended October 1, 2017. During the nine months ended September 30, 2018, we paid $23.2 million as compared to $23.1 million in dividends for the nine months ended October 1, 2017. During the nine months ended September 30, 2018, we had net payments on other credit facilities of $22.9 million as compared to $0.9 million for the nine months ended October 1, 2017. During the nine months ended September 30, 2018, we repurchased 63,506 shares of our common stock to satisfy minimum statutory tax withholding obligations in connection with the vesting of restricted stock awards and restricted stock unit awards granted pursuant to our equity incentive plans and to satisfy obligations related to the exercise of stock options made pursuant to our equity incentive plans, for a total cost of $5.0 million. This compares to repurchases of 73,672 shares of common stock pursuant to our equity incentive plans for the nine months ended October 1, 2017, for a total cost of $3.5 million. During the nine months ended September 30, 2018, we made $12.8 million in payments for acquisition-related contingent consideration, as compared to $8.9 million for the nine months ended October 1, 2017. This cash used in financing activities during the nine months ended September 30, 2018 was partially offset by proceeds of $369.3 million from the sale of our 0.6% senior unsecured notes due in 2021, and we paid $2.6 million for debt issuance costs. During the nine months ended September 30, 2018, borrowings from our senior unsecured revolving credit facility totaled $605.0 million, which were more than offset by debt payments of $1,019.0 million. This compares to borrowings from our senior unsecured revolving credit facility of $147.0 million, which were offset by our debt payments of $147.0 million during the nine months ended October 1, 2017. Proceeds from the issuance of common stock under our stock plans were $19.5 million during the nine months ended September 30, 2018 as compared to $14.0 million for the nine months ended October 1, 2017.

Borrowing Arrangements

Senior Unsecured Revolving Credit Facility. Our senior unsecured revolving credit facility provides for $1.0 billion of revolving loans and has an initial maturity of August 11, 2021. As of September 30, 2018, undrawn letters of credit in the aggregate amount of $11.4 million were treated as issued and outstanding when calculating the borrowing availability under the senior unsecured revolving credit facility. As of September 30, 2018, we had $577.6 million available for additional borrowing under the facility. We use the senior unsecured revolving credit facility for general corporate purposes, which may include working capital, refinancing existing indebtedness, capital expenditures, share repurchases, acquisitions and strategic alliances. The interest rates under the senior unsecured revolving credit facility are based on the Eurocurrency rate or the base rate at the time of borrowing, plus a margin. The base rate is the higher of (i) the rate of interest in effect for such day as publicly announced from time to time by JP Morgan Chase Bank, N.A. as its "prime rate," (ii) the Federal Funds rate plus 50 basis points or (iii) an adjusted one-month Libor plus 1.00%. The Eurocurrency margin as of September 30, 2018 was 110 basis points. The weighted average Eurocurrency interest rate as of September 30, 2018 was 2.19%, resulting in a weighted average effective Eurocurrency rate, including the margin, of 3.29%, which was the interest applicable to the borrowings outstanding under the Eurocurrency rate as of September 30, 2018. As of September 30, 2018, the senior unsecured revolving credit facility had outstanding borrowings of $411.0 million, and $2.6 million of unamortized debt issuance costs. As of December 31, 2017, the senior unsecured revolving credit facility had outstanding borrowings of $625.0 million, and $3.3 million of unamortized debt issuance costs. The credit agreement for the facility contains affirmative, negative and financial covenants and events of default. The financial covenants include a debt-to-capital ratio that remains applicable for so long as our debt is rated as investment grade. In the event that our debt is not rated as investment grade, the debt-to-capital ratio covenant is replaced with a maximum consolidated leverage ratio covenant and a minimum consolidated interest coverage ratio covenant. We were in compliance with all applicable covenants as of September 30, 2018.

Senior Unsecured Term Loan Credit Facility. We entered into a senior unsecured term loan credit facility on August 11, 2017 that provided for $200.0 million of term loans and had an initial maturity of twelve months from December 19, 2017, the date of the initial draw. We utilized the senior unsecured term loan facility for the acquisition of EUROIMMUN. The interest rates under the senior unsecured term loan credit facility were based on the Eurocurrency rate or the base rate at the time of the borrowing, plus a margin. The base rate is the higher of (i) the rate of interest in effect for such day as publicly announced from time to time by JP Morgan Chase Bank, N.A. as its "prime rate," (ii) the Federal Funds rate plus 50 basis points or (iii) an

Table of Contents

adjusted one-month Libor plus 1.00%. In April 2018, we paid in full the outstanding balance of $200.0 million on the senior unsecured term loan credit facility, from the proceeds of the 0.6% senior unsecured notes due in 2021 that were issued in April 2018.

5% Senior Unsecured Notes due in 2021. On October 25, 2011, we issued $500.0 million aggregate principal amount of senior unsecured notes due in 2021 (the “November 2021 Notes”) in a registered public offering and received $493.6 million of net proceeds from the issuance. The November 2021 Notes were issued at 99.4% of the principal amount, which resulted in a discount of $3.1 million. As of September 30, 2018, the November 2021 Notes had an aggregate carrying value of $497.2 million, net of $1.2 million of unamortized original issue discount and $1.7 million of unamortized debt issuance costs. As of December 31, 2017, the November 2021 Notes had an aggregate carrying value of $496.6 million, net of $1.4 million of unamortized original issue discount and $2.0 million of unamortized debt issuance costs. The November 2021 Notes mature in November 2021 and bear interest at an annual rate of 5%. Interest on the November 2021 Notes is payable semi-annually on May 15th and November 15th each year. Prior to August 15, 2021 (three months prior to their maturity date), we may redeem the November 2021 Notes in whole or in part, at our option, at a redemption price equal to the greater of (i) 100% of the principal amount of the November 2021 Notes to be redeemed, plus accrued and unpaid interest, or (ii) the sum of the present values of the remaining scheduled payments of principal and interest in respect to the November 2021 Notes being redeemed, discounted on a semi-annual basis, at the Treasury Rate plus 45 basis points, plus accrued and unpaid interest. At any time on or after August 15, 2021 (three months prior to their maturity date), we may redeem the November 2021 Notes, at our option, at a redemption price equal to 100% of the principal amount of the November 2021 Notes to be redeemed plus accrued and unpaid interest. Upon a change of control (as defined in the indenture governing the November 2021 Notes) and a contemporaneous downgrade of the November 2021 Notes below investment grade, each holder of November 2021 Notes will have the right to require us to repurchase such holder's November 2021 Notes for 101% of their principal amount, plus accrued and unpaid interest.

1.875% Senior Unsecured Notes due 2026. On July 19, 2016, we issued €500.0 million aggregate principal amount of senior unsecured notes due in 2026 (the “2026 Notes”) in a registered public offering and received approximately €492.3 million of net proceeds from the issuance. The 2026 Notes were issued at 99.118% of the principal amount, which resulted in a discount of €4.4 million. The 2026 Notes mature in July 2026 and bear interest at an annual rate of 1.875%. Interest on the 2026 Notes is payable annually on July 19th each year. The proceeds from the 2026 Notes were used to pay in full the outstanding balance of our previous senior unsecured revolving credit facility. As of September 30, 2018, the 2026 Notes had an aggregate carrying value of $572.3 million, net of $4.2 million of unamortized original issue discount and $3.9 million of unamortized debt issuance costs. As of December 31, 2017, the 2026 Notes had an aggregate carrying value of $591.7 million, net of $4.7 million of unamortized original issue discount and $4.3 million of unamortized debt issuance costs.

Prior to April 19, 2026 (three months prior to their maturity date), we may redeem the 2026 Notes in whole at any time or in part from time to time, at our option, at a redemption price equal to the greater of (i) 100% of the principal amount of the 2026 Notes to be redeemed, or (ii) the sum of the present values of the remaining scheduled payments of principal and interest in respect to the 2026 Notes being redeemed, discounted on an annual basis, at the applicable Comparable Government Bond Rate (as defined in the indenture governing the 2026 Notes) plus 35 basis points; plus, in each case, accrued and unpaid interest. In addition, at any time on or after April 19, 2026 (three months prior to their maturity date), we may redeem the 2026 Notes, at our option, at a redemption price equal to 100% of the principal amount of the 2026 Notes due to be redeemed plus accrued and unpaid interest.

Upon a change of control (as defined in the indenture governing the 2026 Notes) and a contemporaneous downgrade of the 2026 Notes below investment grade, we will, in certain circumstances, make an offer to purchase the 2026 Notes at a price equal to 101% of their principal amount plus any accrued and unpaid interest.

0.6% Senior Unsecured Notes due in 2021. On April 11, 2018, we issued €300.0 million aggregate principal amount of senior unsecured notes due in 2021 (the “April 2021 Notes”) in a registered public offering and received approximately €298.7 million of net proceeds from the issuance. The April 2021 Notes were issued at 99.95% of the principal amount, which resulted in a discount of €0.2 million. As of September 30, 2018, the April 2021 Notes had an aggregate carrying value of $345.8 million, net of $0.2 million of unamortized original issue discount and $2.3 million of unamortized debt issuance costs. The April 2021 Notes mature in April 2021 and bear interest at an annual rate of 0.6%. Interest on the April 2021 Notes is payable annually on April 9th each year. The proceeds from the April 2021 Notes were used to pay in full the outstanding balance of our senior unsecured term loan credit facility, and a portion of the outstanding senior unsecured revolving credit facility, and in each case the borrowings were incurred to pay a portion of the purchase price for our acquisition of EUROIMMUN, which closed in December 19, 2017. Prior to the maturity date of the April 2021 Notes, we may redeem them in whole at any time or in part from time to time, at our option, at a redemption price equal to the greater of (i) 100% of the principal amount of the April 2021 Notes to be redeemed, or (ii) the sum of the present values of the remaining scheduled payments of principal and interest in respect to the April 2021 Notes being redeemed, discounted on an annual basis, at the applicable Comparable Government Bond Rate (as defined in the indenture governing the April 2021 Notes) plus 15 basis points; plus, in each case,

Table of Contents

accrued and unpaid interest. Upon a change of control (as defined in the indenture governing the April 2021 Notes) and a contemporaneous downgrade of the April 2021 Notes below investment grade, we will, in certain circumstances, make an offer to purchase the April 2021 Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest.

Other Debt Facilities. Our other debt facilities include Euro-denominated bank loans with an aggregate carrying value of $35.3 million (or €30.4 million) and $57.2 million (or €47.6 million) as of September 30, 2018 and December 31, 2017, respectively. These bank loans are primarily utilized for financing fixed assets and are repaid in monthly or quarterly installments with maturity dates extending to 2031. Of these bank loans, loans in the aggregate amount of $35.1 million bear fixed interest rates between 1.1% and 5.5% and a loan in the amount of $0.2 million bears a variable interest rate based on the Euribor rate plus a margin of 1.5%. An aggregate amount of $5.4 million of the bank loans are secured by mortgages on real property and the remaining $29.9 million are unsecured. Certain credit agreements for the unsecured bank loans include financial covenants which are based on an equity ratio or an equity ratio and minimum interest coverage ratio. We were in compliance with all applicable covenants as of September 30, 2018.

In addition, we have other unsecured revolving credit facilities and a secured bank loan in the amount of $8.1 million and $0.2 million, respectively, as of September 30, 2018. The unsecured revolving debt facilities bear fixed interest rates between 0.05% and 2.30%. The secured bank loan of $0.2 million bears a fixed annual interest rate of 1.95% and is repaid in monthly installments until 2027.

Financing Lease Obligations. In fiscal year 2012, we entered into agreements with the lessors of certain buildings that we are currently occupying and leasing to expand those buildings. We provided a portion of the funds needed for the construction of the additions to the buildings, and as a result we were considered the owner of the buildings during the construction period. At the end of the construction period, we were not reimbursed by the lessors for all of the construction costs. We are therefore deemed to have continuing involvement and the leases qualify as financing leases under sale-leaseback accounting guidance, representing debt obligations for us and non-cash investing and financing activities. As a result, we capitalized $29.3 million in property, plant and equipment, net, representing the fair value of the buildings with a corresponding increase to debt. We have also capitalized $11.5 million in additional construction costs necessary to complete the renovations to the buildings, which were funded by the lessors, with a corresponding increase to debt. At September 30, 2018, we had $34.9 million recorded for these financing lease obligations, of which $1.5 million was recorded as short-term debt and $33.4 million was recorded as long-term debt. At December 31, 2017, we had $35.9 million recorded for these financing lease obligations, of which $1.4 million was recorded as short-term debt and $34.5 million was recorded as long-term debt. The buildings are being depreciated on a straight-line basis over the terms of the leases to their estimated residual values, which will equal the remaining financing obligation at the end of the lease term. At the end of the lease term, the remaining balances in property, plant and equipment, net and debt will be reversed against each other.

Dividends

Our Board declared a regular quarterly cash dividend of $0.07 per share for the first three quarters of fiscal year 2018 and in each quarter of fiscal year 2017. At September 30, 2018, we had accrued $7.8 million for dividends declared on July 23, 2018 for the third quarter of fiscal year 2018 that will be payable on November 9, 2018. On October 24, 2018, we announced that our Board had declared a quarterly dividend of $0.07 per share for the fourth quarter of fiscal year 2018 that will be payable on February 8, 2019. In the future, our Board may determine to reduce or eliminate our common stock dividend in order to fund investments for growth, repurchase shares or conserve capital resources.

Contractual Obligations

Our contractual obligations, as described in the contractual obligations table contained in Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the 2017 Form 10-K have changed due to new lease agreements for certain operating facilities.

During the nine months ended September 30, 2018, we entered into new lease agreements for certain operating facilities. Our total rental payments to the lessors are now expected to be $10.6 million for the remainder of fiscal year 2018, $26.2 million for fiscal year 2019, $19.9 million for fiscal year 2020, $14.9 million for fiscal year 2021, $8.1 million for fiscal year 2022 and $18.2 million in the aggregate thereafter. There have not been any other material changes during the first nine months of fiscal year 2018.

Effects of Recently Adopted and Issued Accounting Pronouncements

See Note 1, Basis of Presentation, in the Notes to Condensed Consolidated Financial Statements for a summary of recently adopted and issued accounting pronouncements.

Table of Contents


Item 3.	Quantitative and Qualitative Disclosures About Market Risk

Market Risk. We are exposed to market risk, including changes in interest rates and currency exchange rates. To manage the volatility relating to these exposures, we enter into various derivative transactions pursuant to our policies to hedge against known or forecasted market exposures. We briefly describe several of the market risks we face below. The following disclosure is not materially different from the disclosure provided under the heading, Item 7A. “Quantitative and Qualitative Disclosure About Market Risk,” in our 2017 Form 10-K.

Foreign Exchange Risk. The potential change in foreign currency exchange rates offers a substantial risk to us, as approximately 70% of our business is conducted outside of the United States, generally in foreign currencies. Our risk management strategy currently uses forward contracts to mitigate certain balance sheet foreign currency transaction exposures. The intent of these economic hedges is to offset gains and losses that occur on the underlying exposures, with gains and losses resulting from the forward contracts that hedge these exposures. Moreover, we are able to partially mitigate the impact that fluctuations in currencies have on our net income as a result of our manufacturing facilities located in countries outside the United States, material sourcing and other spending which occur in countries outside the United States, resulting in natural hedges.

We do not enter into derivative contracts for trading or other speculative purposes, nor do we use leveraged financial instruments. Although we attempt to manage our foreign exchange risk through the above activities, when the U.S. dollar weakens against other currencies in which we transact business, sales and net income generally will be positively but not proportionately impacted. Conversely, when the U.S. dollar strengthens against other currencies in which we transact business, sales and net income will generally be negatively but not proportionately impacted.

In the ordinary course of business, we enter into foreign exchange contracts for periods consistent with our committed exposures to mitigate the effect of foreign currency movements on transactions denominated in foreign currencies. The intent of these economic hedges is to offset gains and losses that occur on the underlying exposures from these currencies, with gains and losses resulting from the forward currency contracts that hedge these exposures. Transactions covered by hedge contracts include intercompany and third-party receivables and payables. The contracts are primarily in European and Asian currencies, have maturities that do not exceed 12 months, have no cash requirements until maturity, and are recorded at fair value on our condensed consolidated balance sheets. The unrealized gains and losses on our foreign currency contracts are recognized immediately in interest and other expense, net. The cash flows related to the settlement of these hedges are included in cash flows from operating activities within our condensed consolidated statement of cash flows.

Principal hedged currencies include the British Pound, Euro, Swedish Krona, Japanese Yen and Singapore Dollar. We held forward foreign exchange contracts, designated as economic hedges, with U.S. dollar equivalent notional amounts totaling $180.4 million, $212.1 million and $140.0 million at September 30, 2018, December 31, 2017 and October 1, 2017, respectively, and the fair value of these foreign currency derivative contracts was insignificant. The gains and losses realized on these foreign currency derivative contracts are not material. The duration of these contracts was generally 30 days or less during each of the nine months ended September 30, 2018 and October 1, 2017.

In addition, in connection with certain intercompany loan agreements utilized to finance our acquisitions and stock repurchase program, we enter into forward foreign exchange contracts intended to hedge movements in foreign exchange rates prior to settlement of such intercompany loans denominated in foreign currencies. We record these hedges at fair value on our condensed consolidated balance sheets. The unrealized gains and losses on these hedges, as well as the gains and losses associated with the remeasurement of the intercompany loans, are recognized immediately in interest and other expense, net. The cash flows related to the settlement of these hedges are included in cash flows from financing activities within our condensed consolidated statement of cash flows.

The outstanding forward exchange contracts designated as economic hedges, which were intended to hedge movements in foreign exchange rates prior to the settlement of certain intercompany loan agreements, included combined Euro notional amounts of €48.7 million and combined U.S. Dollar notional amounts of $28.0 million as of September 30, 2018, combined Euro notional amounts of €57.2 million and combined U.S. Dollar notional amounts of $1.3 billion as of December 31, 2017, and combined Euro notional amounts of €19.0 million and combined U.S. Dollar notional amounts of $12.3 million as of October 1, 2017. The net gains and losses on these derivatives, combined with the gains and losses on the remeasurement of the hedged intercompany loans were not material for each of the three and nine months ended September 30, 2018 and October 1, 2017. We paid $30.3 million and $11.5 million during the nine months ended September 30, 2018 and October 1, 2017, respectively, from the settlement of these hedges.

In April 2018, we entered into a series of foreign currency forward contracts with a notional amount of €298.7 million to hedge our investments in certain foreign subsidiaries. Realized and unrealized translation adjustments from these hedges were

Table of Contents

included in the foreign currency translation component of accumulated other comprehensive income ("AOCI"), which offsets translation adjustments on the underlying net assets of foreign subsidiaries. The cumulative translation gains or losses will remain in AOCI until the foreign subsidiaries are liquidated or sold. The foreign currency forward contracts were settled during the second quarter of 2018 and we recorded a net realized foreign exchange loss in AOCI of $2.6 million for the nine months ended September 30, 2018.

During fiscal year 2016, we designated the 2026 Notes to hedge our investments in certain foreign subsidiaries. In January 2018, we removed the hedging relationship of our 2026 Notes and investments in certain foreign subsidiaries and recognized $2.1 million of unrealized foreign exchange gain in AOCI. In April 2018, we designated a portion of the 2026 Notes to hedge our investments in certain foreign subsidiaries. Unrealized translation adjustments from a portion of the 2026 Notes were included in the foreign currency translation component of AOCI, which offsets translation adjustments on the underlying net assets of foreign subsidiaries. The cumulative translation gains or losses will remain in AOCI until the foreign subsidiaries are liquidated or sold. As of September 30, 2018, the total notional amount of the 2026 Notes that was designated to hedge investments in foreign subsidiaries was €135.1 million. The unrealized foreign exchange gain recorded in AOCI related to the net investment hedge was $0.8 million and $7.7 million for the three and nine months ended September 30, 2018, respectively.

In April 2018, we designated the April 2021 Notes with a notional amount of €298.7 million to hedge our investments in certain foreign subsidiaries. Unrealized translation adjustments from the April 2021 Notes were included in the foreign currency translation component of AOCI, which offsets translation adjustments on the underlying net assets of foreign subsidiaries. The cumulative translation gains or losses will remain in AOCI until the foreign subsidiaries are liquidated or sold. As of September 30, 2018, the total notional amount of the April 2021 Notes that was designated to hedge investments in foreign subsidiaries was €298.7 million. The unrealized foreign exchange gain recorded in AOCI related to the net investment hedge was $1.8 million and $22.6 million for the three and nine months ended September 30, 2018, respectively.

Foreign Currency Exchange Risk—Value-at-Risk Disclosure. We continue to measure foreign currency risk using the Value-at-Risk model described in Item 7A. “Quantitative and Qualitative Disclosure About Market Risk,” in our 2017 Form 10-K. The measures for our Value-at-Risk analysis have not changed materially.

Interest Rate Risk. As described above, our debt portfolio includes variable rate instruments. Fluctuations in interest rates can therefore have a direct impact on both our short-term cash flows, as they relate to interest, and our earnings. To manage the volatility relating to these exposures, we periodically enter into various derivative transactions pursuant to our policies to hedge against known or forecasted interest rate exposures.

Interest Rate Risk—Sensitivity. Our 2017 Form 10-K presents sensitivity measures for our interest rate risk. The measures for our sensitivity analysis have not changed materially. More information is available in Item 7A. “Quantitative and Qualitative Disclosure About Market Risk,” in our 2017 Form 10-K for our sensitivity disclosure.


Item 4.	Controls and Procedures

Evaluation of Disclosure Controls and Procedures. Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of the end of our fiscal quarter ended September 30, 2018. The term “disclosure controls and procedures” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), means controls and other procedures of a company that are designed to provide reasonable assurance that information required to be disclosed by the company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of the end of our fiscal quarter ended September 30, 2018, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter ended September 30, 2018 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II. OTHER INFORMATION


Item 1.	Legal Proceedings

We are subject to various claims, legal proceedings and investigations covering a wide range of matters that arise in the ordinary course of our business activities. Although we have established accruals for potential losses that we believe are probable and reasonably estimable, in the opinion of our management, based on its review of the information available at this time, the total cost of resolving these contingencies at September 30, 2018 should not have a material adverse effect on our condensed consolidated financial statements. However, each of these matters is subject to uncertainties, and it is possible that some of these matters may be resolved unfavorably to us.


Item 1A.	Risk Factors

The following important factors affect our business and operations generally or affect multiple segments of our business and operations:

If the markets into which we sell our products decline or do not grow as anticipated due to a decline in general economic conditions, or there are uncertainties surrounding the approval of government or industrial funding proposals, or there are unfavorable changes in government regulations, we may see an adverse effect on the results of our business operations.

Our customers include pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors and government agencies. Our quarterly revenue and results of operations are highly dependent on the volume and timing of orders received during the quarter. In addition, our revenues and earnings forecasts for future quarters are often based on the expected trends in our markets. However, the markets we serve do not always experience the trends that we may expect. Negative fluctuations in our customers’ markets, the inability of our customers to secure credit or funding, restrictions in capital expenditures, general economic conditions, cuts in government funding or unfavorable changes in government regulations would likely result in a reduction in demand for our products and services. In addition, government funding is subject to economic conditions and the political process, which is inherently fluid and unpredictable. Our revenues may be adversely affected if our customers delay or reduce purchases as a result of uncertainties surrounding the approval of government or industrial funding proposals. Such declines could harm our consolidated financial position, results of operations, cash flows and trading price of our common stock, and could limit our ability to sustain profitability.

Our growth is subject to global economic and political conditions, and operational disruptions at our facilities.

Our business is affected by global economic and political conditions as well as the state of the financial markets, particularly as the United States and other countries balance concerns around debt, inflation, growth and budget allocations in their policy initiatives. There can be no assurance that global economic conditions and financial markets will not worsen and that we will not experience any adverse effects that may be material to our consolidated cash flows, results of operations, financial position or our ability to access capital, such as the adverse effects resulting from a prolonged shutdown in government operations both in the United States and internationally. Our business is also affected by local economic environments, including inflation, recession, financial liquidity and currency volatility or devaluation. Political changes, some of which may be disruptive, could interfere with our supply chain, our customers and all of our activities in a particular location.

While we take precautions to prevent production or service interruptions at our global facilities, a major earthquake, fire, flood, power loss or other catastrophic event that results in the destruction or delay of any of our critical business operations could result in our incurring significant liability to customers or other third parties, cause significant reputational damage or have a material adverse effect on our business, operating results or financial condition.

Certain of these risks can be hedged to a limited degree using financial instruments, or other measures, and some of these risks are insurable, but any such mitigation efforts are costly and may not always be fully successful. Our ability to engage in such mitigation efforts has decreased or become even more costly as a result of recent market developments.

If we do not introduce new products in a timely manner, we may lose market share and be unable to achieve revenue growth targets.

We sell many of our products in industries characterized by rapid technological change, frequent new product and service introductions, and evolving customer needs and industry standards. Many of the businesses competing with us in these industries have significant financial and other resources to invest in new technologies, substantial intellectual property portfolios, substantial experience in new product development, regulatory expertise, manufacturing capabilities, and established

Table of Contents

distribution channels to deliver products to customers. Our products could become technologically obsolete over time, or we may invest in technology that does not lead to revenue growth or continue to sell products for which the demand from our customers is declining, in which case we may lose market share or not achieve our revenue growth targets. The success of our new product offerings will depend upon several factors, including our ability to:


•	accurately anticipate customer needs,


•	innovate and develop new reliable technologies and applications,


•	receive regulatory approvals in a timely manner,


•	successfully commercialize new technologies in a timely manner,


•	price our products competitively, and manufacture and deliver our products in sufficient volumes and on time, and


•	differentiate our offerings from our competitors’ offerings.

Many of our products are used by our customers to develop, test and manufacture their products. We must anticipate industry trends and consistently develop new products to meet our customers’ expectations. In developing new products, we may be required to make significant investments before we can determine the commercial viability of the new product. If we fail to accurately foresee our customers’ needs and future activities, we may invest heavily in research and development of products that do not lead to significant revenue. We may also suffer a loss in market share and potential revenue if we are unable to commercialize our technology in a timely and efficient manner.

In addition, some of our licensed technology is subject to contractual restrictions, which may limit our ability to develop or commercialize products for some applications.

We may not be able to successfully execute acquisitions or divestitures, license technologies, integrate acquired businesses or licensed technologies into our existing businesses, or make acquired businesses or licensed technologies profitable.

We have in the past supplemented, and may in the future supplement, our internal growth by acquiring businesses and licensing technologies that complement or augment our existing product lines, such as our acquisitions of Shanghai Spectrum Instruments Co., Ltd., RHS Limited, DNA Laboratories Sdn. Bhd. and Dani Analitica S.r.l. during fiscal year 2018. However, we may be unable to identify or complete promising acquisitions or license transactions for many reasons, such as:


•	competition among buyers and licensees,


•	the high valuations of businesses and technologies,


•	the need for regulatory and other approval, and


•	our inability to raise capital to fund these acquisitions.

Some of the businesses we acquire may be unprofitable or marginally profitable, or may increase the variability of our revenue recognition. If, for example, we are unable to successfully commercialize products and services related to significant in-process research and development that we have capitalized, we may have to impair the value of such assets. Accordingly, the earnings or losses of acquired businesses may dilute our earnings. For these acquired businesses to achieve acceptable levels of profitability, we would have to improve their management, operations, products and market penetration. We may not be successful in this regard and may encounter other difficulties in integrating acquired businesses into our existing operations, such as incompatible management, information or other systems, cultural differences, loss of key personnel, unforeseen regulatory requirements, previously undisclosed liabilities or difficulties in predicting financial results. Additionally, if we are not successful in selling businesses we seek to divest, the activity of such businesses may dilute our earnings and we may not be able to achieve the expected benefits of such divestitures. As a result, our financial results may differ from our forecasts or the expectations of the investment community in a given quarter or over the long term.

To finance our acquisitions, we may have to raise additional funds, either through public or private financings. We may be unable to obtain such funds or may be able to do so only on terms unacceptable to us. We may also incur expenses related to completing acquisitions or licensing technologies, or in evaluating potential acquisitions or technologies, which may adversely impact our profitability.

We may not be successful in adequately protecting our intellectual property.

Patent and trade secret protection is important to us because developing new products, processes and technologies gives us a competitive advantage, although it is time-consuming and expensive. We own many United States and foreign patents and intend to apply for additional patents. Patent applications we file, however, may not result in issued patents or, if they do, the

Table of Contents

claims allowed in the patents may be narrower than what is needed to protect fully our products, processes and technologies. The expiration of our previously issued patents may cause us to lose a competitive advantage in certain of the products and services we provide. Similarly, applications to register our trademarks may not be granted in all countries in which they are filed. For our intellectual property that is protected by keeping it secret, such as trade secrets and know-how, we may not use adequate measures to protect this intellectual property.

Third parties may also challenge the validity of our issued patents, may circumvent or “design around” our patents and patent applications, or may claim that our products, processes or technologies infringe their patents. In addition, third parties may assert that our product names infringe their trademarks. We may incur significant expense in legal proceedings to protect our intellectual property against infringement by third parties or to defend against claims of infringement by third parties. Claims by third parties in pending or future lawsuits could result in awards of substantial damages against us or court orders that could effectively prevent us from manufacturing, using, importing or selling our products in the United States or other countries.

If we are unable to renew our licenses or otherwise lose our licensed rights, we may have to stop selling products or we may lose competitive advantage.

We may not be able to renew our existing licenses, or licenses we may obtain in the future, on terms acceptable to us, or at all. If we lose the rights to a patented or other proprietary technology, we may need to stop selling products incorporating that technology and possibly other products, redesign our products or lose a competitive advantage. Potential competitors could in-license technologies that we fail to license and potentially erode our market share.

Our licenses typically subject us to various economic and commercialization obligations. If we fail to comply with these obligations, we could lose important rights under a license, such as the right to exclusivity in a market, or incur losses for failing to comply with our contractual obligations. In some cases, we could lose all rights under the license. In addition, rights granted under the license could be lost for reasons out of our control. For example, the licensor could lose patent protection for a number of reasons, including invalidity of the licensed patent, or a third-party could obtain a patent that curtails our freedom to operate under one or more licenses.

If we do not compete effectively, our business will be harmed.

We encounter aggressive competition from numerous competitors in many areas of our business. We may not be able to compete effectively with all of these competitors. To remain competitive, we must develop new products and periodically enhance our existing products. We anticipate that we may also have to adjust the prices of many of our products to stay competitive. In addition, new competitors, technologies or market trends may emerge to threaten or reduce the value of entire product lines.

Our quarterly operating results could be subject to significant fluctuation, and we may not be able to adjust our operations to effectively address changes we do not anticipate, which could increase the volatility of our stock price and potentially cause losses to our shareholders.

Given the nature of the markets in which we participate, we cannot reliably predict future revenue and profitability. Changes in competitive, market and economic conditions may require us to adjust our operations, and we may not be able to make those adjustments or make them quickly enough to adapt to changing conditions. A high proportion of our costs are fixed, due in part to our research and development and manufacturing costs. As a result, small declines in sales could disproportionately affect our operating results in a quarter. Factors that may affect our quarterly operating results include:


•	demand for and market acceptance of our products,


•	competitive pressures resulting in lower selling prices,


•	changes in the level of economic activity in regions in which we do business,


•	changes in general economic conditions or government funding,


•	settlements of income tax audits,


•	expenses incurred in connection with claims related to environmental conditions at locations where we conduct or formerly conducted operations,


•	contract termination and litigation costs,


•	differing tax laws and changes in those laws, or changes in the countries in which we are subject to taxation,


•	changes in our effective tax rate,

Table of Contents


•	changes in industries, such as pharmaceutical and biomedical,


•	changes in the portions of our revenue represented by our various products and customers,


•	our ability to introduce new products,


•	our competitors’ announcement or introduction of new products, services or technological innovations,


•	costs of raw materials, energy or supplies,


•	changes in healthcare or other reimbursement rates paid by government agencies and other third parties for certain of our products and services,


•	our ability to realize the benefit of ongoing productivity initiatives,


•	changes in the volume or timing of product orders,


•	fluctuation in the expense related to the mark-to-market adjustment on postretirement benefit plans,


•	changes in our assumptions underlying future funding of pension obligations,


•	changes in assumptions used to determine contingent consideration in acquisitions, and


•	changes in foreign currency exchange rates.

A significant disruption in third-party package delivery and import/export services, or significant increases in prices for those services, could interfere with our ability to ship products, increase our costs and lower our profitability.

We ship a significant portion of our products to our customers through independent package delivery and import/export companies, including UPS and Federal Express in the United States; TNT, UPS and DHL in Europe; and UPS in Asia. We also ship our products through other carriers, including national trucking firms, overnight carrier services and the United States Postal Service. If one or more of the package delivery or import/export providers experiences a significant disruption in services or institutes a significant price increase, we may have to seek alternative providers and the delivery of our products could be prevented or delayed. Such events could cause us to incur increased shipping costs that could not be passed on to our customers, negatively impacting our profitability and our relationships with certain of our customers.

Disruptions in the supply of raw materials, certain key components and other goods from our limited or single source suppliers could have an adverse effect on the results of our business operations, and could damage our relationships with customers.

The production of our products requires a wide variety of raw materials, key components and other goods that are generally available from alternate sources of supply. However, certain critical raw materials, key components and other goods required for the production and sale of some of our principal products are available from limited or single sources of supply. We generally have multi-year contracts with no minimum purchase requirements with these suppliers, but those contracts may not fully protect us from a failure by certain suppliers to supply critical materials or from the delays inherent in being required to change suppliers and, in some cases, validate new raw materials. Such raw materials, key components and other goods can usually be obtained from alternative sources with the potential for an increase in price, decline in quality or delay in delivery. A prolonged inability to obtain certain raw materials, key components or other goods is possible and could have an adverse effect on our business operations, and could damage our relationships with customers.

We are subject to the rules of the Securities and Exchange Commission requiring disclosure as to whether certain materials known as conflict minerals (tantalum, tin, gold, tungsten and their derivatives) that may be contained in our products are mined from the Democratic Republic of the Congo and adjoining countries. As a result of these rules, we may incur additional costs in complying with the disclosure requirements and in satisfying those customers who require that the components used in our products be certified as conflict-free, and the potential lack of availability of these materials at competitive prices could increase our production costs.

The manufacture and sale of products and services may expose us to product and other liability claims for which we could have substantial liability.

We face an inherent business risk of exposure to product and other liability claims if our products, services or product candidates are alleged or found to have caused injury, damage or loss. We may be unable to obtain insurance with adequate levels of coverage for potential liability on acceptable terms or claims of this nature may be excluded from coverage under the terms of any insurance policy that we obtain. If we are unable to obtain such insurance or the amounts of any claims successfully brought against us substantially exceed our coverage, then our business could be adversely impacted.

Table of Contents

If we fail to maintain satisfactory compliance with the regulations of the United States Food and Drug Administration and other governmental agencies in the United States and abroad, we may be forced to recall products and cease their manufacture and distribution, and we could be subject to civil, criminal or monetary penalties.

Our operations are subject to regulation by different state and federal government agencies in the United States and other countries, as well as to the standards established by international standards bodies. If we fail to comply with those regulations or standards, we could be subject to fines, penalties, criminal prosecution or other sanctions. Some of our products are subject to regulation by the United States Food and Drug Administration and similar foreign and domestic agencies. These regulations govern a wide variety of product activities, from design and development to labeling, manufacturing, promotion, sales and distribution. If we fail to comply with those regulations or standards, we may have to recall products, cease their manufacture and distribution, and may be subject to fines or criminal prosecution.

We are also subject to a variety of laws, regulations and standards that govern, among other things, the importation and exportation of products, the handling, transportation and manufacture of toxic or hazardous substances, and our business practices in the United States and abroad such as anti-bribery, anti-corruption and competition laws. This requires that we devote substantial resources to maintaining our compliance with those laws, regulations and standards. A failure to do so could result in the imposition of civil, criminal or monetary penalties having a material adverse effect on our operations.

Changes in governmental regulations may reduce demand for our products or increase our expenses.

We compete in markets in which we or our customers must comply with federal, state, local and foreign regulations, such as environmental, health and safety, and food and drug regulations. We develop, configure and market our products to meet customer needs created by these regulations. Any significant change in these regulations could reduce demand for our products or increase our costs of producing these products.

The healthcare industry is highly regulated and if we fail to comply with its extensive system of laws and regulations, we could suffer fines and penalties or be required to make significant changes to our operations which could have a significant adverse effect on the results of our business operations.

The healthcare industry, including the genetic screening market, is subject to extensive and frequently changing international and United States federal, state and local laws and regulations. In addition, legislative provisions relating to healthcare fraud and abuse, patient privacy violations and misconduct involving government insurance programs provide federal enforcement personnel with substantial powers and remedies to pursue suspected violations. We believe that our business will continue to be subject to increasing regulation as the federal government continues to strengthen its position on healthcare matters, the scope and effect of which we cannot predict. If we fail to comply with applicable laws and regulations, we could suffer civil and criminal damages, fines and penalties, exclusion from participation in governmental healthcare programs, and the loss of various licenses, certificates and authorizations necessary to operate our business, as well as incur liabilities from third-party claims, all of which could have a significant adverse effect on our business.

Economic, political and other risks associated with foreign operations could adversely affect our international sales and profitability.

Because we sell our products worldwide, our businesses are subject to risks associated with doing business internationally. Our sales originating outside the United States represented the majority of our total revenue in the nine months ended September 30, 2018. We anticipate that sales from international operations will continue to represent a substantial portion of our total revenue. In addition, many of our manufacturing facilities, employees and suppliers are located outside the United States. Accordingly, our future results of operations could be harmed by a variety of factors, including:


•	changes in actual, or from projected, foreign currency exchange rates,


•	changes in a country’s or region’s political or economic conditions, particularly in developing or emerging markets,


•	longer payment cycles of foreign customers and timing of collections in foreign jurisdictions,


•	embargoes, tariffs, trade protection measures and import or export licensing requirements,


•	policies in foreign countries benefiting domestic manufacturers or other policies detrimental to companies headquartered in the United States,


•	differing tax laws and changes in those laws, or changes in the countries in which we are subject to tax,


•	adverse income tax audit settlements or loss of previously negotiated tax incentives,


•	differing business practices associated with foreign operations,

Table of Contents


•	difficulty in transferring cash between international operations and the United States,


•	difficulty in staffing and managing widespread operations,


•	differing labor laws and changes in those laws,


•	differing protection of intellectual property and changes in that protection,


•	expanded enforcement of laws related to data protection and personal privacy,


•	increasing global enforcement of anti-bribery and anti-corruption laws, and


•	differing regulatory requirements and changes in those requirements.

If we do not retain our key personnel, our ability to execute our business strategy will be limited.

Our success depends to a significant extent upon the continued service of our executive officers and key management and technical personnel, particularly our experienced engineers and scientists, and on our ability to continue to attract, retain, and motivate qualified personnel. The competition for these employees is intense. The loss of the services of key personnel could have a material adverse effect on our operating results. In addition, there could be a material adverse effect on us should the turnover rates for key personnel increase significantly or if we are unable to continue to attract qualified personnel. We do not maintain any key person life insurance policies on any of our officers or employees.

Our success also depends on our ability to execute leadership succession plans. The inability to successfully transition key management roles could have a material adverse effect on our operating results.

If we experience a significant disruption in, or breach in security of, our information technology systems or those of our customers, suppliers or other third parties, allowing inappropriate access to or inadvertent transfer of information, or if we fail to implement new systems, software and technologies successfully, our business could be adversely affected.

We rely on several centralized information technology systems throughout our company to develop, manufacture and provide products and services, keep financial records, process orders, manage inventory, process shipments to customers and operate other critical functions. Our information technology systems may be susceptible to damage, disruptions or shutdowns due to power outages, hardware failures, computer viruses, attacks by computer hackers, telecommunication failures, user errors, catastrophes or other unforeseen events. If we were to experience a prolonged system disruption in the information technology systems that involve our interactions with customers, suppliers or other third parties, it could result in the loss of sales and customers and significant incremental costs, which could adversely affect our business. In addition, security breaches of our information technology systems, allowing inappropriate access to or inadvertent transfer of information could result in the misappropriation or unauthorized disclosure of confidential information belonging to us or to our employees, partners, customers or suppliers, which could result in our suffering significant financial or reputational damage.

We have a substantial amount of outstanding debt, which could impact our ability to obtain future financing and limit our ability to make other expenditures in the conduct of our business.

We have a substantial amount of debt and other financial obligations. Our debt level and related debt service obligations could have negative consequences, including:


•	requiring us to dedicate significant cash flow from operations to the payment of principal and interest on our debt, which reduces the funds we have available for other purposes, such as acquisitions and stock repurchases;


•	reducing our flexibility in planning for or reacting to changes in our business and market conditions; and


•	exposing us to interest rate risk since a portion of our debt obligations are at variable rates.

In addition, we may incur additional indebtedness in the future to meet future financing needs. If we add new debt, the risks described above could increase.

Restrictions in our senior unsecured revolving credit facility and other debt instruments may limit our activities.

Our senior unsecured revolving credit facility, senior unsecured notes due in April 2021 ("April 2021 Notes"), senior unsecured notes due in November 2021 ("November 2021 Notes") and senior unsecured notes due in 2026 ("2026 Notes") include restrictive covenants that limit our ability to engage in activities that could otherwise benefit our company. These include restrictions on our ability and the ability of our subsidiaries to:


•	pay dividends on, redeem or repurchase our capital stock,


•	sell assets,

Table of Contents


•	incur obligations that restrict our subsidiaries’ ability to make dividend or other payments to us,


•	guarantee or secure indebtedness,


•	enter into transactions with affiliates, and


•	consolidate, merge or transfer all, or substantially all, of our assets and the assets of our subsidiaries on a consolidated basis.

We are also required to meet specified financial ratios under the terms of certain of our existing debt instruments. Our ability to comply with these financial restrictions and covenants is dependent on our future performance, which is subject to prevailing economic conditions and other factors, including factors that are beyond our control, such as foreign exchange rates, interest rates, changes in technology and changes in the level of competition. In addition, if we are unable to maintain our investment grade credit rating, our borrowing costs would increase and we would be subject to different and potentially more restrictive financial covenants under some of our existing debt instruments.

Any future indebtedness that we incur may include similar or more restrictive covenants. Our failure to comply with any of the restrictions in our senior unsecured revolving credit facility, the April 2021 Notes, the November 2021 Notes, the 2026 Notes or any future indebtedness may result in an event of default under those debt instruments, which could permit acceleration of the debt under those debt instruments, and require us to prepay that debt before its scheduled due date under certain circumstances.

The United Kingdom’s vote in favor of withdrawing from the European Union could adversely impact our results of operations.

Nearly 3% of our net sales from continuing operations in fiscal year 2017 came from the United Kingdom. Following the referendum vote in the United Kingdom in June 2016 in favor of leaving the European Union (commonly referred to as “Brexit”), on March 29, 2017, the country formally notified the European Union of its intention to withdraw. It appears likely that this withdrawal will involve a process of lengthy negotiations between the United Kingdom and European Union member states to determine the future terms of the United Kingdom’s relationship with the European Union. This could lead to a period of considerable uncertainty and volatility, particularly in relation to United Kingdom financial and banking markets. Weakening of economic conditions or economic uncertainties tend to harm our business, and if such conditions emerge in the United Kingdom or in the rest of Europe, it may have a material adverse effect on our operations and sales.

Any significant weakening of the Great Britain Pound to the U.S. dollar will have an adverse impact on our European revenues due to the importance of our sales in the United Kingdom. Currency exchange rates in the pound sterling and the euro with respect to each other and the U.S. dollar have already been adversely affected by Brexit and that may continue to be the case. In addition, depending on the terms of Brexit, the United Kingdom could lose the benefits of global trade agreements negotiated by the European Union on behalf of its members, which may result in increased trade barriers which could make our doing business in Europe more difficult.

Our results of operations will be adversely affected if we fail to realize the full value of our intangible assets.

As of September 30, 2018, our total assets included $4.1 billion of net intangible assets. Net intangible assets consist principally of goodwill associated with acquisitions and costs associated with securing patent rights, trademark rights, customer relationships, core technology and technology licenses and in-process research and development, net of accumulated amortization. We test certain of these items—specifically all of those that are considered “non-amortizing”—at least annually for potential impairment by comparing the carrying value to the fair market value of the reporting unit to which they are assigned. All of our amortizing intangible assets are also evaluated for impairment should events occur that call into question the value of the intangible assets.

Adverse changes in our business, adverse changes in the assumptions used to determine the fair value of our reporting units, or the failure to grow our Discovery & Analytical Solutions and Diagnostics segments may result in impairment of our intangible assets, which could adversely affect our results of operations.

Table of Contents

Our share price will fluctuate.

Over the last several years, stock markets in general and our common stock in particular have experienced significant price and volume volatility. Both the market price and the daily trading volume of our common stock may continue to be subject to significant fluctuations due not only to general stock market conditions but also to a change in sentiment in the market regarding our operations and business prospects. In addition to the risk factors discussed above, the price and volume volatility of our common stock may be affected by:


•	operating results that vary from our financial guidance or the expectations of securities analysts and investors,


•	the financial performance of the major end markets that we target,


•	the operating and securities price performance of companies that investors consider to be comparable to us,


•	announcements of strategic developments, acquisitions and other material events by us or our competitors, and


•	changes in global financial markets and global economies and general market conditions, such as interest or foreign exchange rates, commodity and equity prices and the value of financial assets.

Dividends on our common stock could be reduced or eliminated in the future.

On July 23, 2018, we announced that our Board had declared a quarterly dividend of $0.07 per share for the third quarter of fiscal year 2018 that will be payable on November 9, 2018. On October 24, 2018, we announced that our Board had declared a quarterly dividend of $0.07 per share for the fourth quarter of fiscal year 2018 that will be payable on February 8, 2019. In the future, our Board may determine to reduce or eliminate our common stock dividend in order to fund investments for growth, repurchase shares or conserve capital resources.


Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds

Stock Repurchases

The following table provides information with respect to the shares of common stock repurchased by us for the periods indicated.



	Issuer Repurchases of Equity Securities
Period	Total Number of Shares Purchased⁽¹⁾	Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs⁽²⁾	Maximum Aggregate Number (or Approximate Dollar Value) of Shares that May Yet be Purchased Under the Plans or Programs
July 2, 2018—July 29, 2018	841	$	75.67	—	$	250,000,000
July 30, 2018—August 26, 2018	2,317	86.10		—	250,000,000
August 27, 2018—September 30, 2018	649	95.74		—	250,000,000
Activity for quarter ended September 30, 2018	3,807	$	85.44	—	$	250,000,000

____________________

(1)

Our Board of Directors (our "Board") has authorized us to repurchase shares of common stock to satisfy minimum statutory tax withholding obligations in connection with the vesting of restricted stock awards and restricted stock unit awards granted pursuant to our equity incentive plans and to satisfy obligations related to the exercise of stock options made pursuant to our equity incentive plans. During the three months ended September 30, 2018, we repurchased 3,807 shares of common stock for this purpose at an aggregate cost of $0.3 million. During the nine months ended September 30, 2018, we repurchased 63,506 shares of common stock for this purpose at an aggregate cost of $5.0 million. The repurchased shares have been reflected as additional authorized but unissued shares, with the payments reflected in common stock and capital in excess of par value

(2)

On July 27, 2016, our Board authorized us to repurchase up to 8.0 million shares of common stock under a stock repurchase program (the "Repurchase Program"). On July 23, 2018, our Board authorized us to immediately terminate the Repurchase Program and further authorized us to repurchase shares of common stock for an aggregate amount up to $250.0 million under a new stock repurchase program (the "New Repurchase Program"). The New Repurchase Program will expire on July 23, 2020 unless terminated earlier by our Board and may be suspended or discontinued at

Table of Contents

any time. During the nine months ended September 30, 2018, we had no stock repurchases under the Repurchase Program and New Repurchase Program. No shares remain available for repurchase under the Repurchase Program due to its cancellation. As of September 30, 2018, $250.0 million remained available for aggregate repurchases of shares under the New Repurchase Program.


Item 6.	Exhibits



Exhibit Number		Exhibit Name

31.1		Certification of Chief Executive Officer pursuant to Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certification of Chief Financial Officer pursuant to Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1		Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS		XBRL Instance Document.

101.SCH		XBRL Taxonomy Extension Schema Document.

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF		XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB		XBRL Taxonomy Extension Labels Linkbase Document.

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document.

____________________________

Attached as Exhibit 101 to this report are the following formatted in XBRL (Extensible Business Reporting Language):

(i) Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2018 and October 1, 2017, (ii) Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2018 and October 1, 2017, (iii) Condensed Consolidated Balance Sheets at September 30, 2018 and December 31, 2017, (iv) Condensed Consolidated Statement of Cash Flows for the nine months ended September 30, 2018 and October 1, 2017, and (v) Notes to Condensed Consolidated Financial Statements.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



	PERKINELMER, INC.

November 6, 2018	By:	/s/ JAMES M. MOCK
		James M. Mock Senior Vice President and Chief Financial Officer (Principal Financial Officer)



	PERKINELMER, INC.

November 6, 2018	By:	/s/ ANDREW OKUN
		Andrew Okun Vice President and Chief Accounting Officer (Principal Accounting Officer)

EX-31.1 2 pki-09302018xex_311.htm SECTION 302 CEO CERTIFICATION Exhibit

EXHIBIT 31.1

CERTIFICATION

I, Robert F. Friel, certify that:


1.	I have reviewed this Quarterly Report on Form 10-Q of PerkinElmer, Inc.;


2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.	The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c)	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d)	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and


5.	The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):


a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and


b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.



Date:	November 6, 2018	/s/ ROBERT F. FRIEL
		Robert F. Friel Chairman, Chief Executive Officer and President

EX-31.2 3 pki-09302018xex_312.htm SECTION 302 CFO CERTIFICATION Exhibit

EXHIBIT 31.2

CERTIFICATION

I, James M. Mock, certify that:


1.	I have reviewed this Quarterly Report on Form 10-Q of PerkinElmer, Inc.;


2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.	The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c)	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d)	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and


5.	The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):


a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and


b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.



Date:	November 6, 2018	/s/ JAMES M. MOCK
		James M. Mock Senior Vice President and Chief Financial Officer

EX-32.1 4 pki-09302018xex_321.htm SECTION 906 CEO AND CFO CERTIFICATION Exhibit

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of PerkinElmer, Inc. (the “Company”) for the period ended September 30, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Robert F. Friel, Chairman, Chief Executive Officer and President of the Company, and James M. Mock, Senior Vice President and Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) Based on my knowledge, the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) Based on my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Dated:	November 6, 2018	/S/ ROBERT F. FRIEL
		Robert F. Friel Chairman, Chief Executive Officer and President

Dated:	November 6, 2018	/S/ JAMES M. MOCK
		James M. Mock Senior Vice President and Chief Financial Officer

EX-101.INS 5 pki-20180930.xml XBRL INSTANCE DOCUMENT 0000031791 2018-01-01 2018-09-30 0000031791 2017-01-02 2017-10-01 0000031791 2018-11-01 0000031791 2018-07-02 2018-09-30 0000031791 us-gaap:ServiceMember 2018-07-02 2018-09-30 0000031791 us-gaap:ProductMember 2017-07-03 2017-10-01 0000031791 us-gaap:ServiceMember 2017-07-03 2017-10-01 0000031791 us-gaap:ServiceMember 2018-01-01 2018-09-30 0000031791 us-gaap:ProductMember 2018-01-01 2018-09-30 0000031791 2017-07-03 2017-10-01 0000031791 us-gaap:ProductMember 2017-01-02 2017-10-01 0000031791 us-gaap:ServiceMember 2017-01-02 2017-10-01 0000031791 us-gaap:ProductMember 2018-07-02 2018-09-30 0000031791 2017-12-31 0000031791 2018-09-30 0000031791 2017-10-01 0000031791 2017-01-01 0000031791 us-gaap:AccountingStandardsUpdate201616Member 2018-01-01 0000031791 us-gaap:AccountingStandardsUpdate201409Member 2018-01-01 0000031791 us-gaap:ScenarioForecastMember 2018-01-01 2018-12-30 0000031791 us-gaap:AccountingStandardsUpdate201707Member 2017-07-03 2017-10-01 0000031791 us-gaap:AccountingStandardsUpdate201618Member 2017-10-01 0000031791 us-gaap:AccountingStandardsUpdate201618Member 2017-01-02 2017-10-01 0000031791 us-gaap:AccountingStandardsUpdate201707Member 2017-01-02 2017-10-01 0000031791 2017-01-02 2017-12-31 0000031791 us-gaap:AccountingStandardsUpdate201618Member 2017-01-01 0000031791 srt:AmericasMember pki:DiscoveryAnalyticalSolutionsMember 2018-07-02 2018-09-30 0000031791 srt:AsiaMember 2018-07-02 2018-09-30 0000031791 srt:EuropeMember pki:DiscoveryAnalyticalSolutionsMember 2018-07-02 2018-09-30 0000031791 srt:EuropeMember pki:DiagnosticsMember 2018-07-02 2018-09-30 0000031791 pki:DiagnosticsMember us-gaap:TransferredAtPointInTimeMember 2018-07-02 2018-09-30 0000031791 pki:DiagnosticsMember us-gaap:TransferredOverTimeMember 2018-07-02 2018-09-30 0000031791 us-gaap:TransferredOverTimeMember 2018-07-02 2018-09-30 0000031791 pki:AppliedMarketsMember pki:DiagnosticsMember 2018-07-02 2018-09-30 0000031791 pki:DiagnosticsMember 2018-07-02 2018-09-30 0000031791 srt:AsiaMember pki:DiscoveryAnalyticalSolutionsMember 2018-07-02 2018-09-30 0000031791 pki:DiagnosticsMember pki:DiscoveryAnalyticalSolutionsMember 2018-07-02 2018-09-30 0000031791 pki:LifeSciencesMember pki:DiagnosticsMember 2018-07-02 2018-09-30 0000031791 srt:AmericasMember pki:DiagnosticsMember 2018-07-02 2018-09-30 0000031791 srt:EuropeMember 2018-07-02 2018-09-30 0000031791 pki:DiscoveryAnalyticalSolutionsMember 2018-07-02 2018-09-30 0000031791 pki:DiscoveryAnalyticalSolutionsMember us-gaap:TransferredOverTimeMember 2018-07-02 2018-09-30 0000031791 pki:AppliedMarketsMember pki:DiscoveryAnalyticalSolutionsMember 2018-07-02 2018-09-30 0000031791 pki:LifeSciencesMember 2018-07-02 2018-09-30 0000031791 pki:DiagnosticsMember pki:DiagnosticsMember 2018-07-02 2018-09-30 0000031791 pki:DiscoveryAnalyticalSolutionsMember us-gaap:TransferredAtPointInTimeMember 2018-07-02 2018-09-30 0000031791 us-gaap:TransferredAtPointInTimeMember 2018-07-02 2018-09-30 0000031791 srt:AmericasMember 2018-07-02 2018-09-30 0000031791 pki:DiagnosticsMember 2018-07-02 2018-09-30 0000031791 pki:LifeSciencesMember pki:DiscoveryAnalyticalSolutionsMember 2018-07-02 2018-09-30 0000031791 pki:AppliedMarketsMember 2018-07-02 2018-09-30 0000031791 srt:AsiaMember pki:DiagnosticsMember 2018-07-02 2018-09-30 0000031791 2018-01-01 0000031791 pki:DiscoveryAnalyticalSolutionsMember 2018-01-01 2018-09-30 0000031791 srt:EuropeMember pki:DiagnosticsMember 2018-01-01 2018-09-30 0000031791 pki:DiscoveryAnalyticalSolutionsMember us-gaap:TransferredAtPointInTimeMember 2018-01-01 2018-09-30 0000031791 pki:DiagnosticsMember 2018-01-01 2018-09-30 0000031791 us-gaap:TransferredOverTimeMember 2018-01-01 2018-09-30 0000031791 pki:AppliedMarketsMember pki:DiscoveryAnalyticalSolutionsMember 2018-01-01 2018-09-30 0000031791 pki:AppliedMarketsMember pki:DiagnosticsMember 2018-01-01 2018-09-30 0000031791 srt:AsiaMember pki:DiagnosticsMember 2018-01-01 2018-09-30 0000031791 pki:LifeSciencesMember pki:DiagnosticsMember 2018-01-01 2018-09-30 0000031791 pki:DiagnosticsMember pki:DiscoveryAnalyticalSolutionsMember 2018-01-01 2018-09-30 0000031791 pki:LifeSciencesMember 2018-01-01 2018-09-30 0000031791 srt:AmericasMember pki:DiagnosticsMember 2018-01-01 2018-09-30 0000031791 pki:DiagnosticsMember us-gaap:TransferredOverTimeMember 2018-01-01 2018-09-30 0000031791 us-gaap:TransferredAtPointInTimeMember 2018-01-01 2018-09-30 0000031791 pki:DiagnosticsMember 2018-01-01 2018-09-30 0000031791 srt:AsiaMember 2018-01-01 2018-09-30 0000031791 pki:DiagnosticsMember us-gaap:TransferredAtPointInTimeMember 2018-01-01 2018-09-30 0000031791 pki:AppliedMarketsMember 2018-01-01 2018-09-30 0000031791 srt:AmericasMember pki:DiscoveryAnalyticalSolutionsMember 2018-01-01 2018-09-30 0000031791 pki:DiagnosticsMember pki:DiagnosticsMember 2018-01-01 2018-09-30 0000031791 srt:EuropeMember 2018-01-01 2018-09-30 0000031791 srt:AsiaMember pki:DiscoveryAnalyticalSolutionsMember 2018-01-01 2018-09-30 0000031791 pki:LifeSciencesMember pki:DiscoveryAnalyticalSolutionsMember 2018-01-01 2018-09-30 0000031791 srt:EuropeMember pki:DiscoveryAnalyticalSolutionsMember 2018-01-01 2018-09-30 0000031791 srt:AmericasMember 2018-01-01 2018-09-30 0000031791 pki:DiscoveryAnalyticalSolutionsMember us-gaap:TransferredOverTimeMember 2018-01-01 2018-09-30 0000031791 us-gaap:AccountingStandardsUpdate201409Member 2018-07-02 2018-09-30 0000031791 us-gaap:AccountingStandardsUpdate201409Member 2018-01-01 2018-09-30 0000031791 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-01-01 2018-09-30 0000031791 us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-01-01 2018-09-30 0000031791 us-gaap:ProductMember us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-01-01 2018-09-30 0000031791 us-gaap:ServiceMember us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-01-01 2018-09-30 0000031791 us-gaap:ServiceMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-01-01 2018-09-30 0000031791 us-gaap:ProductMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-01-01 2018-09-30 0000031791 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-09-30 0000031791 us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-09-30 0000031791 us-gaap:ProductMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-07-02 2018-09-30 0000031791 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-07-02 2018-09-30 0000031791 us-gaap:ServiceMember us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-07-02 2018-09-30 0000031791 us-gaap:ProductMember us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-07-02 2018-09-30 0000031791 us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-07-02 2018-09-30 0000031791 us-gaap:ServiceMember us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-07-02 2018-09-30 0000031791 currency:USD pki:DNALabsMember 2018-09-30 0000031791 pki:FiscalYear2017OtherAcquisitionsExcludingTulipMember 2017-01-02 2017-12-31 0000031791 pki:EUROIMMUMMember 2017-01-02 2017-12-31 0000031791 us-gaap:CashAndCashEquivalentsMember currency:USD pki:EUROIMMUMMember 2017-01-02 2017-12-31 0000031791 pki:FiscalYear2017OtherAcquisitionsMember 2017-01-02 2017-12-31 0000031791 pki:EuroimmunMember 2018-07-02 2018-09-30 0000031791 pki:TulipDiagnosticsPrivateLimitedMember 2018-07-02 2018-09-30 0000031791 currency:USD pki:DNALabsMember 2018-01-01 2018-09-30 0000031791 currency:USD pki:FiscalYear2018AcquisitionsMember 2018-01-01 2018-09-30 0000031791 pki:EuroimmunMember 2017-01-02 2017-10-01 0000031791 currency:USD pki:TulipDiagnosticsPrivateLimitedMember 2018-01-01 2018-04-01 0000031791 pki:TulipDiagnosticsPrivateLimitedMember 2018-01-01 2018-09-30 0000031791 pki:FiscalYear2018AcquisitionsMember 2018-01-01 2018-09-30 0000031791 currency:USD pki:TulipDiagnosticsPrivateLimitedMember 2017-12-31 0000031791 pki:TulipDiagnosticsPrivateLimitedMember 2017-01-02 2017-12-31 0000031791 pki:EUROIMMUMMember 2018-01-01 2018-09-30 0000031791 currency:INR pki:TulipDiagnosticsPrivateLimitedMember 2018-09-30 0000031791 pki:TermLoanCreditFacility12MonthsMaturityMember currency:USD pki:EUROIMMUMMember 2017-01-02 2017-12-31 0000031791 pki:LineofCreditMaturingAugust112021Member currency:USD pki:EUROIMMUMMember 2017-01-02 2017-12-31 0000031791 currency:USD pki:ShanghaiSpectrumInstrumentsCo.Ltd.Member 2018-01-01 2018-09-30 0000031791 currency:EUR pki:EUROIMMUMMember 2017-01-02 2017-12-31 0000031791 currency:USD pki:ShanghaiSpectrumInstrumentsCo.Ltd.Member 2018-09-30 0000031791 pki:EUROIMMUMMember 2017-12-31 0000031791 pki:EUROIMMUMMember 2018-09-30 0000031791 currency:USD pki:EUROIMMUMMember 2017-01-02 2017-12-31 0000031791 currency:USD pki:RHSLimitedMember 2018-01-01 2018-09-30 0000031791 currency:INR pki:TulipDiagnosticsPrivateLimitedMember 2018-01-01 2018-04-01 0000031791 currency:INR pki:TulipDiagnosticsPrivateLimitedMember 2017-12-31 0000031791 currency:EUR pki:DaniAnaliticaS.r.l.Member us-gaap:SubsequentEventMember 2018-10-01 2018-12-30 0000031791 pki:EuroimmunMember 2017-07-03 2017-10-01 0000031791 currency:USD pki:TulipDiagnosticsPrivateLimitedMember 2018-09-30 0000031791 pki:EUROIMMUMMember 2017-01-02 2017-10-01 0000031791 pki:EUROIMMUMMember 2017-07-03 2017-10-01 0000031791 pki:EUROIMMUMMember us-gaap:TradeNamesMember 2017-12-31 0000031791 pki:FiscalYear2017OtherAcquisitionsMember 2017-12-31 0000031791 pki:FiscalYear2017OtherAcquisitionsMember us-gaap:CustomerRelationshipsMember 2017-12-31 0000031791 pki:FiscalYear2017OtherAcquisitionsMember us-gaap:TradeNamesMember 2017-12-31 0000031791 pki:EUROIMMUMMember us-gaap:CustomerRelationshipsMember 2018-09-30 0000031791 pki:EUROIMMUMMember pki:CoreTechnologyMember 2017-12-31 0000031791 pki:EUROIMMUMMember us-gaap:InProcessResearchAndDevelopmentMember 2017-12-31 0000031791 pki:FiscalYear2017OtherAcquisitionsMember us-gaap:InProcessResearchAndDevelopmentMember 2017-12-31 0000031791 pki:FiscalYear2017OtherAcquisitionsMember pki:CoreTechnologyMember 2017-12-31 0000031791 pki:FiscalYear2018AcquisitionsMember 2018-09-30 0000031791 pki:FiscalYear2018AcquisitionsMember us-gaap:CustomerRelationshipsMember 2018-09-30 0000031791 pki:FiscalYear2018AcquisitionsMember pki:CoreTechnologyMember 2018-09-30 0000031791 pki:FiscalYear2018AcquisitionsMember us-gaap:TradeNamesMember 2018-09-30 0000031791 pki:MedicalImagingBusinessMember 2018-01-01 2018-09-30 0000031791 pki:MedicalImagingBusinessMember 2017-12-31 0000031791 pki:MedicalImagingBusinessMember 2017-01-02 2017-12-31 0000031791 pki:SuzhouPerkinElmerMedicalLaboratoryCo.LtdMember 2017-12-31 0000031791 pki:MultispectralImagingBusinessMember 2018-07-02 2018-09-30 0000031791 pki:SuzhouPerkinElmerMedicalLaboratoryCo.LtdMember 2017-01-02 2017-12-31 0000031791 pki:MultispectralImagingBusinessMember 2018-09-30 0000031791 us-gaap:EmployeeSeveranceMember pki:Q32018RestructuringPlanMember 2018-09-30 0000031791 us-gaap:EmployeeSeveranceMember pki:Q12018RestructuringPlanMember 2018-09-30 0000031791 us-gaap:EmployeeSeveranceMember pki:Q12018RestructuringPlanMember 2018-01-01 2018-09-30 0000031791 pki:EmployeeSeveranceandFacilityClosingMember pki:PreviousRestructuringAndIntegrationPlansMember 2017-12-31 0000031791 us-gaap:EmployeeSeveranceMember pki:Q12018RestructuringPlanMember 2017-12-31 0000031791 pki:EmployeeSeveranceandFacilityClosingMember 2018-09-30 0000031791 us-gaap:EmployeeSeveranceMember pki:Q32017RestructuringPlanMember 2018-01-01 2018-09-30 0000031791 pki:EmployeeSeveranceandFacilityClosingMember 2018-01-01 2018-09-30 0000031791 us-gaap:EmployeeSeveranceMember pki:Q12017RestructuringPlanMember 2018-01-01 2018-09-30 0000031791 us-gaap:FacilityClosingMember pki:Q12017RestructuringPlanMember 2018-01-01 2018-09-30 0000031791 us-gaap:EmployeeSeveranceMember pki:Q32018RestructuringPlanMember 2018-01-01 2018-09-30 0000031791 pki:EmployeeSeveranceandFacilityClosingMember pki:PreviousRestructuringAndIntegrationPlansMember 2018-01-01 2018-09-30 0000031791 us-gaap:ContractTerminationMember 2018-01-01 2018-09-30 0000031791 us-gaap:EmployeeSeveranceMember pki:Q42017RestructuringPlanMember 2018-09-30 0000031791 us-gaap:FacilityClosingMember pki:Q12017RestructuringPlanMember 2017-12-31 0000031791 us-gaap:ContractTerminationMember 2018-09-30 0000031791 us-gaap:EmployeeSeveranceMember pki:Q42017RestructuringPlanMember 2018-01-01 2018-09-30 0000031791 us-gaap:EmployeeSeveranceMember pki:Q32017RestructuringPlanMember 2017-12-31 0000031791 us-gaap:EmployeeSeveranceMember pki:Q12017RestructuringPlanMember 2018-09-30 0000031791 us-gaap:EmployeeSeveranceMember pki:Q32017RestructuringPlanMember 2018-09-30 0000031791 pki:EmployeeSeveranceandFacilityClosingMember pki:PreviousRestructuringAndIntegrationPlansMember 2018-09-30 0000031791 us-gaap:ContractTerminationMember 2017-12-31 0000031791 us-gaap:EmployeeSeveranceMember pki:Q12017RestructuringPlanMember 2017-12-31 0000031791 us-gaap:EmployeeSeveranceMember pki:Q32018RestructuringPlanMember 2017-12-31 0000031791 us-gaap:EmployeeSeveranceMember pki:Q42017RestructuringPlanMember 2017-12-31 0000031791 pki:EmployeeSeveranceandFacilityClosingMember 2017-12-31 0000031791 us-gaap:FacilityClosingMember pki:Q12017RestructuringPlanMember 2018-09-30 0000031791 us-gaap:FacilityClosingMember pki:Q12017RestructuringPlanMember pki:DiscoveryAnalyticalSolutionsMember 2017-01-02 2017-04-02 0000031791 us-gaap:FacilityClosingMember pki:Q12018RestructuringPlanMember pki:DiscoveryAnalyticalSolutionsMember 2018-01-01 2018-04-01 0000031791 us-gaap:FacilityClosingMember pki:Q42017RestructuringPlanMember pki:DiagnosticsMember 2017-10-02 2017-12-31 0000031791 us-gaap:FacilityClosingMember pki:Q42017RestructuringPlanMember pki:DiscoveryAnalyticalSolutionsMember 2017-10-02 2017-12-31 0000031791 us-gaap:EmployeeSeveranceMember pki:Q12018RestructuringPlanMember pki:DiagnosticsMember 2018-01-01 2018-04-01 0000031791 pki:Q42017RestructuringPlanMember 2017-10-02 2017-12-31 0000031791 pki:Q32018RestructuringPlanMember 2018-07-02 2018-09-30 0000031791 us-gaap:EmployeeSeveranceMember pki:Q32017RestructuringPlanMember pki:DiagnosticsMember 2017-07-03 2017-10-01 0000031791 us-gaap:FacilityClosingMember pki:Q12017RestructuringPlanMember pki:DiagnosticsMember 2017-01-02 2017-04-02 0000031791 us-gaap:EmployeeSeveranceMember pki:Q32018RestructuringPlanMember pki:DiscoveryAnalyticalSolutionsMember 2018-07-02 2018-09-30 0000031791 us-gaap:FacilityClosingMember pki:Q32017RestructuringPlanMember pki:DiagnosticsMember 2017-07-03 2017-10-01 0000031791 pki:Q32017RestructuringPlanMember 2017-07-03 2017-10-01 0000031791 pki:Q12018RestructuringPlanMember 2018-01-01 2018-04-01 0000031791 us-gaap:EmployeeSeveranceMember pki:Q42017RestructuringPlanMember pki:DiscoveryAnalyticalSolutionsMember 2017-10-02 2017-12-31 0000031791 us-gaap:EmployeeSeveranceMember pki:Q42017RestructuringPlanMember pki:DiagnosticsMember 2017-10-02 2017-12-31 0000031791 us-gaap:FacilityClosingMember pki:Q32018RestructuringPlanMember pki:DiagnosticsMember 2018-07-02 2018-09-30 0000031791 us-gaap:EmployeeSeveranceMember pki:Q12017RestructuringPlanMember pki:DiagnosticsMember 2017-01-02 2017-04-02 0000031791 us-gaap:EmployeeSeveranceMember pki:Q32017RestructuringPlanMember pki:DiscoveryAnalyticalSolutionsMember 2017-07-03 2017-10-01 0000031791 pki:Q12017RestructuringPlanMember 2017-01-02 2017-04-02 0000031791 us-gaap:EmployeeSeveranceMember pki:Q12017RestructuringPlanMember pki:DiscoveryAnalyticalSolutionsMember 2017-01-02 2017-04-02 0000031791 us-gaap:FacilityClosingMember pki:Q32017RestructuringPlanMember pki:DiscoveryAnalyticalSolutionsMember 2017-07-03 2017-10-01 0000031791 us-gaap:EmployeeSeveranceMember pki:Q12018RestructuringPlanMember pki:DiscoveryAnalyticalSolutionsMember 2018-01-01 2018-04-01 0000031791 us-gaap:FacilityClosingMember pki:Q12018RestructuringPlanMember pki:DiagnosticsMember 2018-01-01 2018-04-01 0000031791 us-gaap:FacilityClosingMember pki:Q32018RestructuringPlanMember pki:DiscoveryAnalyticalSolutionsMember 2018-07-02 2018-09-30 0000031791 us-gaap:EmployeeSeveranceMember pki:Q32018RestructuringPlanMember pki:DiagnosticsMember 2018-07-02 2018-09-30 0000031791 us-gaap:ContractTerminationMember pki:DiscoveryAnalyticalSolutionsMember 2018-01-01 2018-09-30 0000031791 us-gaap:ContractTerminationMember pki:DiscoveryAnalyticalSolutionsMember 2018-07-02 2018-09-30 0000031791 pki:A2017TaxCutsandJobsActMember 2018-07-02 2018-09-30 0000031791 pki:A2017TaxCutsandJobsActMember 2017-01-02 2017-12-31 0000031791 pki:A2017TaxCutsandJobsActMember 2018-01-01 2018-09-30 0000031791 pki:FivePercentTenYearSeniorUnsecuredNotesMember 2011-10-25 0000031791 pki:FivePercentTenYearSeniorUnsecuredNotesMember 2011-10-01 2011-10-25 0000031791 pki:TermLoanCreditFacility12MonthsMaturityMember 2018-09-30 0000031791 pki:OtherDebtFacilitiesEUROIMMUNMember 2018-09-30 0000031791 pki:A1.875PercentTenYearSeniorUnsecuredNotesMemberMember 2016-07-19 2016-07-19 0000031791 pki:A1.875PercentTenYearSeniorUnsecuredNotesMemberMember us-gaap:FairValueInputsLevel2Member 2017-12-31 0000031791 pki:TermLoanCreditFacility12MonthsMaturityMember 2018-01-01 2018-09-30 0000031791 pki:FinancingLeaseObligationsMember 2012-12-30 0000031791 pki:A1.875PercentTenYearSeniorUnsecuredNotesMemberMember 2017-12-31 0000031791 pki:EuriborRateMember pki:OtherDebtFacilitiesEUROIMMUNMember 2018-01-01 2018-09-30 0000031791 pki:LineofCreditMaturingAugust112021Member 2018-01-01 2018-09-30 0000031791 pki:A1.875PercentTenYearSeniorUnsecuredNotesMemberMember 2016-07-19 0000031791 pki:A0.6PercentSeniorUnsecuredNotesdueinApril2021Member 2018-04-11 0000031791 currency:EUR pki:OtherDebtFacilitiesEUROIMMUNMember 2018-09-30 0000031791 pki:LineofCreditMaturingAugust112021Member 2018-09-30 0000031791 srt:MaximumMember pki:OtherUnsecuredRevolvingDebtFacilitiesMember 2018-09-30 0000031791 pki:FinancingLeaseObligationsMember 2017-12-31 0000031791 pki:OtherSecuredBankLoanMember 2018-09-30 0000031791 pki:A0.6PercentSeniorUnsecuredNotesdueinApril2021Member us-gaap:FairValueInputsLevel2Member 2018-09-30 0000031791 pki:FivePercentTenYearSeniorUnsecuredNotesMember 2017-12-31 0000031791 pki:A0.6PercentSeniorUnsecuredNotesdueinApril2021Member 2018-04-11 2018-04-11 0000031791 pki:FinancingLeaseObligationsMember us-gaap:FairValueInputsLevel2Member 2018-09-30 0000031791 currency:USD pki:OtherDebtFacilitiesEUROIMMUNMember 2018-09-30 0000031791 pki:FinancingLeaseObligationsMember us-gaap:FairValueInputsLevel2Member 2017-12-31 0000031791 pki:FivePercentTenYearSeniorUnsecuredNotesMember us-gaap:FairValueInputsLevel2Member 2017-12-31 0000031791 pki:A0.6PercentSeniorUnsecuredNotesdueinApril2021Member 2018-09-30 0000031791 pki:FinancingLeaseObligationsMember 2018-09-30 0000031791 pki:FivePercentTenYearSeniorUnsecuredNotesMember 2018-09-30 0000031791 pki:LineofCreditMaturingAugust112021Member 2017-12-31 0000031791 pki:FinancingLeaseObligationsMember 2012-01-02 2012-12-30 0000031791 pki:A1.875PercentTenYearSeniorUnsecuredNotesMemberMember 2018-09-30 0000031791 currency:USD srt:MaximumMember pki:OtherDebtFacilitiesEUROIMMUNMember 2018-09-30 0000031791 pki:OtherUnsecuredRevolvingDebtFacilitiesMember 2018-09-30 0000031791 currency:USD pki:OtherDebtFacilitiesEUROIMMUNMember 2017-12-31 0000031791 pki:FivePercentTenYearSeniorUnsecuredNotesMember us-gaap:FairValueInputsLevel2Member 2018-09-30 0000031791 srt:MinimumMember pki:OtherUnsecuredRevolvingDebtFacilitiesMember 2018-09-30 0000031791 currency:EUR pki:OtherDebtFacilitiesEUROIMMUNMember 2017-12-31 0000031791 pki:A1.875PercentTenYearSeniorUnsecuredNotesMemberMember us-gaap:FairValueInputsLevel2Member 2018-09-30 0000031791 currency:USD srt:MinimumMember pki:OtherDebtFacilitiesEUROIMMUNMember 2018-09-30 0000031791 pki:LineofCreditMaturingAugust112021Member us-gaap:LineOfCreditMember 2018-01-01 2018-09-30 0000031791 pki:BaseRateOptionTwoMember us-gaap:LineOfCreditMember 2018-01-01 2018-09-30 0000031791 pki:BaseRateOptionThreeMember pki:LineofCreditMaturingAugust112021Member us-gaap:LineOfCreditMember 2018-01-01 2018-09-30 0000031791 pki:BaseRateOptionTwoMember pki:LineofCreditMaturingAugust112021Member us-gaap:LineOfCreditMember 2018-01-01 2018-09-30 0000031791 pki:OtherSecuredBankLoanMember 2018-01-01 2018-09-30 0000031791 pki:EuroCurrencyRateMember us-gaap:LineOfCreditMember 2018-01-01 2018-09-30 0000031791 pki:FivePercentTenYearSeniorUnsecuredNotesMember 2018-01-01 2018-09-30 0000031791 pki:OtherDebtFacilitiesEUROIMMUNMember 2018-01-01 2018-09-30 0000031791 pki:TreasuryRateMember pki:FivePercentTenYearSeniorUnsecuredNotesMember 2018-01-01 2018-09-30 0000031791 pki:TreasuryRateMember pki:A0.6PercentSeniorUnsecuredNotesdueinApril2021Member 2018-01-01 2018-09-30 0000031791 pki:OtherUnsecuredRevolvingDebtFacilitiesMember 2018-01-01 2018-09-30 0000031791 pki:A0.6PercentSeniorUnsecuredNotesdueinApril2021Member 2018-01-01 2018-09-30 0000031791 pki:EuroCurrencyRateMember pki:LineofCreditMaturingAugust112021Member us-gaap:LineOfCreditMember 2018-01-01 2018-09-30 0000031791 us-gaap:CorporateMember 2018-07-02 2018-09-30 0000031791 us-gaap:ProductMember pki:DiagnosticsMember 2018-07-02 2018-09-30 0000031791 us-gaap:ServiceMember pki:DiagnosticsMember 2017-01-02 2017-10-01 0000031791 us-gaap:CorporateMember 2017-01-02 2017-10-01 0000031791 pki:DiscoveryAnalyticalSolutionsMember 2017-07-03 2017-10-01 0000031791 us-gaap:ProductMember pki:DiscoveryAnalyticalSolutionsMember 2017-07-03 2017-10-01 0000031791 pki:DiagnosticsMember 2017-01-02 2017-10-01 0000031791 pki:DiscoveryAnalyticalSolutionsMember 2017-01-02 2017-10-01 0000031791 us-gaap:ProductMember pki:DiscoveryAnalyticalSolutionsMember 2018-07-02 2018-09-30 0000031791 us-gaap:ProductMember pki:DiagnosticsMember 2018-01-01 2018-09-30 0000031791 us-gaap:CorporateMember 2018-01-01 2018-09-30 0000031791 us-gaap:ServiceMember pki:DiagnosticsMember 2017-07-03 2017-10-01 0000031791 us-gaap:ServiceMember pki:DiagnosticsMember 2018-07-02 2018-09-30 0000031791 us-gaap:ProductMember pki:DiscoveryAnalyticalSolutionsMember 2018-01-01 2018-09-30 0000031791 us-gaap:ServiceMember pki:DiagnosticsMember 2018-01-01 2018-09-30 0000031791 us-gaap:ProductMember pki:DiagnosticsMember 2017-07-03 2017-10-01 0000031791 us-gaap:ServiceMember pki:DiscoveryAnalyticalSolutionsMember 2018-07-02 2018-09-30 0000031791 us-gaap:ProductMember pki:DiagnosticsMember 2017-01-02 2017-10-01 0000031791 us-gaap:ServiceMember pki:DiscoveryAnalyticalSolutionsMember 2017-01-02 2017-10-01 0000031791 us-gaap:ServiceMember pki:DiscoveryAnalyticalSolutionsMember 2018-01-01 2018-09-30 0000031791 us-gaap:ServiceMember pki:DiscoveryAnalyticalSolutionsMember 2017-07-03 2017-10-01 0000031791 us-gaap:CorporateMember 2017-07-03 2017-10-01 0000031791 us-gaap:ProductMember pki:DiscoveryAnalyticalSolutionsMember 2017-01-02 2017-10-01 0000031791 pki:DiagnosticsMember 2017-07-03 2017-10-01 0000031791 us-gaap:SubsequentEventMember 2018-01-01 2018-12-30 0000031791 us-gaap:SubsequentEventMember 2018-12-31 2019-03-31 0000031791 us-gaap:SubsequentEventMember 2018-10-01 2018-12-30 0000031791 2016-07-27 0000031791 2018-07-23 0000031791 2017-10-02 2017-12-31 0000031791 2018-04-02 2018-07-01 0000031791 2018-01-01 2018-04-01 0000031791 pki:RestrictedStockAwardsMember 2018-01-01 2018-09-30 0000031791 pki:RestrictedStockAwardsMember 2017-12-31 0000031791 pki:RestrictedStockAwardsMember 2018-09-30 0000031791 us-gaap:ResearchAndDevelopmentExpenseMember 2018-07-02 2018-09-30 0000031791 us-gaap:ResearchAndDevelopmentExpenseMember 2017-07-03 2017-10-01 0000031791 us-gaap:CostOfSalesMember 2017-07-03 2017-10-01 0000031791 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-01-01 2018-09-30 0000031791 us-gaap:CostOfSalesMember 2018-07-02 2018-09-30 0000031791 us-gaap:ResearchAndDevelopmentExpenseMember 2017-01-02 2017-10-01 0000031791 us-gaap:CostOfSalesMember 2018-01-01 2018-09-30 0000031791 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-07-02 2018-09-30 0000031791 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-01-02 2017-10-01 0000031791 us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-09-30 0000031791 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-07-03 2017-10-01 0000031791 us-gaap:CostOfSalesMember 2017-01-02 2017-10-01 0000031791 us-gaap:EmployeeStockMember 2018-01-01 2018-09-30 0000031791 pki:StockAwardsMember 2018-01-01 2018-09-30 0000031791 us-gaap:EmployeeStockMember 2018-09-30 0000031791 us-gaap:EmployeeStockOptionMember 2017-01-02 2017-10-01 0000031791 pki:PerformanceUnitsMember 2018-01-01 2018-09-30 0000031791 pki:PerformanceRestrictedStockUnitsMember 2018-07-02 2018-09-30 0000031791 us-gaap:EmployeeStockMember 2017-01-02 2017-10-01 0000031791 pki:PerformanceUnitsMember 2018-07-02 2018-09-30 0000031791 pki:PerformanceRestrictedStockUnitsMember 2018-01-01 2018-09-30 0000031791 us-gaap:EmployeeStockOptionMember 2017-07-03 2017-10-01 0000031791 pki:PerformanceUnitsMember 2018-09-30 0000031791 pki:PerformanceRestrictedStockUnitsMember 2017-07-03 2017-10-01 0000031791 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-09-30 0000031791 pki:PerformanceUnitsMember 2017-01-02 2017-10-01 0000031791 pki:StockAwardsMember 2017-01-02 2017-10-01 0000031791 pki:TwoThousandNineIncentivePlanMember 2018-09-30 0000031791 pki:RestrictedStockAwardsMember 2018-07-02 2018-09-30 0000031791 pki:RestrictedStockAwardsMember 2017-07-03 2017-10-01 0000031791 us-gaap:EmployeeStockOptionMember 2018-07-02 2018-09-30 0000031791 pki:PerformanceRestrictedStockUnitsMember 2017-01-02 2017-10-01 0000031791 pki:PerformanceUnitsMember 2017-07-03 2017-10-01 0000031791 pki:RestrictedStockAwardsMember 2017-01-02 2017-10-01 0000031791 pki:PerformanceRestrictedStockUnitsMember 2018-09-30 0000031791 us-gaap:EmployeeStockOptionMember 2018-09-30 0000031791 pki:DiagnosticsMember 2018-09-30 0000031791 pki:DiscoveryAnalyticalSolutionsMember 2018-09-30 0000031791 pki:DiscoveryAnalyticalSolutionsMember 2017-12-31 0000031791 pki:DiagnosticsMember 2017-12-31 0000031791 srt:MinimumMember 2018-01-01 2018-01-01 0000031791 2018-01-01 2018-01-01 0000031791 srt:MaximumMember 2018-01-01 2018-01-01 0000031791 pki:InformaticsMember 2018-01-01 0000031791 us-gaap:LicensingAgreementsMember 2018-09-30 0000031791 us-gaap:LicensingAgreementsMember 2017-12-31 0000031791 us-gaap:InProcessResearchAndDevelopmentMember 2017-12-31 0000031791 pki:TradeNamesAndTrademarksMember 2018-09-30 0000031791 pki:CoreTechnologyMember 2018-09-30 0000031791 pki:TradeNamesAndTrademarksMember 2017-12-31 0000031791 us-gaap:PatentsMember 2018-09-30 0000031791 pki:CoreTechnologyMember 2017-12-31 0000031791 us-gaap:PatentsMember 2017-12-31 0000031791 us-gaap:CustomerRelationshipsMember 2017-12-31 0000031791 us-gaap:InProcessResearchAndDevelopmentMember 2018-09-30 0000031791 us-gaap:CustomerRelationshipsMember 2018-09-30 0000031791 2018-07-01 0000031791 2017-07-02 0000031791 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-01-01 2018-09-30 0000031791 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-07-02 2018-09-30 0000031791 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-01-02 2017-10-01 0000031791 us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-09-30 0000031791 us-gaap:PensionPlansDefinedBenefitMember 2018-07-02 2018-09-30 0000031791 us-gaap:PensionPlansDefinedBenefitMember 2017-07-03 2017-10-01 0000031791 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-07-03 2017-10-01 0000031791 us-gaap:PensionPlansDefinedBenefitMember 2017-01-02 2017-10-01 0000031791 us-gaap:ForeignPlanMember 2017-01-02 2017-10-01 0000031791 us-gaap:ForeignPlanMember 2018-01-01 2018-09-30 0000031791 country:US 2018-01-01 2018-09-30 0000031791 us-gaap:NetInvestmentHedgingMember pki:A0.6PercentSeniorUnsecuredNotesdueinApril2021Member 2018-01-01 2018-09-30 0000031791 pki:NotionalAmountofUSDollarDerivativesMember us-gaap:CashFlowHedgingMember 2017-12-31 0000031791 us-gaap:NetInvestmentHedgingMember pki:A1.875PercentTenYearSeniorUnsecuredNotesMemberMember 2018-01-01 2018-09-30 0000031791 us-gaap:NetInvestmentHedgingMember pki:A0.6PercentSeniorUnsecuredNotesdueinApril2021Member 2018-07-02 2018-09-30 0000031791 us-gaap:FairValueHedgingMember 2018-09-30 0000031791 pki:NotionalAmountofEuroDerivativesMember 2018-04-27 0000031791 pki:NotionalAmountofEuroDerivativesMember 2017-12-31 0000031791 pki:NotionalAmountofUSDollarDerivativesMember us-gaap:CashFlowHedgingMember 2018-09-30 0000031791 us-gaap:FairValueHedgingMember 2017-12-31 0000031791 pki:NotionalAmountofUSDollarDerivativesMember us-gaap:CashFlowHedgingMember 2017-10-01 0000031791 us-gaap:NetInvestmentHedgingMember pki:A1.875PercentTenYearSeniorUnsecuredNotesMemberMember 2018-01-01 2018-04-01 0000031791 pki:NotionalAmountofEuroDerivativesMember 2017-10-01 0000031791 us-gaap:FairValueHedgingMember 2017-10-01 0000031791 us-gaap:NetInvestmentHedgingMember pki:A0.6PercentSeniorUnsecuredNotesdueinApril2021Member 2018-04-11 2018-04-11 0000031791 us-gaap:NetInvestmentHedgingMember pki:A1.875PercentTenYearSeniorUnsecuredNotesMemberMember 2018-07-02 2018-09-30 0000031791 pki:NotionalAmountofEuroDerivativesMember 2018-09-30 0000031791 pki:EuropeanAndAsianCurrenciesMember 2018-01-01 2018-09-30 0000031791 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000031791 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000031791 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000031791 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0000031791 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-09-30 0000031791 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-09-30 0000031791 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-09-30 0000031791 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2018-09-30 0000031791 pki:OtherDebtFacilitiesEUROIMMUNMember us-gaap:FairValueInputsLevel2Member 2017-12-31 0000031791 currency:EUR pki:A1.875PercentTenYearSeniorUnsecuredNotesMemberMember 2017-12-31 0000031791 srt:MinimumMember pki:VanadisDiagnosticsABMember 2018-09-30 0000031791 pki:LineofCreditMaturingAugust112021Member us-gaap:FairValueInputsLevel2Member 2017-12-31 0000031791 srt:MaximumMember pki:VanadisDiagnosticsABMember us-gaap:MeasurementInputDiscountRateMember 2018-01-01 2018-09-30 0000031791 srt:MinimumMember pki:VanadisDiagnosticsABMember 2018-01-01 2018-09-30 0000031791 pki:VanadisDiagnosticsABMember 2014-12-29 2016-01-03 0000031791 srt:MinimumMember pki:OtherDebtFacilitiesEUROIMMUNMember 2018-09-30 0000031791 pki:VanadisDiagnosticsABMember 2018-07-02 2018-09-30 0000031791 pki:LineofCreditMaturingAugust112021Member us-gaap:FairValueInputsLevel2Member 2018-09-30 0000031791 pki:OtherDebtFacilitiesEUROIMMUNMember us-gaap:FairValueInputsLevel2Member 2018-09-30 0000031791 pki:VanadisDiagnosticsABMember 2016-01-03 0000031791 srt:MinimumMember pki:VanadisDiagnosticsABMember us-gaap:MeasurementInputDiscountRateMember 2018-01-01 2018-09-30 0000031791 srt:MaximumMember pki:VanadisDiagnosticsABMember 2018-01-01 2018-09-30 0000031791 srt:MaximumMember pki:VanadisDiagnosticsABMember 2018-09-30 0000031791 pki:VanadisDiagnosticsABMember 2018-01-01 2018-09-30 0000031791 srt:MaximumMember pki:OtherDebtFacilitiesEUROIMMUNMember 2018-09-30 0000031791 currency:EUR pki:A1.875PercentTenYearSeniorUnsecuredNotesMemberMember 2018-09-30 iso4217:USD xbrli:shares pki:employees iso4217:USD xbrli:shares xbrli:pure pki:plan pki:years pki:segments iso4217:EUR false --12-30 Q3 2018 2018-09-30 10-Q 0000031791 111239214 Yes false Large Accelerated Filer 2400 PERKINELMER INC false 19000000 12300000 140000000 57200000 1253000000 212100000 48700000 28000000 180400000 298700000 -116118000 -111341000 11500000 300000 5000000 4240000 18160000 710000000 200000000 503780000 1200000000 1413780000 14700000 142041000 127280000 9000000 55395000 19442000 15398000 43060000 56878000 5800000 1700000 7500000 59599000 0 -93000 599000 1000000 2500000 2400000 P2Y0M P0Y7M -66000 -1200000 -265000 500000 716286000 11254000 15735000 253288000 2524000 803600000 11100000 1600000000 25200000 700000 25018000 -2439000 -1138000 0.100 0.98 0.95 17600000 0.98 0.84 0.99372 0.99118 0.99950 1.01 1.01 1.01 0.150 0.090 7100000 -5400000 4200000 0 4891000 0 0 P30D -3600000 -5400000 0 -301000 13031000 13031000 -23729000 -15749000 -7980000 2300000 13300000 -11500000 10700000 -12800000 85000000 -5100000 735000 669000 791000 813000 255000 196000 232000 198000 29300000 0.050 0.030 0.065 0.034 1 P1Y 10 2010 8100000 -8940000 16500000 -12800000 123578000 44057000 0.70 1.00 2019 2018 3807 63506 -3269000 -12920000 -6508000 -6508000 0 -13086000 -13086000 0 2900000 17634000 9981000 2106000 7653000 -1174000 4273000 868000 0 1538000 22000 3000000 200000000 -21100000 -2100000 -1800000 -800000 -22600000 -7700000 6400000

222093000

180693000

552304000

551385000

539831000

11554000

9400000

8500000

500642000

475743000

494655000

18912000

332853000

407004000

-258000

-190000

-322000

-46582000

-160780000

-46518000

-160648000

P11Y9M

P16Y1M

P14Y7M

58828000

89970000

200000

800000

2300000

1100000

357000

373000

3682000

600000

3600000

7800000

700000

3500000

898000

1077000

14204000

1300000

5300000

3000000

1400000

430000

335000

10362000

2200000

7600000

8700000

800000

4000000

1093000

1029000

21153000

1936000

2454000

17700000

52300000

35300000

100700000

14000

377000

358000

346000

6091463000

5862355000

5857730000

4625000

1199955000

1165495000

0.9998

0.86

1.57

0.85

1.56

94055000

172672000

640154000

1846233000

-30800000

-30100000

1700000

5500000

1388762000.000

139602000.000

54257000.000

1273000

3354000

1560000

10804000

Contingent consideration is measured at fair value at the acquisition date, based on the probability that revenue thresholds or product development milestones will be achieved during the earnout period, with changes in the fair value after the acquisition date affecting earnings to the extent it is to be settled in cash.

93000000

76500000

8000000

2000000

52200000

61300000

13100000

5800000

-1000000

13500000

121174000

16268000

3469000

160000000

1400000

36000000

12400000

43700000

3000000

710000000

15957000

10800000

1010000

8328000

86530000

4037000

1388762000

139602000

54257000

61357000

208000

1691000

49679000

430000

130512000

11356000

937000

709488000

202134000

149513000

376568000

709724000

202371000

152717000

333156000

-49654000

-533000

272779000

-4806000

-200000

0.07

0.21

0.07

0.21

0.07

300000000

110361000

111087000

110361000

111087000

110361000

111087000

100930000

381036000

46466000

52505000

31200000

22700000

26300000

29000000

-20400000

165015000

120293000

501079000

347948000

213672000

213574000

98000

128314000

663651000

655871000

7780000

393307000

285308000

849027000

341986000

341888000

98000

1056958000

1049178000

7780000

10200000

2000000

0.01

0.0050

0.015

0.0110

0.0015

0.0045

Federal Funds

Eurocurrency

500000000

300000000

508900000

536600000

502900000

301200000

515600000

The weighted average Eurocurrency interest rate as of September 30, 2018 was 2.19%, resulting in a weighted average effective Eurocurrency rate, including the margin, of 3.29%,

0.055

0.011

0.055

0.0230

0.001

0.0005

0.0195

0.05

0.01875

0.006

Interest on the April 2021 Notes is payable annually on April 9th each year.

Interest on the November 2021 Notes is payable semi-annually on May 15th and November 15th each year. Prior to August 15, 2021 (three months prior to their maturity date), the Company may redeem the November 2021 Notes in whole or in part, at its option, at a redemption price equal to the greater of (i) 100% of the principal amount of the November 2021 Notes to be redeemed, plus accrued and unpaid interest, or (ii) the sum of the present values of the remaining scheduled payments of principal and interest in respect to the November 2021 Notes being redeemed, discounted on a semi-annual basis, at the Treasury Rate plus 45 basis points, plus accrued and unpaid interest.

The interest rates under the senior unsecured revolving credit facility are based on the Eurocurrency rate or the base rate at the time of borrowing, plus a margin. The base rate is the higher of (i) the rate of interest in effect for such day as publicly announced from time to time by JP Morgan Chase Bank, N.A. as its "prime rate," (ii) the Federal Funds rate plus 50 basis points or (iii) an adjusted one-month Libor plus 1.00%. The Eurocurrency margin as of September 30, 2018 was 110 basis points.

Of these bank loans, loans in the aggregate amount of $35.1 million bear fixed interest rates between 1.1% and 5.5% and a loan in the amount of $0.2 million bears a variable interest rate based on the Euribor rate plus a margin of 1.5%.

The secured bank loan of $0.3 million bears a fixed annual interest rate of 1.95% and is repaid in monthly installments until 2027.

The unsecured revolving debt facilities bear fixed interest rates between 0.05% and 2.30% and will mature in 2018.

The interest rates under the senior unsecured term loan credit facility were based on the Eurocurrency rate or the base rate at the time of the borrowing, plus a margin. The base rate is the higher of (i) the rate of interest in effect for such day as publicly announced from time to time by JP Morgan Chase Bank, N.A. as its "prime rate," (ii) the Federal Funds rate plus 50 basis points or (iii) an adjusted one-month Libor plus 1.00%.

2021-11-25

2026-07-19

2021-04-09

4700000

1400000

200000

4200000

1200000

3100000

4400000

200000

13900000

-49000

-144000

-41000

-123000

6200000

15000000

6400000

279000

6568000

836000

19609000

314000

7270000

941000

21926000

32000

4160000

94000

12420000

30000

4051000

90000

12212000

-224000

-1226000

-673000

-3666000

-257000

-1548000

-771000

-4657000

-1800000

1800000

-5400000

5400000

-2500000

-7500000

23000

1231000

69000

3667000

27000

1712000

80000

5180000

75507000

133386000

-206000

180171000

179615000

-1108000

-308000

13031000

-308000

-859000

650000

P0Y12M0D

5262000

42405000

-1411000

-1341000

43131000

277400000

2300000

37300000

32933000

5869000

44343000

2018-11-09

2019-02-08

7800000

2018-07-23

2018-10-24

0.83

3.04

0.69

1.51

0.82

3.02

0.69

1.49

19945000

-200000

-7410000

400000

18900000

8000000

P1Y6M9D

P2Y0M

1900000

9900000

6100000

10600000

651000

1560000

3740000

10805000

0.000

5800000

7500000

34000

16507000

63201000

64076000

64727000

65328000

74093000

67126000

244916000

28250000

242840000

5427000

42635000

35085000

272475000

32251000

290616000

9808000

44889000

37046000

37600000

123800000

135200000

150400000

148300000

471740000

80974000

1141511000

88025000

53300000

39959000

476403000

78628000

1108220000

81813000

52261000

42951000

1276356000

226824000

52724000

898671000

82598000

10665000

4874000

1153191000

203928000

46377000

817604000

72005000

7372000

5905000

1431000

1273000

23638000

4694000

2700000

36300000

5400000

42000000

-4300000

100000

8800000

1000000

32700000

34400000

2500000

-9800000

557000

3002198000

75250000

1657963000

1344235000

2920689000

581172000

28423000

2920689000

1610601000

1310088000

217200000

-57780000

-31613000

-26167000

-1520000

96546000

195334000

75445000

73112000

-2333000

166153000

152824000

-13329000

105054000

215829000

78041000

74894000

-3147000

178254000

160172000

-18082000

0.88

1.78

0.68

1.50

0.87

1.77

0.68

1.49

-5468000

138416000

1103000

482000

-0.05

1.26

0.01

0.00

-0.05

1.25

0.01

0.00

8508000

20495000

2596000

1782000

-814000

12101000

7348000

-4753000

13770000

62900000

1185000

10760000

-12459000

-36587000

-10971000

12670000

25208000

41313000

-17218000

29500000

70584000

907400000

1346940000

1223775000

10974000

32510000

16684000

50745000

211123000

215589000

351675000

354244000

361695000

7451000

122100000

117266000

18452000

21389000

802000

1512000

316000

754000

2208000

2405000

11400000

3588275000

3289886000

3308798000

18912000

6091463000

5862355000

5857730000

4625000

950902000

686752000

2102000

2165000

625000000

411000000

2021-08-11

1000000000

577600000

591700000

496600000

621700000

345800000

572300000

497200000

408400000

217306000

20072000

1788803000

1882502000

35100000

43300000

200000

P12M

-34450000

-121962000

-33917000

-121962000

187304000

-71901000

-85475000

-71901000

160357000

151619000

165163000

151819000

91078000

333750000

76548000

74215000

-2333000

166635000

153306000

-13329000

27016000

13797000

-2161000

-29947000

298700000

135100000

78038000

43361000

47258000

-12581000

202032000

113024000

128604000

-39596000

80202000

77055000

-3147000

47411000

48381000

-15590000

208201000

190119000

-18082000

104585000

149243000

-45627000

93842000

110353000

109831000

522000

244304000

235347000

9805000

47205000

-30105000

-114198000

2600000

9852000

47286000

-30082000

-114130000

47000

81000

23000

68000

848570000

720632000

47600000

57200000

35900000

60200000

30400000

35300000

34900000

43500000

1400000

1500000

34500000

33400000

37188000

45096000

1176000

7013000

12800000

3700000

30285000

11539000

30285000

3480000

4974000

2634000

23077000

23222000

1413780000.000

140861000

43942000

32000000

5500000

22362000

60443000

1000000

60420000

38027000

369340000

493600000

492300000

298700000

45000

72000

146952000

605000000

-872000

-22871000

14004000

14000000

19484000

19500000

9012000

9088000

8313000

9050000

8943000

8448000

3488000

10625000

3547000

10514000

-730000

-215000

-226000

110000

3326000

9706000

3327000

10012000

630919000

724053000

298066000

317049000

146965000

1019000000

0.200

34885000

101731000

48848000

142028000

17302000

236000

3204000

1631000

5000000

33000

6697000

1021000

1321000

2342000

255000

1680000

1935000

902000

5096000

5998000

4744000

618000

1146000

1764000

12506000

7762000

4744000

4971000

5998000

1764000

13969000

10921000

4399000

3048000

2498000

2072000

1919000

33000

9421000

9055000

2646000

366000

1324000

1725000

1204000

1764000

381000

11000

580000

353000

227000

8759000

8079000

2300000

1300000

2380517000

2532060000

2508523000

-23537000

554275000

354819000

132201000

222618000

199456000

36692000

162764000

168893000

385382000

1615352000

1043534000

378466000

665068000

571818000

106616000

465202000

485082000

1130270000

674313000

183975000

268147000

222191000

474523000

471325000

3198000

227273000

247250000

199790000

40874000

158916000

264973000

95607000

169366000

230113000

104060000

126053000

179227000

68480000

110747000

671115000

3198000

268147000

247189000

20958000

406166000

290929000

115237000

538118000

136195000

2021647000

557512000

788328000

675807000

1417739000

1392177000

25562000

669469000

748270000

603908000

118859000

485049000

780369000

282536000

497833000

677620000

299900000

377720000

563658000

205892000

357766000

1996085000

25562000

788328000

726058000

62270000

1233319000

874517000

358802000

1600575000

421072000

5400000

200000

152775000

449642000

196769000

196816000

47000

601374000

601674000

300000

4412000

16179000

11127000

23275000

5797

32000

53.67

18483

39133

37281

206000

1386

21321

64.73

80.31

73.23

75.78

72.17

69.57

496000

87673

201762

470000

50.30

61.38

200000

500000

9800000

1100000

10000000

50.18

0.004

0.224

0.207

0.015

0.029

5000000

10000000

800000

1113000

43.10

700000

12800000

18900000

25300000

43000

363000

14.32

11.79

18.65

17.56

88100000

2154000

1920000

42.77

51.38

35.19

51.62

77.81

P5Y

60300000

P3Y2M

P4Y4M

twelve months

200000000

117000

435000

-49000

-210000

554000

250000000

8000000

250000000

2503188000

2572469000

2548932000

-23537000

-7000000

21500000

-1800000

-7100000

-300000

4300000

2000000

3300000

2300000

3900000

1700000

2600000

30500000

28800000

29900000

110993000

110653000

111747000

111510000

110003000

109788000

110724000

110499000

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable intangible asset balances at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;"> by category were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,951</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,959</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Accumulated amortization</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(37,046</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35,085</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net patents</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,905</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,874</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names and trademarks</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,628</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80,974</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Accumulated amortization</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(32,251</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(28,250</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net trade names and trademarks</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46,377</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52,724</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Licenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52,261</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53,300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Accumulated amortization</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(44,889</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(42,635</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net licenses</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,372</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,665</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Core technology</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">476,403</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">471,740</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Accumulated amortization</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(272,475</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(244,916</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net core technology</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">203,928</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">226,824</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,108,220</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,141,511</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Accumulated amortization</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(290,616</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(242,840</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">817,604</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">898,671</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">IPR&D</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81,813</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,025</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Accumulated amortization</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,808</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,427</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net IPR&D</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72,005</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82,598</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net amortizable intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,153,191</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,276,356</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-amortizing intangible asset:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade name</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70,584</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70,584</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,223,775</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,346,940</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;padding-top:12px;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">     </font><font style="font-family:inherit;font-size:10pt;">The condensed consolidated financial statements included herein have been prepared by PerkinElmer, Inc. (the “Company”), in accordance with accounting principles generally accepted in the United States of America (the “U.S.” or the "United States") and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information in the footnote disclosures of the financial statements has been condensed or omitted where it substantially duplicates information provided in the Company’s latest audited consolidated financial statements, in accordance with the rules and regulations of the SEC. These condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes included in its Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, filed with the SEC (the “</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> Form 10-K”). The balance sheet amounts at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;"> in this report were derived from the Company’s audited </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> consolidated financial statements included in the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> Form 10-K. The condensed consolidated financial statements reflect all adjustments that, in the opinion of management, are necessary to present fairly the Company’s financial position, results of operations and cash flows for the periods indicated. The preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts and classifications of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The results of operations for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 1, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively, are not necessarily indicative of the results for the entire fiscal year or any future period. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s fiscal year ends on the Sunday nearest December 31. The Company reports fiscal years under a 52/53 week format and as a result, certain fiscal years will contain 53 weeks. The fiscal year ending </font><font style="font-family:inherit;font-size:10pt;">December 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> ("</font><font style="font-family:inherit;font-size:10pt;">fiscal year 2018</font><font style="font-family:inherit;font-size:10pt;">") will include </font><font style="font-family:inherit;font-size:10pt;">52</font><font style="font-family:inherit;font-size:10pt;"> weeks, and the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;"> ("</font><font style="font-family:inherit;font-size:10pt;">fiscal year 2017</font><font style="font-family:inherit;font-size:10pt;">") included </font><font style="font-family:inherit;font-size:10pt;">52</font><font style="font-family:inherit;font-size:10pt;"> weeks. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Adopted and Issued Accounting Pronouncements: </font><font style="font-family:inherit;font-size:10pt;">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (the "FASB") and are adopted by the Company as of the specified effective dates. Unless otherwise discussed, such pronouncements did not have or will not have a significant impact on the Company’s consolidated financial position, results of operations and cash flows or do not apply to the Company’s operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued Accounting Standards Update No. 2018-15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles-Goodwill and Other- Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract </font><font style="font-family:inherit;font-size:10pt;">("ASU 2018-15"). ASU 2018-15 aligns the accounting for implementation costs incurred in a hosting arrangement that is a service contract with the guidance on capitalizing costs associated with developing or obtaining internal-use software (and hosting arrangements that include an internal use software license). Specifically, ASU 2018-15 amends </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles-Goodwill and Other (Topic 350) </font><font style="font-family:inherit;font-size:10pt;">to include in its scope implementation costs incurred in a hosting arrangement that is a service contract and clarifies that a customer should apply </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Subtopic 350-40</font><font style="font-family:inherit;font-size:10pt;"> to determine which implementation costs to capitalize as an asset related to the service contract and which costs to expense. The provisions of this guidance are to be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. ASU 2018-15 is effective for annual reporting periods beginning after December 15, 2019, and interim periods within those years with early adoption permitted. The Company is currently evaluating the requirements of this guidance and has not yet determined the impact of its adoption on the Company's consolidated financial position, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued Accounting Standards Update No. 2018-14, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans </font><font style="font-family:inherit;font-size:10pt;">("ASU 2018-14"). ASU 2018-14 adds, removes, and clarifies disclosure requirements related to defined benefit pension and other postretirement plans. ASU 2018-14 adds requirements for an entity to disclose the weighted-average interest crediting rates used in the entity’s cash balance pension plans and other similar plans; and an explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">.</font><font style="font-family:inherit;font-size:10pt;"> Further, ASU 2018-14 removes guidance that currently requires the following disclosures: the amounts in accumulated other comprehensive income expected to be recognized as part of net periodic benefit cost over the next year; the amount and timing of plan assets expected to be returned to the employer; information about (1) benefits covered by related-party insurance and annuity contracts and (2) significant transactions between the plan and related parties; and the effects of a one-percentage-point change on the assumed health care costs and the effect of this change in rates on service cost, interest cost, and the benefit obligation for postretirement health care benefits. ASU 2018-14 also clarifies the guidance in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation-Retirement Benefits</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">(Topic 715-20-50-3)</font><font style="font-family:inherit;font-size:10pt;"> on defined benefit plans to require disclosure of (1) the projected benefit obligation ("PBO") and fair value of plan assets for pension plans with PBOs in excess of plan assets (the same disclosure with reference to the accumulated postretirement benefit obligation rather than the PBO is required for other postretirement benefit plans) and (2) the accumulated benefit obligation ("ABO") and fair value of plan assets for pension plans with ABOs in excess of plan assets. The provisions of this guidance are to be applied retrospectively to all periods presented upon their effective date. ASU 2018-14 is effective for annual reporting periods beginning after December 15, 2020, and interim periods within those years with early adoption permitted. The Company is currently evaluating the requirements of this guidance and has not yet determined the impact of its adoption on the Company's consolidated financial position, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued Accounting Standards Update No. 2018-13, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement </font><font style="font-family:inherit;font-size:10pt;">("ASU 2018-13"). ASU 2018-13 adds, removes, and modifies certain disclosures related to fair value measurements. ASU 2018-13 adds requirements for an entity to disclose the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period; and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. Further, ASU 2018-13 removes the requirement to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy; the policy for timing of transfers between levels; and the valuation processes for Level 3 fair value measurements. ASU 2018-13 also modifies existing disclosure requirements related to measurement uncertainty. The amendments regarding changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty are to be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments are to be applied retrospectively to all periods presented upon their effective date. ASU 2018-13 is effective for annual reporting periods beginning after December 15, 2019, and interim periods within those years. Early adoption is permitted for any removed or modified disclosures. The Company is currently evaluating the requirements of this guidance and has not yet determined the impact of its adoption on the Company's consolidated financial position, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2018, the FASB issued Accounting Standards Update No. 2018-07, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation - Stock Compensation (Topic 718), Improvements to Nonemployee Share-Based Payment Accounting</font><font style="font-family:inherit;font-size:10pt;"> ("ASU 2018-07") which supersedes Subtopic 505-50, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Equity - Equity-Based Payments to Non-employees</font><font style="font-family:inherit;font-size:10pt;">, and expands the scope of Topic 718 (which currently only includes share-based payments to employees) to also include share-based payments issued to non-employees for goods and services, except for specific guidance on inputs to an option pricing model and the attribution of cost (that is, the period of time over which share-based payment awards vest and the pattern of cost recognition over that period). ASU 2018-07 specifies that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards, except for financing transactions, or awards issued to customers as part of a contract accounted for under Topic 606, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;"> ("Topic 606"). The provisions of this guidance are to be applied using a modified retrospective approach, with a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year, for all (1) liability-classified non-employee awards that have not been settled as of the adoption date and (2) equity-classified non-employee awards for which a measurement date has not been established. ASU 2018-07 is effective for annual reporting periods beginning after December 15, 2018, and interim periods within those years. Early adoption is permitted, but no earlier than a company’s adoption date of Topic 606. The Company early adopted the provisions of this guidance effective July 2, 2018. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flow.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2018, the FASB Issued Accounting Standards Update No. 2018-05, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes (Topic 740): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118</font><font style="font-family:inherit;font-size:10pt;"> ("ASU 2018-05"). ASU 2018-05 was issued to incorporate into Topic 740 recent SEC guidance related to the income tax accounting implications of the Tax Cut and Jobs Act (the "Tax Act"). The SEC issued Staff Accounting Bulletin No. 118 ("SAB 118") to address concerns about reporting entities’ ability to timely comply with the accounting requirements to recognize all of the effects of the Tax Act in the period of enactment. SAB 118 permits companies to disclose that some or all of the income tax effects from the Tax Act are incomplete by the due date of the financial statements, and if possible, disclose a reasonable estimate of such tax effects. ASU 2018-05 is effective immediately. The Company is applying the guidance in ASU 2018-05 when accounting for the enactment date effects of the Tax Act. At </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company has not completed the accounting for all of the tax effects of the Tax Act; however, it has made a reasonable estimate of their effects based on currently available information. Management will continue to refine the calculations as additional guidance is available. These estimates may be affected as additional clarification and implementation guidance becomes available. These changes could be material to income tax expense (see Note 9, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes</font><font style="font-family:inherit;font-size:10pt;"> for further disclosures).</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2018, the FASB Issued Accounting Standards Update No. 2018-03, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Technical Corrections and Improvements to Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities</font><font style="font-family:inherit;font-size:10pt;"> ("ASU 2018-03")</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">.</font><font style="font-family:inherit;font-size:10pt;"> ASU 2018-03 was issued to clarify certain aspects of guidance concerning the recognition of financial assets and liabilities established in Accounting Standards Update No. 2016-01, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments - Overall (Subtopic 825-10):</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recognition and Measurement of Financial Assets and Financial Liabilities </font><font style="font-family:inherit;font-size:10pt;">("ASU 2016-01"). This includes treatment for discontinuations and adjustments for equity securities without a readily determinable market value, forward contracts and purchased options, presentation requirements for certain fair value option liabilities, fair value option liabilities denominated in a foreign currency, and transition guidance for equity securities without a readily determinable fair value. ASU 2018-03 is effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years beginning after June 15, 2018. Early adoption is permitted for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years, as long as the Company has adopted ASU 2016-01. The Company adopted the provisions of this guidance effective July 2, 2018. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2018, the FASB Issued Accounting Standards Update No. 2018-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income </font><font style="font-family:inherit;font-size:10pt;">("ASU 2018-02")</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">.</font><font style="font-family:inherit;font-size:10pt;"> ASU 2018-02 provides entities with an option to reclassify stranded tax effects within Accumulated Other Comprehensive Income ("AOCI") to retained earnings in each period in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Act (or portion thereof) is recorded. ASU 2018-02 requires entities to disclose a description of the accounting policy for releasing income tax effects from AOCI; whether they elect to reclassify the stranded income tax effects from the Tax Act; and information about the other income tax effects that are reclassified. ASU 2018-02 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted, and entities should apply the proposed amendments either in the period of adoption or retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Act is recognized. The Company is currently evaluating the requirements of this guidance and has not yet determined the impact of its adoption on the Company's consolidated financial position, results of operations and cash flows. </font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2017, the FASB issued Accounting Standards Update No. 2017-12, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivatives and Hedging (Topic 815), Targeted Improvements to Accounting for Hedging Activities </font><font style="font-family:inherit;font-size:10pt;">("ASU 2017-12")</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">, </font><font style="font-family:inherit;font-size:10pt;">which amends the hedge accounting recognition and presentation requirements in Topic 815. ASU 2017-12 makes targeted changes to the existing hedge accounting model to better align an entity’s financial reporting for hedging relationships with the entity’s risk management activities, and to reduce the complexity of, and simplify the application of, the hedge accounting model. Specifically, ASU 2017-12 expands the types of transactions eligible for hedge accounting, eliminates the requirement to separately measure and present hedge ineffectiveness, simplifies the way assessments of hedge ineffectiveness may be performed, relaxes the documentation requirements for entering into hedging positions, provides targeted improvements to fair value hedges of interest rate risk, and permits an entity to exclude the change in the fair value of cross-currency basis spreads in currency swaps from the assessment of hedge effectiveness. The standard also requires entities to provide new disclosures about the impact fair value and cash flow hedges have on their income statements and about cumulative basis adjustments arising from fair value hedges. The provisions of this guidance are to be applied using a modified retrospective approach to existing hedging relationships as of the adoption date. However, the transition provisions allow for certain elections at the date of adoption and entities may choose to apply any of the provided elections. ASU 2017-12 is effective for annual reporting periods beginning after December 15, 2018, and interim periods within those years. Early adoption is permitted, including adoption in any interim period. The Company early adopted the provisions of this guidance effective January 1, 2018. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2017, the FASB issued Accounting Standards Update No. 2017-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation - Stock Compensation (Topic 718), Scope of Modification Accounting </font><font style="font-family:inherit;font-size:10pt;">("ASU 2017-09")</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">, </font><font style="font-family:inherit;font-size:10pt;">which amends the scope of modification accounting for share-based payment arrangements. ASU 2017-09 provides guidance on the types of changes to the terms or conditions of share-based payment awards to which an entity would be required to apply modification accounting under Topic 718. Specifically, an entity would not apply modification accounting if the fair value, vesting conditions, and classification of the awards are the same immediately before and after the modification. If an entity modifies its awards and concludes that it is not required to apply modification accounting under the standard, it must still consider whether the modification affects its application of other guidance. Additionally, if a significant modification does not result in incremental compensation cost, entities are required to disclose the “lack of” incremental compensation cost resulting from such significant modification. The standard also removes the guidance in Topic 718 stating that modification accounting is not required when an entity adds an antidilution provision as long as that modification is not made in contemplation of an equity restructuring. The provisions of this guidance are to be applied on a prospective basis to awards modified on or after the effective date. ASU 2017-09 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years. Early adoption is permitted, including adoption in any interim period. The Company adopted ASU 2017-09 effective January 1, 2018. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2017, the FASB issued Accounting Standards Update No. 2017-07, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation - Retirement Benefits (Topic 715), Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost </font><font style="font-family:inherit;font-size:10pt;">("ASU 2017-07")</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">, </font><font style="font-family:inherit;font-size:10pt;">which amends the requirements in Topic 715 related to the income statement presentation of the components of net periodic benefit cost for an entity’s sponsored defined benefit pension and other postretirement plans. ASU 2017-07 requires entities to (1) disaggregate the current-service-cost component from the other components of net benefit cost (the “other components”) and present it with other current employee compensation costs in their income statements and (2) present the other components elsewhere in their income statements and outside of income from operations, and disclose the income statement lines that contain the other components if they are not presented on appropriately described separate lines. Additionally, the standard requires that only the service-cost component of net benefit cost is eligible for capitalization (e.g., as part of inventory or property, plant, and equipment). The change in income statement presentation requires retrospective application, while the change in capitalized benefit cost is to be applied prospectively. ASU 2017-07 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years, with early adoption permitted. The standard provides a practical expedient that permits entities to use the components of cost disclosed in prior years as a basis for the retrospective application of the new income statement presentation. Entities need to disclose the use of the practical expedient. The Company adopted ASU 2017-07 effective January 1, 2018 using a retrospective approach for each period presented. For the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">October 1, 2017</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$1.8 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$5.4 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, of net periodic pension credit previously presented within operating income has been presented outside of operating income in the line item "Interest and other expense, net" in the condensed consolidated statement of operations due to the retrospective adoption of ASU 2017-07. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows, other than the impact discussed above.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued Accounting Standards Update No. 2017-01, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Business Combinations (Topic 805), Clarifying the Definition of a Business </font><font style="font-family:inherit;font-size:10pt;">("ASU 2017-01"), which amends Topic 805 to provide a screen to determine when a set of assets and liabilities is not a business. The screen requires that when substantially all of the fair value of the gross assets acquired (or disposed of) is concentrated in a single identifiable asset or a group of similar identifiable assets, the set is not a business. This screen reduces the number of transactions that need to be further evaluated. If the screen is not met, the standard (1) requires that to be considered a business, a set must include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create output and (2) removes the evaluation of whether a market participant could replace missing elements. The standard provides a framework to assist entities in evaluating whether both an input and a substantive process are present. The standard also provides a framework that includes two sets of criteria to consider that depend on whether a set has outputs and a more stringent criteria for sets without outputs. Lastly, the standard narrows the definition of the term "output" so that the term is consistent with how outputs are described in Topic 606, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;">. The provisions of this guidance are to be applied prospectively. ASU 2017-01 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years, with early adoption permitted in limited circumstances. The Company adopted ASU 2017-01 effective January 1, 2018. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2016, the FASB issued Accounting Standards Update No. 2016-18, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Statement of Cash Flows (Topic 230), Restricted Cash </font><font style="font-family:inherit;font-size:10pt;">("ASU 2016-18"), which amends Topic 230 to add or clarify guidance on the classification and presentation of restricted cash in the statement of cash flows. The standard requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The provisions of this guidance are to be applied using a retrospective transition method to each period presented. ASU 2016-18 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years, with early adoption permitted. The Company adopted ASU 2016-18 effective January 1, 2018. For the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">October 1, 2017</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$17.2 million</font><font style="font-family:inherit;font-size:10pt;"> of changes in restricted cash balances that was previously presented within investing activities in the condensed consolidated statement of cash flows has been excluded from the cash flows used in investing activities and the effect of exchange rate changes increased by </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> due to the retrospective adoption of ASU 2016-18. Restricted cash amounting to </font><font style="font-family:inherit;font-size:10pt;">$17.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> at January 1, 2017 and </font><font style="font-family:inherit;font-size:10pt;">October 1, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively, have been included with the cash and cash equivalents when reconciling the beginning of period and end of period total amounts on the condensed consolidated statement of cash flows for the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">October 1, 2017</font><font style="font-family:inherit;font-size:10pt;">. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows, other than the impact discussed above. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October 2016, the FASB issued Accounting Standards Update No. 2016-16, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes (Topic 740), Intra-entity Transfer of Assets Other than Inventory </font><font style="font-family:inherit;font-size:10pt;">("ASU 2016-16"). ASU 2016-16 removes the prohibition in Topic 740 against the immediate recognition of the current and deferred income tax effects of intra-entity transfers of assets other than inventory. The standard requires entities to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. The provisions of this guidance are to be applied on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. ASU 2016-16 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years, with early adoption permitted. The Company adopted ASU 2016-16 on January 1, 2018. The adoption of the standard resulted in a decrease in the retained earnings at January 1, 2018 of approximately </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;"> with corresponding increase in deferred tax assets of </font><font style="font-family:inherit;font-size:10pt;">$10.7 million</font><font style="font-family:inherit;font-size:10pt;"> and decrease in prepaid taxes of </font><font style="font-family:inherit;font-size:10pt;">$12.8 million</font><font style="font-family:inherit;font-size:10pt;"> related to prior years’ intra-entity transfers of assets other than inventory. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows, other than the impact discussed above.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued Accounting Standards Update No. 2016-13, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments </font><font style="font-family:inherit;font-size:10pt;">("ASU 2016-13"). ASU 2016-13 changes how entities will measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. The standard requires entities to use the expected loss impairment model and will apply to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities, net investments in leases and off-balance sheet credit exposures. Entities are required to estimate the lifetime “expected credit loss” for each applicable financial asset and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The standard also amends the impairment model for available-for-sale (“AFS”) debt securities and requires entities to determine whether all or a portion of the unrealized loss on an AFS debt security is a credit loss. An entity will recognize an allowance for credit losses on an AFS debt security as a contra-account to the amortized cost basis rather than as a direct reduction of the amortized cost basis of the investment. The provisions of this guidance are to be applied using a modified-retrospective approach. A prospective transition approach is required for debt securities for which an other-than-temporary impairment had been recognized before the effective date. ASU 2016-13 is effective for annual reporting periods beginning after December 15, 2019, and interim periods within those years. Early adoption is permitted for annual periods beginning after December 15, 2018, and interim periods therein. The Company is currently evaluating the requirements of this guidance and has not yet determined the impact of its adoption on the Company's consolidated financial position, results of operations and cash flows. </font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued Accounting Standards Update No. 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases </font><font style="font-family:inherit;font-size:10pt;">("ASU 2016-02"). ASU 2016-02 requires organizations that lease assets to recognize assets and liabilities on the balance sheet related to the rights and obligations created by those leases, regardless of whether they are classified as finance or operating leases. Consistent with current guidance, the recognition, measurement, and presentation of expenses and cash flows arising from a lease of assets will primarily depend on its classification as a finance or operating lease. ASU 2016-02 also requires new disclosures to help financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases. The provisions of this guidance are effective for annual periods beginning after December 15, 2018, and interim periods within those years, with early adoption permitted. ASU 2016-02 is to be applied using a modified retrospective approach. Subsequent to the issuance of ASU 2016-02, in July 2018, the FASB issued Accounting Standards Update No. 2018-10, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Codification Improvements to Topic 842, Leases </font><font style="font-family:inherit;font-size:10pt;">("ASU 2018-10") and Accounting Standards Update No. 2018-11, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842): Targeted Improvements</font><font style="font-family:inherit;font-size:10pt;"> ("ASU 2018-11"). The amendments in ASU 2018-10 clarify, correct or remove inconsistencies in the guidance provided under ASU 2016-02 related to sixteen specific issues identified. The amendments in ASU 2018-11 provide entities with an additional (and optional) transition method to adopt the new leases standard. Under the new transition method, an entity initially applies the new leases standard at the adoption date and recognizes a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. Consequently, an entity's reporting for the comparative periods presented in the financial statements in the period of adoption will continue to be in accordance with ASC 840, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases ("ASC 840"</font><font style="font-family:inherit;font-size:10pt;">). An entity that elects this additional (and optional) transition method must provide the required disclosures under ASC 840 for all periods that continue to be in accordance with ASC 840. ASU 2018-11 also provides lessors with a practical expedient, by class of underlying asset, to not separate nonlease components from the associated lease component and, instead, to account for those components as a single component if certain criteria are met. The effective date and transition requirements for these two standards are the same as the effective date and transition requirements of ASU 2016-02. The Company is in the process of completing its evaluation of the impact of the new leases standard upon adoption and has not yet determined the impact of adoption on its consolidated financial position, results of operations and cash flows. The Company intends to adopt the new leases standard using the optional transition method and will apply the new leases standard on December 31, 2018 (the first day of fiscal year 2019).</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued Accounting Standards Update No. 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers </font><font style="font-family:inherit;font-size:10pt;">("ASU 2014-09"). Under this new guidance, an entity should use a five-step process to recognize revenue, depicting the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard also requires new disclosures regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. Subsequent to the issuance of the standard, the FASB decided to defer the effective date for one year to annual reporting periods beginning after December 15, 2017, with early adoption permitted for annual reporting periods beginning after December 15, 2016. In November 2017, the FASB also issued Accounting Standards Update No. 2017-14, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Statement-Reporting Comprehensive Income (Topic 220), Revenue Recognition (Topic 605), and Revenue from Contracts with Customers (Topic 606)</font><font style="font-family:inherit;font-size:10pt;">. ASU 2017-14 includes amendments to certain SEC paragraphs within the FASB Accounting Standards Codification ("Codification"). ASU 2017-14 amends the Codification to incorporate SEC Staff Accounting Bulletin No. 116 and SEC Interpretive Release on Vaccines for Federal Government Stockpiles (SEC Release No. 33-10403) to align existing SEC staff guidance with Revenue from Contracts with Customers (Topic 606). In May 2016, the FASB also issued Accounting Standards Update No. 2016-12,</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> Revenue from Contracts with Customers (Topic 606), Narrow-Scope Improvements and Practical Expedients </font><font style="font-family:inherit;font-size:10pt;">("ASU 2016-12")</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">, </font><font style="font-family:inherit;font-size:10pt;">which amended its revenue recognition guidance in ASU 2014-09 on transition, collectability, non-cash consideration, contract modifications and completed contracts at transition and the presentation of sales and other similar taxes collected from customers. In April 2016, the FASB also issued Accounting Standards Update No. 2016-10,</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> Revenue from Contracts with Customers (Topic 606), Identifying Performance Obligations and Licensing </font><font style="font-family:inherit;font-size:10pt;">("ASU 2016-10")</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">, </font><font style="font-family:inherit;font-size:10pt;">which amended its revenue recognition guidance in ASU 2014-09 on identifying performance obligations to allow entities to disregard items that are immaterial in the context of the contract, clarify when a promised good or service is separately identifiable (i.e., distinct within the context of the contract) and allow an entity to elect to account for the cost of shipping and handling performed after control of a good has been transferred to the customer as a fulfillment cost (i.e., an expense). ASU 2016-10 also clarifies how an entity should evaluate the nature of its promise in granting a license of intellectual property ("IP") and requires entities to classify IP in one of two categories: functional IP or symbolic IP, which will determine whether it recognizes revenue over time or at a point in time. ASU 2016-10 also addresses how entities should consider license renewals and restrictions and apply the exception for sales- and usage-based royalties received in exchange for licenses of IP. In March 2016, the FASB also issued Accounting Standards Update No. 2016-08, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers (Topic 606), Principal versus Agent Considerations (Reporting Revenue Gross versus Net) </font><font style="font-family:inherit;font-size:10pt;">("ASU 2016-08"), which amended the principal-versus-agent implementation guidance and illustrations in ASU 2014-09. ASU 2016-08 clarifies that an entity should evaluate when it is the principal or agent for each specified good or service promised in a contract with a customer. ASU 2017-14, ASU 2016-12, ASU 2016-10, ASU 2016-08 and ASU 2014-09 may be adopted either using a full retrospective approach or a modified retrospective approach. The Company adopted these standards beginning on </font><font style="font-family:inherit;font-size:10pt;">January 1, 2018</font><font style="font-family:inherit;font-size:10pt;"> using the modified retrospective approach only to contracts not completed as of </font><font style="font-family:inherit;font-size:10pt;">January 1, 2018</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The most significant impact of the standards relates to the accounting for certain transactions with multiple elements or “bundled” arrangements. Specifically, for sales of software subscriptions or sales of licenses and maintenance, the Company will recognize the license revenue predominantly at the time of billing and delivery rather than recognizing the entire sales price ratably over the maintenance period, which is the Company's current practice. In addition, for certain sales of instruments that include customer-specified acceptance criteria, the Company will recognize revenue when the customer obtains control of the instrument which is typically upon delivery or when title has transferred to the customer, as the Company believes acceptance is perfunctory. The Company will also capitalize incremental commission fees as a result of obtaining contracts when these fees are recoverable and will amortize the assets based on the transfer of goods or services to which the assets relate which typically range from two to six years. The adoption of the standards resulted in an increase in retained earnings at January 1, 2018 of approximately </font><font style="font-family:inherit;font-size:10pt;">$10.2 million</font><font style="font-family:inherit;font-size:10pt;"> for the cumulative effect of initially applying the standards as of that date. In addition, the adoption of the standards resulted primarily in a reduction in deferred revenue of approximately </font><font style="font-family:inherit;font-size:10pt;">$11.5 million</font><font style="font-family:inherit;font-size:10pt;">, mainly driven by the upfront recognition of license revenue and certain multi-year software subscriptions, and an increase in deferred income tax liability of approximately </font><font style="font-family:inherit;font-size:10pt;">$3.0 million</font><font style="font-family:inherit;font-size:10pt;"> for the tax impact of the cumulative adjustments. The cumulative effect of recognizing instrument sales upon delivery or transfer of title and capitalizing the incremental commission fees were not material at January 1, 2018. The adoption of the standards had </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> impact to cash from or used in operating, investing, or financing activities in the Company's consolidated statement of cash flows at January 1, 2018. Refer to Note 3, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Changes in Accounting Policies, </font><font style="font-family:inherit;font-size:10pt;">for the impact of adoption of the standards on the Company's condensed consolidated financial statements for the quarter ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">. Also refer to Note 2, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue,</font><font style="font-family:inherit;font-size:10pt;"> for the disclosures required by the standards.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Changes in Accounting Policies</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Except for the changes below, the Company has consistently applied the accounting policies to all periods presented in these condensed consolidated financial statements. </font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company adopted ASC 606, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;"> ("ASC 606"), with a date of the initial application of January 1, 2018. As a result, the Company has changed its accounting policy for revenue recognition as detailed below.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company applied ASC 606 using the modified retrospective method only to contracts that are not completed contracts as of January 1, 2018, and the cumulative effect of initially applying ASC 606 is recognized as an adjustment to the beginning retained earnings. Therefore, the comparative information has not been adjusted and continues to be reported under ASC 605. The details of the significant changes and quantitative impact of the changes are disclosed below.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">A. Sales of software subscriptions or sales of licenses and maintenance in bundled arrangements</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company previously recognized revenue from software licenses sold together with maintenance and/or consulting services upon shipment using the residual method, provided that the undelivered items in the arrangement have value to the customer on a stand-alone basis and vendor-specific objective evidence ("VSOE") of fair value can be determined. If VSOE of fair value for the undelivered elements cannot be established, the Company deferred all revenue from the arrangement until the earlier of the point at which such sufficient VSOE does exist or all elements of the arrangement have been delivered, or if the undelivered element is maintenance, then the Company recognized the entire fee ratably over the maintenance period. Under ASC 606, the total consideration in the contract is allocated to all products and services based on their stand-alone selling prices. The stand-alone selling prices are determined based on the list prices at which the Company sells the software license, software subscription, maintenance and/or consulting services. Accordingly, the Company now recognizes higher license revenue upfront and less service revenue over time.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">B. Sales of instruments</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company previously recognized revenue from sale of instruments when persuasive evidence of an arrangement existed, delivery had occurred, the price to the buyer was fixed or determinable, and collectability was reasonably assured. For certain sales of instruments that included customer-specified acceptance criteria, the Company previously recognized revenue after the acceptance criteria had been met. Under ASC 606, revenue is recognized when the Company satisfies a performance obligation by transferring control of the product to a customer. Accordingly, the Company now recognizes product revenue upon delivery or when title has transferred to the customer, as the Company believes acceptance is perfunctory. </font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">C. Sales commissions</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company previously recognized commission fees related to sales of products and services as selling expenses when they were incurred. Under ASC 606, the Company capitalizes those commission fees as costs of obtaining a contract, when they are incremental and, if they are expected to be recovered, the Company amortizes them consistently with the pattern of transfer of the product or service to which the asset relates. If the expected amortization period is one year or less, the commission fee is expensed when incurred.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">D. Impacts on financial statements</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables summarize the impacts of ASC 606 adoption on the Company's condensed consolidated financial statements for the quarter ended </font><font style="font-family:inherit;font-size:10pt;font-weight:normal;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Consolidated Balance Sheet</font></div><div style="line-height:120%;text-align:center;padding-left:60px;text-indent:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.14634146341463%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balances without adoption of ASC 606</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">149,513</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">149,513</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">551,385</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11,554</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">539,831</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">354,244</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,451</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">361,695</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110,353</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(522</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">109,831</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">317,049</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">317,049</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,223,775</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,223,775</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,920,689</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,920,689</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">235,347</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">235,347</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,862,355</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,625</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,857,730</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current portion of long-term debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,072</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,072</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180,693</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180,693</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued restructuring and contract termination charges</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,079</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,079</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses and other current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">475,743</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,912</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">494,655</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current liabilities of discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,165</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,165</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,882,502</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,882,502</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">720,632</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">720,632</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,289,886</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,912</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,308,798</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commitments and contingencies</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Preferred stock</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">111,087</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">111,087</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital in excess of par value</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,970</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,970</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Retained earnings</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,532,060</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23,537</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,508,523</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated other comprehensive loss</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(160,648</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(160,648</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total stockholders’ equity</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,572,469</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23,537</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,548,932</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total liabilities and stockholders’ equity</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,862,355</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,625</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,857,730</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;font-style:italic;">    </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">    </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Consolidated Statement of Operations</font></div><div style="line-height:120%;text-align:center;padding-left:48px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:92.87804878048782%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balances without adoption of ASC 606</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">474,523</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,198</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">471,325</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service revenue</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199,790</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199,790</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total revenue</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">674,313</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,198</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">671,115</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of product revenue</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">213,672</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(98</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">213,574</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of service revenue</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">128,314</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">128,314</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total cost of revenue</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">341,986</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(98</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">341,888</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">196,769</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">196,816</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,848</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,848</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring and contract termination charges, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,508</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,508</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Operating income from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80,202</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,147</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,055</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest and other expense, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,161</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,161</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from continuing operations before income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,041</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,147</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74,894</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provision for income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,596</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(814</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,782</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Income from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,445</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,333</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73,112</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss on disposition of discontinued operations before income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(308</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(308</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Benefit from income taxes on discontinued operations and dispositions</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,411</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,411</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gain from discontinued operations and dispositions</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,103</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,103</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76,548</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,333</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74,215</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Consolidated Statement of Operations</font></div><div style="line-height:120%;text-align:center;padding-left:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:92.87804878048782%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balances without adoption of ASC 606</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,417,739</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,562</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,392,177</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service revenue</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">603,908</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">603,908</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total revenue</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,021,647</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,562</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,996,085</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of product revenue</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">663,651</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,780</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">655,871</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of service revenue</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">393,307</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">393,307</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total cost of revenue</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,056,958</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,780</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,049,178</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">601,374</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">300</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">601,674</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">142,028</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">142,028</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring and contract termination charges, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,086</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,086</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Operating income from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">208,201</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18,082</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">190,119</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest and other expense, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,947</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,947</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from continuing operations before income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">178,254</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18,082</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">160,172</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provision for income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,101</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,753</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,348</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Income from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">166,153</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13,329</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">152,824</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss on disposition of discontinued operations before income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(859</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(859</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Benefit from income taxes on discontinued operations and dispositions</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,341</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,341</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gain from discontinued operations and dispositions</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">482</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">482</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">166,635</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13,329</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">153,306</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;">The adoption of ASC 606 increased comprehensive income by </font><font style="font-family:inherit;font-size:10pt;">$2.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$13.3 million</font><font style="font-family:inherit;font-size:10pt;"> in the Company's condensed consolidated statement of comprehensive income for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, respectively. The adoption of ASC 606 had </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> impact on cash from or used in operating, investing, or financing activities in the Company's condensed consolidated statement of cash flows as of and for the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following unaudited pro forma information presents the combined financial results for the Company and EUROIMMUN as if the acquisition of EUROIMMUN had been completed at the beginning of fiscal year 2016:</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div><div style="line-height:120%;text-align:center;text-indent:36px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:93.5546875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 1, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine Months Ended</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 1, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands, except per share data)</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Pro Forma Statement of Operations Information (Unaudited):</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">640,154</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,846,233</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94,055</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">172,672</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Basic earnings per share:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.86</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.57</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Diluted earnings per share:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.85</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.56</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The unaudited pro forma information for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">October 1, 2017</font><font style="font-family:inherit;font-size:10pt;"> has been calculated after applying the Company's accounting policies and the impact of acquisition date fair value adjustments. These pro forma condensed consolidated financial results have been prepared for comparative purposes only and include certain adjustments, such as increased interest expense on debt obtained to finance the transaction and increased amortization for the acquired intangible assets recorded at fair value.</font></div><div style="line-height:120%;padding-top:12px;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The pro forma information does not reflect the effect of costs or synergies that would have been expected to result from the integration of the acquisition. The pro forma information does not purport to be indicative of the results of operations that actually would have resulted had the combination occurred at the beginning of each period presented, or of future results of the consolidated entities.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Business Combinations</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Acquisitions in fiscal year 2018</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During </font><font style="font-family:inherit;font-size:10pt;">fiscal year 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company has completed the acquisition of three businesses for aggregate consideration of </font><font style="font-family:inherit;font-size:10pt;">$55.4 million</font><font style="font-family:inherit;font-size:10pt;">. The acquired businesses were Shanghai Spectrum Instruments Co., Ltd. ("SSI"), which was acquired for total consideration of </font><font style="font-family:inherit;font-size:10pt;">$15.4 million</font><font style="font-family:inherit;font-size:10pt;"> in cash, RHS Limited ("RHS"), which was acquired for total consideration of </font><font style="font-family:inherit;font-size:10pt;">$19.4 million</font><font style="font-family:inherit;font-size:10pt;"> in cash, and DNA Laboratories Sdn. Bhd. ("DNA Labs"), which was acquired for total consideration of </font><font style="font-family:inherit;font-size:10pt;">$9.0 million</font><font style="font-family:inherit;font-size:10pt;"> in cash. The Company has an obligation to pay the former shareholders of SSI an additional consideration of </font><font style="font-family:inherit;font-size:10pt;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;"> in fiscal year 2019, which at closing had a present value of </font><font style="font-family:inherit;font-size:10pt;">$2.4 million</font><font style="font-family:inherit;font-size:10pt;">, and additional contingent consideration of up to </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;">, which at closing had an estimated fair value of </font><font style="font-family:inherit;font-size:10pt;">$1.7 million</font><font style="font-family:inherit;font-size:10pt;">. The Company has an obligation to pay the former shareholders of DNA Labs an additional cash consideration of </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;"> and a working capital adjustment of up to </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;"> in the fourth quarter of fiscal year 2018. The Company also has an obligation to pay the former shareholders of DNA Labs additional contingent consideration of up to </font><font style="font-family:inherit;font-size:10pt;">$8.0 million</font><font style="font-family:inherit;font-size:10pt;">, which at closing had an estimated fair value of </font><font style="font-family:inherit;font-size:10pt;">$5.8 million</font><font style="font-family:inherit;font-size:10pt;">. The excess of the purchase price over the fair value of the acquired businesses' net assets represents cost and revenue synergies specific to the Company, as well as non-capitalizable intangible assets, such as the employee workforce acquired, and has been allocated to goodwill, which is not tax deductible. The Company has reported the operations for SSI within the results of the Company's DAS segment and the other acquisitions within the results of the Company's Diagnostics segment from the acquisition dates. Identifiable definite-lived intangible assets, such as core technology, trade names and customer relationships, acquired as part of these acquisitions had a weighted average amortization period of </font><font style="font-family:inherit;font-size:10pt;">14.6 years</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The total purchase price for the acquisitions in </font><font style="font-family:inherit;font-size:10pt;">fiscal year 2018</font><font style="font-family:inherit;font-size:10pt;"> has been allocated to the estimated fair values of assets acquired and liabilities assumed as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:87%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 Acquisitions</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of business combination:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash payments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,942</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other liability</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,354</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Working capital and other adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">599</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: cash acquired</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,138</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54,257</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable assets acquired and liabilities assumed:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,469</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">937</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">430</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable intangible assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Core technology</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,957</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,010</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,800</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,423</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,524</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities assumed</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,037</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt assumed</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(208</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54,257</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subsequent to </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company completed the acquisition of Dani Analitica S.r.l. (“Dani”), a company based in Milan, Italy, for a total consideration of </font><font style="font-family:inherit;font-size:10pt;">€43.1 million</font><font style="font-family:inherit;font-size:10pt;"> in cash, net of cash acquired, as of the closing date. The operations for this acquisition will be reported within the results of the Company's DAS segment from the acquisition date.</font></div><div style="line-height:120%;padding-bottom:4px;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:4px;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Acquisitions in fiscal year 2017</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Acquisition of EUROIMMUN Medizinische Labordiagnostika AG. </font><font style="font-family:inherit;font-size:10pt;">During </font><font style="font-family:inherit;font-size:10pt;">fiscal year 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company completed the acquisition of </font><font style="font-family:inherit;font-size:10pt;">99.98%</font><font style="font-family:inherit;font-size:10pt;"> of the outstanding stock of EUROIMMUN Medizinische Labordiagnostika AG (“EUROIMMUN”) for aggregate consideration of </font><font style="font-family:inherit;font-size:10pt;">€1.2 billion</font><font style="font-family:inherit;font-size:10pt;"> (equivalent to </font><font style="font-family:inherit;font-size:10pt;">$1.4 billion</font><font style="font-family:inherit;font-size:10pt;"> at December 19, 2017, the time of closing). The purchase price was funded by borrowings from the Company's senior unsecured revolving credit facility and senior unsecured term loan credit facility of </font><font style="font-family:inherit;font-size:10pt;">$710.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$200.0 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, and available cash on hand of </font><font style="font-family:inherit;font-size:10pt;">$503.8 million</font><font style="font-family:inherit;font-size:10pt;">. EUROIMMUN is based in Lübeck, Germany, has approximately </font><font style="font-family:inherit;font-size:10pt;">2,400</font><font style="font-family:inherit;font-size:10pt;"> employees, and is recognized as a global leader in autoimmune testing and an emerging force in infectious disease and allergy testing. The excess of the purchase price over the fair value of the acquired net assets represents cost and revenue synergies specific to the Company, as well as non-capitalizable intangible assets, such as the employee workforce acquired. As a result of the acquisition, the Company recorded goodwill of </font><font style="font-family:inherit;font-size:10pt;">$581.2 million</font><font style="font-family:inherit;font-size:10pt;">, which is not tax deductible, and intangible assets of </font><font style="font-family:inherit;font-size:10pt;">$907.4 million</font><font style="font-family:inherit;font-size:10pt;">. The Company has reported the operations for this acquisition within the results of the Company's Diagnostics segment from the acquisition date. Identifiable definite-lived intangible assets, such as core technology, trade names and customer relationships, acquired as part of this acquisition had a weighted average amortization period of </font><font style="font-family:inherit;font-size:10pt;">16.1 years</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other acquisitions in 2017. </font><font style="font-family:inherit;font-size:10pt;">During fiscal year 2017, the Company also completed the acquisition of two other businesses for aggregate consideration of </font><font style="font-family:inherit;font-size:10pt;">$142.0 million</font><font style="font-family:inherit;font-size:10pt;">. The acquired businesses were Tulip Diagnostics Private Limited (“Tulip”), which was acquired for total consideration of </font><font style="font-family:inherit;font-size:10pt;">$127.3 million</font><font style="font-family:inherit;font-size:10pt;"> in cash and one other business acquired for total consideration of </font><font style="font-family:inherit;font-size:10pt;">$14.7 million</font><font style="font-family:inherit;font-size:10pt;"> in cash. At the time of closing, the Company had a potential obligation to pay the former shareholders of Tulip up to INR</font><font style="font-family:inherit;font-size:10pt;">1.6 billion</font><font style="font-family:inherit;font-size:10pt;">, equivalent to </font><font style="font-family:inherit;font-size:10pt;">$25.2 million</font><font style="font-family:inherit;font-size:10pt;">, in additional consideration over a two year period that is accounted for as compensation expense in the Company's financial statements over a two year period and is excluded from the purchase price allocation shown below. The excess of the purchase prices over the fair values of the acquired businesses' net assets represents cost and revenue synergies specific to the Company, as well as non-capitalizable intangible assets, such as the employee workforces acquired, and has been allocated to goodwill, which is not tax deductible. The Company has reported the operations of Tulip within the results of the Company's Diagnostics segment and the other acquired business within the results of the Company's DAS segment from the acquisition date. Identifiable definite-lived intangible assets, such as core technology, trade names and customer relationships, acquired as part of these acquisitions had a weighted average amortization period of </font><font style="font-family:inherit;font-size:10pt;">11.8 years</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the first quarter of fiscal year 2018, the Company paid the former shareholders of Tulip a portion of the additional consideration amounting to INR</font><font style="font-family:inherit;font-size:10pt;">716.3 million</font><font style="font-family:inherit;font-size:10pt;"> (equivalent to </font><font style="font-family:inherit;font-size:10pt;">$11.3 million</font><font style="font-family:inherit;font-size:10pt;">). As of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company may have to pay the former shareholders of Tulip additional consideration of up to INR</font><font style="font-family:inherit;font-size:10pt;">803.6 million</font><font style="font-family:inherit;font-size:10pt;"> (currently equivalent to </font><font style="font-family:inherit;font-size:10pt;">$11.1 million</font><font style="font-family:inherit;font-size:10pt;">) in the first quarter of fiscal year 2019. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The total purchase price for the acquisitions in </font><font style="font-family:inherit;font-size:10pt;">fiscal year 2017</font><font style="font-family:inherit;font-size:10pt;"> has been allocated to the estimated fair values of assets acquired and liabilities assumed as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">EUROIMMUN</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Acquisitions</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of business combination:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash payments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,413,780</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">140,861</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other liability</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,273</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Working capital and other adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(93</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: cash acquired</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,439</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,388,762</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139,602</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable assets acquired and liabilities assumed:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121,174</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,268</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130,512</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,356</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,679</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,691</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable intangible assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Core technology</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">160,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,400</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">710,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In-process research and development ("IPR&D")</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,400</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">581,172</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,250</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(253,288</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,735</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities assumed</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(86,530</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,328</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt assumed</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(61,357</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,388,762</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139,602</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">EUROIMMUN's revenue and net loss for the period from the acquisition date to December 31, 2017 were </font><font style="font-family:inherit;font-size:10pt;">$13.5 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The following unaudited pro forma information presents the combined financial results for the Company and EUROIMMUN as if the acquisition of EUROIMMUN had been completed at the beginning of fiscal year 2016:</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div><div style="line-height:120%;text-align:center;text-indent:36px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:93.5546875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 1, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine Months Ended</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 1, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands, except per share data)</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Pro Forma Statement of Operations Information (Unaudited):</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">640,154</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,846,233</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94,055</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">172,672</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Basic earnings per share:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.86</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.57</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Diluted earnings per share:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.85</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.56</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The unaudited pro forma information for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">October 1, 2017</font><font style="font-family:inherit;font-size:10pt;"> has been calculated after applying the Company's accounting policies and the impact of acquisition date fair value adjustments. These pro forma condensed consolidated financial results have been prepared for comparative purposes only and include certain adjustments, such as increased interest expense on debt obtained to finance the transaction and increased amortization for the acquired intangible assets recorded at fair value.</font></div><div style="line-height:120%;padding-top:12px;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The pro forma information does not reflect the effect of costs or synergies that would have been expected to result from the integration of the acquisition. The pro forma information does not purport to be indicative of the results of operations that actually would have resulted had the combination occurred at the beginning of each period presented, or of future results of the consolidated entities.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preliminary allocations of the purchase prices for acquisitions are based upon initial valuations. The Company's estimates and assumptions underlying the initial valuations are subject to the collection of information necessary to complete its valuations within the measurement periods, which are up to </font><font style="font-family:inherit;font-size:10pt;">one year</font><font style="font-family:inherit;font-size:10pt;"> from the respective acquisition dates. The primary areas of the preliminary purchase price allocations that are not yet finalized relate to the fair value of certain tangible and intangible assets acquired and liabilities assumed, assets and liabilities related to income taxes and related valuation allowances, and residual goodwill. The Company expects to continue to obtain information to assist in determining the fair values of the net assets acquired at the acquisition dates during the measurement periods. During the measurement periods, the Company will adjust assets or liabilities if new information is obtained about facts and circumstances that existed as of the acquisition dates that, if known, would have resulted in the recognition of those assets and liabilities as of those dates. These adjustments will be made in the periods in which the amounts are determined and the cumulative effect of such adjustments will be calculated as if the adjustments had been completed as of the acquisition dates. All changes that do not qualify as adjustments made during the measurement periods are also included in current period earnings.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allocations of the purchase price for acquisitions are based on estimates of the fair value of the net assets acquired and are subject to adjustment upon finalization of the purchase price allocations. The accounting for business combinations requires estimates and judgments as to expectations for future cash flows of the acquired business, and the allocation of those cash flows to identifiable intangible assets, in determining the estimated fair values for assets acquired and liabilities assumed. The fair values assigned to tangible and intangible assets acquired and liabilities assumed, including contingent consideration, are based on management’s estimates and assumptions, as well as other information compiled by management, including valuations that utilize customary valuation procedures and techniques. Contingent consideration is measured at fair value at the acquisition date, based on the probability that revenue thresholds or product development milestones will be achieved during the earnout period, with changes in the fair value after the acquisition date affecting earnings to the extent it is to be settled in cash. Increases or decreases in the fair value of contingent consideration liabilities primarily result from changes in the estimated probabilities of achieving revenue thresholds, changes in discount rates or product development milestones during the earnout period.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">third</font><font style="font-family:inherit;font-size:10pt;"> quarter of </font><font style="font-family:inherit;font-size:10pt;">fiscal year 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company obtained information relevant to determining the fair values of certain tangible and intangible assets acquired, and liabilities assumed, related to recent acquisitions and adjusted its purchase price allocation. Based on this information, for the EUROIMMUN acquisition, the Company recognized a decrease in deferred tax liabilities of </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">, an increase in property and equipment of </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">, a decrease in liabilities assumed of </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;">, a decrease in other assets of </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> and a decrease in goodwill of </font><font style="font-family:inherit;font-size:10pt;">$1.5 million</font><font style="font-family:inherit;font-size:10pt;"> during the </font><font style="font-family:inherit;font-size:10pt;">third</font><font style="font-family:inherit;font-size:10pt;"> quarter of </font><font style="font-family:inherit;font-size:10pt;">fiscal year 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company may have to pay contingent consideration related to acquisitions with open contingency periods of up to </font><font style="font-family:inherit;font-size:10pt;">$76.5 million</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company has recorded contingent consideration obligations with an estimated fair value of </font><font style="font-family:inherit;font-size:10pt;">$67.1 million</font><font style="font-family:inherit;font-size:10pt;">, of which </font><font style="font-family:inherit;font-size:10pt;">$61.3 million</font><font style="font-family:inherit;font-size:10pt;"> was recorded in accrued expenses and other current liabilities, and </font><font style="font-family:inherit;font-size:10pt;">$5.8 million</font><font style="font-family:inherit;font-size:10pt;"> was recorded in long-term liabilities. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company had recorded contingent consideration obligations with an estimated fair value of </font><font style="font-family:inherit;font-size:10pt;">$65.3 million</font><font style="font-family:inherit;font-size:10pt;">, of which </font><font style="font-family:inherit;font-size:10pt;">$52.2 million</font><font style="font-family:inherit;font-size:10pt;"> was recorded in accrued expenses and other current liabilities, and </font><font style="font-family:inherit;font-size:10pt;">$13.1 million</font><font style="font-family:inherit;font-size:10pt;"> was recorded in long-term liabilities. If the actual results differ from the estimates and judgments used in these fair values, the amounts recorded in the condensed consolidated financial statements could result in a possible impairment of the intangible assets and goodwill, require acceleration of the amortization expense of definite-lived intangible assets or the recognition of additional contingent consideration which would be recognized as a component of operating expenses from continuing operations.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total acquisition and divestiture-related costs for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> were </font><font style="font-family:inherit;font-size:10pt;">$1.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$5.5 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. These amounts include </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;"> of net foreign exchange gain related to the foreign currency denominated stay bonus associated with the Tulip acquisition for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, respectively. Total acquisition and divestiture-related costs (income) for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">October 1, 2017</font><font style="font-family:inherit;font-size:10pt;"> were </font><font style="font-family:inherit;font-size:10pt;">$(30.8) million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$(30.1) million</font><font style="font-family:inherit;font-size:10pt;">, respectively. These amounts include </font><font style="font-family:inherit;font-size:10pt;">$36.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$42.0 million</font><font style="font-family:inherit;font-size:10pt;"> of net foreign exchange gain related to the foreign currency forward contracts associated with the planned acquisition of EUROIMMUN for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">October 1, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively. These acquisition and divestiture-related costs (income) were expensed as incurred and recorded in selling, general and administrative expenses and interest and other (income) expense, net in the Company's condensed consolidated statements of operations.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the following tables, revenue is disaggregated by primary geographical market, end-markets and timing of revenue recognition. The tables also include a reconciliation of the disaggregated revenue with the reportable segments revenue.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.6328125%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Reportable Segments</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Discovery & Analytical Solutions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Primary geographical markets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Americas</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">169,366</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95,607</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">264,973</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110,747</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68,480</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">179,227</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">126,053</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104,060</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">230,113</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">406,166</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268,147</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">674,313</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Primary end-markets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268,147</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268,147</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Life sciences</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">222,191</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">222,191</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Applied markets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">183,975</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">183,975</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">406,166</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268,147</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">674,313</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Timing of revenue recognition</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Products and services transferred at a point in time</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">290,929</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">247,189</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">538,118</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Services transferred over time</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115,237</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,958</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">136,195</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">406,166</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268,147</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">674,313</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.6328125%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Reportable Segments</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Discovery & Analytical Solutions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Primary geographical markets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Americas</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">497,833</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">282,536</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">780,369</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">357,766</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">205,892</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">563,658</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">377,720</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">299,900</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">677,620</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,233,319</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">788,328</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,021,647</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Primary end-markets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">788,328</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">788,328</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Life sciences</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">675,807</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">675,807</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Applied markets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">557,512</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">557,512</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,233,319</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">788,328</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,021,647</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Timing of revenue recognition</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Products and services transferred at a point in time</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">874,517</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">726,058</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,600,575</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Services transferred over time</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">358,802</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62,270</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">421,072</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,233,319</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">788,328</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,021,647</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A reconciliation of the beginning and ending Level 3 net liabilities for contingent consideration is as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(74,093</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(64,076</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(65,328</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(63,201</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,800</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,500</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts paid and foreign currency translation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,507</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,507</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value (included within selling, general and administrative expenses)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,740</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(651</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,805</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,560</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(67,126</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(64,727</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(67,126</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(64,727</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Adopted and Issued Accounting Pronouncements: </font><font style="font-family:inherit;font-size:10pt;">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (the "FASB") and are adopted by the Company as of the specified effective dates. Unless otherwise discussed, such pronouncements did not have or will not have a significant impact on the Company’s consolidated financial position, results of operations and cash flows or do not apply to the Company’s operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued Accounting Standards Update No. 2018-15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles-Goodwill and Other- Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract </font><font style="font-family:inherit;font-size:10pt;">("ASU 2018-15"). ASU 2018-15 aligns the accounting for implementation costs incurred in a hosting arrangement that is a service contract with the guidance on capitalizing costs associated with developing or obtaining internal-use software (and hosting arrangements that include an internal use software license). Specifically, ASU 2018-15 amends </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles-Goodwill and Other (Topic 350) </font><font style="font-family:inherit;font-size:10pt;">to include in its scope implementation costs incurred in a hosting arrangement that is a service contract and clarifies that a customer should apply </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Subtopic 350-40</font><font style="font-family:inherit;font-size:10pt;"> to determine which implementation costs to capitalize as an asset related to the service contract and which costs to expense. The provisions of this guidance are to be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. ASU 2018-15 is effective for annual reporting periods beginning after December 15, 2019, and interim periods within those years with early adoption permitted. The Company is currently evaluating the requirements of this guidance and has not yet determined the impact of its adoption on the Company's consolidated financial position, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued Accounting Standards Update No. 2018-14, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans </font><font style="font-family:inherit;font-size:10pt;">("ASU 2018-14"). ASU 2018-14 adds, removes, and clarifies disclosure requirements related to defined benefit pension and other postretirement plans. ASU 2018-14 adds requirements for an entity to disclose the weighted-average interest crediting rates used in the entity’s cash balance pension plans and other similar plans; and an explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">.</font><font style="font-family:inherit;font-size:10pt;"> Further, ASU 2018-14 removes guidance that currently requires the following disclosures: the amounts in accumulated other comprehensive income expected to be recognized as part of net periodic benefit cost over the next year; the amount and timing of plan assets expected to be returned to the employer; information about (1) benefits covered by related-party insurance and annuity contracts and (2) significant transactions between the plan and related parties; and the effects of a one-percentage-point change on the assumed health care costs and the effect of this change in rates on service cost, interest cost, and the benefit obligation for postretirement health care benefits. ASU 2018-14 also clarifies the guidance in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation-Retirement Benefits</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">(Topic 715-20-50-3)</font><font style="font-family:inherit;font-size:10pt;"> on defined benefit plans to require disclosure of (1) the projected benefit obligation ("PBO") and fair value of plan assets for pension plans with PBOs in excess of plan assets (the same disclosure with reference to the accumulated postretirement benefit obligation rather than the PBO is required for other postretirement benefit plans) and (2) the accumulated benefit obligation ("ABO") and fair value of plan assets for pension plans with ABOs in excess of plan assets. The provisions of this guidance are to be applied retrospectively to all periods presented upon their effective date. ASU 2018-14 is effective for annual reporting periods beginning after December 15, 2020, and interim periods within those years with early adoption permitted. The Company is currently evaluating the requirements of this guidance and has not yet determined the impact of its adoption on the Company's consolidated financial position, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued Accounting Standards Update No. 2018-13, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement </font><font style="font-family:inherit;font-size:10pt;">("ASU 2018-13"). ASU 2018-13 adds, removes, and modifies certain disclosures related to fair value measurements. ASU 2018-13 adds requirements for an entity to disclose the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period; and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. Further, ASU 2018-13 removes the requirement to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy; the policy for timing of transfers between levels; and the valuation processes for Level 3 fair value measurements. ASU 2018-13 also modifies existing disclosure requirements related to measurement uncertainty. The amendments regarding changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty are to be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments are to be applied retrospectively to all periods presented upon their effective date. ASU 2018-13 is effective for annual reporting periods beginning after December 15, 2019, and interim periods within those years. Early adoption is permitted for any removed or modified disclosures. The Company is currently evaluating the requirements of this guidance and has not yet determined the impact of its adoption on the Company's consolidated financial position, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2018, the FASB issued Accounting Standards Update No. 2018-07, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation - Stock Compensation (Topic 718), Improvements to Nonemployee Share-Based Payment Accounting</font><font style="font-family:inherit;font-size:10pt;"> ("ASU 2018-07") which supersedes Subtopic 505-50, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Equity - Equity-Based Payments to Non-employees</font><font style="font-family:inherit;font-size:10pt;">, and expands the scope of Topic 718 (which currently only includes share-based payments to employees) to also include share-based payments issued to non-employees for goods and services, except for specific guidance on inputs to an option pricing model and the attribution of cost (that is, the period of time over which share-based payment awards vest and the pattern of cost recognition over that period). ASU 2018-07 specifies that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards, except for financing transactions, or awards issued to customers as part of a contract accounted for under Topic 606, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;"> ("Topic 606"). The provisions of this guidance are to be applied using a modified retrospective approach, with a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year, for all (1) liability-classified non-employee awards that have not been settled as of the adoption date and (2) equity-classified non-employee awards for which a measurement date has not been established. ASU 2018-07 is effective for annual reporting periods beginning after December 15, 2018, and interim periods within those years. Early adoption is permitted, but no earlier than a company’s adoption date of Topic 606. The Company early adopted the provisions of this guidance effective July 2, 2018. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flow.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2018, the FASB Issued Accounting Standards Update No. 2018-05, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes (Topic 740): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118</font><font style="font-family:inherit;font-size:10pt;"> ("ASU 2018-05"). ASU 2018-05 was issued to incorporate into Topic 740 recent SEC guidance related to the income tax accounting implications of the Tax Cut and Jobs Act (the "Tax Act"). The SEC issued Staff Accounting Bulletin No. 118 ("SAB 118") to address concerns about reporting entities’ ability to timely comply with the accounting requirements to recognize all of the effects of the Tax Act in the period of enactment. SAB 118 permits companies to disclose that some or all of the income tax effects from the Tax Act are incomplete by the due date of the financial statements, and if possible, disclose a reasonable estimate of such tax effects. ASU 2018-05 is effective immediately. The Company is applying the guidance in ASU 2018-05 when accounting for the enactment date effects of the Tax Act. At </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company has not completed the accounting for all of the tax effects of the Tax Act; however, it has made a reasonable estimate of their effects based on currently available information. Management will continue to refine the calculations as additional guidance is available. These estimates may be affected as additional clarification and implementation guidance becomes available. These changes could be material to income tax expense (see Note 9, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes</font><font style="font-family:inherit;font-size:10pt;"> for further disclosures).</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2018, the FASB Issued Accounting Standards Update No. 2018-03, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Technical Corrections and Improvements to Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities</font><font style="font-family:inherit;font-size:10pt;"> ("ASU 2018-03")</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">.</font><font style="font-family:inherit;font-size:10pt;"> ASU 2018-03 was issued to clarify certain aspects of guidance concerning the recognition of financial assets and liabilities established in Accounting Standards Update No. 2016-01, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments - Overall (Subtopic 825-10):</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recognition and Measurement of Financial Assets and Financial Liabilities </font><font style="font-family:inherit;font-size:10pt;">("ASU 2016-01"). This includes treatment for discontinuations and adjustments for equity securities without a readily determinable market value, forward contracts and purchased options, presentation requirements for certain fair value option liabilities, fair value option liabilities denominated in a foreign currency, and transition guidance for equity securities without a readily determinable fair value. ASU 2018-03 is effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years beginning after June 15, 2018. Early adoption is permitted for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years, as long as the Company has adopted ASU 2016-01. The Company adopted the provisions of this guidance effective July 2, 2018. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2018, the FASB Issued Accounting Standards Update No. 2018-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income </font><font style="font-family:inherit;font-size:10pt;">("ASU 2018-02")</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">.</font><font style="font-family:inherit;font-size:10pt;"> ASU 2018-02 provides entities with an option to reclassify stranded tax effects within Accumulated Other Comprehensive Income ("AOCI") to retained earnings in each period in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Act (or portion thereof) is recorded. ASU 2018-02 requires entities to disclose a description of the accounting policy for releasing income tax effects from AOCI; whether they elect to reclassify the stranded income tax effects from the Tax Act; and information about the other income tax effects that are reclassified. ASU 2018-02 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted, and entities should apply the proposed amendments either in the period of adoption or retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Act is recognized. The Company is currently evaluating the requirements of this guidance and has not yet determined the impact of its adoption on the Company's consolidated financial position, results of operations and cash flows. </font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2017, the FASB issued Accounting Standards Update No. 2017-12, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivatives and Hedging (Topic 815), Targeted Improvements to Accounting for Hedging Activities </font><font style="font-family:inherit;font-size:10pt;">("ASU 2017-12")</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">, </font><font style="font-family:inherit;font-size:10pt;">which amends the hedge accounting recognition and presentation requirements in Topic 815. ASU 2017-12 makes targeted changes to the existing hedge accounting model to better align an entity’s financial reporting for hedging relationships with the entity’s risk management activities, and to reduce the complexity of, and simplify the application of, the hedge accounting model. Specifically, ASU 2017-12 expands the types of transactions eligible for hedge accounting, eliminates the requirement to separately measure and present hedge ineffectiveness, simplifies the way assessments of hedge ineffectiveness may be performed, relaxes the documentation requirements for entering into hedging positions, provides targeted improvements to fair value hedges of interest rate risk, and permits an entity to exclude the change in the fair value of cross-currency basis spreads in currency swaps from the assessment of hedge effectiveness. The standard also requires entities to provide new disclosures about the impact fair value and cash flow hedges have on their income statements and about cumulative basis adjustments arising from fair value hedges. The provisions of this guidance are to be applied using a modified retrospective approach to existing hedging relationships as of the adoption date. However, the transition provisions allow for certain elections at the date of adoption and entities may choose to apply any of the provided elections. ASU 2017-12 is effective for annual reporting periods beginning after December 15, 2018, and interim periods within those years. Early adoption is permitted, including adoption in any interim period. The Company early adopted the provisions of this guidance effective January 1, 2018. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2017, the FASB issued Accounting Standards Update No. 2017-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation - Stock Compensation (Topic 718), Scope of Modification Accounting </font><font style="font-family:inherit;font-size:10pt;">("ASU 2017-09")</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">, </font><font style="font-family:inherit;font-size:10pt;">which amends the scope of modification accounting for share-based payment arrangements. ASU 2017-09 provides guidance on the types of changes to the terms or conditions of share-based payment awards to which an entity would be required to apply modification accounting under Topic 718. Specifically, an entity would not apply modification accounting if the fair value, vesting conditions, and classification of the awards are the same immediately before and after the modification. If an entity modifies its awards and concludes that it is not required to apply modification accounting under the standard, it must still consider whether the modification affects its application of other guidance. Additionally, if a significant modification does not result in incremental compensation cost, entities are required to disclose the “lack of” incremental compensation cost resulting from such significant modification. The standard also removes the guidance in Topic 718 stating that modification accounting is not required when an entity adds an antidilution provision as long as that modification is not made in contemplation of an equity restructuring. The provisions of this guidance are to be applied on a prospective basis to awards modified on or after the effective date. ASU 2017-09 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years. Early adoption is permitted, including adoption in any interim period. The Company adopted ASU 2017-09 effective January 1, 2018. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2017, the FASB issued Accounting Standards Update No. 2017-07, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation - Retirement Benefits (Topic 715), Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost </font><font style="font-family:inherit;font-size:10pt;">("ASU 2017-07")</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">, </font><font style="font-family:inherit;font-size:10pt;">which amends the requirements in Topic 715 related to the income statement presentation of the components of net periodic benefit cost for an entity’s sponsored defined benefit pension and other postretirement plans. ASU 2017-07 requires entities to (1) disaggregate the current-service-cost component from the other components of net benefit cost (the “other components”) and present it with other current employee compensation costs in their income statements and (2) present the other components elsewhere in their income statements and outside of income from operations, and disclose the income statement lines that contain the other components if they are not presented on appropriately described separate lines. Additionally, the standard requires that only the service-cost component of net benefit cost is eligible for capitalization (e.g., as part of inventory or property, plant, and equipment). The change in income statement presentation requires retrospective application, while the change in capitalized benefit cost is to be applied prospectively. ASU 2017-07 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years, with early adoption permitted. The standard provides a practical expedient that permits entities to use the components of cost disclosed in prior years as a basis for the retrospective application of the new income statement presentation. Entities need to disclose the use of the practical expedient. The Company adopted ASU 2017-07 effective January 1, 2018 using a retrospective approach for each period presented. For the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">October 1, 2017</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$1.8 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$5.4 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, of net periodic pension credit previously presented within operating income has been presented outside of operating income in the line item "Interest and other expense, net" in the condensed consolidated statement of operations due to the retrospective adoption of ASU 2017-07. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows, other than the impact discussed above.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued Accounting Standards Update No. 2017-01, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Business Combinations (Topic 805), Clarifying the Definition of a Business </font><font style="font-family:inherit;font-size:10pt;">("ASU 2017-01"), which amends Topic 805 to provide a screen to determine when a set of assets and liabilities is not a business. The screen requires that when substantially all of the fair value of the gross assets acquired (or disposed of) is concentrated in a single identifiable asset or a group of similar identifiable assets, the set is not a business. This screen reduces the number of transactions that need to be further evaluated. If the screen is not met, the standard (1) requires that to be considered a business, a set must include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create output and (2) removes the evaluation of whether a market participant could replace missing elements. The standard provides a framework to assist entities in evaluating whether both an input and a substantive process are present. The standard also provides a framework that includes two sets of criteria to consider that depend on whether a set has outputs and a more stringent criteria for sets without outputs. Lastly, the standard narrows the definition of the term "output" so that the term is consistent with how outputs are described in Topic 606, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;">. The provisions of this guidance are to be applied prospectively. ASU 2017-01 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years, with early adoption permitted in limited circumstances. The Company adopted ASU 2017-01 effective January 1, 2018. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2016, the FASB issued Accounting Standards Update No. 2016-18, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Statement of Cash Flows (Topic 230), Restricted Cash </font><font style="font-family:inherit;font-size:10pt;">("ASU 2016-18"), which amends Topic 230 to add or clarify guidance on the classification and presentation of restricted cash in the statement of cash flows. The standard requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The provisions of this guidance are to be applied using a retrospective transition method to each period presented. ASU 2016-18 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years, with early adoption permitted. The Company adopted ASU 2016-18 effective January 1, 2018. For the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">October 1, 2017</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$17.2 million</font><font style="font-family:inherit;font-size:10pt;"> of changes in restricted cash balances that was previously presented within investing activities in the condensed consolidated statement of cash flows has been excluded from the cash flows used in investing activities and the effect of exchange rate changes increased by </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> due to the retrospective adoption of ASU 2016-18. Restricted cash amounting to </font><font style="font-family:inherit;font-size:10pt;">$17.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> at January 1, 2017 and </font><font style="font-family:inherit;font-size:10pt;">October 1, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively, have been included with the cash and cash equivalents when reconciling the beginning of period and end of period total amounts on the condensed consolidated statement of cash flows for the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">October 1, 2017</font><font style="font-family:inherit;font-size:10pt;">. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows, other than the impact discussed above. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October 2016, the FASB issued Accounting Standards Update No. 2016-16, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes (Topic 740), Intra-entity Transfer of Assets Other than Inventory </font><font style="font-family:inherit;font-size:10pt;">("ASU 2016-16"). ASU 2016-16 removes the prohibition in Topic 740 against the immediate recognition of the current and deferred income tax effects of intra-entity transfers of assets other than inventory. The standard requires entities to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. The provisions of this guidance are to be applied on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. ASU 2016-16 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years, with early adoption permitted. The Company adopted ASU 2016-16 on January 1, 2018. The adoption of the standard resulted in a decrease in the retained earnings at January 1, 2018 of approximately </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;"> with corresponding increase in deferred tax assets of </font><font style="font-family:inherit;font-size:10pt;">$10.7 million</font><font style="font-family:inherit;font-size:10pt;"> and decrease in prepaid taxes of </font><font style="font-family:inherit;font-size:10pt;">$12.8 million</font><font style="font-family:inherit;font-size:10pt;"> related to prior years’ intra-entity transfers of assets other than inventory. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows, other than the impact discussed above.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued Accounting Standards Update No. 2016-13, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments </font><font style="font-family:inherit;font-size:10pt;">("ASU 2016-13"). ASU 2016-13 changes how entities will measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. The standard requires entities to use the expected loss impairment model and will apply to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities, net investments in leases and off-balance sheet credit exposures. Entities are required to estimate the lifetime “expected credit loss” for each applicable financial asset and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The standard also amends the impairment model for available-for-sale (“AFS”) debt securities and requires entities to determine whether all or a portion of the unrealized loss on an AFS debt security is a credit loss. An entity will recognize an allowance for credit losses on an AFS debt security as a contra-account to the amortized cost basis rather than as a direct reduction of the amortized cost basis of the investment. The provisions of this guidance are to be applied using a modified-retrospective approach. A prospective transition approach is required for debt securities for which an other-than-temporary impairment had been recognized before the effective date. ASU 2016-13 is effective for annual reporting periods beginning after December 15, 2019, and interim periods within those years. Early adoption is permitted for annual periods beginning after December 15, 2018, and interim periods therein. The Company is currently evaluating the requirements of this guidance and has not yet determined the impact of its adoption on the Company's consolidated financial position, results of operations and cash flows. </font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued Accounting Standards Update No. 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases </font><font style="font-family:inherit;font-size:10pt;">("ASU 2016-02"). ASU 2016-02 requires organizations that lease assets to recognize assets and liabilities on the balance sheet related to the rights and obligations created by those leases, regardless of whether they are classified as finance or operating leases. Consistent with current guidance, the recognition, measurement, and presentation of expenses and cash flows arising from a lease of assets will primarily depend on its classification as a finance or operating lease. ASU 2016-02 also requires new disclosures to help financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases. The provisions of this guidance are effective for annual periods beginning after December 15, 2018, and interim periods within those years, with early adoption permitted. ASU 2016-02 is to be applied using a modified retrospective approach. Subsequent to the issuance of ASU 2016-02, in July 2018, the FASB issued Accounting Standards Update No. 2018-10, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Codification Improvements to Topic 842, Leases </font><font style="font-family:inherit;font-size:10pt;">("ASU 2018-10") and Accounting Standards Update No. 2018-11, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842): Targeted Improvements</font><font style="font-family:inherit;font-size:10pt;"> ("ASU 2018-11"). The amendments in ASU 2018-10 clarify, correct or remove inconsistencies in the guidance provided under ASU 2016-02 related to sixteen specific issues identified. The amendments in ASU 2018-11 provide entities with an additional (and optional) transition method to adopt the new leases standard. Under the new transition method, an entity initially applies the new leases standard at the adoption date and recognizes a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. Consequently, an entity's reporting for the comparative periods presented in the financial statements in the period of adoption will continue to be in accordance with ASC 840, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases ("ASC 840"</font><font style="font-family:inherit;font-size:10pt;">). An entity that elects this additional (and optional) transition method must provide the required disclosures under ASC 840 for all periods that continue to be in accordance with ASC 840. ASU 2018-11 also provides lessors with a practical expedient, by class of underlying asset, to not separate nonlease components from the associated lease component and, instead, to account for those components as a single component if certain criteria are met. The effective date and transition requirements for these two standards are the same as the effective date and transition requirements of ASU 2016-02. The Company is in the process of completing its evaluation of the impact of the new leases standard upon adoption and has not yet determined the impact of adoption on its consolidated financial position, results of operations and cash flows. The Company intends to adopt the new leases standard using the optional transition method and will apply the new leases standard on December 31, 2018 (the first day of fiscal year 2019).</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued Accounting Standards Update No. 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers </font><font style="font-family:inherit;font-size:10pt;">("ASU 2014-09"). Under this new guidance, an entity should use a five-step process to recognize revenue, depicting the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard also requires new disclosures regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. Subsequent to the issuance of the standard, the FASB decided to defer the effective date for one year to annual reporting periods beginning after December 15, 2017, with early adoption permitted for annual reporting periods beginning after December 15, 2016. In November 2017, the FASB also issued Accounting Standards Update No. 2017-14, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Statement-Reporting Comprehensive Income (Topic 220), Revenue Recognition (Topic 605), and Revenue from Contracts with Customers (Topic 606)</font><font style="font-family:inherit;font-size:10pt;">. ASU 2017-14 includes amendments to certain SEC paragraphs within the FASB Accounting Standards Codification ("Codification"). ASU 2017-14 amends the Codification to incorporate SEC Staff Accounting Bulletin No. 116 and SEC Interpretive Release on Vaccines for Federal Government Stockpiles (SEC Release No. 33-10403) to align existing SEC staff guidance with Revenue from Contracts with Customers (Topic 606). In May 2016, the FASB also issued Accounting Standards Update No. 2016-12,</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> Revenue from Contracts with Customers (Topic 606), Narrow-Scope Improvements and Practical Expedients </font><font style="font-family:inherit;font-size:10pt;">("ASU 2016-12")</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">, </font><font style="font-family:inherit;font-size:10pt;">which amended its revenue recognition guidance in ASU 2014-09 on transition, collectability, non-cash consideration, contract modifications and completed contracts at transition and the presentation of sales and other similar taxes collected from customers. In April 2016, the FASB also issued Accounting Standards Update No. 2016-10,</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> Revenue from Contracts with Customers (Topic 606), Identifying Performance Obligations and Licensing </font><font style="font-family:inherit;font-size:10pt;">("ASU 2016-10")</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">, </font><font style="font-family:inherit;font-size:10pt;">which amended its revenue recognition guidance in ASU 2014-09 on identifying performance obligations to allow entities to disregard items that are immaterial in the context of the contract, clarify when a promised good or service is separately identifiable (i.e., distinct within the context of the contract) and allow an entity to elect to account for the cost of shipping and handling performed after control of a good has been transferred to the customer as a fulfillment cost (i.e., an expense). ASU 2016-10 also clarifies how an entity should evaluate the nature of its promise in granting a license of intellectual property ("IP") and requires entities to classify IP in one of two categories: functional IP or symbolic IP, which will determine whether it recognizes revenue over time or at a point in time. ASU 2016-10 also addresses how entities should consider license renewals and restrictions and apply the exception for sales- and usage-based royalties received in exchange for licenses of IP. In March 2016, the FASB also issued Accounting Standards Update No. 2016-08, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers (Topic 606), Principal versus Agent Considerations (Reporting Revenue Gross versus Net) </font><font style="font-family:inherit;font-size:10pt;">("ASU 2016-08"), which amended the principal-versus-agent implementation guidance and illustrations in ASU 2014-09. ASU 2016-08 clarifies that an entity should evaluate when it is the principal or agent for each specified good or service promised in a contract with a customer. ASU 2017-14, ASU 2016-12, ASU 2016-10, ASU 2016-08 and ASU 2014-09 may be adopted either using a full retrospective approach or a modified retrospective approach. The Company adopted these standards beginning on </font><font style="font-family:inherit;font-size:10pt;">January 1, 2018</font><font style="font-family:inherit;font-size:10pt;"> using the modified retrospective approach only to contracts not completed as of </font><font style="font-family:inherit;font-size:10pt;">January 1, 2018</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The most significant impact of the standards relates to the accounting for certain transactions with multiple elements or “bundled” arrangements. Specifically, for sales of software subscriptions or sales of licenses and maintenance, the Company will recognize the license revenue predominantly at the time of billing and delivery rather than recognizing the entire sales price ratably over the maintenance period, which is the Company's current practice. In addition, for certain sales of instruments that include customer-specified acceptance criteria, the Company will recognize revenue when the customer obtains control of the instrument which is typically upon delivery or when title has transferred to the customer, as the Company believes acceptance is perfunctory. The Company will also capitalize incremental commission fees as a result of obtaining contracts when these fees are recoverable and will amortize the assets based on the transfer of goods or services to which the assets relate which typically range from two to six years. The adoption of the standards resulted in an increase in retained earnings at January 1, 2018 of approximately </font><font style="font-family:inherit;font-size:10pt;">$10.2 million</font><font style="font-family:inherit;font-size:10pt;"> for the cumulative effect of initially applying the standards as of that date. In addition, the adoption of the standards resulted primarily in a reduction in deferred revenue of approximately </font><font style="font-family:inherit;font-size:10pt;">$11.5 million</font><font style="font-family:inherit;font-size:10pt;">, mainly driven by the upfront recognition of license revenue and certain multi-year software subscriptions, and an increase in deferred income tax liability of approximately </font><font style="font-family:inherit;font-size:10pt;">$3.0 million</font><font style="font-family:inherit;font-size:10pt;"> for the tax impact of the cumulative adjustments. The cumulative effect of recognizing instrument sales upon delivery or transfer of title and capitalizing the incremental commission fees were not material at January 1, 2018. The adoption of the standards had </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> impact to cash from or used in operating, investing, or financing activities in the Company's consolidated statement of cash flows at January 1, 2018. Refer to Note 3, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Changes in Accounting Policies, </font><font style="font-family:inherit;font-size:10pt;">for the impact of adoption of the standards on the Company's condensed consolidated financial statements for the quarter ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">. Also refer to Note 2, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue,</font><font style="font-family:inherit;font-size:10pt;"> for the disclosures required by the standards.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restructuring and Contract Termination Charges, Net</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has undertaken a series of restructuring actions related to the impact of acquisitions and divestitures, the alignment of the Company's operations with its growth strategy, the integration of its business units and its productivity initiatives. The current portion of restructuring and contract termination charges is recorded in accrued restructuring and contract termination charges and the long-term portion of restructuring and contract termination charges is recorded in long-term liabilities. The activities associated with these plans have been reported as restructuring and contract termination charges, net, as applicable, and are included as a component of income from continuing operations.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company implemented a restructuring plan in each of the first and third quarters of fiscal year 2018 consisting of workforce reductions principally intended to realign resources to emphasize growth initiatives (the "Q1 2018 Plan" and "Q3 2018 Plan", respectively). The Company implemented a restructuring plan in each of the fourth and third quarters of fiscal year 2017 consisting of workforce reductions principally intended to realign resources to emphasize growth initiatives (the "Q4 2017 Plan" and "Q3 2017 Plan", respectively). The Company implemented a restructuring plan in the first quarter of fiscal year 2017 consisting of workforce reductions and the closure of excess facility space principally intended to focus resources on higher growth end markets (the "Q1 2017 Plan"). Details of the plans initiated in previous years (the “Previous Plans”) are discussed more fully in Note 4 to the audited consolidated financial statements in the </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> Form 10-K.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the reductions in headcount, the initial restructuring or contract termination charges by reporting segment, and the dates by which payments were substantially completed, or the dates by which payments are expected to be substantially completed, for restructuring actions implemented during </font><font style="font-family:inherit;font-size:10pt;">fiscal years 2018 and 2017</font><font style="font-family:inherit;font-size:10pt;"> in continuing operations:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.8515625%;border-collapse:collapse;text-align:left;"><tr><td colspan="26" rowspan="1"></td></tr><tr><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Workforce Reductions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Closure of Excess Facility</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Expected) Date Payments Substantially Completed by</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Headcount Reduction</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Discovery & Analytical Solutions</font></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Discovery & Analytical Solutions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Severance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Excess Facility</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="21" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands, except headcount data)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q3 2018 Plan</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,146</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">618</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,764</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q2 FY2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q1 2018 Plan</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,096</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">902</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,998</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q2 FY2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q4 2017 Plan</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,680</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">255</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,935</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q1 FY2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q3 2017 Plan</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,321</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,342</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q4 FY2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q1 2017 Plan</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,631</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,697</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q4 FY2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q4 FY2018</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company does not currently expect to incur any future charges for these plans. The Company expects to make payments under the Previous Plans for remaining residual lease obligations, with terms varying in length, through fiscal year </font><font style="font-family:inherit;font-size:10pt;">2022</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the termination of various contractual commitments, the Company recorded additional pre-tax charges of </font><font style="font-family:inherit;font-size:10pt;">$4.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;"> during the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, respectively, in the DAS segment.</font></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;">$9.4 million</font><font style="font-family:inherit;font-size:10pt;"> recorded for accrued restructuring and contract termination charges, of which </font><font style="font-family:inherit;font-size:10pt;">$8.1 million</font><font style="font-family:inherit;font-size:10pt;"> was recorded in short-term accrued restructuring and contract termination charges and </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;"> was recorded in long-term liabilities. At </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;">$14.0 million</font><font style="font-family:inherit;font-size:10pt;"> recorded for accrued restructuring and contract termination charges, of which </font><font style="font-family:inherit;font-size:10pt;">$8.8 million</font><font style="font-family:inherit;font-size:10pt;"> was recorded in short-term accrued restructuring and contract termination charges, </font><font style="font-family:inherit;font-size:10pt;">$2.3 million</font><font style="font-family:inherit;font-size:10pt;"> was recorded in long-term liabilities and </font><font style="font-family:inherit;font-size:10pt;">$2.9 million</font><font style="font-family:inherit;font-size:10pt;"> was recorded in other reserves. The following table summarizes the Company's restructuring and contract termination accrual balances and related activity by restructuring plan, as well as contract termination accrual balances and related activity, during the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:31%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance at December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 Charges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 Changes in Estimates, Net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 Amounts Paid</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance at September 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="19" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Severance:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q3 2018 Plan</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,764</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,764</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q1 2018 Plan</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,998</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,273</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,725</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q4 2017 Plan</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,919</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,538</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">381</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q3 2017 Plan</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,072</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(868</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,204</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q1 2017 Plan</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,498</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,174</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,324</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Facility:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q1 2017 Plan</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Previous Plans</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,399</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">353</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,106</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,646</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,921</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,762</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">353</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,981</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,055</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contract Termination</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,048</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,744</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">227</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,653</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">366</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Restructuring and Contract Termination</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,969</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,506</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">580</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17,634</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,421</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Significant accounting policy</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company enters into contracts that can include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations. The Company recognizes revenue in an amount that reflects the consideration the Company expects to receive in exchange for the promised products or services when it satisfies a performance obligation by transferring control of those products or services to customers.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by the Company from a customer, are excluded from revenue.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company reports shipping and handling charges in revenue, to the extent these are billed to customers, and the associated costs in cost of product revenue. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Nature of goods and services</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following is a description of principal activities - separated by reportable segments - from which the Company generates its revenue. For more detailed information about the reportable segments, see Note 12.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">i. Discovery & Analytical Solutions</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Discovery & Analytical Solutions ("DAS") segment of the Company principally generates revenue from (a) sales of instruments, consumables and services in the applied markets, (b) sales of instruments, reagents, informatics, detection and imaging technologies, extended warranty, training and services in the life sciences market. Products and services may be sold separately or in bundled packages. The typical length of a contract for service is 12 to 36 months.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For bundled packages, the Company accounts for individual products and services separately if they are distinct - i.e. if a product or service is separately identifiable from other items in the bundled package and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The consideration (including any discounts) is allocated between separate products and services in a bundle based on their stand-alone selling prices. The stand-alone selling prices are determined based on the prices at which the Company separately sells the products, extended warranties, and services. For items that are not sold separately, the Company estimates stand-alone selling prices by reference to the amount charged for similar items on a stand-alone basis.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company sells products and services predominantly through its direct sales force. As a result, the use of distributors is generally limited to geographic regions where the Company has no direct sales force. The Company does not offer product return or exchange rights (other than those relating to defective goods under warranty) or price protection allowances to its customers, including distributors. Payment terms granted to distributors are the same as those granted to end-customers and payments are not dependent upon the distributor's receipt of payment from their end-user customers. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In instances where the timing of revenue recognition differs from the timing of invoicing, the Company determined that the contracts generally do not include a significant financing component. The primary purpose of its invoicing terms is to provide customers with simplified and predictable ways of purchasing products and services, rather than to receive financing from the customers or to provide customers with financing. Examples include invoicing at the beginning of a subscription term with revenue recognized ratably over the contract period, and multi-year software licenses or software subscriptions that are invoiced annually with revenue recognized upfront. In limited circumstances where the Company provides the customer with a significant benefit of financing, the Company uses the practical expedient and only adjusts the transaction price for the effects of the time value of money and only on contracts where the duration of financing is more than one year. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:92.1875%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:79%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Products and services</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Nature, timing of satisfaction of performance obligations, and significant payment terms</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Instruments</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For instruments that include installation, and if the installation meets the criteria to be considered a separate performance obligation, product revenue is generally recognized upon delivery or when title has transferred to the customer, which is generally the point in time where control of the products has been transferred to customers, and installation revenue is recognized when the installation is complete. Certain of the Company's products require specialized installation and configuration at the customer's site. Revenue for these products is deferred until installation is complete and customer acceptance has been received. Payment terms and conditions vary, although terms generally include a requirement of payment within 30 to 60 days.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consumables and reagents</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes revenue from the sale of consumables and reagents upon delivery or when title has transferred to the customer, which is generally the point in time where control of the products has been transferred to customers. Payment terms and conditions vary, although terms generally include a requirement of payment within 30 days.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Software licenses and subscriptions</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customers may purchase perpetual or term licenses, or subscribe to licenses, which provide customers with the same functionality and differ mainly in the duration over which the customer benefits from the software.</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company sells its software subscriptions or software licenses with maintenance services and, in some cases, with consulting services. The Company recognizes revenue for the software upfront at the point in time when the software is made available to the customer. For maintenance and consulting services, revenue is recognized ratably over the period in which the services are provided. Payment terms and conditions vary by contract type, although terms generally include a requirement of payment within 30 to 60 days. Software subscriptions and maintenance service contracts are non-cancelable. </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cloud services</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cloud services, which allow customers to use hosted software over the contract period without taking possession of the software, are provided on either a subscription or consumption basis. Revenue related to cloud services provided on a subscription basis is recognized ratably over the contract period. Revenue related to cloud services provided on a consumption basis, such as the amount of storage used in a period, is recognized based on the customer utilization of such resources. Payment terms are generally net 30 days from signing of contract and contracts are non-cancelable.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Extended warranty</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes revenue for extended warranties on a straight-line basis over the extended warranty period in service revenue. In the majority of countries in which the Company operates, the customary warranty period is one year and the extended warranty covers periods beyond year one. Customers typically pay for extended warranties on an annual basis over the term of the warranty. In general, customers can cancel the extended warranty at any time with 30 days notice without significant penalty.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Laboratory services and training</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's service offerings include service contracts, field service, including related time and materials, and training. The Company recognizes revenue as the services are performed. Revenue for the service contracts is recognized over the contract period or at a point in time when the service is billable based on time and materials. The Company recognizes revenue as training is provided in service revenue. Payment terms and conditions vary by contract type, although terms generally include a requirement of payment within 30 to 60 days. In general, customers can cancel the service contracts at any time with 30 to 90 days notice without significant penalty.</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ii. Diagnostics</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Diagnostics segment of the Company principally generates revenue from sales of instruments, solutions, consumables, reagents, extended warranty and services in the diagnostics market. Products and services may be sold separately or in bundled packages. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For bundled packages, the Company accounts for individual products and services separately if they are distinct - i.e. if a product or service is separately identifiable from other items in the bundled package and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The consideration (including any discounts) is allocated between separate products and services in a bundle based on their stand-alone selling prices. The stand-alone selling prices are determined based on the prices at which the Company separately sells the products, extended warranties, and services. For items that are not sold separately, the Company estimates stand-alone selling prices by reference to the amount charged for similar items on a stand-alone basis.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company sells products and services predominantly through its direct sales force. As a result, the use of distributors is generally limited to geographic regions where the Company has no direct sales force. The Company does not offer product return or exchange rights (other than those relating to defective goods under warranty) or price protection allowances to its customers, including distributors. Payment terms granted to distributors are the same as those granted to end-customers and payments are not dependent upon the distributor's receipt of payment from their end-user customers. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In instances where the timing of revenue recognition differs from the timing of invoicing, the Company determined that the contracts generally do not include a significant financing component. The primary purpose of its invoicing terms is to provide customers with simplified and predictable ways of purchasing products and services, rather than to receive financing from the customers or to provide customers with financing. Examples include invoicing at the beginning of a storage period with revenue recognized ratably over the contract period. In limited circumstances where the Company provides the customer with a significant benefit of financing, the Company uses the practical expedient and only adjusts the transaction price for the effects of the time value of money and only on contracts where the duration of financing is more than one year. </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:92.1875%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:79%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Products and services</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Nature, timing of satisfaction of performance obligations, and significant payment terms</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Instruments</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For instruments that include installation, and if the installation meets the criteria to be considered a separate performance obligation, product revenue is generally recognized upon delivery or when title has transferred to the customer, which is generally the point in time where control of the products has been transferred to customers, and installation revenue is recognized when the installation is complete. Certain of the Company's products require specialized installation and configuration at the customer's site. Revenue for these products is deferred until installation is complete and customer acceptance has been received. Payment terms and conditions vary, although terms generally include a requirement of payment within 30 to 60 days.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consumables and reagents</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes revenue from the sale of consumables and reagents upon delivery or when title has transferred to the customer, which is generally the point in time where control of the products has been transferred to customers. Payment terms and conditions vary, although terms generally include a requirement of payment within 30 days.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Solutions</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">When the Company sells the instrument and reagents that work only on those instruments to a customer or distributor, the Company considers the instrument and reagents as separate performance obligations. The Company recognizes revenue when an instrument is sold to the customer upon delivery or when title has transferred to the customer, which is generally the point in time where control of the products has been transferred to customers. Revenue from the sale of reagents is also recognized at the time of delivery or when title has transferred to the customer. Payment terms for instrument and reagent sales are usually net 30 days from invoice date.</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">When the Company places the instrument at the customer's site and sells the reagents to a customer, the instrument and reagents are accounted for together as one performance obligation. The Company does not charge a fee for the use of the instrument and retains ownership of the placed instrument. The Company has a right to remove the instrument and replace it with another instrument at the customer's site at any time throughout the contract term. The Company recognizes revenue upon delivery of reagents, which is the point in time where the Company has performed its obligation to provide a screening solution to the customer. Payment terms are usually net 30 days from invoice date. Payment terms for certain contracts are based on equal installments over the duration of the contract.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Extended warranty</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes revenue for extended warranties on a straight-line basis over the extended warranty period in service revenue. In the majority of countries in which the Company operates, the customary warranty period is one year and the extended warranty covers periods beyond year one. Customers typically pay for extended warranties on an annual basis over the term of the warranty. In general, customers can cancel the extended warranty at any time with 30 days notice without significant penalty.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Services</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's service offerings include cord blood processing and storage, and training. The Company recognizes revenue for the cord blood processing and training as the services are performed in service revenue. Revenue for the storage contracts are recognized over the contract period. Storage is typically for a period of 1, 20, or 25 years or lifetime. Lifetime storage is recognized over a certain period that is based on the life expectancy estimate from Social Security data. For cord blood processing, customers pay the processing fee in full at the point of sale. The processing fee is non-refundable unless the cord blood is non-viable for storage. For storage, customers are required to pay the storage fees in full upfront. Storage fees are refundable to the customer on a pro-rated basis if the contract is canceled.</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Disaggregation of revenue</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the following tables, revenue is disaggregated by primary geographical market, end-markets and timing of revenue recognition. The tables also include a reconciliation of the disaggregated revenue with the reportable segments revenue.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.6328125%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Reportable Segments</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Discovery & Analytical Solutions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Primary geographical markets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Americas</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">169,366</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95,607</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">264,973</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110,747</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68,480</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">179,227</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">126,053</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104,060</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">230,113</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">406,166</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268,147</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">674,313</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Primary end-markets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268,147</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268,147</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Life sciences</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">222,191</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">222,191</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Applied markets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">183,975</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">183,975</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">406,166</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268,147</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">674,313</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Timing of revenue recognition</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Products and services transferred at a point in time</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">290,929</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">247,189</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">538,118</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Services transferred over time</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115,237</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,958</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">136,195</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">406,166</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268,147</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">674,313</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.6328125%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Reportable Segments</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Discovery & Analytical Solutions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Primary geographical markets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Americas</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">497,833</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">282,536</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">780,369</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">357,766</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">205,892</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">563,658</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">377,720</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">299,900</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">677,620</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,233,319</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">788,328</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,021,647</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Primary end-markets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">788,328</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">788,328</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Life sciences</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">675,807</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">675,807</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Applied markets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">557,512</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">557,512</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,233,319</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">788,328</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,021,647</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Timing of revenue recognition</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Products and services transferred at a point in time</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">874,517</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">726,058</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,600,575</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Services transferred over time</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">358,802</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62,270</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">421,072</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,233,319</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">788,328</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,021,647</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contract Balances</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contract assets: </font><font style="font-family:inherit;font-size:10pt;">The unbilled receivables (contract assets) primarily relate to the Company's right to consideration for work completed but not billed at the reporting date. The unbilled receivables are transferred to trade receivables when billed to customers. Contracts assets are generally classified as current assets and are included in "Accounts receivable, net" in the consolidated balance sheet. The balance of contract assets as of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and as of the date of adoption of ASC 606 were </font><font style="font-family:inherit;font-size:10pt;">$31.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$22.7 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The amount of unbilled receivables recognized at the beginning of the period that were transferred to trade receivables during the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$21.1 million</font><font style="font-family:inherit;font-size:10pt;">. The increase in unbilled receivables during the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> as a result of recognition of revenue before billing to customers, excluding amounts transferred to trade receivables during the period, amounted to </font><font style="font-family:inherit;font-size:10pt;">$29.5 million</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contract liabilities: </font><font style="font-family:inherit;font-size:10pt;">The contract liabilities primarily relate to the advance consideration received from customers for products and related installation for which transfer of control has not occurred at the balance sheet date. Contract liabilities are classified as either current in "Accounts payable" or long-term in "Long-term liabilities" in the consolidated balance sheet based on the timing of when the Company expects to recognize revenue. The balance of contract liabilities as of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and as of the date of adoption of ASC 606 were </font><font style="font-family:inherit;font-size:10pt;">$26.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$29.0 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The increase in contract liabilities during the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> due to cash received, excluding amounts recognized as revenue during the period, was </font><font style="font-family:inherit;font-size:10pt;">$17.6 million</font><font style="font-family:inherit;font-size:10pt;">. The amount of revenue recognized during the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> that was included in the contract liability balance at the beginning of the period was </font><font style="font-family:inherit;font-size:10pt;">$20.4 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contract costs: </font><font style="font-family:inherit;font-size:10pt;">The Company recognizes the incremental costs of obtaining a contract with a customer as an asset if it expects the benefit of those costs to be longer than one year. The Company determined that certain sales incentive programs meet the requirements to be capitalized. Total capitalized costs to obtain a contract were immaterial during the period and are included in other current and long-term assets on the condensed consolidated balance sheet. The Company applies a practical expedient to expense costs as incurred for costs to obtain a contract with a customer when the amortization period would have been one year or less. These costs include the Company's internal sales force compensation program, as the Company determined that annual compensation is commensurate with annual sales activities.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Transaction price allocated to the remaining performance obligations</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company applies the practical expedient in ASC 606-10-50-14 and does not disclose information about remaining performance obligations that have original expected durations of one year or less. The estimated revenue expected to be recognized beyond one year in the future related to performance obligations that are unsatisfied (or partially unsatisfied) at the end of the period are not material to the Company. Remaining performance obligations primarily include noncancelable purchase orders and noncancelable software subscriptions and cloud service contracts.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company adopted ASC 606, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;"> ("ASC 606"), with a date of the initial application of January 1, 2018. As a result, the Company has changed its accounting policy for revenue recognition as detailed below.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company applied ASC 606 using the modified retrospective method only to contracts that are not completed contracts as of January 1, 2018, and the cumulative effect of initially applying ASC 606 is recognized as an adjustment to the beginning retained earnings. Therefore, the comparative information has not been adjusted and continues to be reported under ASC 605. The details of the significant changes and quantitative impact of the changes are disclosed below.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">A. Sales of software subscriptions or sales of licenses and maintenance in bundled arrangements</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company previously recognized revenue from software licenses sold together with maintenance and/or consulting services upon shipment using the residual method, provided that the undelivered items in the arrangement have value to the customer on a stand-alone basis and vendor-specific objective evidence ("VSOE") of fair value can be determined. If VSOE of fair value for the undelivered elements cannot be established, the Company deferred all revenue from the arrangement until the earlier of the point at which such sufficient VSOE does exist or all elements of the arrangement have been delivered, or if the undelivered element is maintenance, then the Company recognized the entire fee ratably over the maintenance period. Under ASC 606, the total consideration in the contract is allocated to all products and services based on their stand-alone selling prices. The stand-alone selling prices are determined based on the list prices at which the Company sells the software license, software subscription, maintenance and/or consulting services. Accordingly, the Company now recognizes higher license revenue upfront and less service revenue over time.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">B. Sales of instruments</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company previously recognized revenue from sale of instruments when persuasive evidence of an arrangement existed, delivery had occurred, the price to the buyer was fixed or determinable, and collectability was reasonably assured. For certain sales of instruments that included customer-specified acceptance criteria, the Company previously recognized revenue after the acceptance criteria had been met. Under ASC 606, revenue is recognized when the Company satisfies a performance obligation by transferring control of the product to a customer. Accordingly, the Company now recognizes product revenue upon delivery or when title has transferred to the customer, as the Company believes acceptance is perfunctory. </font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">C. Sales commissions</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company previously recognized commission fees related to sales of products and services as selling expenses when they were incurred. Under ASC 606, the Company capitalizes those commission fees as costs of obtaining a contract, when they are incremental and, if they are expected to be recovered, the Company amortizes them consistently with the pattern of transfer of the product or service to which the asset relates. If the expected amortization period is one year or less, the commission fee is expensed when incurred.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of accumulated other comprehensive loss consisted of the following:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency translation adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(160,780</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(46,582</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrecognized prior service costs, net of income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">322</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">322</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized net losses on securities, net of income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(190</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(258</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated other comprehensive loss</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(160,648</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(46,518</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The total purchase price for the acquisitions in </font><font style="font-family:inherit;font-size:10pt;">fiscal year 2017</font><font style="font-family:inherit;font-size:10pt;"> has been allocated to the estimated fair values of assets acquired and liabilities assumed as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">EUROIMMUN</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Acquisitions</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of business combination:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash payments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,413,780</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">140,861</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other liability</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,273</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Working capital and other adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(93</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: cash acquired</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,439</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,388,762</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139,602</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable assets acquired and liabilities assumed:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121,174</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,268</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130,512</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,356</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,679</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,691</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable intangible assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Core technology</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">160,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,400</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">710,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In-process research and development ("IPR&D")</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,400</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">581,172</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,250</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(253,288</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,735</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities assumed</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(86,530</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,328</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt assumed</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(61,357</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,388,762</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139,602</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The total purchase price for the acquisitions in </font><font style="font-family:inherit;font-size:10pt;">fiscal year 2018</font><font style="font-family:inherit;font-size:10pt;"> has been allocated to the estimated fair values of assets acquired and liabilities assumed as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:87%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 Acquisitions</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of business combination:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash payments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,942</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other liability</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,354</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Working capital and other adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">599</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: cash acquired</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,138</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54,257</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable assets acquired and liabilities assumed:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,469</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">937</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">430</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable intangible assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Core technology</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,957</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,010</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,800</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,423</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,524</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities assumed</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,037</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt assumed</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(208</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54,257</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The summary pre-tax operating results of the discontinued operations, were as follows for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended: </font></div><div style="line-height:120%;text-align:right;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,343</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenue</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,933</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,869</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,891</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Loss) income from discontinued operations before income taxes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">650</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables show the assets and liabilities carried at fair value measured on a recurring basis as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;"> classified in one of the three classifications described above:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurements at September 30, 2018 Using:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total Carrying Value at September 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Active Markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable<br clear="none"/>Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketable securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,405</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,405</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange derivative assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,273</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,273</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange derivative liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,694</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,694</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(67,126</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(67,126</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurements at December 31, 2017 Using:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total Carrying Value at December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Active Markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketable securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,208</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,208</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange derivative assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,431</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,431</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange derivative liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23,638</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23,638</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(65,328</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(65,328</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The total provision for income taxes included in the condensed consolidated statement of operations consisted of the following:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,596</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,508</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,101</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,495</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,411</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,262</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,341</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,405</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,185</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,770</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,760</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62,900</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;"> consisted of the following:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117,266</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">122,100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work in progress</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,389</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,452</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">215,589</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">211,123</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total inventories</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">354,244</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">351,675</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the components of net periodic pension credit for the Company’s various defined benefit employee pension and postretirement plans for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October 1, 2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Defined Benefit</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Pension Benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Postretirement</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Medical Benefits</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service and administrative costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,712</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,231</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,051</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,160</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected return on plan assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,270</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,568</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(314</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(279</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of prior service costs</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(41</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(49</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic pension credit</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,548</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,226</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(257</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(224</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Defined Benefit</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Pension Benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Postretirement</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Medical Benefits</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service and administrative costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,180</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,667</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,212</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,420</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected return on plan assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21,926</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19,609</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(941</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(836</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of prior service costs</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(123</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(144</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic benefit credit</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,657</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,666</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(771</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(673</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest and other expense, net, consisted of the following:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(316</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(802</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(754</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,512</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,684</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,974</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,745</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,510</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Gain) loss on disposition of businesses and assets, net (see Note 5)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13,031</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13,031</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">301</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,176</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(37,188</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,013</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(45,096</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total interest and other expense (income), net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,161</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(27,016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,947</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13,797</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Impacts on financial statements</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables summarize the impacts of ASC 606 adoption on the Company's condensed consolidated financial statements for the quarter ended </font><font style="font-family:inherit;font-size:10pt;font-weight:normal;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Consolidated Balance Sheet</font></div><div style="line-height:120%;text-align:center;padding-left:60px;text-indent:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.14634146341463%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balances without adoption of ASC 606</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">149,513</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">149,513</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">551,385</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11,554</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">539,831</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">354,244</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,451</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">361,695</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110,353</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(522</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">109,831</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">317,049</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">317,049</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,223,775</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,223,775</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,920,689</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,920,689</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">235,347</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">235,347</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,862,355</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,625</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,857,730</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current portion of long-term debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,072</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,072</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180,693</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180,693</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued restructuring and contract termination charges</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,079</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,079</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses and other current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">475,743</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,912</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">494,655</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current liabilities of discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,165</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,165</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,882,502</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,882,502</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">720,632</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">720,632</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,289,886</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,912</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,308,798</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commitments and contingencies</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Preferred stock</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">111,087</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">111,087</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital in excess of par value</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,970</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,970</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Retained earnings</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,532,060</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23,537</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,508,523</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated other comprehensive loss</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(160,648</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(160,648</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total stockholders’ equity</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,572,469</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23,537</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,548,932</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total liabilities and stockholders’ equity</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,862,355</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,625</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,857,730</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;font-style:italic;">    </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">    </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Consolidated Statement of Operations</font></div><div style="line-height:120%;text-align:center;padding-left:48px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:92.87804878048782%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balances without adoption of ASC 606</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">474,523</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,198</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">471,325</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service revenue</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199,790</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199,790</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total revenue</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">674,313</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,198</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">671,115</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of product revenue</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">213,672</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(98</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">213,574</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of service revenue</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">128,314</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">128,314</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total cost of revenue</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">341,986</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(98</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">341,888</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">196,769</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">196,816</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,848</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,848</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring and contract termination charges, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,508</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,508</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Operating income from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80,202</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,147</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,055</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest and other expense, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,161</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,161</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from continuing operations before income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,041</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,147</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74,894</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provision for income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,596</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(814</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,782</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Income from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,445</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,333</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73,112</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss on disposition of discontinued operations before income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(308</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(308</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Benefit from income taxes on discontinued operations and dispositions</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,411</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,411</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gain from discontinued operations and dispositions</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,103</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,103</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76,548</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,333</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74,215</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Consolidated Statement of Operations</font></div><div style="line-height:120%;text-align:center;padding-left:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:92.87804878048782%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balances without adoption of ASC 606</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,417,739</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,562</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,392,177</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service revenue</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">603,908</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">603,908</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total revenue</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,021,647</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,562</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,996,085</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of product revenue</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">663,651</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,780</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">655,871</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of service revenue</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">393,307</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">393,307</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total cost of revenue</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,056,958</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,780</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,049,178</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">601,374</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">300</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">601,674</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">142,028</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">142,028</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring and contract termination charges, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,086</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,086</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Operating income from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">208,201</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18,082</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">190,119</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest and other expense, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,947</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,947</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from continuing operations before income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">178,254</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18,082</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">160,172</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provision for income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,101</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,753</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,348</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Income from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">166,153</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13,329</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">152,824</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss on disposition of discontinued operations before income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(859</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(859</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Benefit from income taxes on discontinued operations and dispositions</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,341</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,341</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gain from discontinued operations and dispositions</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">482</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">482</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">166,635</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13,329</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">153,306</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;">The adoption of ASC 606 increased comprehensive income by </font><font style="font-family:inherit;font-size:10pt;">$2.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$13.3 million</font><font style="font-family:inherit;font-size:10pt;"> in the Company's condensed consolidated statement of comprehensive income for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, respectively. The adoption of ASC 606 had </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> impact on cash from or used in operating, investing, or financing activities in the Company's condensed consolidated statement of cash flows as of and for the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the reductions in headcount, the initial restructuring or contract termination charges by reporting segment, and the dates by which payments were substantially completed, or the dates by which payments are expected to be substantially completed, for restructuring actions implemented during </font><font style="font-family:inherit;font-size:10pt;">fiscal years 2018 and 2017</font><font style="font-family:inherit;font-size:10pt;"> in continuing operations:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.8515625%;border-collapse:collapse;text-align:left;"><tr><td colspan="26" rowspan="1"></td></tr><tr><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Workforce Reductions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Closure of Excess Facility</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Expected) Date Payments Substantially Completed by</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Headcount Reduction</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Discovery & Analytical Solutions</font></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Discovery & Analytical Solutions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Severance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Excess Facility</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="21" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands, except headcount data)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q3 2018 Plan</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,146</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">618</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,764</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q2 FY2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q1 2018 Plan</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,096</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">902</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,998</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q2 FY2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q4 2017 Plan</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,680</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">255</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,935</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q1 FY2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q3 2017 Plan</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,321</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,342</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q4 FY2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q1 2017 Plan</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,631</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,697</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q4 FY2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q4 FY2018</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the Company's restructuring and contract termination accrual balances and related activity by restructuring plan, as well as contract termination accrual balances and related activity, during the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:31%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance at December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 Charges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 Changes in Estimates, Net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 Amounts Paid</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance at September 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="19" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Severance:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q3 2018 Plan</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,764</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,764</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q1 2018 Plan</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,998</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,273</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,725</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q4 2017 Plan</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,919</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,538</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">381</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q3 2017 Plan</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,072</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(868</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,204</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q1 2017 Plan</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,498</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,174</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,324</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Facility:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Q1 2017 Plan</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Previous Plans</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,399</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">353</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,106</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,646</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,921</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,762</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">353</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,981</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,055</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contract Termination</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,048</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,744</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">227</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,653</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">366</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Restructuring and Contract Termination</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,969</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,506</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">580</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17,634</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,421</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue and operating income (loss) from continuing operations by operating segment are shown in the table below:</font><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Discovery & Analytical Solutions</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">247,250</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">222,618</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">748,270</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">665,068</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service revenue</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">158,916</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162,764</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">485,049</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">465,202</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total revenue</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">406,166</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">385,382</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,233,319</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,130,270</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,381</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,258</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">149,243</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">128,604</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Diagnostics</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product revenue</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">227,273</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">132,201</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">669,469</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">378,466</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service revenue</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,874</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,692</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118,859</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">106,616</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total revenue</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268,147</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168,893</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">788,328</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">485,082</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,411</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,361</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104,585</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113,024</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Corporate</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating loss from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,590</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,581</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(45,627</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(39,596</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Continuing Operations</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product revenue</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">474,523</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">354,819</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,417,739</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,043,534</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service revenue</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199,790</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199,456</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">603,908</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">571,818</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total revenue</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">674,313</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">554,275</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,021,647</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,615,352</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80,202</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,038</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">208,201</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">202,032</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest and other expense (income), net (see Note 7)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,161</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(27,016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,947</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13,797</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from continuing operations before income taxes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,041</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">105,054</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">178,254</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">215,829</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes stock option activity for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.4140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Average Exercise</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Remaining</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Contractual </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Term</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Intrinsic</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,154</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.77</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">363</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77.81</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(554</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(43</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51.62</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at September 30, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,920</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51.38</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable at September 30, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,113</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43.10</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s weighted-average assumptions used in the Black-Scholes option pricing model were as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three and Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-free interest rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected dividend yield</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected term</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected stock volatility</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table reconciles the number of shares utilized in the earnings per share calculations:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of common shares—basic</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110,724</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110,003</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110,499</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">109,788</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of dilutive securities:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">791</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">735</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">813</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">669</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock awards</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">232</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">255</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">198</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">196</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of common shares—diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">111,747</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110,993</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">111,510</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110,653</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of potentially dilutive securities excluded from calculation due to antidilutive impact</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">358</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">346</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">377</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Industry Segment Information</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company discloses information about its operating segments based on the way that management organizes the segments within the Company for making operating decisions and assessing financial performance. The Company evaluates the performance of its operating segments based on revenue and operating income. Intersegment revenue and transfers are not significant. The accounting policies of the operating segments are the same as those described in Note 1 to the audited consolidated financial statements in the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> Form 10-K. </font></div><div style="line-height:120%;text-indent:36px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:4px;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The principal products and services of the Company's </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> operating segments are:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Discovery & Analytical Solutions</font><font style="font-family:inherit;font-size:10pt;">. Provides products and services targeted towards the life sciences and applied markets.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Diagnostics</font><font style="font-family:inherit;font-size:10pt;">. Develops diagnostics, tools and applications focused on clinically-oriented customers, especially within the reproductive health, emerging market diagnostics and applied genomics markets. The Diagnostics segment serves the diagnostics market.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has included the expenses for its corporate headquarters, such as legal, tax, audit, human resources, information technology, and other management and compliance costs, as well as the activity related to the mark-to-market adjustment on postretirement benefit plans, as “Corporate” below. The Company has a process to allocate and recharge expenses to the reportable segments when these costs are administered or paid by the corporate headquarters based on the extent to which the segment benefited from the expenses. These amounts have been calculated in a consistent manner and are included in the Company’s calculations of segment results to internally plan and assess the performance of each segment for all purposes, including determining the compensation of the business leaders for each of the Company’s operating segments. </font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue and operating income (loss) from continuing operations by operating segment are shown in the table below:</font><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 1, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 1, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Discovery & Analytical Solutions</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">247,250</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">222,618</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">748,270</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">665,068</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service revenue</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">158,916</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162,764</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">485,049</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">465,202</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total revenue</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">406,166</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">385,382</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,233,319</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,130,270</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,381</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,258</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">149,243</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">128,604</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Diagnostics</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product revenue</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">227,273</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">132,201</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">669,469</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">378,466</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service revenue</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,874</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,692</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118,859</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">106,616</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total revenue</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268,147</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168,893</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">788,328</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">485,082</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,411</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,361</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104,585</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113,024</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Corporate</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating loss from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,590</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,581</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(45,627</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(39,596</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Continuing Operations</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product revenue</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">474,523</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">354,819</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,417,739</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,043,534</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service revenue</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199,790</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199,456</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">603,908</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">571,818</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total revenue</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">674,313</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">554,275</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,021,647</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,615,352</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80,202</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,038</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">208,201</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">202,032</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest and other expense (income), net (see Note 7)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,161</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(27,016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,947</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13,797</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from continuing operations before income taxes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,041</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">105,054</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">178,254</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">215,829</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stockholders’ Equity</font></div><div style="line-height:120%;padding-top:6px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Comprehensive Income:</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of accumulated other comprehensive loss consisted of the following:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency translation adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(160,780</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(46,582</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrecognized prior service costs, net of income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">322</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">322</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized net losses on securities, net of income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(190</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(258</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated other comprehensive loss</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(160,648</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(46,518</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Stock Repurchases:</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 27, 2016, the Board of Directors (the "Board") authorized the Company to repurchase up to </font><font style="font-family:inherit;font-size:10pt;">8.0 million</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock under a stock repurchase program (the "Repurchase Program"). On July 23, 2018, the Board authorized the Company to immediately terminate the Repurchase Program and further authorized the Company to repurchase shares of common stock for an aggregate amount up to </font><font style="font-family:inherit;font-size:10pt;">$250.0 million</font><font style="font-family:inherit;font-size:10pt;"> under a new stock repurchase program (the "New Repurchase Program"). The New Repurchase Program will expire on July 23, 2020 unless terminated earlier by the Board and may be suspended or discontinued at any time. During the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company had no stock repurchases under either the Repurchase Program or the New Repurchase Program. No shares remain available for repurchase under the Repurchase Program due to its cancellation. As of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$250.0 million</font><font style="font-family:inherit;font-size:10pt;"> remained available for aggregate repurchases of shares under the New Repurchase Program. </font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, the Board has authorized the Company to repurchase shares of common stock to satisfy minimum statutory tax withholding obligations in connection with the vesting of restricted stock awards and restricted stock unit awards granted pursuant to the Company’s equity incentive plans and to satisfy obligations related to the exercise of stock options made pursuant to the Company's equity incentive plans. During the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company repurchased </font><font style="font-family:inherit;font-size:10pt;">3,807</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock for this purpose at an aggregate cost of </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">. During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company repurchased </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">63,506</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock for this purpose at an aggregate cost of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;">. The repurchased shares have been reflected as additional authorized but unissued shares, with the payments reflected in common stock and capital in excess of par value.</font></div><div style="line-height:120%;text-indent:32px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Dividends:</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Board declared a regular quarterly cash dividend of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.07</font><font style="font-family:inherit;font-size:10pt;"> per share for the first </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> quarters of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">fiscal year 2018</font><font style="font-family:inherit;font-size:10pt;"> and in each quarter of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">fiscal year 2017</font><font style="font-family:inherit;font-size:10pt;">. At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company has accrued </font><font style="font-family:inherit;font-size:10pt;">$7.8 million</font><font style="font-family:inherit;font-size:10pt;"> for dividends declared on </font><font style="font-family:inherit;font-size:10pt;">July 23, 2018</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">third</font><font style="font-family:inherit;font-size:10pt;"> quarter of </font><font style="font-family:inherit;font-size:10pt;">fiscal year 2018</font><font style="font-family:inherit;font-size:10pt;"> that will be payable on </font><font style="font-family:inherit;font-size:10pt;">November 9, 2018</font><font style="font-family:inherit;font-size:10pt;">. On </font><font style="font-family:inherit;font-size:10pt;">October 24, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company announced that the Board had declared a quarterly dividend of </font><font style="font-family:inherit;font-size:10pt;">$0.07</font><font style="font-family:inherit;font-size:10pt;"> per share for the </font><font style="font-family:inherit;font-size:10pt;">fourth</font><font style="font-family:inherit;font-size:10pt;"> quarter of </font><font style="font-family:inherit;font-size:10pt;">fiscal year 2018</font><font style="font-family:inherit;font-size:10pt;"> that will be payable on </font><font style="font-family:inherit;font-size:10pt;">February 8, 2019</font><font style="font-family:inherit;font-size:10pt;">. In the future, the Board may determine to reduce or eliminate the Company’s common stock dividend in order to fund investments for growth, repurchase shares or conserve capital resources.</font></div></div>

EX-101.SCH 6 pki-20180930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2101100 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 2401402 - Disclosure - Basis of Presentation (Basis of Presentation) (Details) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Basis of Presentation (Policies) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Business Combinations link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - Business Combinations (Fair Values of the Business Combinations and Allocations for the Acquisitions Completed) (Details) link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Business Combinations (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Business Combinations (Tables) link:presentationLink link:calculationLink link:definitionLink 2403403 - Disclosure - Changes in Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Changes in Accounting Policies (Notes) link:presentationLink link:calculationLink link:definitionLink 2203201 - Disclosure - Changes in Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2303302 - Disclosure - Changes in Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1003501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Condensed Consolidated Income Statements link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 2121100 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 2421401 - Disclosure - Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 2410401 - Disclosure - Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2119100 - Disclosure - Derivatives And Hedging Activities link:presentationLink link:calculationLink link:definitionLink 2419401 - Disclosure - Derivatives And Hedging Activities (Details) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Discontinued Operations link:presentationLink link:calculationLink link:definitionLink 2405403 - Disclosure - Discontinued Operations Benefit (Details) link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Discontinued Operations (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Discontinued Operations (Tables) link:presentationLink link:calculationLink link:definitionLink 2422402 - Disclosure - Disposition of Businesses and Assets, Net (Details) link:presentationLink link:calculationLink link:definitionLink 2122100 - Disclosure - Disposition of Businesses and Assets, Net (Notes) link:presentationLink link:calculationLink link:definitionLink 2322301 - Disclosure - Disposition of Businesses and Assets, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - Earnings Per Share (Schedule of Reconciliation of Number of Shares Utilized in Earnings Per Share Calculations) (Details) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Employee Benefit Plans link:presentationLink link:calculationLink link:definitionLink 2417402 - Disclosure - Employee Benefit Plans (Components of Net Periodic Benefit Cost (Credit)) (Details) link:presentationLink link:calculationLink link:definitionLink 2317301 - Disclosure - Employee Benefit Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 2120100 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2420403 - Disclosure - Fair Value Measurements (Assets and Liabilities Carried at Fair Value Measured on a Recurring Basis) (Details) link:presentationLink link:calculationLink link:definitionLink 2420402 - Disclosure - Fair Value Measurements (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2420404 - Disclosure - Fair Value Measurements (Reconciliation of Beginning and Ending Level 3 Net Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 2320301 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2115100 - Disclosure - Goodwill and Intangible Assets, Net link:presentationLink link:calculationLink link:definitionLink 2415403 - Disclosure - Goodwill and Intangible Assets, Net (Changes in the Carrying Amount of Goodwill) (Details) link:presentationLink link:calculationLink link:definitionLink 2415404 - Disclosure - Goodwill and Intangible Assets, Net (Identifiable Intangible Asset Balances) (Details) link:presentationLink link:calculationLink link:definitionLink 2415402 - Disclosure - Goodwill and Intangible Assets, Net (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2315301 - Disclosure - Goodwill and Intangible Assets, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Industry Segment Information link:presentationLink link:calculationLink link:definitionLink 2412402 - Disclosure - Industry Segment Information Industry Segment Information Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2412403 - Disclosure - Industry Segment Information (Schedule of Sales and Operating Income by Operating Segment, Excluding Discontinued Operations) (Details) link:presentationLink link:calculationLink link:definitionLink 2312301 - Disclosure - Industry Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Interest and Other Expense (Income), Net link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Interest and Other Expense (Income), Net (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Interest and Other Expense (Income), Net (Tables) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Inventories, Net link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Inventories, Net (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Inventories, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Restructuring and Lease Charges, Net link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Restructuring and Lease Charges, Net (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - Restructuring and Lease Charges, Net (Schedule of Initial Charges) (Details) link:presentationLink link:calculationLink link:definitionLink 2406404 - Disclosure - Restructuring and Lease Charges, Net (Schedule of Restructuring Plan Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Restructuring and Lease Charges, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 2402403 - Disclosure - Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - Revenue (Notes) link:presentationLink link:calculationLink link:definitionLink 2202201 - Disclosure - Revenue (Policies) link:presentationLink link:calculationLink link:definitionLink 2302302 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - Stock Plans link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - Stock Plans (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2414406 - Disclosure - Stock Plans (Summary of Restricted Stock Award Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 2414405 - Disclosure - Stock Plans (Summary of Stock Option Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 2414403 - Disclosure - Stock Plans (Summary of Total Compensation Recognized Related to Outstanding Stock Options) (Details) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - Stock Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 2414404 - Disclosure - Stock Plans (Weighted-Average Assumptions Used in the Black-Scholes Option Pricing Model) (Details) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 2413403 - Disclosure - Stockholders' Equity (Components Of Accumulated Other Comprehensive Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - Stockholders' Equity (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - Warranty Reserves link:presentationLink link:calculationLink link:definitionLink 2416402 - Disclosure - Warranty Reserves (Details) link:presentationLink link:calculationLink link:definitionLink 2316301 - Disclosure - Warranty Reserves (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 pki-20180930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 pki-20180930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 pki-20180930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Summary of Total Compensation Recognized Related to Outstanding Equity Awards Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Weighted-Average Assumptions Used in the Black-Scholes Option Pricing Model Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Summary of Stock Option Activity Share-based Compensation, Stock Options, Activity [Table Text Block] Summary of Restricted Stock Award Activity Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block] Inventory Disclosure [Abstract] Inventories, Net Inventory Disclosure [Text Block] Revenue [Abstract] Revenue [Abstract] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Primary end-markets [Axis] Primary end-markets [Axis] Primary end-markets [Axis] Primary end-markets [Domain] Primary end-markets [Domain] [Domain] for Primary end-markets [Axis] Diagnostics [Member] Diagnostics [Member] Diagnostics [Member] Life Sciences [Member] Life Sciences [Member] Life Sciences [Member] Applied Markets [Member] Applied Markets [Member] Applied Markets [Member] Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] Discovery & Analytical Solutions [Member] Discovery & Analytical Solutions [Member] Discovery & Analytical Solutions [Member] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] Americas [Member] Americas [Member] Europe [Member] Europe [Member] Asia [Member] Asia [Member] Contract with Customer, Basis of Pricing [Axis] Contract with Customer, Basis of Pricing [Axis] Contract with Customer, Basis of Pricing [Domain] Contract with Customer, Basis of Pricing [Domain] Contract with Customer, Duration [Axis] Contract with Customer, Duration [Axis] Contract with Customer, Duration [Domain] Contract with Customer, Duration [Domain] Timing of Transfer of Good or Service [Axis] Timing of Transfer of Good or Service [Axis] Timing of Transfer of Good or Service [Domain] Timing of Transfer of Good or Service [Domain] Transferred at Point in Time [Member] Transferred at Point in Time [Member] Transferred over Time [Member] Transferred over Time [Member] Contract with Customer, Sales Channel [Axis] Contract with Customer, Sales Channel [Axis] Contract with Customer, Sales Channel [Domain] Contract with Customer, Sales Channel [Domain] Customer [Axis] Customer [Axis] Customer [Domain] Customer [Domain] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Revenue from Contract with Customer, Excluding Assessed Tax Revenue from Contract with Customer, Excluding Assessed Tax Contract with Customer, Asset and Liability [Abstract] Contract with Customer, Asset and Liability [Abstract] Contract with Customer, Asset, Net, Current Contract with Customer, Asset, Net, Current Contract with Customer, Liability, Current Contract with Customer, Liability, Current Contract with Customer, Liability, Revenue Recognized Contract with Customer, Liability, Revenue Recognized Increase (Decrease) in Unbilled Receivables Increase (Decrease) in Unbilled Receivables Unbilled Contracts Receivable Unbilled Contracts Receivable Unbilled Receivables Transferred To Accounts Receivables Unbilled Receivables Transferred To Accounts Receivables Unbilled Receivables Transferred To Accounts Receivables Contract with Customer, Liability, Increase (Decrease) Contract with Customer, Liability, Increase (Decrease) Contract with Customer, Liability, Increase (Decrease) Commitments and Contingencies Disclosure [Abstract] Management's estimate of total cost of ultimate disposition Accrual for Environmental Loss Contingencies Number of years over which estimated environmental cost will be paid Number Of Years Over Which Estimated Environmental Cost Will Be Paid Number Of Years Over Which Estimated Environmental Cost Will Be Paid Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets, Net Goodwill and Intangible Assets Disclosure [Text Block] Earnings Per Share [Abstract] Number of common shares-basic Weighted Average Number of Shares Outstanding, Basic Effect of dilutive securities, Stock options Incremental Common Shares Attributable to Share Based Payment Arrangements, Stock Options Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements stock options using the treasury stock method. Effect of dilutive securities, Restricted stock Incremental Common Shares Attributable to Share Based Payments Arrangements, Restricted Stock Awards Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements restricted stock awards using the treasury stock method. Number of common shares-diluted Weighted Average Number of Shares Outstanding, Diluted Number of potentially dilutive securities excluded from calculation due to antidilutive impact Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis] Income Statement Location [Axis] Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain] Income Statement Location [Domain] Cost of sales [Member] Cost of Sales [Member] Research and development expenses [Member ] Research and Development Expense [Member] Selling, general and administrative and other expenses [Member] Selling, General and Administrative Expenses [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Total pre-tax stock-based compensation expense Allocated Share-based Compensation Expense Share-based Compensation Share-based Compensation Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Plan Name [Axis] Plan Name [Axis] Plan Name [Domain] Plan Name [Domain] 2009 Incentive Plan [Member] Two Thousand Nine Incentive Plan [Member] Two Thousand Nine Incentive Plan [Member] Award Type [Axis] Award Type [Axis] Award Type [Domain] Equity Award [Domain] Stock Options [Member] Employee Stock Option [Member] Restricted Stock Awards [Member] Restricted Stock Awards [Member] Restricted Stock Awards [Member] Performance Units [Member] Performance Units [Member] Performance Units [Member] Stock Awards [Member] Stock Awards [Member] Stock Awards [Member] Employee Stock Purchase Plan [Member] Employee Stock [Member] Performance Restricted Stock Units [Member] Performance Restricted Stock Units [Member] Performance Restricted Stock Units [Member] Number of Former Stock-based Compensation Plans Number of Former Stock-based Compensation Plans Number of Former Stock-based Compensation Plans Shares authorized under plan Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Total income tax benefit recognized for stock-based compensation Employee Service Share-based Compensation, Tax Benefit from Compensation Expense Stock-based compensation costs capitalized as part of inventory Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Capitalized Amount Weighted-average grant-date fair value of options Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Total intrinsic value of options exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Proceeds from issuance of common stock under stock plans Proceeds from Stock Options Exercised Total unrecognized compensation cost, net of estimated forfeitures, related to nonvested stock, granted Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Weighted-average period for recognition of unrecognized compensation cost, years Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Awards/units outstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Number of Shares, Granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Weighted-average grant-date fair value of stock granted (per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Fair value of restricted stock awards vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Deferred Compensation Share-based Arrangements, Liability, Current and Noncurrent Deferred Compensation Share-based Arrangements, Liability, Current and Noncurrent Shares available for grant under employee stock purchase plan Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Debt Disclosure [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Significant Other Observable Inputs (Level 2) [Member] Fair Value, Inputs, Level 2 [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum [Member] Minimum [Member] Maximum [Member] Maximum [Member] Currency [Axis] Currency [Axis] All Currencies [Domain] All Currencies [Domain] United States of America, Dollars United States of America, Dollars Euro Member Countries, Euro Euro Member Countries, Euro Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Event [Member] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Unsecured Revolving Credit Facility [Member] Line of Credit [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Other Secured Bank Loan [Member] Other Secured Bank Loan [Member] Other Secured Bank Loan [Member] Line of Credit, Maturing August 11, 2021 [Member] Line of Credit, Maturing August 11, 2021 [Member] Line of Credit, Maturing August 11, 2021 [Member] Term Loan Credit Facility, 12 Months Maturity [Member] Term Loan Credit Facility, 12 Months Maturity [Member] Term Loan Credit Facility, 12 Months Maturity [Member] 2021 Notes [Member] Five Percent Ten Year Senior Unsecured Notes [Member] Five Percent Ten Year Senior Unsecured Notes [Member] Financing Lease Obligations [Member] Financing Lease Obligations [Member] Financing Lease Obligations [Member] 1.875 Percent Ten Year Senior Unsecured Notes [Member] 1.875 Percent Ten Year Senior Unsecured Notes [Member] [Member] 1.875 Percent Ten Year Senior Unsecured Notes [Member] 0.6 Percent Senior Unsecured Notes due in April 2021 [Member] 0.6 Percent Senior Unsecured Notes due in April 2021 [Member] 0.6 Percent Senior Unsecured Notes due in April 2021 [Member] Other Debt Facilities - EUROIMMUN [Member] Other Debt Facilities - EUROIMMUN [Member] Other Debt Facilities - EUROIMMUN [Member] Other Unsecured Revolving Debt Facilities [Member] Other Unsecured Revolving Debt Facilities [Member] Other Unsecured Revolving Debt Facilities [Member] Rate Basis by Type [Axis] Rate Basis by Type [Axis] Rate Basis by Type [Axis] Rate Basis, Type [Domain] Rate Basis, Type [Domain] Euribor Rate [Member] Euribor Rate [Member] Euribor Rate [Member] Base Rate Option Two [Member] Base Rate Option Two [Member] Base Rate Option Three [Member] Base Rate Option Three [Member] Base Rate Option Three [Member] Eurocurrency Rate [Member] Euro Currency Rate [Member] Euro Currency Rate [Member] Treasury Rate [Member] Treasury Rate [Member] Treasury Rate [Member] Statement [Line Items] Statement [Line Items] Unsecured Debt Unsecured Debt Other Unsecured Revolving Credit Facilities Other Unsecured Revolving Credit Facilities Other Unsecured Revolving Credit Facilities Line of Credit Facility, Maximum Borrowing Capacity Line of Credit Facility, Maximum Borrowing Capacity Unsecured revolving credit facility, expiry date Line of Credit Facility, Expiration Date Letters of credit issued and outstanding Letters of Credit Outstanding, Amount Line of Credit Facility, Remaining Borrowing Capacity Line of Credit Facility, Remaining Borrowing Capacity Interest rate terms under amended senior unsecured revolving credit facility Debt Instrument, Interest Rate Terms Weighted average interest rates under amended senior unsecured revolving credit facility Debt Instrument, Interest Rate, Basis for Effective Rate Description of variable rate basis Debt Instrument, Description of Variable Rate Basis Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Secured Debt Secured Debt Weighted average Eurocurrency interest rate Debt Instrument, Weighted Average Interest Rate Basis Debt Instrument, Weighted Average Interest Rate Basis Weighted average effective Eurocurrency rate, including the margin Debt, Weighted Average Interest Rate Aggregate borrowings under the amended facility Long-term Line of Credit Debt Instrument, Interest Rate, Stated Percentage Debt Instrument, Interest Rate, Stated Percentage Long-term Debt, Percentage Bearing Variable Interest, Amount Long-term Debt, Percentage Bearing Variable Interest, Amount Unsecured senior notes, face value Debt Instrument, Face Amount Gross proceeds from the issuance of debt instrument Proceeds from Issuance of Unsecured Debt Senior unsecured notes issuance as percentage of principal amount Debt Instrument, Issuance as Percentage of Principal Amount Debt Instrument, Issuance as Percentage of Principal Amount Debt Instrument, Unamortized Discount Debt Instrument, Unamortized Discount Debt instrument maturity date Debt Instrument, Maturity Date Percentage of redemption of senior notes on or after August 15, 2021 Percentage Of Redemption Of Senior Notes Percentage Of Redemption Of Senior Notes Percentage of redemption upon a change of control and a contemporaneous downgrade of the Notes Debt Instrument, Redemption Percentage Upon Change of Control and Downgrade of Debt Instrument Debt Instrument, Redemption Percentage Upon Change of Control and Downgrade of Debt Instrument Initial Fair Value of Other Long-term Debt Related to Financing Lease Obligations Initial Fair Value of Other Long-term Debt Related to Financing Lease Obligations Initial Fair Value of Other Long-term Debt Related to Financing Lease Obligations Additional Financing Lease Obligations, funded by lessors Additional Financing Lease Obligations, funded by lessors Additional Financing Lease Obligations, funded by lessors Other Long-term Debt Other Long-term Debt Long-term Debt, Percentage Bearing Fixed Interest, Amount Long-term Debt, Percentage Bearing Fixed Interest, Amount Other Long-term Debt, Current Other Long-term Debt, Current Other Long-term Debt, Noncurrent Other Long-term Debt, Noncurrent Long-term Debt Long-term Debt Unamortized Debt Issuance Expense Unamortized Debt Issuance Expense Term Loan Credit Facility, Maximum Borrowing Capacity Term Loan Credit Facility, Maximum Borrowing Capacity Term Loan Credit Facility, Maximum Borrowing Capacity Short-term Debt, Terms Short-term Debt, Terms Short-term Debt, Maximum Amount Outstanding During Period Short-term Debt, Maximum Amount Outstanding During Period Contingencies Commitments and Contingencies Disclosure [Text Block] Stock Plans Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Fair Value Disclosures [Abstract] Fair Value Measurements Fair Value Disclosures [Text Block] Basis of Presentation [Abstract] Basis of Presentation [Abstract] Basis of Presentation [Table] Basis of Presentation [Table] Basis of Presentation [Table] Retirement Plan Type [Axis] Retirement Plan Type [Axis] Retirement Plan Type [Domain] Retirement Plan Type [Domain] Pension Plan [Member] Pension Plan [Member] Statement, Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Scenario, Forecast [Member] Scenario, Forecast [Member] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] Adjustments for New Accounting Pronouncement [Member] Adjustments for New Accounting Pronouncement [Member] Accounting Standards Update 2014-09 [Member] Accounting Standards Update 2014-09 [Member] Accounting Standards Update 2016-16 [Member] Accounting Standards Update 2016-16 [Member] Accounting Standards Update 2016-18 [Member] Accounting Standards Update 2016-18 [Member] Accounting Standards Update 2017-07 [Member] Accounting Standards Update 2017-07 [Member] Basis of Presentation [Line Items] Basis of Presentation [Line Items] [Line Items] for Basis of Presentation [Table] Defined Benefit Plan, Other Cost (Credit) Defined Benefit Plan, Other Cost (Credit) Increase (Decrease) in Restricted Cash Increase (Decrease) in Restricted Cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Restricted Cash Restricted Cash Impact of New Accounting Principle, Cash Flows Impact of New Accounting Principle, Cash Flows Impact of New Accounting Principle, Cash Flows Operating Cycle Operating Cycle Cumulative Effect of New Accounting Principle in Period of Adoption Cumulative Effect of New Accounting Principle in Period of Adoption Impact of New Accounting Principle, Deferred Revenue Impact of New Accounting Principle, Deferred Revenue Impact of New Accounting Principle, Deferred Revenue EX-101.PRE 10 pki-20180930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2018	Nov. 01, 2018
Document and Entity Information [Abstract]
Entity Registrant Name	PERKINELMER INC
Entity Central Index Key	0000031791
Current Fiscal Year End Date	--12-30
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Document Period End Date	Sep. 30, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Common Stock, Shares Outstanding		111,239,214
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Current Reporting Status	Yes

XML 12 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Income Statements - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Oct. 01, 2017	Sep. 30, 2018	Oct. 01, 2017
Revenue from Contract with Customer, Excluding Assessed Tax	$ 674,313	$ 554,275	$ 2,021,647	$ 1,615,352
Cost of Revenue	341,986	285,308	1,056,958	849,027
Selling, general and administrative expenses	196,769	152,775	601,374	449,642
Research and development expenses	48,848	34,885	142,028	101,731
Restructuring and contract termination charges, net	6,508	3,269	13,086	12,920
Operating income from continuing operations	80,202	78,038	208,201	202,032
Interest and other expense, net	2,161	(27,016)	29,947	(13,797)
Income from continuing operations before income taxes	78,041	105,054	178,254	215,829
Provision for income taxes	2,596	8,508	12,101	20,495
Income from continuing operations	75,445	96,546	166,153	195,334
Income from discontinued operations before income taxes	0	0	0	650
(Loss) gain on disposition of discontinued operations before income taxes	(308)	(206)	(859)	180,171
(Benefit from) provision for income taxes on discontinued operations and dispositions	(1,411)	5,262	(1,341)	42,405
Gain (loss) from discontinued operations and dispositions	1,103	(5,468)	482	138,416
Net income	$ 76,548	$ 91,078	$ 166,635	$ 333,750
Basic earnings (loss) per share:
Income (loss) from continuing operations (per share)	$ 0.68	$ 0.88	$ 1.50	$ 1.78
Gain (loss) on discontinued operations and dispositions (per share)	0.01	(0.05)	0.00	1.26
Net income (per share)	0.69	0.83	1.51	3.04
Diluted earnings (loss) per share:
Income (loss) from continuing operations (per share)	0.68	0.87	1.49	1.77
Gain (loss) on discontinued operations and dispositions (per share)	0.01	(0.05)	0.00	1.25
Net income (per share)	$ 0.69	$ 0.82	$ 1.49	$ 3.02
Weighted average shares of common stock outstanding:
Basic (in shares)	110,724	110,003	110,499	109,788
Diluted (in shares)	111,747	110,993	111,510	110,653
Cash dividends per common share	$ 0.07	$ 0.07	$ 0.21	$ 0.21
Product [Member]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 474,523	$ 354,819	$ 1,417,739	$ 1,043,534
Cost of Goods and Services Sold	(213,672)	(165,015)	(663,651)	(501,079)
Service [Member]
Revenue from Contract with Customer, Excluding Assessed Tax	199,790	199,456	603,908	571,818
Cost of Goods and Services Sold	$ (128,314)	$ (120,293)	$ (393,307)	$ (347,948)

XML 13 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Oct. 01, 2017	Sep. 30, 2018	Oct. 01, 2017
Net income	$ 76,548	$ 91,078	$ 166,635	$ 333,750
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Foreign currency translation adjustments	(30,105)	9,805	(114,198)	47,205
Unrealized gains on securities, net of tax	23	47	68	81
Other comprehensive (loss) income	(30,082)	9,852	(114,130)	47,286
Comprehensive income	$ 46,466	$ 100,930	$ 52,505	$ 381,036

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

XML 14 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents	$ 149,513	$ 202,134
Accounts receivable, net	551,385	552,304
Inventories	354,244	351,675
Other current assets	110,353	93,842
Total current assets	1,165,495	1,199,955
Property, plant and equipment, net:
At cost	724,053	630,919
Accumulated depreciation	(407,004)	(332,853)
Property, plant and equipment, net	317,049	298,066
Intangible assets, net	1,223,775	1,346,940
Goodwill	2,920,689	3,002,198
Other assets, net	235,347	244,304
Total assets	5,862,355	6,091,463
Current liabilities:
Current portion of long-term debt	20,072	217,306
Accounts payable	180,693	222,093
Accrued expenses and other current liabilities	8,079	8,759
Accrued expenses and other current liabilities	475,743	500,642
Current liabilities of discontinued operations	2,165	2,102
Total current liabilities	686,752	950,902
Long-term debt	1,882,502	1,788,803
Long-term liabilities	720,632	848,570
Total liabilities	3,289,886	3,588,275
Commitments and contingencies (see Note 20)
Stockholders' equity:
Preferred stock—$1 par value per share, authorized 1,000,000 shares; none issued or outstanding	0	0
Common stock—$1 par value per share, authorized 300,000,000 shares; issued and outstanding 111,087,000 shares and 110,361,000 shares at September 30, 2018 and at December 31, 2017, respectively	111,087	110,361
Capital in excess of par value	89,970	58,828
Retained earnings	2,532,060	2,380,517
Accumulated other comprehensive loss	(160,648)	(46,518)
Total stockholders’ equity	2,572,469	2,503,188
Total liabilities and stockholders’ equity	$ 5,862,355	$ 6,091,463

XML 15 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2018	Dec. 31, 2017
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 1	$ 1
Preferred stock, authorized	1,000,000	1,000,000
Preferred stock, issued	0	0
Preferred stock, outstanding	0	0
Common stock, par value	$ 1	$ 1
Common stock, authorized	300,000,000	300,000,000
Common stock, issued	111,087,000	110,361,000
Common stock, outstanding	111,087,000	110,361,000

XML 16 R6.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2018	Oct. 01, 2017
Operating activities:
Net income	$ 166,635	$ 333,750
Gain from discontinued operations and dispositions, net of income taxes	(482)	(138,416)
Income from continuing operations	166,153	195,334
Adjustments to reconcile net income from continuing operations to net cash provided by continuing operations:
Restructuring and contract termination charges, net	13,086	12,920
Depreciation and amortization	133,386	75,507
Gain on disposition of businesses and assets, net	(13,031)	301
Gain on Sale of Investments	(557)	0
Stock-based compensation	23,275	16,179
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	10,804	1,560
Amortization of deferred debt financing costs and accretion of discount	2,454	1,936
Amortization of acquired inventory revaluation	18,160	4,240
Changes in operating assets and liabilities which provided (used) cash, excluding effects from companies purchased and divested:
Accounts receivable, net	(12,670)	10,971
Inventories	(41,313)	(25,208)
Accounts payable	(36,587)	(12,459)
Accrued expenses and other	(111,341)	(116,118)
Net cash provided by operating activities of continuing operations	151,819	165,163
Net cash used in operating activities of discontinued operations	(200)	(4,806)
Net cash provided by operating activities	151,619	160,357
Investing activities:
Capital expenditures	(60,443)	(22,362)
Proceeds from Derivative Instrument, Investing Activities	0	60,420
Proceeds from surrender of life insurance policies	72	45
Proceeds from Divestiture of Businesses	38,027	0
Payments to Acquire Investments	(5,500)	0
Activity related to acquisitions, net of cash and cash equivalents acquired	(44,057)	(123,578)
Net cash used in investing activities of continuing operations	(71,901)	(85,475)
Net cash provided by investing activities of discontinued operations	0	272,779
Net cash (used in) provided by investing activities	(71,901)	187,304
Financing activities:
Payments on borrowings	(1,019,000)	(146,965)
Proceeds from borrowings	605,000	146,952
Proceeds from sale of senior debt	369,340	0
Payments of debt financing costs	(2,634)	0
Settlement of cash flow hedges	(30,285)	(11,539)
Net payments on other credit facilities	(22,871)	(872)
Payments for acquisition-related contingent consideration	(12,800)	(8,940)
Proceeds from issuance of common stock under stock plans	19,484	14,004
Purchases of common stock	(4,974)	(3,480)
Dividends paid	(23,222)	(23,077)
Net Cash Provided by (Used in) Financing Activities, Continuing Operations	(121,962)	(33,917)
Cash Provided by (Used in) Financing Activities, Discontinued Operations	0	(533)
Net cash used in financing activities	(121,962)	(34,450)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	(7,410)	19,945
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalent	(49,654)	333,156
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at beginning of period	202,371	376,568
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at end of period	152,717	709,724
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ 202,371	$ 376,568

XML 17 R7.htm IDEA: XBRL DOCUMENT

Basis of Presentation	9 Months Ended
Basis of Presentation	Sep. 30, 2018
Accounting Policies [Abstract]
Basis of Accounting [Text Block]	Basis of Presentation The condensed consolidated financial statements included herein have been prepared by PerkinElmer, Inc. (the “Company”), in accordance with accounting principles generally accepted in the United States of America (the “U.S.” or the "United States") and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information in the footnote disclosures of the financial statements has been condensed or omitted where it substantially duplicates information provided in the Company’s latest audited consolidated financial statements, in accordance with the rules and regulations of the SEC. These condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes included in its Annual Report on Form 10-K for the fiscal year ended December 31, 2017, filed with the SEC (the “2017 Form 10-K”). The balance sheet amounts at December 31, 2017 in this report were derived from the Company’s audited 2017 consolidated financial statements included in the 2017 Form 10-K. The condensed consolidated financial statements reflect all adjustments that, in the opinion of management, are necessary to present fairly the Company’s financial position, results of operations and cash flows for the periods indicated. The preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts and classifications of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The results of operations for the three and nine months ended September 30, 2018 and October 1, 2017, respectively, are not necessarily indicative of the results for the entire fiscal year or any future period. The Company’s fiscal year ends on the Sunday nearest December 31. The Company reports fiscal years under a 52/53 week format and as a result, certain fiscal years will contain 53 weeks. The fiscal year ending December 30, 2018 ("fiscal year 2018") will include 52 weeks, and the fiscal year ended December 31, 2017 ("fiscal year 2017") included 52 weeks. Recently Adopted and Issued Accounting Pronouncements: From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (the "FASB") and are adopted by the Company as of the specified effective dates. Unless otherwise discussed, such pronouncements did not have or will not have a significant impact on the Company’s consolidated financial position, results of operations and cash flows or do not apply to the Company’s operations. In August 2018, the FASB issued Accounting Standards Update No. 2018-15, Intangibles-Goodwill and Other- Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract ("ASU 2018-15"). ASU 2018-15 aligns the accounting for implementation costs incurred in a hosting arrangement that is a service contract with the guidance on capitalizing costs associated with developing or obtaining internal-use software (and hosting arrangements that include an internal use software license). Specifically, ASU 2018-15 amends Intangibles-Goodwill and Other (Topic 350) to include in its scope implementation costs incurred in a hosting arrangement that is a service contract and clarifies that a customer should apply Subtopic 350-40 to determine which implementation costs to capitalize as an asset related to the service contract and which costs to expense. The provisions of this guidance are to be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. ASU 2018-15 is effective for annual reporting periods beginning after December 15, 2019, and interim periods within those years with early adoption permitted. The Company is currently evaluating the requirements of this guidance and has not yet determined the impact of its adoption on the Company's consolidated financial position, results of operations and cash flows. In August 2018, the FASB issued Accounting Standards Update No. 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans ("ASU 2018-14"). ASU 2018-14 adds, removes, and clarifies disclosure requirements related to defined benefit pension and other postretirement plans. ASU 2018-14 adds requirements for an entity to disclose the weighted-average interest crediting rates used in the entity’s cash balance pension plans and other similar plans; and an explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period. Further, ASU 2018-14 removes guidance that currently requires the following disclosures: the amounts in accumulated other comprehensive income expected to be recognized as part of net periodic benefit cost over the next year; the amount and timing of plan assets expected to be returned to the employer; information about (1) benefits covered by related-party insurance and annuity contracts and (2) significant transactions between the plan and related parties; and the effects of a one-percentage-point change on the assumed health care costs and the effect of this change in rates on service cost, interest cost, and the benefit obligation for postretirement health care benefits. ASU 2018-14 also clarifies the guidance in Compensation-Retirement Benefits (Topic 715-20-50-3) on defined benefit plans to require disclosure of (1) the projected benefit obligation ("PBO") and fair value of plan assets for pension plans with PBOs in excess of plan assets (the same disclosure with reference to the accumulated postretirement benefit obligation rather than the PBO is required for other postretirement benefit plans) and (2) the accumulated benefit obligation ("ABO") and fair value of plan assets for pension plans with ABOs in excess of plan assets. The provisions of this guidance are to be applied retrospectively to all periods presented upon their effective date. ASU 2018-14 is effective for annual reporting periods beginning after December 15, 2020, and interim periods within those years with early adoption permitted. The Company is currently evaluating the requirements of this guidance and has not yet determined the impact of its adoption on the Company's consolidated financial position, results of operations and cash flows. In August 2018, the FASB issued Accounting Standards Update No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement ("ASU 2018-13"). ASU 2018-13 adds, removes, and modifies certain disclosures related to fair value measurements. ASU 2018-13 adds requirements for an entity to disclose the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period; and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. Further, ASU 2018-13 removes the requirement to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy; the policy for timing of transfers between levels; and the valuation processes for Level 3 fair value measurements. ASU 2018-13 also modifies existing disclosure requirements related to measurement uncertainty. The amendments regarding changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty are to be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments are to be applied retrospectively to all periods presented upon their effective date. ASU 2018-13 is effective for annual reporting periods beginning after December 15, 2019, and interim periods within those years. Early adoption is permitted for any removed or modified disclosures. The Company is currently evaluating the requirements of this guidance and has not yet determined the impact of its adoption on the Company's consolidated financial position, results of operations and cash flows. In June 2018, the FASB issued Accounting Standards Update No. 2018-07, Compensation - Stock Compensation (Topic 718), Improvements to Nonemployee Share-Based Payment Accounting ("ASU 2018-07") which supersedes Subtopic 505-50, Equity - Equity-Based Payments to Non-employees, and expands the scope of Topic 718 (which currently only includes share-based payments to employees) to also include share-based payments issued to non-employees for goods and services, except for specific guidance on inputs to an option pricing model and the attribution of cost (that is, the period of time over which share-based payment awards vest and the pattern of cost recognition over that period). ASU 2018-07 specifies that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards, except for financing transactions, or awards issued to customers as part of a contract accounted for under Topic 606, Revenue from Contracts with Customers ("Topic 606"). The provisions of this guidance are to be applied using a modified retrospective approach, with a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year, for all (1) liability-classified non-employee awards that have not been settled as of the adoption date and (2) equity-classified non-employee awards for which a measurement date has not been established. ASU 2018-07 is effective for annual reporting periods beginning after December 15, 2018, and interim periods within those years. Early adoption is permitted, but no earlier than a company’s adoption date of Topic 606. The Company early adopted the provisions of this guidance effective July 2, 2018. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flow. In March 2018, the FASB Issued Accounting Standards Update No. 2018-05, Income Taxes (Topic 740): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118 ("ASU 2018-05"). ASU 2018-05 was issued to incorporate into Topic 740 recent SEC guidance related to the income tax accounting implications of the Tax Cut and Jobs Act (the "Tax Act"). The SEC issued Staff Accounting Bulletin No. 118 ("SAB 118") to address concerns about reporting entities’ ability to timely comply with the accounting requirements to recognize all of the effects of the Tax Act in the period of enactment. SAB 118 permits companies to disclose that some or all of the income tax effects from the Tax Act are incomplete by the due date of the financial statements, and if possible, disclose a reasonable estimate of such tax effects. ASU 2018-05 is effective immediately. The Company is applying the guidance in ASU 2018-05 when accounting for the enactment date effects of the Tax Act. At September 30, 2018, the Company has not completed the accounting for all of the tax effects of the Tax Act; however, it has made a reasonable estimate of their effects based on currently available information. Management will continue to refine the calculations as additional guidance is available. These estimates may be affected as additional clarification and implementation guidance becomes available. These changes could be material to income tax expense (see Note 9, Income Taxes for further disclosures). In February 2018, the FASB Issued Accounting Standards Update No. 2018-03, Technical Corrections and Improvements to Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities ("ASU 2018-03"). ASU 2018-03 was issued to clarify certain aspects of guidance concerning the recognition of financial assets and liabilities established in Accounting Standards Update No. 2016-01, Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities ("ASU 2016-01"). This includes treatment for discontinuations and adjustments for equity securities without a readily determinable market value, forward contracts and purchased options, presentation requirements for certain fair value option liabilities, fair value option liabilities denominated in a foreign currency, and transition guidance for equity securities without a readily determinable fair value. ASU 2018-03 is effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years beginning after June 15, 2018. Early adoption is permitted for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years, as long as the Company has adopted ASU 2016-01. The Company adopted the provisions of this guidance effective July 2, 2018. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows. In February 2018, the FASB Issued Accounting Standards Update No. 2018-02, Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income ("ASU 2018-02"). ASU 2018-02 provides entities with an option to reclassify stranded tax effects within Accumulated Other Comprehensive Income ("AOCI") to retained earnings in each period in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Act (or portion thereof) is recorded. ASU 2018-02 requires entities to disclose a description of the accounting policy for releasing income tax effects from AOCI; whether they elect to reclassify the stranded income tax effects from the Tax Act; and information about the other income tax effects that are reclassified. ASU 2018-02 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted, and entities should apply the proposed amendments either in the period of adoption or retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Act is recognized. The Company is currently evaluating the requirements of this guidance and has not yet determined the impact of its adoption on the Company's consolidated financial position, results of operations and cash flows. In August 2017, the FASB issued Accounting Standards Update No. 2017-12, Derivatives and Hedging (Topic 815), Targeted Improvements to Accounting for Hedging Activities ("ASU 2017-12"), which amends the hedge accounting recognition and presentation requirements in Topic 815. ASU 2017-12 makes targeted changes to the existing hedge accounting model to better align an entity’s financial reporting for hedging relationships with the entity’s risk management activities, and to reduce the complexity of, and simplify the application of, the hedge accounting model. Specifically, ASU 2017-12 expands the types of transactions eligible for hedge accounting, eliminates the requirement to separately measure and present hedge ineffectiveness, simplifies the way assessments of hedge ineffectiveness may be performed, relaxes the documentation requirements for entering into hedging positions, provides targeted improvements to fair value hedges of interest rate risk, and permits an entity to exclude the change in the fair value of cross-currency basis spreads in currency swaps from the assessment of hedge effectiveness. The standard also requires entities to provide new disclosures about the impact fair value and cash flow hedges have on their income statements and about cumulative basis adjustments arising from fair value hedges. The provisions of this guidance are to be applied using a modified retrospective approach to existing hedging relationships as of the adoption date. However, the transition provisions allow for certain elections at the date of adoption and entities may choose to apply any of the provided elections. ASU 2017-12 is effective for annual reporting periods beginning after December 15, 2018, and interim periods within those years. Early adoption is permitted, including adoption in any interim period. The Company early adopted the provisions of this guidance effective January 1, 2018. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows. In May 2017, the FASB issued Accounting Standards Update No. 2017-09, Compensation - Stock Compensation (Topic 718), Scope of Modification Accounting ("ASU 2017-09"), which amends the scope of modification accounting for share-based payment arrangements. ASU 2017-09 provides guidance on the types of changes to the terms or conditions of share-based payment awards to which an entity would be required to apply modification accounting under Topic 718. Specifically, an entity would not apply modification accounting if the fair value, vesting conditions, and classification of the awards are the same immediately before and after the modification. If an entity modifies its awards and concludes that it is not required to apply modification accounting under the standard, it must still consider whether the modification affects its application of other guidance. Additionally, if a significant modification does not result in incremental compensation cost, entities are required to disclose the “lack of” incremental compensation cost resulting from such significant modification. The standard also removes the guidance in Topic 718 stating that modification accounting is not required when an entity adds an antidilution provision as long as that modification is not made in contemplation of an equity restructuring. The provisions of this guidance are to be applied on a prospective basis to awards modified on or after the effective date. ASU 2017-09 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years. Early adoption is permitted, including adoption in any interim period. The Company adopted ASU 2017-09 effective January 1, 2018. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows. In March 2017, the FASB issued Accounting Standards Update No. 2017-07, Compensation - Retirement Benefits (Topic 715), Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost ("ASU 2017-07"), which amends the requirements in Topic 715 related to the income statement presentation of the components of net periodic benefit cost for an entity’s sponsored defined benefit pension and other postretirement plans. ASU 2017-07 requires entities to (1) disaggregate the current-service-cost component from the other components of net benefit cost (the “other components”) and present it with other current employee compensation costs in their income statements and (2) present the other components elsewhere in their income statements and outside of income from operations, and disclose the income statement lines that contain the other components if they are not presented on appropriately described separate lines. Additionally, the standard requires that only the service-cost component of net benefit cost is eligible for capitalization (e.g., as part of inventory or property, plant, and equipment). The change in income statement presentation requires retrospective application, while the change in capitalized benefit cost is to be applied prospectively. ASU 2017-07 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years, with early adoption permitted. The standard provides a practical expedient that permits entities to use the components of cost disclosed in prior years as a basis for the retrospective application of the new income statement presentation. Entities need to disclose the use of the practical expedient. The Company adopted ASU 2017-07 effective January 1, 2018 using a retrospective approach for each period presented. For the three and nine months ended October 1, 2017, $1.8 million and $5.4 million, respectively, of net periodic pension credit previously presented within operating income has been presented outside of operating income in the line item "Interest and other expense, net" in the condensed consolidated statement of operations due to the retrospective adoption of ASU 2017-07. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows, other than the impact discussed above. In January 2017, the FASB issued Accounting Standards Update No. 2017-01, Business Combinations (Topic 805), Clarifying the Definition of a Business ("ASU 2017-01"), which amends Topic 805 to provide a screen to determine when a set of assets and liabilities is not a business. The screen requires that when substantially all of the fair value of the gross assets acquired (or disposed of) is concentrated in a single identifiable asset or a group of similar identifiable assets, the set is not a business. This screen reduces the number of transactions that need to be further evaluated. If the screen is not met, the standard (1) requires that to be considered a business, a set must include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create output and (2) removes the evaluation of whether a market participant could replace missing elements. The standard provides a framework to assist entities in evaluating whether both an input and a substantive process are present. The standard also provides a framework that includes two sets of criteria to consider that depend on whether a set has outputs and a more stringent criteria for sets without outputs. Lastly, the standard narrows the definition of the term "output" so that the term is consistent with how outputs are described in Topic 606, Revenue from Contracts with Customers. The provisions of this guidance are to be applied prospectively. ASU 2017-01 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years, with early adoption permitted in limited circumstances. The Company adopted ASU 2017-01 effective January 1, 2018. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows. In November 2016, the FASB issued Accounting Standards Update No. 2016-18, Statement of Cash Flows (Topic 230), Restricted Cash ("ASU 2016-18"), which amends Topic 230 to add or clarify guidance on the classification and presentation of restricted cash in the statement of cash flows. The standard requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The provisions of this guidance are to be applied using a retrospective transition method to each period presented. ASU 2016-18 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years, with early adoption permitted. The Company adopted ASU 2016-18 effective January 1, 2018. For the nine months ended October 1, 2017, $17.2 million of changes in restricted cash balances that was previously presented within investing activities in the condensed consolidated statement of cash flows has been excluded from the cash flows used in investing activities and the effect of exchange rate changes increased by $0.2 million due to the retrospective adoption of ASU 2016-18. Restricted cash amounting to $17.3 million and $0.2 million at January 1, 2017 and October 1, 2017, respectively, have been included with the cash and cash equivalents when reconciling the beginning of period and end of period total amounts on the condensed consolidated statement of cash flows for the nine months ended October 1, 2017. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows, other than the impact discussed above. In October 2016, the FASB issued Accounting Standards Update No. 2016-16, Income Taxes (Topic 740), Intra-entity Transfer of Assets Other than Inventory ("ASU 2016-16"). ASU 2016-16 removes the prohibition in Topic 740 against the immediate recognition of the current and deferred income tax effects of intra-entity transfers of assets other than inventory. The standard requires entities to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. The provisions of this guidance are to be applied on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. ASU 2016-16 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years, with early adoption permitted. The Company adopted ASU 2016-16 on January 1, 2018. The adoption of the standard resulted in a decrease in the retained earnings at January 1, 2018 of approximately $2.0 million with corresponding increase in deferred tax assets of $10.7 million and decrease in prepaid taxes of $12.8 million related to prior years’ intra-entity transfers of assets other than inventory. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows, other than the impact discussed above. In June 2016, the FASB issued Accounting Standards Update No. 2016-13, Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments ("ASU 2016-13"). ASU 2016-13 changes how entities will measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. The standard requires entities to use the expected loss impairment model and will apply to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities, net investments in leases and off-balance sheet credit exposures. Entities are required to estimate the lifetime “expected credit loss” for each applicable financial asset and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The standard also amends the impairment model for available-for-sale (“AFS”) debt securities and requires entities to determine whether all or a portion of the unrealized loss on an AFS debt security is a credit loss. An entity will recognize an allowance for credit losses on an AFS debt security as a contra-account to the amortized cost basis rather than as a direct reduction of the amortized cost basis of the investment. The provisions of this guidance are to be applied using a modified-retrospective approach. A prospective transition approach is required for debt securities for which an other-than-temporary impairment had been recognized before the effective date. ASU 2016-13 is effective for annual reporting periods beginning after December 15, 2019, and interim periods within those years. Early adoption is permitted for annual periods beginning after December 15, 2018, and interim periods therein. The Company is currently evaluating the requirements of this guidance and has not yet determined the impact of its adoption on the Company's consolidated financial position, results of operations and cash flows. In February 2016, the FASB issued Accounting Standards Update No. 2016-02, Leases ("ASU 2016-02"). ASU 2016-02 requires organizations that lease assets to recognize assets and liabilities on the balance sheet related to the rights and obligations created by those leases, regardless of whether they are classified as finance or operating leases. Consistent with current guidance, the recognition, measurement, and presentation of expenses and cash flows arising from a lease of assets will primarily depend on its classification as a finance or operating lease. ASU 2016-02 also requires new disclosures to help financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases. The provisions of this guidance are effective for annual periods beginning after December 15, 2018, and interim periods within those years, with early adoption permitted. ASU 2016-02 is to be applied using a modified retrospective approach. Subsequent to the issuance of ASU 2016-02, in July 2018, the FASB issued Accounting Standards Update No. 2018-10, Codification Improvements to Topic 842, Leases ("ASU 2018-10") and Accounting Standards Update No. 2018-11, Leases (Topic 842): Targeted Improvements ("ASU 2018-11"). The amendments in ASU 2018-10 clarify, correct or remove inconsistencies in the guidance provided under ASU 2016-02 related to sixteen specific issues identified. The amendments in ASU 2018-11 provide entities with an additional (and optional) transition method to adopt the new leases standard. Under the new transition method, an entity initially applies the new leases standard at the adoption date and recognizes a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. Consequently, an entity's reporting for the comparative periods presented in the financial statements in the period of adoption will continue to be in accordance with ASC 840, Leases ("ASC 840"). An entity that elects this additional (and optional) transition method must provide the required disclosures under ASC 840 for all periods that continue to be in accordance with ASC 840. ASU 2018-11 also provides lessors with a practical expedient, by class of underlying asset, to not separate nonlease components from the associated lease component and, instead, to account for those components as a single component if certain criteria are met. The effective date and transition requirements for these two standards are the same as the effective date and transition requirements of ASU 2016-02. The Company is in the process of completing its evaluation of the impact of the new leases standard upon adoption and has not yet determined the impact of adoption on its consolidated financial position, results of operations and cash flows. The Company intends to adopt the new leases standard using the optional transition method and will apply the new leases standard on December 31, 2018 (the first day of fiscal year 2019). In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers ("ASU 2014-09"). Under this new guidance, an entity should use a five-step process to recognize revenue, depicting the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard also requires new disclosures regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. Subsequent to the issuance of the standard, the FASB decided to defer the effective date for one year to annual reporting periods beginning after December 15, 2017, with early adoption permitted for annual reporting periods beginning after December 15, 2016. In November 2017, the FASB also issued Accounting Standards Update No. 2017-14, Income Statement-Reporting Comprehensive Income (Topic 220), Revenue Recognition (Topic 605), and Revenue from Contracts with Customers (Topic 606). ASU 2017-14 includes amendments to certain SEC paragraphs within the FASB Accounting Standards Codification ("Codification"). ASU 2017-14 amends the Codification to incorporate SEC Staff Accounting Bulletin No. 116 and SEC Interpretive Release on Vaccines for Federal Government Stockpiles (SEC Release No. 33-10403) to align existing SEC staff guidance with Revenue from Contracts with Customers (Topic 606). In May 2016, the FASB also issued Accounting Standards Update No. 2016-12, Revenue from Contracts with Customers (Topic 606), Narrow-Scope Improvements and Practical Expedients ("ASU 2016-12"), which amended its revenue recognition guidance in ASU 2014-09 on transition, collectability, non-cash consideration, contract modifications and completed contracts at transition and the presentation of sales and other similar taxes collected from customers. In April 2016, the FASB also issued Accounting Standards Update No. 2016-10, Revenue from Contracts with Customers (Topic 606), Identifying Performance Obligations and Licensing ("ASU 2016-10"), which amended its revenue recognition guidance in ASU 2014-09 on identifying performance obligations to allow entities to disregard items that are immaterial in the context of the contract, clarify when a promised good or service is separately identifiable (i.e., distinct within the context of the contract) and allow an entity to elect to account for the cost of shipping and handling performed after control of a good has been transferred to the customer as a fulfillment cost (i.e., an expense). ASU 2016-10 also clarifies how an entity should evaluate the nature of its promise in granting a license of intellectual property ("IP") and requires entities to classify IP in one of two categories: functional IP or symbolic IP, which will determine whether it recognizes revenue over time or at a point in time. ASU 2016-10 also addresses how entities should consider license renewals and restrictions and apply the exception for sales- and usage-based royalties received in exchange for licenses of IP. In March 2016, the FASB also issued Accounting Standards Update No. 2016-08, Revenue from Contracts with Customers (Topic 606), Principal versus Agent Considerations (Reporting Revenue Gross versus Net) ("ASU 2016-08"), which amended the principal-versus-agent implementation guidance and illustrations in ASU 2014-09. ASU 2016-08 clarifies that an entity should evaluate when it is the principal or agent for each specified good or service promised in a contract with a customer. ASU 2017-14, ASU 2016-12, ASU 2016-10, ASU 2016-08 and ASU 2014-09 may be adopted either using a full retrospective approach or a modified retrospective approach. The Company adopted these standards beginning on January 1, 2018 using the modified retrospective approach only to contracts not completed as of January 1, 2018. The most significant impact of the standards relates to the accounting for certain transactions with multiple elements or “bundled” arrangements. Specifically, for sales of software subscriptions or sales of licenses and maintenance, the Company will recognize the license revenue predominantly at the time of billing and delivery rather than recognizing the entire sales price ratably over the maintenance period, which is the Company's current practice. In addition, for certain sales of instruments that include customer-specified acceptance criteria, the Company will recognize revenue when the customer obtains control of the instrument which is typically upon delivery or when title has transferred to the customer, as the Company believes acceptance is perfunctory. The Company will also capitalize incremental commission fees as a result of obtaining contracts when these fees are recoverable and will amortize the assets based on the transfer of goods or services to which the assets relate which typically range from two to six years. The adoption of the standards resulted in an increase in retained earnings at January 1, 2018 of approximately $10.2 million for the cumulative effect of initially applying the standards as of that date. In addition, the adoption of the standards resulted primarily in a reduction in deferred revenue of approximately $11.5 million, mainly driven by the upfront recognition of license revenue and certain multi-year software subscriptions, and an increase in deferred income tax liability of approximately $3.0 million for the tax impact of the cumulative adjustments. The cumulative effect of recognizing instrument sales upon delivery or transfer of title and capitalizing the incremental commission fees were not material at January 1, 2018. The adoption of the standards had no impact to cash from or used in operating, investing, or financing activities in the Company's consolidated statement of cash flows at January 1, 2018. Refer to Note 3, Changes in Accounting Policies, for the impact of adoption of the standards on the Company's condensed consolidated financial statements for the quarter ended September 30, 2018. Also refer to Note 2, Revenue, for the disclosures required by the standards.

XML 18 R8.htm IDEA: XBRL DOCUMENT

Revenue (Notes) - USD ($)
$ in Thousands

3 Months Ended

9 Months Ended

Sep. 30, 2018

Oct. 01, 2017

Sep. 30, 2018

Oct. 01, 2017

Revenue [Abstract]

Revenue from Contract with Customer [Text Block]

Revenue

Significant accounting policy

The Company reports shipping and handling charges in revenue, to the extent these are billed to customers, and the associated costs in cost of product revenue.

Nature of goods and services

i. Discovery & Analytical Solutions



Products and services	Nature, timing of satisfaction of performance obligations, and significant payment terms

Instruments	For instruments that include installation, and if the installation meets the criteria to be considered a separate performance obligation, product revenue is generally recognized upon delivery or when title has transferred to the customer, which is generally the point in time where control of the products has been transferred to customers, and installation revenue is recognized when the installation is complete. Certain of the Company's products require specialized installation and configuration at the customer's site. Revenue for these products is deferred until installation is complete and customer acceptance has been received. Payment terms and conditions vary, although terms generally include a requirement of payment within 30 to 60 days.
Consumables and reagents	The Company recognizes revenue from the sale of consumables and reagents upon delivery or when title has transferred to the customer, which is generally the point in time where control of the products has been transferred to customers. Payment terms and conditions vary, although terms generally include a requirement of payment within 30 days.
Software licenses and subscriptions	Customers may purchase perpetual or term licenses, or subscribe to licenses, which provide customers with the same functionality and differ mainly in the duration over which the customer benefits from the software. The Company sells its software subscriptions or software licenses with maintenance services and, in some cases, with consulting services. The Company recognizes revenue for the software upfront at the point in time when the software is made available to the customer. For maintenance and consulting services, revenue is recognized ratably over the period in which the services are provided. Payment terms and conditions vary by contract type, although terms generally include a requirement of payment within 30 to 60 days. Software subscriptions and maintenance service contracts are non-cancelable.
Cloud services	Cloud services, which allow customers to use hosted software over the contract period without taking possession of the software, are provided on either a subscription or consumption basis. Revenue related to cloud services provided on a subscription basis is recognized ratably over the contract period. Revenue related to cloud services provided on a consumption basis, such as the amount of storage used in a period, is recognized based on the customer utilization of such resources. Payment terms are generally net 30 days from signing of contract and contracts are non-cancelable.
Extended warranty	The Company recognizes revenue for extended warranties on a straight-line basis over the extended warranty period in service revenue. In the majority of countries in which the Company operates, the customary warranty period is one year and the extended warranty covers periods beyond year one. Customers typically pay for extended warranties on an annual basis over the term of the warranty. In general, customers can cancel the extended warranty at any time with 30 days notice without significant penalty.
Laboratory services and training	The Company's service offerings include service contracts, field service, including related time and materials, and training. The Company recognizes revenue as the services are performed. Revenue for the service contracts is recognized over the contract period or at a point in time when the service is billable based on time and materials. The Company recognizes revenue as training is provided in service revenue. Payment terms and conditions vary by contract type, although terms generally include a requirement of payment within 30 to 60 days. In general, customers can cancel the service contracts at any time with 30 to 90 days notice without significant penalty.

ii. Diagnostics

In instances where the timing of revenue recognition differs from the timing of invoicing, the Company determined that the contracts generally do not include a significant financing component. The primary purpose of its invoicing terms is to provide customers with simplified and predictable ways of purchasing products and services, rather than to receive financing from the customers or to provide customers with financing. Examples include invoicing at the beginning of a storage period with revenue recognized ratably over the contract period. In limited circumstances where the Company provides the customer with a significant benefit of financing, the Company uses the practical expedient and only adjusts the transaction price for the effects of the time value of money and only on contracts where the duration of financing is more than one year.



Products and services	Nature, timing of satisfaction of performance obligations, and significant payment terms

Instruments	For instruments that include installation, and if the installation meets the criteria to be considered a separate performance obligation, product revenue is generally recognized upon delivery or when title has transferred to the customer, which is generally the point in time where control of the products has been transferred to customers, and installation revenue is recognized when the installation is complete. Certain of the Company's products require specialized installation and configuration at the customer's site. Revenue for these products is deferred until installation is complete and customer acceptance has been received. Payment terms and conditions vary, although terms generally include a requirement of payment within 30 to 60 days.
Consumables and reagents	The Company recognizes revenue from the sale of consumables and reagents upon delivery or when title has transferred to the customer, which is generally the point in time where control of the products has been transferred to customers. Payment terms and conditions vary, although terms generally include a requirement of payment within 30 days.
Solutions	When the Company sells the instrument and reagents that work only on those instruments to a customer or distributor, the Company considers the instrument and reagents as separate performance obligations. The Company recognizes revenue when an instrument is sold to the customer upon delivery or when title has transferred to the customer, which is generally the point in time where control of the products has been transferred to customers. Revenue from the sale of reagents is also recognized at the time of delivery or when title has transferred to the customer. Payment terms for instrument and reagent sales are usually net 30 days from invoice date. When the Company places the instrument at the customer's site and sells the reagents to a customer, the instrument and reagents are accounted for together as one performance obligation. The Company does not charge a fee for the use of the instrument and retains ownership of the placed instrument. The Company has a right to remove the instrument and replace it with another instrument at the customer's site at any time throughout the contract term. The Company recognizes revenue upon delivery of reagents, which is the point in time where the Company has performed its obligation to provide a screening solution to the customer. Payment terms are usually net 30 days from invoice date. Payment terms for certain contracts are based on equal installments over the duration of the contract.
Extended warranty	The Company recognizes revenue for extended warranties on a straight-line basis over the extended warranty period in service revenue. In the majority of countries in which the Company operates, the customary warranty period is one year and the extended warranty covers periods beyond year one. Customers typically pay for extended warranties on an annual basis over the term of the warranty. In general, customers can cancel the extended warranty at any time with 30 days notice without significant penalty.
Services	The Company's service offerings include cord blood processing and storage, and training. The Company recognizes revenue for the cord blood processing and training as the services are performed in service revenue. Revenue for the storage contracts are recognized over the contract period. Storage is typically for a period of 1, 20, or 25 years or lifetime. Lifetime storage is recognized over a certain period that is based on the life expectancy estimate from Social Security data. For cord blood processing, customers pay the processing fee in full at the point of sale. The processing fee is non-refundable unless the cord blood is non-viable for storage. For storage, customers are required to pay the storage fees in full upfront. Storage fees are refundable to the customer on a pro-rated basis if the contract is canceled.

Disaggregation of revenue



	Reportable Segments
	Three Months Ended
	September 30, 2018
	Discovery & Analytical Solutions		Diagnostics		Total
	(In thousands)
Primary geographical markets
Americas	$	169,366	$	95,607	$	264,973
Europe	110,747		68,480		179,227
Asia	126,053		104,060		230,113
	$	406,166	$	268,147	$	674,313

Primary end-markets
Diagnostics	$	—	$	268,147	$	268,147
Life sciences	222,191		—		222,191
Applied markets	183,975		—		183,975
	$	406,166	$	268,147	$	674,313

Timing of revenue recognition
Products and services transferred at a point in time	$	290,929	$	247,189	$	538,118
Services transferred over time	115,237		20,958		136,195
	$	406,166	$	268,147	$	674,313



	Reportable Segments
	Nine Months Ended
	September 30, 2018
	Discovery & Analytical Solutions		Diagnostics		Total
	(In thousands)
Primary geographical markets
Americas	$	497,833	$	282,536	$	780,369
Europe	357,766		205,892		563,658
Asia	377,720		299,900		677,620
	$	1,233,319	$	788,328	$	2,021,647

Primary end-markets
Diagnostics	$	—	$	788,328	$	788,328
Life sciences	675,807		—		675,807
Applied markets	557,512		—		557,512
	$	1,233,319	$	788,328	$	2,021,647

Timing of revenue recognition
Products and services transferred at a point in time	$	874,517	$	726,058	$	1,600,575
Services transferred over time	358,802		62,270		421,072
	$	1,233,319	$	788,328	$	2,021,647

Contract Balances

Contract assets: The unbilled receivables (contract assets) primarily relate to the Company's right to consideration for work completed but not billed at the reporting date. The unbilled receivables are transferred to trade receivables when billed to customers. Contracts assets are generally classified as current assets and are included in "Accounts receivable, net" in the consolidated balance sheet. The balance of contract assets as of September 30, 2018 and as of the date of adoption of ASC 606 were $31.2 million and $22.7 million, respectively. The amount of unbilled receivables recognized at the beginning of the period that were transferred to trade receivables during the nine months ended September 30, 2018 was $21.1 million. The increase in unbilled receivables during the nine months ended September 30, 2018 as a result of recognition of revenue before billing to customers, excluding amounts transferred to trade receivables during the period, amounted to $29.5 million.

Transaction price allocated to the remaining performance obligations

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

$ 674,313

$ 554,275

$ 2,021,647

$ 1,615,352

Transferred at Point in Time [Member]

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

538,118

1,600,575

Transferred over Time [Member]

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

136,195

421,072

Americas [Member]

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

264,973

780,369

Europe [Member]

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

179,227

563,658

Asia [Member]

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

230,113

677,620

Diagnostics [Member]

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

268,147

788,328

Life Sciences [Member]

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

222,191

675,807

Applied Markets [Member]

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

183,975

557,512

Discovery & Analytical Solutions [Member]

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

406,166

385,382

1,233,319

1,130,270

Discovery & Analytical Solutions [Member] | Transferred at Point in Time [Member]

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

290,929

874,517

Discovery & Analytical Solutions [Member] | Transferred over Time [Member]

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

115,237

358,802

Discovery & Analytical Solutions [Member] | Americas [Member]

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

169,366

497,833

Discovery & Analytical Solutions [Member] | Europe [Member]

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

110,747

357,766

Discovery & Analytical Solutions [Member] | Asia [Member]

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

126,053

377,720

Discovery & Analytical Solutions [Member] | Diagnostics [Member]

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

Discovery & Analytical Solutions [Member] | Life Sciences [Member]

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

222,191

675,807

Discovery & Analytical Solutions [Member] | Applied Markets [Member]

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

183,975

557,512

Diagnostics [Member]

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

268,147

$ 168,893

788,328

$ 485,082

Diagnostics [Member] | Transferred at Point in Time [Member]

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

247,189

726,058

Diagnostics [Member] | Transferred over Time [Member]

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

20,958

62,270

Diagnostics [Member] | Americas [Member]

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

95,607

282,536

Diagnostics [Member] | Europe [Member]

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

68,480

205,892

Diagnostics [Member] | Asia [Member]

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

104,060

299,900

Diagnostics [Member] | Diagnostics [Member]

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

268,147

788,328

Diagnostics [Member] | Life Sciences [Member]

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

Diagnostics [Member] | Applied Markets [Member]

Disaggregation of Revenue [Line Items]

Revenue from Contract with Customer, Excluding Assessed Tax

$ 0

XML 19 R9.htm IDEA: XBRL DOCUMENT

Changes in Accounting Policies (Notes)

9 Months Ended

Sep. 30, 2018

Accounting Policies [Abstract]

Basis of Presentation and Significant Accounting Policies [Text Block]

Changes in Accounting Policies

Except for the changes below, the Company has consistently applied the accounting policies to all periods presented in these condensed consolidated financial statements.

A. Sales of software subscriptions or sales of licenses and maintenance in bundled arrangements

B. Sales of instruments

C. Sales commissions

D. Impacts on financial statements

The following tables summarize the impacts of ASC 606 adoption on the Company's condensed consolidated financial statements for the quarter ended September 30, 2018.

Consolidated Balance Sheet



	As reported			Adjustments			Balances without adoption of ASC 606
	(In thousands)
Cash and cash equivalents	$	149,513		$	—		$	149,513
Accounts receivable, net	551,385			(11,554		)	539,831
Inventories	354,244			7,451			361,695
Other current assets	110,353			(522		)	109,831
Property, plant and equipment, net	317,049			—			317,049
Intangible assets, net	1,223,775			—			1,223,775
Goodwill	2,920,689			—			2,920,689
Other assets, net	235,347			—			235,347
Total assets	$	5,862,355		$	(4,625	)	$	5,857,730
Current portion of long-term debt	$	20,072		$	—		$	20,072
Accounts payable	180,693			—			180,693
Accrued restructuring and contract termination charges	8,079			—			8,079
Accrued expenses and other current liabilities	475,743			18,912			494,655
Current liabilities of discontinued operations	2,165			—			2,165
Long-term debt	1,882,502			—			1,882,502
Long-term liabilities	720,632			—			720,632
Total liabilities	3,289,886			18,912			3,308,798
Commitments and contingencies
Preferred stock	—			—			—
Common stock	111,087			—			111,087
Capital in excess of par value	89,970			—			89,970
Retained earnings	2,532,060			(23,537		)	2,508,523
Accumulated other comprehensive loss	(160,648		)	—			(160,648		)
Total stockholders’ equity	2,572,469			(23,537		)	2,548,932
Total liabilities and stockholders’ equity	$	5,862,355		$	(4,625	)	$	5,857,730

Consolidated Statement of Operations



	Three Months Ended
	September 30, 2018
	As reported			Adjustments			Balances without adoption of ASC 606
	(In thousands)
Product revenue	$	474,523		$	(3,198	)	$	471,325
Service revenue	199,790			—			199,790
Total revenue	674,313			(3,198		)	671,115
Cost of product revenue	213,672			(98		)	213,574
Cost of service revenue	128,314			—			128,314
Total cost of revenue	341,986			(98		)	341,888
Selling, general and administrative expenses	196,769			47			196,816
Research and development expenses	48,848			—			48,848
Restructuring and contract termination charges, net	6,508			—			6,508
Operating income from continuing operations	80,202			(3,147		)	77,055
Interest and other expense, net	2,161			—			2,161
Income from continuing operations before income taxes	78,041			(3,147		)	74,894
Provision for income taxes	2,596			(814		)	1,782
Income from continuing operations	75,445			(2,333		)	73,112
Loss on disposition of discontinued operations before income taxes	(308		)	—			(308		)
Benefit from income taxes on discontinued operations and dispositions	(1,411		)	—			(1,411		)
Gain from discontinued operations and dispositions	1,103			—			1,103
Net income	$	76,548		$	(2,333	)	$	74,215

Consolidated Statement of Operations



	Nine Months Ended
	September 30, 2018
	As reported			Adjustments			Balances without adoption of ASC 606
	(In thousands)
Product revenue	$	1,417,739		$	(25,562	)	$	1,392,177
Service revenue	603,908			—			603,908
Total revenue	2,021,647			(25,562		)	1,996,085
Cost of product revenue	663,651			(7,780		)	655,871
Cost of service revenue	393,307			—			393,307
Total cost of revenue	1,056,958			(7,780		)	1,049,178
Selling, general and administrative expenses	601,374			300			601,674
Research and development expenses	142,028			—			142,028
Restructuring and contract termination charges, net	13,086			—			13,086
Operating income from continuing operations	208,201			(18,082		)	190,119
Interest and other expense, net	29,947			—			29,947
Income from continuing operations before income taxes	178,254			(18,082		)	160,172
Provision for income taxes	12,101			(4,753		)	7,348
Income from continuing operations	166,153			(13,329		)	152,824
Loss on disposition of discontinued operations before income taxes	(859		)	—			(859		)
Benefit from income taxes on discontinued operations and dispositions	(1,341		)	—			(1,341		)
Gain from discontinued operations and dispositions	482			—			482
Net income	$	166,635		$	(13,329	)	$	153,306

XML 20 R10.htm IDEA: XBRL DOCUMENT

Business Combinations

9 Months Ended

Sep. 30, 2018

Business Combinations [Abstract]

Business Combinations

Acquisitions in fiscal year 2018

The total purchase price for the acquisitions in fiscal year 2018 has been allocated to the estimated fair values of assets acquired and liabilities assumed as follows:



	2018 Acquisitions
	(In thousands)
Fair value of business combination:
Cash payments	$	43,942
Other liability	3,354
Contingent consideration	7,500
Working capital and other adjustments	599
Less: cash acquired	(1,138		)
Total	$	54,257
Identifiable assets acquired and liabilities assumed:
Current assets	$	3,469
Property, plant and equipment	937
Other assets	430
Identifiable intangible assets:
Core technology	15,957
Trade names	1,010
Customer relationships	10,800
Goodwill	28,423
Deferred taxes	(2,524		)
Liabilities assumed	(4,037		)
Debt assumed	(208		)
Total	$	54,257

Acquisitions in fiscal year 2017

Other acquisitions in 2017. During fiscal year 2017, the Company also completed the acquisition of two other businesses for aggregate consideration of $142.0 million. The acquired businesses were Tulip Diagnostics Private Limited (“Tulip”), which was acquired for total consideration of $127.3 million in cash and one other business acquired for total consideration of $14.7 million in cash. At the time of closing, the Company had a potential obligation to pay the former shareholders of Tulip up to INR1.6 billion, equivalent to $25.2 million, in additional consideration over a two year period that is accounted for as compensation expense in the Company's financial statements over a two year period and is excluded from the purchase price allocation shown below. The excess of the purchase prices over the fair values of the acquired businesses' net assets represents cost and revenue synergies specific to the Company, as well as non-capitalizable intangible assets, such as the employee workforces acquired, and has been allocated to goodwill, which is not tax deductible. The Company has reported the operations of Tulip within the results of the Company's Diagnostics segment and the other acquired business within the results of the Company's DAS segment from the acquisition date. Identifiable definite-lived intangible assets, such as core technology, trade names and customer relationships, acquired as part of these acquisitions had a weighted average amortization period of 11.8 years.

The total purchase price for the acquisitions in fiscal year 2017 has been allocated to the estimated fair values of assets acquired and liabilities assumed as follows:



	EUROIMMUN			Other Acquisitions
	(In thousands)
Fair value of business combination:
Cash payments	$	1,413,780		$	140,861
Other liability	—			1,273
Working capital and other adjustments	—			(93		)
Less: cash acquired	(25,018		)	(2,439		)
Total	$	1,388,762		$	139,602
Identifiable assets acquired and liabilities assumed:
Current assets	$	121,174		$	16,268
Property, plant and equipment	130,512			11,356
Other assets	49,679			1,691
Identifiable intangible assets:
Core technology	160,000			12,400
Trade names	36,000			3,000
Customer relationships	710,000			43,700
In-process research and development ("IPR&D")	1,400			—
Goodwill	581,172			75,250
Deferred taxes	(253,288		)	(15,735		)
Liabilities assumed	(86,530		)	(8,328		)
Debt assumed	(61,357		)	—
Total	$	1,388,762		$	139,602



	Three Months Ended October 1, 2017		Nine Months Ended October 1, 2017
	(In thousands, except per share data)
Pro Forma Statement of Operations Information (Unaudited):
Revenue	$	640,154	$	1,846,233
Income from continuing operations	94,055		172,672
Basic earnings per share:
Income from continuing operations	$	0.86	$	1.57
Diluted earnings per share:
Income from continuing operations	$	0.85	$	1.56

As of September 30, 2018, the Company may have to pay contingent consideration related to acquisitions with open contingency periods of up to $76.5 million. As of September 30, 2018, the Company has recorded contingent consideration obligations with an estimated fair value of $67.1 million, of which $61.3 million was recorded in accrued expenses and other current liabilities, and $5.8 million was recorded in long-term liabilities. As of December 31, 2017, the Company had recorded contingent consideration obligations with an estimated fair value of $65.3 million, of which $52.2 million was recorded in accrued expenses and other current liabilities, and $13.1 million was recorded in long-term liabilities. If the actual results differ from the estimates and judgments used in these fair values, the amounts recorded in the condensed consolidated financial statements could result in a possible impairment of the intangible assets and goodwill, require acceleration of the amortization expense of definite-lived intangible assets or the recognition of additional contingent consideration which would be recognized as a component of operating expenses from continuing operations.

XML 21 R11.htm IDEA: XBRL DOCUMENT

Discontinued Operations

9 Months Ended

Sep. 30, 2018

Discontinued Operations and Disposal Groups [Abstract]

Discontinued Operations

Disposition of Businesses and Assets

The summary pre-tax operating results of the discontinued operations, were as follows for the three and nine months ended:



	Three Months Ended				Nine Months Ended
	September 30, 2018		October 1, 2017		September 30, 2018		October 1, 2017
	(In thousands)
Revenue	$	—	$	—	$	—	$	44,343
Cost of revenue	—		—		—		32,933
Selling, general and administrative expenses	—		—		—		5,869
Research and development expenses	—		—		—		4,891
(Loss) income from discontinued operations before income taxes	$	—	$	—	$	—	$	650

XML 22 R12.htm IDEA: XBRL DOCUMENT

Restructuring and Lease Charges, Net

9 Months Ended

Sep. 30, 2018

Restructuring and Related Activities [Abstract]

Restructuring and Lease Charges, Net

Restructuring and Contract Termination Charges, Net



	Workforce Reductions					Closure of Excess Facility				Total		(Expected) Date Payments Substantially Completed by
	Headcount Reduction	Discovery & Analytical Solutions		Diagnostics		Discovery & Analytical Solutions		Diagnostics				Severance	Excess Facility
	Headcount Reduction	Discovery & Analytical Solutions		Diagnostics		Discovery & Analytical Solutions		Diagnostics				Severance	Excess Facility
	(In thousands, except headcount data)
Q3 2018 Plan	61	$	1,146	$	618	$	—	$	—	$	1,764	Q2 FY2019	—
Q1 2018 Plan	47	5,096		902		—		—		5,998		Q2 FY2019	—
Q4 2017 Plan	29	1,680		255		—		—		1,935		Q1 FY2019	—
Q3 2017 Plan	27	1,321		1,021		—		—		2,342		Q4 FY2018	—
Q1 2017 Plan	90	5,000		1,631		33		33		6,697		Q4 FY2018	Q4 FY2018



	Balance at December 31, 2017		2018 Charges		2018 Changes in Estimates, Net		2018 Amounts Paid			Balance at September 30, 2018
	(In thousands)
Severance:
Q3 2018 Plan	$	—	$	1,764	$	—	$	—		$	1,764
Q1 2018 Plan	—		5,998		—		(4,273		)	1,725
Q4 2017 Plan	1,919		—		—		(1,538		)	381
Q3 2017 Plan	2,072		—		—		(868		)	1,204
Q1 2017 Plan	2,498		—		—		(1,174		)	1,324

Facility:
Q1 2017 Plan	33		—		—		(22		)	11

Previous Plans	4,399		—		353		(2,106		)	2,646
Restructuring	10,921		7,762		353		(9,981		)	9,055
Contract Termination	3,048		4,744		227		(7,653		)	366
Total Restructuring and Contract Termination	$	13,969	$	12,506	$	580	$	(17,634	)	$	9,421

XML 23 R13.htm IDEA: XBRL DOCUMENT

Interest and Other Expense (Income), Net

9 Months Ended

Sep. 30, 2018

Other Income and Expenses [Abstract]

Interest and Other Expense (Income), Net

Interest and Other Expense, Net

Interest and other expense, net, consisted of the following:



	Three Months Ended						Nine Months Ended
	September 30, 2018			October 1, 2017			September 30, 2018			October 1, 2017
	(In thousands)
Interest income	$	(316	)	$	(802	)	$	(754	)	$	(1,512	)
Interest expense	16,684			10,974			50,745			32,510
(Gain) loss on disposition of businesses and assets, net (see Note 5)	(13,031		)	—			(13,031		)	301
Other income, net	(1,176		)	(37,188		)	(7,013		)	(45,096		)
Total interest and other expense (income), net	$	2,161		$	(27,016	)	$	29,947		$	(13,797	)

XML 24 R14.htm IDEA: XBRL DOCUMENT

Inventories, Net

9 Months Ended

Sep. 30, 2018

Inventory Disclosure [Abstract]

Inventories, Net

Inventories

Inventories as of September 30, 2018 and December 31, 2017 consisted of the following:



	September 30, 2018		December 31, 2017
	(In thousands)
Raw materials	$	117,266	$	122,100
Work in progress	21,389		18,452
Finished goods	215,589		211,123
Total inventories	$	354,244	$	351,675

XML 25 R15.htm IDEA: XBRL DOCUMENT

Income Taxes

9 Months Ended

Sep. 30, 2018

Income Tax Disclosure [Abstract]

Income Taxes

The total provision for income taxes included in the condensed consolidated statement of operations consisted of the following:



	Three Months Ended					Nine Months Ended
	September 30, 2018			October 1, 2017		September 30, 2018			October 1, 2017
	(In thousands)
Continuing operations	$	2,596		$	8,508	$	12,101		$	20,495
Discontinued operations	(1,411		)	5,262		(1,341		)	42,405
Total	$	1,185		$	13,770	$	10,760		$	62,900

XML 26 R16.htm IDEA: XBRL DOCUMENT

Debt	9 Months Ended
Debt	Sep. 30, 2018
Debt Disclosure [Abstract]
Debt	Debt Senior Unsecured Revolving Credit Facility. The Company's senior unsecured revolving credit facility provides for $1.0 billion of revolving loans and has an initial maturity of August 11, 2021. As of September 30, 2018, undrawn letters of credit in the aggregate amount of $11.4 million were treated as issued and outstanding when calculating the borrowing availability under the senior unsecured revolving credit facility. As of September 30, 2018, the Company had $577.6 million available for additional borrowing under the facility. The Company uses the senior unsecured revolving credit facility for general corporate purposes, which may include working capital, refinancing existing indebtedness, capital expenditures, share repurchases, acquisitions and strategic alliances. The interest rates under the senior unsecured revolving credit facility are based on the Eurocurrency rate or the base rate at the time of borrowing, plus a margin. The base rate is the higher of (i) the rate of interest in effect for such day as publicly announced from time to time by JP Morgan Chase Bank, N.A. as its "prime rate," (ii) the Federal Funds rate plus 50 basis points or (iii) an adjusted one-month Libor plus 1.00%. The Eurocurrency margin as of September 30, 2018 was 110 basis points. The weighted average Eurocurrency interest rate as of September 30, 2018 was 2.19%, resulting in a weighted average effective Eurocurrency rate, including the margin, of 3.29%, which was the interest applicable to the borrowings outstanding under the Eurocurrency rate as of September 30, 2018. As of September 30, 2018, the senior unsecured revolving credit facility had outstanding borrowings of $411.0 million, and $2.6 million of unamortized debt issuance costs. As of December 31, 2017, the senior unsecured revolving credit facility had outstanding borrowings of $625.0 million, and $3.3 million of unamortized debt issuance costs. The credit agreement for the facility contains affirmative, negative and financial covenants and events of default. The financial covenants include a debt-to-capital ratio that remains applicable for so long as the Company's debt is rated as investment grade. In the event that the Company's debt is not rated as investment grade, the debt-to-capital ratio covenant is replaced with a maximum consolidated leverage ratio covenant and a minimum consolidated interest coverage ratio covenant. Senior Unsecured Term Loan Credit Facility. The Company entered into a senior unsecured term loan credit facility on August 11, 2017 that provided for $200.0 million of term loans and had an initial maturity of twelve months from December 19, 2017, the date of the initial draw. The Company utilized the senior unsecured term loan facility for the acquisition of EUROIMMUN. The interest rates under the senior unsecured term loan credit facility were based on the Eurocurrency rate or the base rate at the time of the borrowing, plus a margin. The base rate is the higher of (i) the rate of interest in effect for such day as publicly announced from time to time by JP Morgan Chase Bank, N.A. as its "prime rate," (ii) the Federal Funds rate plus 50 basis points or (iii) an adjusted one-month Libor plus 1.00%. In April 2018, the Company paid in full the outstanding balance of $200.0 million on the Company’s senior unsecured term loan credit facility, from the proceeds of the 0.6% senior unsecured notes due in 2021 that were issued in April 2018. 5% Senior Unsecured Notes due in 2021. On October 25, 2011, the Company issued $500.0 million aggregate principal amount of senior unsecured notes due in 2021 (the “November 2021 Notes”) in a registered public offering and received $493.6 million of net proceeds from the issuance. The November 2021 Notes were issued at 99.4% of the principal amount, which resulted in a discount of $3.1 million. As of September 30, 2018, the November 2021 Notes had an aggregate carrying value of $497.2 million, net of $1.2 million of unamortized original issue discount and $1.7 million of unamortized debt issuance costs. As of December 31, 2017, the November 2021 Notes had an aggregate carrying value of $496.6 million, net of $1.4 million of unamortized original issue discount and $2.0 million of unamortized debt issuance costs. The November 2021 Notes mature in November 2021 and bear interest at an annual rate of 5%. Interest on the November 2021 Notes is payable semi-annually on May 15th and November 15th each year. Prior to August 15, 2021 (three months prior to their maturity date), the Company may redeem the November 2021 Notes in whole or in part, at its option, at a redemption price equal to the greater of (i) 100% of the principal amount of the November 2021 Notes to be redeemed, plus accrued and unpaid interest, or (ii) the sum of the present values of the remaining scheduled payments of principal and interest in respect to the November 2021 Notes being redeemed, discounted on a semi-annual basis, at the Treasury Rate plus 45 basis points, plus accrued and unpaid interest. At any time on or after August 15, 2021 (three months prior to their maturity date), the Company may redeem the November 2021 Notes, at its option, at a redemption price equal to 100% of the principal amount of the November 2021 Notes to be redeemed plus accrued and unpaid interest. Upon a change of control (as defined in the indenture governing the November 2021 Notes) and a contemporaneous downgrade of the November 2021 Notes below investment grade, each holder of November 2021 Notes will have the right to require the Company to repurchase such holder's November 2021 Notes for 101% of their principal amount, plus accrued and unpaid interest. 1.875% Senior Unsecured Notes due 2026. On July 19, 2016, the Company issued €500.0 million aggregate principal amount of senior unsecured notes due in 2026 (the “2026 Notes”) in a registered public offering and received approximately €492.3 million of net proceeds from the issuance. The 2026 Notes were issued at 99.118% of the principal amount, which resulted in a discount of €4.4 million. The 2026 Notes mature in July 2026 and bear interest at an annual rate of 1.875%. Interest on the 2026 Notes is payable annually on July 19th each year. The proceeds from the 2026 Notes were used to pay in full the outstanding balance of the Company's previous senior unsecured revolving credit facility. As of September 30, 2018, the 2026 Notes had an aggregate carrying value of $572.3 million, net of $4.2 million of unamortized original issue discount and $3.9 million of unamortized debt issuance costs. As of December 31, 2017, the 2026 Notes had an aggregate carrying value of $591.7 million, net of $4.7 million of unamortized original issue discount and $4.3 million of unamortized debt issuance costs. Prior to April 19, 2026 (three months prior to their maturity date), the Company may redeem the 2026 Notes in whole at any time or in part from time to time, at its option, at a redemption price equal to the greater of (i) 100% of the principal amount of the 2026 Notes to be redeemed, or (ii) the sum of the present values of the remaining scheduled payments of principal and interest in respect to the 2026 Notes being redeemed, discounted on an annual basis, at the applicable Comparable Government Bond Rate (as defined in the indenture governing the 2026 Notes) plus 35 basis points; plus, in each case, accrued and unpaid interest. In addition, at any time on or after April 19, 2026 (three months prior to their maturity date), the Company may redeem the 2026 Notes, at its option, at a redemption price equal to 100% of the principal amount of the 2026 Notes due to be redeemed plus accrued and unpaid interest. Upon a change of control (as defined in the indenture governing the 2026 Notes) and a contemporaneous downgrade of the 2026 Notes below investment grade, the Company will, in certain circumstances, make an offer to purchase the 2026 Notes at a price equal to 101% of their principal amount plus any accrued and unpaid interest. 0.6% Senior Unsecured Notes due in 2021. On April 11, 2018, the Company issued €300.0 million aggregate principal amount of senior unsecured notes due in 2021 (the “April 2021 Notes”) in a registered public offering and received approximately €298.7 million of net proceeds from the issuance. The April 2021 Notes were issued at 99.95% of the principal amount, which resulted in a discount of €0.2 million. As of September 30, 2018, the April 2021 Notes had an aggregate carrying value of $345.8 million, net of $0.2 million of unamortized original issue discount and $2.3 million of unamortized debt issuance costs. The April 2021 Notes mature in April 2021 and bear interest at an annual rate of 0.6%. Interest on the April 2021 Notes is payable annually on April 9th each year. The proceeds from the April 2021 Notes were used to pay in full the outstanding balance of the Company’s senior unsecured term loan credit facility, and a portion of the outstanding senior unsecured revolving credit facility, and in each case the borrowings were incurred to pay a portion of the purchase price for the Company's acquisition of EUROIMMUN, which closed in December 19, 2017. Prior to the maturity date of the April 2021 Notes, the Company may redeem them in whole at any time or in part from time to time, at its option, at a redemption price equal to the greater of (i) 100% of the principal amount of the April 2021 Notes to be redeemed, or (ii) the sum of the present values of the remaining scheduled payments of principal and interest in respect to the April 2021 Notes being redeemed, discounted on an annual basis, at the applicable Comparable Government Bond Rate (as defined in the indenture governing the April 2021 Notes) plus 15 basis points; plus, in each case, accrued and unpaid interest. Upon a change of control (as defined in the indenture governing the April 2021 Notes) and a contemporaneous downgrade of the April 2021 Notes below investment grade, the Company will, in certain circumstances, make an offer to purchase the April 2021 Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest. Other Debt Facilities. The Company's other debt facilities include Euro-denominated bank loans with an aggregate carrying value of $35.3 million (or €30.4 million) and $57.2 million (or €47.6 million) as of September 30, 2018 and December 31, 2017, respectively. These bank loans are primarily utilized for financing fixed assets and are repaid in monthly or quarterly installments with maturity dates extending to 2031. Of these bank loans, loans in the aggregate amount of $35.1 million bear fixed interest rates between 1.1% and 5.5% and a loan in the amount of $0.2 million bears a variable interest rate based on the Euribor rate plus a margin of 1.5%. An aggregate amount of $5.4 million of the bank loans are secured by mortgages on real property and the remaining $29.9 million are unsecured. Certain credit agreements for the unsecured bank loans include financial covenants which are based on an equity ratio or an equity ratio and minimum interest coverage ratio. In addition, the Company has other unsecured revolving credit facilities and a secured bank loan in the amount of $8.1 million and $0.2 million, respectively, as of September 30, 2018. The unsecured revolving debt facilities bear fixed interest rates between 0.05% and 2.30%. The secured bank loan of $0.2 million bears a fixed annual interest rate of 1.95% and is repaid in monthly installments until 2027. Financing Lease Obligations. In fiscal year 2012, the Company entered into agreements with the lessors of certain buildings that the Company is currently occupying and leasing to expand those buildings. The Company provided a portion of the funds needed for the construction of the additions to the buildings, and as a result the Company was considered the owner of the buildings during the construction period. At the end of the construction period, the Company was not reimbursed by the lessors for all of the construction costs. The Company is therefore deemed to have continuing involvement and the leases qualify as financing leases under sale-leaseback accounting guidance, representing debt obligations for the Company and non-cash investing and financing activities. As a result, the Company capitalized $29.3 million in property, plant and equipment, net, representing the fair value of the buildings with a corresponding increase to debt. The Company has also capitalized $11.5 million in additional construction costs necessary to complete the renovations to the buildings, which were funded by the lessors, with a corresponding increase to debt. At September 30, 2018, the Company had $34.9 million recorded for these financing lease obligations, of which $1.5 million was recorded as short-term debt and $33.4 million was recorded as long-term debt. At December 31, 2017, the Company had $35.9 million recorded for these financing lease obligations, of which $1.4 million was recorded as short-term debt and $34.5 million was recorded as long-term debt. The buildings are being depreciated on a straight-line basis over the terms of the leases to their estimated residual values, which will equal the remaining financing obligation at the end of the lease term. At the end of the lease term, the remaining balances in property, plant and equipment, net and debt will be reversed against each other.

XML 27 R17.htm IDEA: XBRL DOCUMENT

Earnings Per Share

9 Months Ended

Sep. 30, 2018

Earnings Per Share [Abstract]

Earnings Per Share

Basic earnings per share was computed by dividing net income by the weighted-average number of common shares outstanding during the period less restricted unvested shares. Diluted earnings per share was computed by dividing net income by the weighted-average number of common shares outstanding plus all potentially dilutive common stock equivalents, primarily shares issuable upon the exercise of stock options using the treasury stock method. The following table reconciles the number of shares utilized in the earnings per share calculations:



	Three Months Ended		Nine Months Ended
	September 30, 2018	October 1, 2017	September 30, 2018	October 1, 2017
	(In thousands)
Number of common shares—basic	110,724	110,003	110,499	109,788
Effect of dilutive securities:
Stock options	791	735	813	669
Restricted stock awards	232	255	198	196
Number of common shares—diluted	111,747	110,993	111,510	110,653
Number of potentially dilutive securities excluded from calculation due to antidilutive impact	358	14	346	377

XML 28 R18.htm IDEA: XBRL DOCUMENT

Industry Segment Information

9 Months Ended

Sep. 30, 2018

Segment Reporting [Abstract]

Industry Segment Information

The principal products and services of the Company's two operating segments are:


•	Discovery & Analytical Solutions. Provides products and services targeted towards the life sciences and applied markets.


•	Diagnostics. Develops diagnostics, tools and applications focused on clinically-oriented customers, especially within the reproductive health, emerging market diagnostics and applied genomics markets. The Diagnostics segment serves the diagnostics market.

Revenue and operating income (loss) from continuing operations by operating segment are shown in the table below:



	Three Months Ended						Nine Months Ended
	September 30, 2018			October 1, 2017			September 30, 2018			October 1, 2017
	(In thousands)
Discovery & Analytical Solutions
Product revenue	$	247,250		$	222,618		$	748,270		$	665,068
Service revenue	158,916			162,764			485,049			465,202
Total revenue	406,166			385,382			1,233,319			1,130,270
Operating income from continuing operations	48,381			47,258			149,243			128,604
Diagnostics
Product revenue	227,273			132,201			669,469			378,466
Service revenue	40,874			36,692			118,859			106,616
Total revenue	268,147			168,893			788,328			485,082
Operating income from continuing operations	47,411			43,361			104,585			113,024
Corporate
Operating loss from continuing operations	(15,590		)	(12,581		)	(45,627		)	(39,596		)
Continuing Operations
Product revenue	474,523			354,819			1,417,739			1,043,534
Service revenue	199,790			199,456			603,908			571,818
Total revenue	674,313			554,275			2,021,647			1,615,352
Operating income from continuing operations	80,202			78,038			208,201			202,032
Interest and other expense (income), net (see Note 7)	2,161			(27,016		)	29,947			(13,797		)
Income from continuing operations before income taxes	$	78,041		$	105,054		$	178,254		$	215,829

XML 29 R19.htm IDEA: XBRL DOCUMENT

Stockholders' Equity

9 Months Ended

Sep. 30, 2018

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Stockholders’ Equity

Comprehensive Income:

The components of accumulated other comprehensive loss consisted of the following:



	September 30, 2018			December 31, 2017
	(In thousands)
Foreign currency translation adjustments	$	(160,780	)	$	(46,582	)
Unrecognized prior service costs, net of income taxes	322			322
Unrealized net losses on securities, net of income taxes	(190		)	(258		)
Accumulated other comprehensive loss	$	(160,648	)	$	(46,518	)

Stock Repurchases:

In addition, the Board has authorized the Company to repurchase shares of common stock to satisfy minimum statutory tax withholding obligations in connection with the vesting of restricted stock awards and restricted stock unit awards granted pursuant to the Company’s equity incentive plans and to satisfy obligations related to the exercise of stock options made pursuant to the Company's equity incentive plans. During the three months ended September 30, 2018, the Company repurchased 3,807 shares of common stock for this purpose at an aggregate cost of $0.3 million. During the nine months ended September 30, 2018, the Company repurchased 63,506 shares of common stock for this purpose at an aggregate cost of $5.0 million. The repurchased shares have been reflected as additional authorized but unissued shares, with the payments reflected in common stock and capital in excess of par value.

Dividends:

XML 30 R20.htm IDEA: XBRL DOCUMENT

Stock Plans

9 Months Ended

Sep. 30, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock Plans



	Three Months Ended				Nine Months Ended
	September 30, 2018		October 1, 2017		September 30, 2018		October 1, 2017
	(In thousands)
Cost of revenue	$	430	$	357	$	1,093	$	898
Research and development expenses	335		373		1,029		1,077
Selling, general and administrative expenses	10,362		3,682		21,153		14,204
Total stock-based compensation expense	$	11,127	$	4,412	$	23,275	$	16,179



	Three and Nine Months Ended
	September 30, 2018		October 1, 2017
Risk-free interest rate	2.9	%	1.5	%
Expected dividend yield	0.4	%	0.4	%
Expected term	5 years		5 years
Expected stock volatility	20.7	%	22.4	%

The following table summarizes stock option activity for the nine months ended September 30, 2018:



	Number of Shares		Weighted- Average Exercise Price		Weighted-Average Remaining Contractual Term	Total Intrinsic Value
	(In thousands)				(In years)	(In millions)
Outstanding at December 31, 2017	2,154		$	42.77
Granted	363		77.81
Exercised	(554	)	35.19
Forfeited	(43	)	51.62
Outstanding at September 30, 2018	1,920		$	51.38	4.3	$	88.1
Exercisable at September 30, 2018	1,113		$	43.10	3.2	$	60.3

Restricted Stock Awards: The following table summarizes restricted stock award activity for the nine months ended September 30, 2018:



	Number of Shares		Weighted- Average Grant- Date Fair Value
	(In thousands)
Nonvested at December 31, 2017	496		$	50.30
Granted	206		75.78
Vested	(200	)	50.18
Forfeited	(32	)	53.67
Nonvested at September 30, 2018	470		$	61.38

Performance Restricted Stock Units: As part of the Company's executive compensation program, the Company granted 39,133 performance restricted stock units during the nine months ended September 30, 2018 that will vest based on performance of the Company. The weighted-average per-share grant date fair value of performance restricted stock units granted during the nine months ended September 30, 2018 was $80.31. During the nine months ended September 30, 2018, 5,797 performance restricted stock units were forfeited. As of September 30, 2018, there were 87,673 performance restricted stock units outstanding. The total compensation expense recognized related to the performance restricted stock units was $1.3 million and $2.2 million for the three and nine months ended September 30, 2018, respectively, and $0.2 million and $0.6 million for the three and nine months ended October 1, 2017, respectively.

XML 31 R21.htm IDEA: XBRL DOCUMENT

Goodwill and Intangible Assets, Net

9 Months Ended

Sep. 30, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets, Net

The Company has consistently employed the relief from royalty model to estimate the current fair value when testing for impairment of non-amortizing intangible assets. The impairment test consists of a comparison of the fair value of the non-amortizing intangible asset with its carrying amount. If the carrying amount of a non-amortizing intangible asset exceeds its fair value, an impairment loss in an amount equal to that excess is recognized. In addition, the Company evaluates the remaining useful lives of its non-amortizing intangible assets at least annually to determine whether events or circumstances continue to support an indefinite useful life. If events or circumstances indicate that the useful lives of non-amortizing intangible assets are no longer indefinite, the assets will be tested for impairment. These intangible assets will then be amortized prospectively over their estimated remaining useful lives and accounted for in the same manner as other intangible assets that are subject to amortization. The Company performed its annual impairment testing as of January 1, 2018, and concluded that there was no impairment of non-amortizing intangible assets. An assessment of the recoverability of amortizing intangible assets takes place when events have occurred that may give rise to an impairment. No such events occurred during the first nine months of fiscal year 2018.

The changes in the carrying amount of goodwill for the nine months ended September 30, 2018 were as follows:



	Discovery & Analytical Solutions			Diagnostics			Consolidated
	(In thousands)
Balance at December 31, 2017	$	1,344,235		$	1,657,963		$	3,002,198
Foreign currency translation	(26,167		)	(31,613		)	(57,780		)
Acquisitions and other	(7,980		)	(15,749		)	(23,729		)
Balance at September 30, 2018	$	1,310,088		$	1,610,601		$	2,920,689

Identifiable intangible asset balances at September 30, 2018 and December 31, 2017 by category were as follows:



	September 30, 2018			December 31, 2017
	(In thousands)
Patents	$	42,951		$	39,959
Less: Accumulated amortization	(37,046		)	(35,085		)
Net patents	5,905			4,874
Trade names and trademarks	78,628			80,974
Less: Accumulated amortization	(32,251		)	(28,250		)
Net trade names and trademarks	46,377			52,724
Licenses	52,261			53,300
Less: Accumulated amortization	(44,889		)	(42,635		)
Net licenses	7,372			10,665
Core technology	476,403			471,740
Less: Accumulated amortization	(272,475		)	(244,916		)
Net core technology	203,928			226,824
Customer relationships	1,108,220			1,141,511
Less: Accumulated amortization	(290,616		)	(242,840		)
Net customer relationships	817,604			898,671
IPR&D	81,813			88,025
Less: Accumulated amortization	(9,808		)	(5,427		)
Net IPR&D	72,005			82,598
Net amortizable intangible assets	1,153,191			1,276,356
Non-amortizing intangible asset:
Trade name	70,584			70,584
Total	$	1,223,775		$	1,346,940

Total amortization expense related to definite-lived intangible assets was $35.3 million and $100.7 million for the three and nine months ended September 30, 2018, respectively, and $17.7 million and $52.3 million for the three and nine months ended October 1, 2017, respectively. Estimated amortization expense related to definite-lived intangible assets for each of the next five years is $37.6 million for the remainder of fiscal year 2018, $148.3 million for fiscal year 2019, $150.4 million for fiscal year 2020, $135.2 million for fiscal year 2021, and $123.8 million for fiscal year 2022.

XML 32 R22.htm IDEA: XBRL DOCUMENT

Warranty Reserves

9 Months Ended

Sep. 30, 2018

Product Warranties Disclosures [Abstract]

Warranty Reserves

A summary of warranty reserve activity for the three and nine months ended September 30, 2018 and October 1, 2017 is as follows:



	Three Months Ended						Nine Months Ended
	September 30, 2018			October 1, 2017			September 30, 2018			October 1, 2017
	(In thousands)
Balance at beginning of period	$	8,943		$	9,088		$	9,050		$	9,012
Provision charged to income	3,327			3,326			10,012			9,706
Payments	(3,547		)	(3,488		)	(10,514		)	(10,625		)
Adjustments to previously provided warranties, net	(226		)	(730		)	110			(215		)
Foreign currency translation and acquisitions	(49		)	117			(210		)	435
Balance at end of period	$	8,448		$	8,313		$	8,448		$	8,313

XML 33 R23.htm IDEA: XBRL DOCUMENT

Employee Benefit Plans

9 Months Ended

Sep. 30, 2018

Retirement Benefits [Abstract]

Employee Benefit Plans

Employee Postretirement Benefit Plans



	Defined Benefit Pension Benefits						Postretirement Medical Benefits
	Three Months Ended
	September 30, 2018			October 1, 2017			September 30, 2018			October 1, 2017
	(In thousands)
Service and administrative costs	$	1,712		$	1,231		$	27		$	23
Interest cost	4,051			4,160			30			32
Expected return on plan assets	(7,270		)	(6,568		)	(314		)	(279		)
Amortization of prior service costs	(41		)	(49		)	—			—
Net periodic pension credit	$	(1,548	)	$	(1,226	)	$	(257	)	$	(224	)

	Defined Benefit Pension Benefits						Postretirement Medical Benefits
	Nine Months Ended
	September 30, 2018			October 1, 2017			September 30, 2018			October 1, 2017
	(In thousands)
Service and administrative costs	$	5,180		$	3,667		$	80		$	69
Interest cost	12,212			12,420			90			94
Expected return on plan assets	(21,926		)	(19,609		)	(941		)	(836		)
Amortization of prior service costs	(123		)	(144		)	—			—
Net periodic benefit credit	$	(4,657	)	$	(3,666	)	$	(771	)	$	(673	)

During the nine months ended September 30, 2018 and October 1, 2017, the Company contributed $6.4 million and $6.2 million, respectively, in the aggregate, to pension plans outside of the United States. During the nine months ended September 30, 2018, the Company contributed $15.0 million to its defined benefit pension plan in the United States for the plan year 2017.

XML 34 R24.htm IDEA: XBRL DOCUMENT

Derivatives And Hedging Activities	9 Months Ended
Derivatives And Hedging Activities	Sep. 30, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives and Hedging Activities	Derivatives and Hedging Activities The Company uses derivative instruments as part of its risk management strategy only, and includes derivatives utilized as economic hedges that are not designated as hedging instruments. By nature, all financial instruments involve market and credit risks. The Company enters into derivative instruments with major investment grade financial institutions and has policies to monitor the credit risk of those counterparties. The Company does not enter into derivative contracts for trading or other speculative purposes, nor does the Company use leveraged financial instruments. Approximately 70% of the Company’s business is conducted outside of the United States, generally in foreign currencies. As a result, fluctuations in foreign currency exchange rates can increase the costs of financing, investing and operating the business. In the ordinary course of business, the Company enters into foreign exchange contracts for periods consistent with its committed exposures to mitigate the effect of foreign currency movements on transactions denominated in foreign currencies. The intent of these economic hedges is to offset gains and losses that occur on the underlying exposures from these currencies, with gains and losses resulting from the forward currency contracts that hedge these exposures. Transactions covered by hedge contracts include intercompany and third-party receivables and payables. The contracts are primarily in European and Asian currencies, have maturities that do not exceed 12 months, have no cash requirements until maturity, and are recorded at fair value on the Company’s condensed consolidated balance sheets. The unrealized gains and losses on the Company’s foreign currency contracts are recognized immediately in interest and other expense, net. The cash flows related to the settlement of these hedges are included in cash flows from operating activities within the Company’s condensed consolidated statement of cash flows. Principal hedged currencies include the British Pound, Euro, Swedish Krona, Japanese Yen and Singapore Dollar. The Company held forward foreign exchange contracts, designated as economic hedges, with U.S. dollar equivalent notional amounts totaling $180.4 million, $212.1 million and $140.0 million at September 30, 2018, December 31, 2017 and October 1, 2017, respectively, and the fair value of these foreign currency derivative contracts was insignificant. The gains and losses realized on these foreign currency derivative contracts are not material. The duration of these contracts was generally 30 days or less during each of the nine months ended September 30, 2018 and October 1, 2017. In addition, in connection with certain intercompany loan agreements utilized to finance its acquisitions and stock repurchase program, the Company enters into forward foreign exchange contracts intended to hedge movements in foreign exchange rates prior to settlement of such intercompany loans denominated in foreign currencies. The Company records these hedges at fair value on the Company’s condensed consolidated balance sheets. The unrealized gains and losses on these hedges, as well as the gains and losses associated with the remeasurement of the intercompany loans, are recognized immediately in interest and other expense, net. The cash flows related to the settlement of these hedges are included in cash flows from financing activities within the Company’s condensed consolidated statement of cash flows. The outstanding forward exchange contracts designated as economic hedges, which were intended to hedge movements in foreign exchange rates prior to the settlement of certain intercompany loan agreements, included combined Euro notional amounts of €48.7 million and combined U.S. Dollar notional amounts of $28.0 million as of September 30, 2018, combined Euro notional amounts of €57.2 million and combined U.S. Dollar notional amounts of $1.3 billion as of December 31, 2017, and combined Euro notional amounts of €19.0 million and combined U.S. Dollar notional amounts of $12.3 million as of October 1, 2017. The net gains and losses on these derivatives, combined with the gains and losses on the remeasurement of the hedged intercompany loans were not material for each of the three and nine months ended September 30, 2018 and October 1, 2017. The Company paid $30.3 million and $11.5 million during the nine months ended September 30, 2018 and October 1, 2017, respectively, from the settlement of these hedges. In April 2018, the Company entered into a series of foreign currency forward contracts with a notional amount of €298.7 million to hedge its investments in certain foreign subsidiaries. Realized and unrealized translation adjustments from these hedges were included in the foreign currency translation component of accumulated other comprehensive income ("AOCI"), which offsets translation adjustments on the underlying net assets of foreign subsidiaries. The cumulative translation gains or losses will remain in AOCI until the foreign subsidiaries are liquidated or sold. The foreign currency forward contracts were settled during the second quarter of 2018 and the Company recorded a net realized foreign exchange loss in AOCI of $2.6 million for the nine months ended September 30, 2018. During fiscal year 2016, the Company designated the 2026 Notes to hedge its investments in certain foreign subsidiaries. In January 2018, the Company removed the hedging relationship of its 2026 Notes and investments in certain foreign subsidiaries and recognized $2.1 million of unrealized foreign exchange gain in AOCI. In April 2018, the Company designated a portion of the 2026 Notes to hedge its investments in certain foreign subsidiaries. Unrealized translation adjustments from a portion of the 2026 Notes were included in the foreign currency translation component of AOCI, which offsets translation adjustments on the underlying net assets of foreign subsidiaries. The cumulative translation gains or losses will remain in AOCI until the foreign subsidiaries are liquidated or sold. As of September 30, 2018, the total notional amount of the 2026 Notes that was designated to hedge investments in foreign subsidiaries was €135.1 million. The unrealized foreign exchange gain recorded in AOCI related to the net investment hedge was $0.8 million and $7.7 million for the three and nine months ended September 30, 2018, respectively. In April 2018, the Company designated the April 2021 Notes with a notional amount of €298.7 million to hedge its investments in certain foreign subsidiaries. Unrealized translation adjustments from the April 2021 Notes were included in the foreign currency translation component of AOCI, which offsets translation adjustments on the underlying net assets of foreign subsidiaries. The cumulative translation gains or losses will remain in AOCI until the foreign subsidiaries are liquidated or sold. As of September 30, 2018, the total notional amount of the April 2021 Notes that was designated to hedge investments in foreign subsidiaries was €298.7 million. The unrealized foreign exchange gain recorded in AOCI related to the net investment hedge was $1.8 million and $22.6 million for the three and nine months ended September 30, 2018, respectively. The Company does not expect any material net pre-tax gains or losses to be reclassified from accumulated other comprehensive loss into interest and other expense, net within the next twelve months.

XML 35 R25.htm IDEA: XBRL DOCUMENT

Fair Value Measurements

9 Months Ended

Sep. 30, 2018

Fair Value Disclosures [Abstract]

Fair Value Measurements



				Fair Value Measurements at September 30, 2018 Using:
	Total Carrying Value at September 30, 2018			Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)
	(In thousands)
Marketable securities	$	2,405		$	2,405	$	—		$	—
Foreign exchange derivative assets	1,273			—		1,273			—
Foreign exchange derivative liabilities	(4,694		)	—		(4,694		)	—
Contingent consideration	(67,126		)	—		—			(67,126		)



				Fair Value Measurements at December 31, 2017 Using:
	Total Carrying Value at December 31, 2017			Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)
	(In thousands)
Marketable securities	$	2,208		$	2,208	$	—		$	—
Foreign exchange derivative assets	1,431			—		1,431			—
Foreign exchange derivative liabilities	(23,638		)	—		(23,638		)	—
Contingent consideration	(65,328		)	—		—			(65,328		)

Marketable securities: Include equity and fixed-income securities measured at fair value using the quoted market prices in active markets at the reporting date.

A reconciliation of the beginning and ending Level 3 net liabilities for contingent consideration is as follows:



	Three Months Ended						Nine Months Ended
	September 30, 2018			October 1, 2017			September 30, 2018			October 1, 2017
	(In thousands)
Balance at beginning of period	$	(74,093	)	$	(64,076	)	$	(65,328	)	$	(63,201	)
Additions	(5,800		)	—			(7,500		)	—
Amounts paid and foreign currency translation	16,507			—			16,507			34
Change in fair value (included within selling, general and administrative expenses)	(3,740		)	(651		)	(10,805		)	(1,560		)
Balance at end of period	$	(67,126	)	$	(64,727	)	$	(67,126	)	$	(64,727	)

The Company's 2026 Notes, with a face value of €500.0 million, had an aggregate carrying value of $572.3 million, net of $4.2 million of unamortized original issue discount and $3.9 million of unamortized debt issuance costs as of September 30, 2018. The 2026 Notes had an aggregate carrying value of $591.7 million, net of $4.7 million of unamortized original issue discount and $4.3 million of unamortized debt issuance costs as of December 31, 2017. The 2026 Notes had a fair value of €502.9 million and €508.9 million as of September 30, 2018 and December 31, 2017, respectively. The fair value of the 2026 Notes is estimated using market quotes from brokers and is based on current rates offered for similar debt.

As of September 30, 2018, the November 2021 Notes, 2026 Notes, April 2021 Notes and financing lease obligations were classified as Level 2.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 36 R26.htm IDEA: XBRL DOCUMENT

Contingencies	9 Months Ended
Contingencies	Sep. 30, 2018
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Contingencies The Company is conducting a number of environmental investigations and remedial actions at current and former locations of the Company and, along with other companies, has been named a potentially responsible party (“PRP”) for certain waste disposal sites. The Company accrues for environmental issues in the accounting period that the Company’s responsibility is established and when the cost can be reasonably estimated. The Company has accrued $8.5 million and $9.4 million as of September 30, 2018 and December 31, 2017, respectively, which represents its management’s estimate of the cost of the remediation of known environmental matters, and does not include any potential liability for related personal injury or property damage claims. These amounts were included in accrued expenses and other current liabilities. The Company's environmental accrual is not discounted and does not reflect the recovery of any material amounts through insurance or indemnification arrangements. The cost estimates are subject to a number of variables, including the stage of the environmental investigations, the magnitude of the possible contamination, the nature of the potential remedies, possible joint and several liability, the time period over which remediation may occur, and the possible effects of changing laws and regulations. For sites where the Company has been named a PRP, management does not currently anticipate any additional liability to result from the inability of other significant named parties to contribute. The Company expects that the majority of such accrued amounts could be paid out over a period of up to ten years. As assessment and remediation activities progress at each individual site, these liabilities are reviewed and adjusted to reflect additional information as it becomes available. There have been no environmental problems to date that have had, or are expected to have, a material adverse effect on the Company’s condensed consolidated financial statements. While it is possible that a loss exceeding the amounts recorded in the condensed consolidated financial statements may be incurred, the potential exposure is not expected to be materially different from those amounts recorded. The Company is subject to various claims, legal proceedings and investigations covering a wide range of matters that arise in the ordinary course of its business activities. Although the Company has established accruals for potential losses that it believes are probable and reasonably estimable, in the opinion of the Company’s management, based on its review of the information available at this time, the total cost of resolving these contingencies at September 30, 2018 would not have a material adverse effect on the Company’s condensed consolidated financial statements. However, each of these matters is subject to uncertainties, and it is possible that some of these matters may be resolved unfavorably to the Company.

XML 37 R27.htm IDEA: XBRL DOCUMENT

Basis of Presentation (Policies)	9 Months Ended
Basis of Presentation (Policies)	Sep. 30, 2018
Accounting Policies [Abstract]
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Adopted and Issued Accounting Pronouncements: From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (the "FASB") and are adopted by the Company as of the specified effective dates. Unless otherwise discussed, such pronouncements did not have or will not have a significant impact on the Company’s consolidated financial position, results of operations and cash flows or do not apply to the Company’s operations. In August 2018, the FASB issued Accounting Standards Update No. 2018-15, Intangibles-Goodwill and Other- Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract ("ASU 2018-15"). ASU 2018-15 aligns the accounting for implementation costs incurred in a hosting arrangement that is a service contract with the guidance on capitalizing costs associated with developing or obtaining internal-use software (and hosting arrangements that include an internal use software license). Specifically, ASU 2018-15 amends Intangibles-Goodwill and Other (Topic 350) to include in its scope implementation costs incurred in a hosting arrangement that is a service contract and clarifies that a customer should apply Subtopic 350-40 to determine which implementation costs to capitalize as an asset related to the service contract and which costs to expense. The provisions of this guidance are to be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. ASU 2018-15 is effective for annual reporting periods beginning after December 15, 2019, and interim periods within those years with early adoption permitted. The Company is currently evaluating the requirements of this guidance and has not yet determined the impact of its adoption on the Company's consolidated financial position, results of operations and cash flows. In August 2018, the FASB issued Accounting Standards Update No. 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans ("ASU 2018-14"). ASU 2018-14 adds, removes, and clarifies disclosure requirements related to defined benefit pension and other postretirement plans. ASU 2018-14 adds requirements for an entity to disclose the weighted-average interest crediting rates used in the entity’s cash balance pension plans and other similar plans; and an explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period. Further, ASU 2018-14 removes guidance that currently requires the following disclosures: the amounts in accumulated other comprehensive income expected to be recognized as part of net periodic benefit cost over the next year; the amount and timing of plan assets expected to be returned to the employer; information about (1) benefits covered by related-party insurance and annuity contracts and (2) significant transactions between the plan and related parties; and the effects of a one-percentage-point change on the assumed health care costs and the effect of this change in rates on service cost, interest cost, and the benefit obligation for postretirement health care benefits. ASU 2018-14 also clarifies the guidance in Compensation-Retirement Benefits (Topic 715-20-50-3) on defined benefit plans to require disclosure of (1) the projected benefit obligation ("PBO") and fair value of plan assets for pension plans with PBOs in excess of plan assets (the same disclosure with reference to the accumulated postretirement benefit obligation rather than the PBO is required for other postretirement benefit plans) and (2) the accumulated benefit obligation ("ABO") and fair value of plan assets for pension plans with ABOs in excess of plan assets. The provisions of this guidance are to be applied retrospectively to all periods presented upon their effective date. ASU 2018-14 is effective for annual reporting periods beginning after December 15, 2020, and interim periods within those years with early adoption permitted. The Company is currently evaluating the requirements of this guidance and has not yet determined the impact of its adoption on the Company's consolidated financial position, results of operations and cash flows. In August 2018, the FASB issued Accounting Standards Update No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement ("ASU 2018-13"). ASU 2018-13 adds, removes, and modifies certain disclosures related to fair value measurements. ASU 2018-13 adds requirements for an entity to disclose the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period; and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. Further, ASU 2018-13 removes the requirement to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy; the policy for timing of transfers between levels; and the valuation processes for Level 3 fair value measurements. ASU 2018-13 also modifies existing disclosure requirements related to measurement uncertainty. The amendments regarding changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty are to be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments are to be applied retrospectively to all periods presented upon their effective date. ASU 2018-13 is effective for annual reporting periods beginning after December 15, 2019, and interim periods within those years. Early adoption is permitted for any removed or modified disclosures. The Company is currently evaluating the requirements of this guidance and has not yet determined the impact of its adoption on the Company's consolidated financial position, results of operations and cash flows. In June 2018, the FASB issued Accounting Standards Update No. 2018-07, Compensation - Stock Compensation (Topic 718), Improvements to Nonemployee Share-Based Payment Accounting ("ASU 2018-07") which supersedes Subtopic 505-50, Equity - Equity-Based Payments to Non-employees, and expands the scope of Topic 718 (which currently only includes share-based payments to employees) to also include share-based payments issued to non-employees for goods and services, except for specific guidance on inputs to an option pricing model and the attribution of cost (that is, the period of time over which share-based payment awards vest and the pattern of cost recognition over that period). ASU 2018-07 specifies that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards, except for financing transactions, or awards issued to customers as part of a contract accounted for under Topic 606, Revenue from Contracts with Customers ("Topic 606"). The provisions of this guidance are to be applied using a modified retrospective approach, with a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year, for all (1) liability-classified non-employee awards that have not been settled as of the adoption date and (2) equity-classified non-employee awards for which a measurement date has not been established. ASU 2018-07 is effective for annual reporting periods beginning after December 15, 2018, and interim periods within those years. Early adoption is permitted, but no earlier than a company’s adoption date of Topic 606. The Company early adopted the provisions of this guidance effective July 2, 2018. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flow. In March 2018, the FASB Issued Accounting Standards Update No. 2018-05, Income Taxes (Topic 740): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118 ("ASU 2018-05"). ASU 2018-05 was issued to incorporate into Topic 740 recent SEC guidance related to the income tax accounting implications of the Tax Cut and Jobs Act (the "Tax Act"). The SEC issued Staff Accounting Bulletin No. 118 ("SAB 118") to address concerns about reporting entities’ ability to timely comply with the accounting requirements to recognize all of the effects of the Tax Act in the period of enactment. SAB 118 permits companies to disclose that some or all of the income tax effects from the Tax Act are incomplete by the due date of the financial statements, and if possible, disclose a reasonable estimate of such tax effects. ASU 2018-05 is effective immediately. The Company is applying the guidance in ASU 2018-05 when accounting for the enactment date effects of the Tax Act. At September 30, 2018, the Company has not completed the accounting for all of the tax effects of the Tax Act; however, it has made a reasonable estimate of their effects based on currently available information. Management will continue to refine the calculations as additional guidance is available. These estimates may be affected as additional clarification and implementation guidance becomes available. These changes could be material to income tax expense (see Note 9, Income Taxes for further disclosures). In February 2018, the FASB Issued Accounting Standards Update No. 2018-03, Technical Corrections and Improvements to Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities ("ASU 2018-03"). ASU 2018-03 was issued to clarify certain aspects of guidance concerning the recognition of financial assets and liabilities established in Accounting Standards Update No. 2016-01, Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities ("ASU 2016-01"). This includes treatment for discontinuations and adjustments for equity securities without a readily determinable market value, forward contracts and purchased options, presentation requirements for certain fair value option liabilities, fair value option liabilities denominated in a foreign currency, and transition guidance for equity securities without a readily determinable fair value. ASU 2018-03 is effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years beginning after June 15, 2018. Early adoption is permitted for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years, as long as the Company has adopted ASU 2016-01. The Company adopted the provisions of this guidance effective July 2, 2018. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows. In February 2018, the FASB Issued Accounting Standards Update No. 2018-02, Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income ("ASU 2018-02"). ASU 2018-02 provides entities with an option to reclassify stranded tax effects within Accumulated Other Comprehensive Income ("AOCI") to retained earnings in each period in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Act (or portion thereof) is recorded. ASU 2018-02 requires entities to disclose a description of the accounting policy for releasing income tax effects from AOCI; whether they elect to reclassify the stranded income tax effects from the Tax Act; and information about the other income tax effects that are reclassified. ASU 2018-02 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted, and entities should apply the proposed amendments either in the period of adoption or retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Act is recognized. The Company is currently evaluating the requirements of this guidance and has not yet determined the impact of its adoption on the Company's consolidated financial position, results of operations and cash flows. In August 2017, the FASB issued Accounting Standards Update No. 2017-12, Derivatives and Hedging (Topic 815), Targeted Improvements to Accounting for Hedging Activities ("ASU 2017-12"), which amends the hedge accounting recognition and presentation requirements in Topic 815. ASU 2017-12 makes targeted changes to the existing hedge accounting model to better align an entity’s financial reporting for hedging relationships with the entity’s risk management activities, and to reduce the complexity of, and simplify the application of, the hedge accounting model. Specifically, ASU 2017-12 expands the types of transactions eligible for hedge accounting, eliminates the requirement to separately measure and present hedge ineffectiveness, simplifies the way assessments of hedge ineffectiveness may be performed, relaxes the documentation requirements for entering into hedging positions, provides targeted improvements to fair value hedges of interest rate risk, and permits an entity to exclude the change in the fair value of cross-currency basis spreads in currency swaps from the assessment of hedge effectiveness. The standard also requires entities to provide new disclosures about the impact fair value and cash flow hedges have on their income statements and about cumulative basis adjustments arising from fair value hedges. The provisions of this guidance are to be applied using a modified retrospective approach to existing hedging relationships as of the adoption date. However, the transition provisions allow for certain elections at the date of adoption and entities may choose to apply any of the provided elections. ASU 2017-12 is effective for annual reporting periods beginning after December 15, 2018, and interim periods within those years. Early adoption is permitted, including adoption in any interim period. The Company early adopted the provisions of this guidance effective January 1, 2018. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows. In May 2017, the FASB issued Accounting Standards Update No. 2017-09, Compensation - Stock Compensation (Topic 718), Scope of Modification Accounting ("ASU 2017-09"), which amends the scope of modification accounting for share-based payment arrangements. ASU 2017-09 provides guidance on the types of changes to the terms or conditions of share-based payment awards to which an entity would be required to apply modification accounting under Topic 718. Specifically, an entity would not apply modification accounting if the fair value, vesting conditions, and classification of the awards are the same immediately before and after the modification. If an entity modifies its awards and concludes that it is not required to apply modification accounting under the standard, it must still consider whether the modification affects its application of other guidance. Additionally, if a significant modification does not result in incremental compensation cost, entities are required to disclose the “lack of” incremental compensation cost resulting from such significant modification. The standard also removes the guidance in Topic 718 stating that modification accounting is not required when an entity adds an antidilution provision as long as that modification is not made in contemplation of an equity restructuring. The provisions of this guidance are to be applied on a prospective basis to awards modified on or after the effective date. ASU 2017-09 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years. Early adoption is permitted, including adoption in any interim period. The Company adopted ASU 2017-09 effective January 1, 2018. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows. In March 2017, the FASB issued Accounting Standards Update No. 2017-07, Compensation - Retirement Benefits (Topic 715), Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost ("ASU 2017-07"), which amends the requirements in Topic 715 related to the income statement presentation of the components of net periodic benefit cost for an entity’s sponsored defined benefit pension and other postretirement plans. ASU 2017-07 requires entities to (1) disaggregate the current-service-cost component from the other components of net benefit cost (the “other components”) and present it with other current employee compensation costs in their income statements and (2) present the other components elsewhere in their income statements and outside of income from operations, and disclose the income statement lines that contain the other components if they are not presented on appropriately described separate lines. Additionally, the standard requires that only the service-cost component of net benefit cost is eligible for capitalization (e.g., as part of inventory or property, plant, and equipment). The change in income statement presentation requires retrospective application, while the change in capitalized benefit cost is to be applied prospectively. ASU 2017-07 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years, with early adoption permitted. The standard provides a practical expedient that permits entities to use the components of cost disclosed in prior years as a basis for the retrospective application of the new income statement presentation. Entities need to disclose the use of the practical expedient. The Company adopted ASU 2017-07 effective January 1, 2018 using a retrospective approach for each period presented. For the three and nine months ended October 1, 2017, $1.8 million and $5.4 million, respectively, of net periodic pension credit previously presented within operating income has been presented outside of operating income in the line item "Interest and other expense, net" in the condensed consolidated statement of operations due to the retrospective adoption of ASU 2017-07. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows, other than the impact discussed above. In January 2017, the FASB issued Accounting Standards Update No. 2017-01, Business Combinations (Topic 805), Clarifying the Definition of a Business ("ASU 2017-01"), which amends Topic 805 to provide a screen to determine when a set of assets and liabilities is not a business. The screen requires that when substantially all of the fair value of the gross assets acquired (or disposed of) is concentrated in a single identifiable asset or a group of similar identifiable assets, the set is not a business. This screen reduces the number of transactions that need to be further evaluated. If the screen is not met, the standard (1) requires that to be considered a business, a set must include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create output and (2) removes the evaluation of whether a market participant could replace missing elements. The standard provides a framework to assist entities in evaluating whether both an input and a substantive process are present. The standard also provides a framework that includes two sets of criteria to consider that depend on whether a set has outputs and a more stringent criteria for sets without outputs. Lastly, the standard narrows the definition of the term "output" so that the term is consistent with how outputs are described in Topic 606, Revenue from Contracts with Customers. The provisions of this guidance are to be applied prospectively. ASU 2017-01 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years, with early adoption permitted in limited circumstances. The Company adopted ASU 2017-01 effective January 1, 2018. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows. In November 2016, the FASB issued Accounting Standards Update No. 2016-18, Statement of Cash Flows (Topic 230), Restricted Cash ("ASU 2016-18"), which amends Topic 230 to add or clarify guidance on the classification and presentation of restricted cash in the statement of cash flows. The standard requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The provisions of this guidance are to be applied using a retrospective transition method to each period presented. ASU 2016-18 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years, with early adoption permitted. The Company adopted ASU 2016-18 effective January 1, 2018. For the nine months ended October 1, 2017, $17.2 million of changes in restricted cash balances that was previously presented within investing activities in the condensed consolidated statement of cash flows has been excluded from the cash flows used in investing activities and the effect of exchange rate changes increased by $0.2 million due to the retrospective adoption of ASU 2016-18. Restricted cash amounting to $17.3 million and $0.2 million at January 1, 2017 and October 1, 2017, respectively, have been included with the cash and cash equivalents when reconciling the beginning of period and end of period total amounts on the condensed consolidated statement of cash flows for the nine months ended October 1, 2017. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows, other than the impact discussed above. In October 2016, the FASB issued Accounting Standards Update No. 2016-16, Income Taxes (Topic 740), Intra-entity Transfer of Assets Other than Inventory ("ASU 2016-16"). ASU 2016-16 removes the prohibition in Topic 740 against the immediate recognition of the current and deferred income tax effects of intra-entity transfers of assets other than inventory. The standard requires entities to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. The provisions of this guidance are to be applied on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. ASU 2016-16 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those years, with early adoption permitted. The Company adopted ASU 2016-16 on January 1, 2018. The adoption of the standard resulted in a decrease in the retained earnings at January 1, 2018 of approximately $2.0 million with corresponding increase in deferred tax assets of $10.7 million and decrease in prepaid taxes of $12.8 million related to prior years’ intra-entity transfers of assets other than inventory. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows, other than the impact discussed above. In June 2016, the FASB issued Accounting Standards Update No. 2016-13, Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments ("ASU 2016-13"). ASU 2016-13 changes how entities will measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. The standard requires entities to use the expected loss impairment model and will apply to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities, net investments in leases and off-balance sheet credit exposures. Entities are required to estimate the lifetime “expected credit loss” for each applicable financial asset and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The standard also amends the impairment model for available-for-sale (“AFS”) debt securities and requires entities to determine whether all or a portion of the unrealized loss on an AFS debt security is a credit loss. An entity will recognize an allowance for credit losses on an AFS debt security as a contra-account to the amortized cost basis rather than as a direct reduction of the amortized cost basis of the investment. The provisions of this guidance are to be applied using a modified-retrospective approach. A prospective transition approach is required for debt securities for which an other-than-temporary impairment had been recognized before the effective date. ASU 2016-13 is effective for annual reporting periods beginning after December 15, 2019, and interim periods within those years. Early adoption is permitted for annual periods beginning after December 15, 2018, and interim periods therein. The Company is currently evaluating the requirements of this guidance and has not yet determined the impact of its adoption on the Company's consolidated financial position, results of operations and cash flows. In February 2016, the FASB issued Accounting Standards Update No. 2016-02, Leases ("ASU 2016-02"). ASU 2016-02 requires organizations that lease assets to recognize assets and liabilities on the balance sheet related to the rights and obligations created by those leases, regardless of whether they are classified as finance or operating leases. Consistent with current guidance, the recognition, measurement, and presentation of expenses and cash flows arising from a lease of assets will primarily depend on its classification as a finance or operating lease. ASU 2016-02 also requires new disclosures to help financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases. The provisions of this guidance are effective for annual periods beginning after December 15, 2018, and interim periods within those years, with early adoption permitted. ASU 2016-02 is to be applied using a modified retrospective approach. Subsequent to the issuance of ASU 2016-02, in July 2018, the FASB issued Accounting Standards Update No. 2018-10, Codification Improvements to Topic 842, Leases ("ASU 2018-10") and Accounting Standards Update No. 2018-11, Leases (Topic 842): Targeted Improvements ("ASU 2018-11"). The amendments in ASU 2018-10 clarify, correct or remove inconsistencies in the guidance provided under ASU 2016-02 related to sixteen specific issues identified. The amendments in ASU 2018-11 provide entities with an additional (and optional) transition method to adopt the new leases standard. Under the new transition method, an entity initially applies the new leases standard at the adoption date and recognizes a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. Consequently, an entity's reporting for the comparative periods presented in the financial statements in the period of adoption will continue to be in accordance with ASC 840, Leases ("ASC 840"). An entity that elects this additional (and optional) transition method must provide the required disclosures under ASC 840 for all periods that continue to be in accordance with ASC 840. ASU 2018-11 also provides lessors with a practical expedient, by class of underlying asset, to not separate nonlease components from the associated lease component and, instead, to account for those components as a single component if certain criteria are met. The effective date and transition requirements for these two standards are the same as the effective date and transition requirements of ASU 2016-02. The Company is in the process of completing its evaluation of the impact of the new leases standard upon adoption and has not yet determined the impact of adoption on its consolidated financial position, results of operations and cash flows. The Company intends to adopt the new leases standard using the optional transition method and will apply the new leases standard on December 31, 2018 (the first day of fiscal year 2019). In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers ("ASU 2014-09"). Under this new guidance, an entity should use a five-step process to recognize revenue, depicting the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard also requires new disclosures regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. Subsequent to the issuance of the standard, the FASB decided to defer the effective date for one year to annual reporting periods beginning after December 15, 2017, with early adoption permitted for annual reporting periods beginning after December 15, 2016. In November 2017, the FASB also issued Accounting Standards Update No. 2017-14, Income Statement-Reporting Comprehensive Income (Topic 220), Revenue Recognition (Topic 605), and Revenue from Contracts with Customers (Topic 606). ASU 2017-14 includes amendments to certain SEC paragraphs within the FASB Accounting Standards Codification ("Codification"). ASU 2017-14 amends the Codification to incorporate SEC Staff Accounting Bulletin No. 116 and SEC Interpretive Release on Vaccines for Federal Government Stockpiles (SEC Release No. 33-10403) to align existing SEC staff guidance with Revenue from Contracts with Customers (Topic 606). In May 2016, the FASB also issued Accounting Standards Update No. 2016-12, Revenue from Contracts with Customers (Topic 606), Narrow-Scope Improvements and Practical Expedients ("ASU 2016-12"), which amended its revenue recognition guidance in ASU 2014-09 on transition, collectability, non-cash consideration, contract modifications and completed contracts at transition and the presentation of sales and other similar taxes collected from customers. In April 2016, the FASB also issued Accounting Standards Update No. 2016-10, Revenue from Contracts with Customers (Topic 606), Identifying Performance Obligations and Licensing ("ASU 2016-10"), which amended its revenue recognition guidance in ASU 2014-09 on identifying performance obligations to allow entities to disregard items that are immaterial in the context of the contract, clarify when a promised good or service is separately identifiable (i.e., distinct within the context of the contract) and allow an entity to elect to account for the cost of shipping and handling performed after control of a good has been transferred to the customer as a fulfillment cost (i.e., an expense). ASU 2016-10 also clarifies how an entity should evaluate the nature of its promise in granting a license of intellectual property ("IP") and requires entities to classify IP in one of two categories: functional IP or symbolic IP, which will determine whether it recognizes revenue over time or at a point in time. ASU 2016-10 also addresses how entities should consider license renewals and restrictions and apply the exception for sales- and usage-based royalties received in exchange for licenses of IP. In March 2016, the FASB also issued Accounting Standards Update No. 2016-08, Revenue from Contracts with Customers (Topic 606), Principal versus Agent Considerations (Reporting Revenue Gross versus Net) ("ASU 2016-08"), which amended the principal-versus-agent implementation guidance and illustrations in ASU 2014-09. ASU 2016-08 clarifies that an entity should evaluate when it is the principal or agent for each specified good or service promised in a contract with a customer. ASU 2017-14, ASU 2016-12, ASU 2016-10, ASU 2016-08 and ASU 2014-09 may be adopted either using a full retrospective approach or a modified retrospective approach. The Company adopted these standards beginning on January 1, 2018 using the modified retrospective approach only to contracts not completed as of January 1, 2018. The most significant impact of the standards relates to the accounting for certain transactions with multiple elements or “bundled” arrangements. Specifically, for sales of software subscriptions or sales of licenses and maintenance, the Company will recognize the license revenue predominantly at the time of billing and delivery rather than recognizing the entire sales price ratably over the maintenance period, which is the Company's current practice. In addition, for certain sales of instruments that include customer-specified acceptance criteria, the Company will recognize revenue when the customer obtains control of the instrument which is typically upon delivery or when title has transferred to the customer, as the Company believes acceptance is perfunctory. The Company will also capitalize incremental commission fees as a result of obtaining contracts when these fees are recoverable and will amortize the assets based on the transfer of goods or services to which the assets relate which typically range from two to six years. The adoption of the standards resulted in an increase in retained earnings at January 1, 2018 of approximately $10.2 million for the cumulative effect of initially applying the standards as of that date. In addition, the adoption of the standards resulted primarily in a reduction in deferred revenue of approximately $11.5 million, mainly driven by the upfront recognition of license revenue and certain multi-year software subscriptions, and an increase in deferred income tax liability of approximately $3.0 million for the tax impact of the cumulative adjustments. The cumulative effect of recognizing instrument sales upon delivery or transfer of title and capitalizing the incremental commission fees were not material at January 1, 2018. The adoption of the standards had no impact to cash from or used in operating, investing, or financing activities in the Company's consolidated statement of cash flows at January 1, 2018. Refer to Note 3, Changes in Accounting Policies, for the impact of adoption of the standards on the Company's condensed consolidated financial statements for the quarter ended September 30, 2018. Also refer to Note 2, Revenue, for the disclosures required by the standards.
Revenue Recognition, Policy [Policy Text Block]	The Company adopted ASC 606, Revenue from Contracts with Customers ("ASC 606"), with a date of the initial application of January 1, 2018. As a result, the Company has changed its accounting policy for revenue recognition as detailed below. The Company applied ASC 606 using the modified retrospective method only to contracts that are not completed contracts as of January 1, 2018, and the cumulative effect of initially applying ASC 606 is recognized as an adjustment to the beginning retained earnings. Therefore, the comparative information has not been adjusted and continues to be reported under ASC 605. The details of the significant changes and quantitative impact of the changes are disclosed below. A. Sales of software subscriptions or sales of licenses and maintenance in bundled arrangements The Company previously recognized revenue from software licenses sold together with maintenance and/or consulting services upon shipment using the residual method, provided that the undelivered items in the arrangement have value to the customer on a stand-alone basis and vendor-specific objective evidence ("VSOE") of fair value can be determined. If VSOE of fair value for the undelivered elements cannot be established, the Company deferred all revenue from the arrangement until the earlier of the point at which such sufficient VSOE does exist or all elements of the arrangement have been delivered, or if the undelivered element is maintenance, then the Company recognized the entire fee ratably over the maintenance period. Under ASC 606, the total consideration in the contract is allocated to all products and services based on their stand-alone selling prices. The stand-alone selling prices are determined based on the list prices at which the Company sells the software license, software subscription, maintenance and/or consulting services. Accordingly, the Company now recognizes higher license revenue upfront and less service revenue over time. B. Sales of instruments The Company previously recognized revenue from sale of instruments when persuasive evidence of an arrangement existed, delivery had occurred, the price to the buyer was fixed or determinable, and collectability was reasonably assured. For certain sales of instruments that included customer-specified acceptance criteria, the Company previously recognized revenue after the acceptance criteria had been met. Under ASC 606, revenue is recognized when the Company satisfies a performance obligation by transferring control of the product to a customer. Accordingly, the Company now recognizes product revenue upon delivery or when title has transferred to the customer, as the Company believes acceptance is perfunctory. C. Sales commissions The Company previously recognized commission fees related to sales of products and services as selling expenses when they were incurred. Under ASC 606, the Company capitalizes those commission fees as costs of obtaining a contract, when they are incremental and, if they are expected to be recovered, the Company amortizes them consistently with the pattern of transfer of the product or service to which the asset relates. If the expected amortization period is one year or less, the commission fee is expensed when incurred.

XML 38 R28.htm IDEA: XBRL DOCUMENT

Revenue (Tables)

9 Months Ended

Sep. 30, 2018

Disaggregation of Revenue [Line Items]

Disaggregation of Revenue [Table Text Block]



	Reportable Segments
	Three Months Ended
	September 30, 2018
	Discovery & Analytical Solutions		Diagnostics		Total
	(In thousands)
Primary geographical markets
Americas	$	169,366	$	95,607	$	264,973
Europe	110,747		68,480		179,227
Asia	126,053		104,060		230,113
	$	406,166	$	268,147	$	674,313

Primary end-markets
Diagnostics	$	—	$	268,147	$	268,147
Life sciences	222,191		—		222,191
Applied markets	183,975		—		183,975
	$	406,166	$	268,147	$	674,313

Timing of revenue recognition
Products and services transferred at a point in time	$	290,929	$	247,189	$	538,118
Services transferred over time	115,237		20,958		136,195
	$	406,166	$	268,147	$	674,313



	Reportable Segments
	Nine Months Ended
	September 30, 2018
	Discovery & Analytical Solutions		Diagnostics		Total
	(In thousands)
Primary geographical markets
Americas	$	497,833	$	282,536	$	780,369
Europe	357,766		205,892		563,658
Asia	377,720		299,900		677,620
	$	1,233,319	$	788,328	$	2,021,647

Primary end-markets
Diagnostics	$	—	$	788,328	$	788,328
Life sciences	675,807		—		675,807
Applied markets	557,512		—		557,512
	$	1,233,319	$	788,328	$	2,021,647

Timing of revenue recognition
Products and services transferred at a point in time	$	874,517	$	726,058	$	1,600,575
Services transferred over time	358,802		62,270		421,072
	$	1,233,319	$	788,328	$	2,021,647

XML 39 R29.htm IDEA: XBRL DOCUMENT

Changes in Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2018

Accounting Policies [Abstract]

Schedule of Prospective Adoption of New Accounting Pronouncements [Table Text Block]

Impacts on financial statements

The following tables summarize the impacts of ASC 606 adoption on the Company's condensed consolidated financial statements for the quarter ended September 30, 2018.

Consolidated Balance Sheet



	As reported			Adjustments			Balances without adoption of ASC 606
	(In thousands)
Cash and cash equivalents	$	149,513		$	—		$	149,513
Accounts receivable, net	551,385			(11,554		)	539,831
Inventories	354,244			7,451			361,695
Other current assets	110,353			(522		)	109,831
Property, plant and equipment, net	317,049			—			317,049
Intangible assets, net	1,223,775			—			1,223,775
Goodwill	2,920,689			—			2,920,689
Other assets, net	235,347			—			235,347
Total assets	$	5,862,355		$	(4,625	)	$	5,857,730
Current portion of long-term debt	$	20,072		$	—		$	20,072
Accounts payable	180,693			—			180,693
Accrued restructuring and contract termination charges	8,079			—			8,079
Accrued expenses and other current liabilities	475,743			18,912			494,655
Current liabilities of discontinued operations	2,165			—			2,165
Long-term debt	1,882,502			—			1,882,502
Long-term liabilities	720,632			—			720,632
Total liabilities	3,289,886			18,912			3,308,798
Commitments and contingencies
Preferred stock	—			—			—
Common stock	111,087			—			111,087
Capital in excess of par value	89,970			—			89,970
Retained earnings	2,532,060			(23,537		)	2,508,523
Accumulated other comprehensive loss	(160,648		)	—			(160,648		)
Total stockholders’ equity	2,572,469			(23,537		)	2,548,932
Total liabilities and stockholders’ equity	$	5,862,355		$	(4,625	)	$	5,857,730

Consolidated Statement of Operations



	Three Months Ended
	September 30, 2018
	As reported			Adjustments			Balances without adoption of ASC 606
	(In thousands)
Product revenue	$	474,523		$	(3,198	)	$	471,325
Service revenue	199,790			—			199,790
Total revenue	674,313			(3,198		)	671,115
Cost of product revenue	213,672			(98		)	213,574
Cost of service revenue	128,314			—			128,314
Total cost of revenue	341,986			(98		)	341,888
Selling, general and administrative expenses	196,769			47			196,816
Research and development expenses	48,848			—			48,848
Restructuring and contract termination charges, net	6,508			—			6,508
Operating income from continuing operations	80,202			(3,147		)	77,055
Interest and other expense, net	2,161			—			2,161
Income from continuing operations before income taxes	78,041			(3,147		)	74,894
Provision for income taxes	2,596			(814		)	1,782
Income from continuing operations	75,445			(2,333		)	73,112
Loss on disposition of discontinued operations before income taxes	(308		)	—			(308		)
Benefit from income taxes on discontinued operations and dispositions	(1,411		)	—			(1,411		)
Gain from discontinued operations and dispositions	1,103			—			1,103
Net income	$	76,548		$	(2,333	)	$	74,215

Consolidated Statement of Operations



	Nine Months Ended
	September 30, 2018
	As reported			Adjustments			Balances without adoption of ASC 606
	(In thousands)
Product revenue	$	1,417,739		$	(25,562	)	$	1,392,177
Service revenue	603,908			—			603,908
Total revenue	2,021,647			(25,562		)	1,996,085
Cost of product revenue	663,651			(7,780		)	655,871
Cost of service revenue	393,307			—			393,307
Total cost of revenue	1,056,958			(7,780		)	1,049,178
Selling, general and administrative expenses	601,374			300			601,674
Research and development expenses	142,028			—			142,028
Restructuring and contract termination charges, net	13,086			—			13,086
Operating income from continuing operations	208,201			(18,082		)	190,119
Interest and other expense, net	29,947			—			29,947
Income from continuing operations before income taxes	178,254			(18,082		)	160,172
Provision for income taxes	12,101			(4,753		)	7,348
Income from continuing operations	166,153			(13,329		)	152,824
Loss on disposition of discontinued operations before income taxes	(859		)	—			(859		)
Benefit from income taxes on discontinued operations and dispositions	(1,341		)	—			(1,341		)
Gain from discontinued operations and dispositions	482			—			482
Net income	$	166,635		$	(13,329	)	$	153,306

XML 40 R30.htm IDEA: XBRL DOCUMENT

Business Combinations (Tables)

9 Months Ended

Sep. 30, 2018

Oct. 01, 2017

Business Acquisition [Line Items]

Business Acquisition, Pro Forma Information [Table Text Block]

The following unaudited pro forma information presents the combined financial results for the Company and EUROIMMUN as if the acquisition of EUROIMMUN had been completed at the beginning of fiscal year 2016:



	Three Months Ended October 1, 2017		Nine Months Ended October 1, 2017
	(In thousands, except per share data)
Pro Forma Statement of Operations Information (Unaudited):
Revenue	$	640,154	$	1,846,233
Income from continuing operations	94,055		172,672
Basic earnings per share:
Income from continuing operations	$	0.86	$	1.57
Diluted earnings per share:
Income from continuing operations	$	0.85	$	1.56

Schedule of Business Acquisitions, by Acquisition [Table Text Block]

The total purchase price for the acquisitions in fiscal year 2017 has been allocated to the estimated fair values of assets acquired and liabilities assumed as follows:



	EUROIMMUN			Other Acquisitions
	(In thousands)
Fair value of business combination:
Cash payments	$	1,413,780		$	140,861
Other liability	—			1,273
Working capital and other adjustments	—			(93		)
Less: cash acquired	(25,018		)	(2,439		)
Total	$	1,388,762		$	139,602
Identifiable assets acquired and liabilities assumed:
Current assets	$	121,174		$	16,268
Property, plant and equipment	130,512			11,356
Other assets	49,679			1,691
Identifiable intangible assets:
Core technology	160,000			12,400
Trade names	36,000			3,000
Customer relationships	710,000			43,700
In-process research and development ("IPR&D")	1,400			—
Goodwill	581,172			75,250
Deferred taxes	(253,288		)	(15,735		)
Liabilities assumed	(86,530		)	(8,328		)
Debt assumed	(61,357		)	—
Total	$	1,388,762		$	139,602

The total purchase price for the acquisitions in fiscal year 2018 has been allocated to the estimated fair values of assets acquired and liabilities assumed as follows:



	2018 Acquisitions
	(In thousands)
Fair value of business combination:
Cash payments	$	43,942
Other liability	3,354
Contingent consideration	7,500
Working capital and other adjustments	599
Less: cash acquired	(1,138		)
Total	$	54,257
Identifiable assets acquired and liabilities assumed:
Current assets	$	3,469
Property, plant and equipment	937
Other assets	430
Identifiable intangible assets:
Core technology	15,957
Trade names	1,010
Customer relationships	10,800
Goodwill	28,423
Deferred taxes	(2,524		)
Liabilities assumed	(4,037		)
Debt assumed	(208		)
Total	$	54,257

XML 41 R31.htm IDEA: XBRL DOCUMENT

Discontinued Operations (Tables)

9 Months Ended

Sep. 30, 2018

Discontinued Operations and Disposal Groups [Abstract]

Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures [Table Text Block]

The summary pre-tax operating results of the discontinued operations, were as follows for the three and nine months ended:



	Three Months Ended				Nine Months Ended
	September 30, 2018		October 1, 2017		September 30, 2018		October 1, 2017
	(In thousands)
Revenue	$	—	$	—	$	—	$	44,343
Cost of revenue	—		—		—		32,933
Selling, general and administrative expenses	—		—		—		5,869
Research and development expenses	—		—		—		4,891
(Loss) income from discontinued operations before income taxes	$	—	$	—	$	—	$	650

- Definition

Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5D
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5C
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5A
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5B
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760

+ Details

XML 42 R32.htm IDEA: XBRL DOCUMENT

Restructuring and Lease Charges, Net (Tables)

9 Months Ended

Sep. 30, 2018

Restructuring Cost and Reserve [Line Items]

Schedule of Restructuring Plan Activity [Table Text Block]



	Workforce Reductions					Closure of Excess Facility				Total		(Expected) Date Payments Substantially Completed by
	Headcount Reduction	Discovery & Analytical Solutions		Diagnostics		Discovery & Analytical Solutions		Diagnostics				Severance	Excess Facility
	Headcount Reduction	Discovery & Analytical Solutions		Diagnostics		Discovery & Analytical Solutions		Diagnostics				Severance	Excess Facility
	(In thousands, except headcount data)
Q3 2018 Plan	61	$	1,146	$	618	$	—	$	—	$	1,764	Q2 FY2019	—
Q1 2018 Plan	47	5,096		902		—		—		5,998		Q2 FY2019	—
Q4 2017 Plan	29	1,680		255		—		—		1,935		Q1 FY2019	—
Q3 2017 Plan	27	1,321		1,021		—		—		2,342		Q4 FY2018	—
Q1 2017 Plan	90	5,000		1,631		33		33		6,697		Q4 FY2018	Q4 FY2018

Schedule of Restructuring Reserve by Type of Cost [Table Text Block]

The following table summarizes the Company's restructuring and contract termination accrual balances and related activity by restructuring plan, as well as contract termination accrual balances and related activity, during the nine months ended September 30, 2018:



	Balance at December 31, 2017		2018 Charges		2018 Changes in Estimates, Net		2018 Amounts Paid			Balance at September 30, 2018
	(In thousands)
Severance:
Q3 2018 Plan	$	—	$	1,764	$	—	$	—		$	1,764
Q1 2018 Plan	—		5,998		—		(4,273		)	1,725
Q4 2017 Plan	1,919		—		—		(1,538		)	381
Q3 2017 Plan	2,072		—		—		(868		)	1,204
Q1 2017 Plan	2,498		—		—		(1,174		)	1,324

Facility:
Q1 2017 Plan	33		—		—		(22		)	11

Previous Plans	4,399		—		353		(2,106		)	2,646
Restructuring	10,921		7,762		353		(9,981		)	9,055
Contract Termination	3,048		4,744		227		(7,653		)	366
Total Restructuring and Contract Termination	$	13,969	$	12,506	$	580	$	(17,634	)	$	9,421

XML 43 R33.htm IDEA: XBRL DOCUMENT

Interest and Other Expense (Income), Net (Tables)

9 Months Ended

Sep. 30, 2018

Other Income and Expenses [Abstract]

Interest and Other Expense (Income), Net

Interest and other expense, net, consisted of the following:



	Three Months Ended						Nine Months Ended
	September 30, 2018			October 1, 2017			September 30, 2018			October 1, 2017
	(In thousands)
Interest income	$	(316	)	$	(802	)	$	(754	)	$	(1,512	)
Interest expense	16,684			10,974			50,745			32,510
(Gain) loss on disposition of businesses and assets, net (see Note 5)	(13,031		)	—			(13,031		)	301
Other income, net	(1,176		)	(37,188		)	(7,013		)	(45,096		)
Total interest and other expense (income), net	$	2,161		$	(27,016	)	$	29,947		$	(13,797	)

XML 44 R34.htm IDEA: XBRL DOCUMENT

Inventories, Net (Tables)

9 Months Ended

Sep. 30, 2018

Inventory Disclosure [Abstract]

Schedule of Net Inventories

Inventories as of September 30, 2018 and December 31, 2017 consisted of the following:



	September 30, 2018		December 31, 2017
	(In thousands)
Raw materials	$	117,266	$	122,100
Work in progress	21,389		18,452
Finished goods	215,589		211,123
Total inventories	$	354,244	$	351,675

XML 45 R35.htm IDEA: XBRL DOCUMENT

Income Taxes (Tables)

9 Months Ended

Sep. 30, 2018

Income Tax Disclosure [Abstract]

Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]

The total provision for income taxes included in the condensed consolidated statement of operations consisted of the following:



	Three Months Ended					Nine Months Ended
	September 30, 2018			October 1, 2017		September 30, 2018			October 1, 2017
	(In thousands)
Continuing operations	$	2,596		$	8,508	$	12,101		$	20,495
Discontinued operations	(1,411		)	5,262		(1,341		)	42,405
Total	$	1,185		$	13,770	$	10,760		$	62,900

XML 46 R36.htm IDEA: XBRL DOCUMENT

Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2018

Earnings Per Share [Abstract]

Schedule of Reconciliation of Number of Shares Utilized in Earnings Per Share Calculations

The following table reconciles the number of shares utilized in the earnings per share calculations:



	Three Months Ended		Nine Months Ended
	September 30, 2018	October 1, 2017	September 30, 2018	October 1, 2017
	(In thousands)
Number of common shares—basic	110,724	110,003	110,499	109,788
Effect of dilutive securities:
Stock options	791	735	813	669
Restricted stock awards	232	255	198	196
Number of common shares—diluted	111,747	110,993	111,510	110,653
Number of potentially dilutive securities excluded from calculation due to antidilutive impact	358	14	346	377

XML 47 R37.htm IDEA: XBRL DOCUMENT

Industry Segment Information (Tables)

9 Months Ended

Sep. 30, 2018

Segment Reporting [Abstract]

Schedule of Sales and Operating Income by Operating Segment, Excluding Discontinued Operations

Revenue and operating income (loss) from continuing operations by operating segment are shown in the table below:



	Three Months Ended						Nine Months Ended
	September 30, 2018			October 1, 2017			September 30, 2018			October 1, 2017
	(In thousands)
Discovery & Analytical Solutions
Product revenue	$	247,250		$	222,618		$	748,270		$	665,068
Service revenue	158,916			162,764			485,049			465,202
Total revenue	406,166			385,382			1,233,319			1,130,270
Operating income from continuing operations	48,381			47,258			149,243			128,604
Diagnostics
Product revenue	227,273			132,201			669,469			378,466
Service revenue	40,874			36,692			118,859			106,616
Total revenue	268,147			168,893			788,328			485,082
Operating income from continuing operations	47,411			43,361			104,585			113,024
Corporate
Operating loss from continuing operations	(15,590		)	(12,581		)	(45,627		)	(39,596		)
Continuing Operations
Product revenue	474,523			354,819			1,417,739			1,043,534
Service revenue	199,790			199,456			603,908			571,818
Total revenue	674,313			554,275			2,021,647			1,615,352
Operating income from continuing operations	80,202			78,038			208,201			202,032
Interest and other expense (income), net (see Note 7)	2,161			(27,016		)	29,947			(13,797		)
Income from continuing operations before income taxes	$	78,041		$	105,054		$	178,254		$	215,829

XML 48 R38.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2018

Stockholders' Equity Note [Abstract]

Components of Accumulated Other Comprehensive Loss

The components of accumulated other comprehensive loss consisted of the following:



	September 30, 2018			December 31, 2017
	(In thousands)
Foreign currency translation adjustments	$	(160,780	)	$	(46,582	)
Unrecognized prior service costs, net of income taxes	322			322
Unrealized net losses on securities, net of income taxes	(190		)	(258		)
Accumulated other comprehensive loss	$	(160,648	)	$	(46,518	)

XML 49 R39.htm IDEA: XBRL DOCUMENT

Stock Plans (Tables)

9 Months Ended

Sep. 30, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Summary of Total Compensation Recognized Related to Outstanding Equity Awards



	Three Months Ended				Nine Months Ended
	September 30, 2018		October 1, 2017		September 30, 2018		October 1, 2017
	(In thousands)
Cost of revenue	$	430	$	357	$	1,093	$	898
Research and development expenses	335		373		1,029		1,077
Selling, general and administrative expenses	10,362		3,682		21,153		14,204
Total stock-based compensation expense	$	11,127	$	4,412	$	23,275	$	16,179

Weighted-Average Assumptions Used in the Black-Scholes Option Pricing Model

The Company’s weighted-average assumptions used in the Black-Scholes option pricing model were as follows:



	Three and Nine Months Ended
	September 30, 2018		October 1, 2017
Risk-free interest rate	2.9	%	1.5	%
Expected dividend yield	0.4	%	0.4	%
Expected term	5 years		5 years
Expected stock volatility	20.7	%	22.4	%

Summary of Stock Option Activity

The following table summarizes stock option activity for the nine months ended September 30, 2018:



	Number of Shares		Weighted- Average Exercise Price		Weighted-Average Remaining Contractual Term	Total Intrinsic Value
	(In thousands)				(In years)	(In millions)
Outstanding at December 31, 2017	2,154		$	42.77
Granted	363		77.81
Exercised	(554	)	35.19
Forfeited	(43	)	51.62
Outstanding at September 30, 2018	1,920		$	51.38	4.3	$	88.1
Exercisable at September 30, 2018	1,113		$	43.10	3.2	$	60.3

Summary of Restricted Stock Award Activity

The following table summarizes restricted stock award activity for the nine months ended September 30, 2018:



	Number of Shares		Weighted- Average Grant- Date Fair Value
	(In thousands)
Nonvested at December 31, 2017	496		$	50.30
Granted	206		75.78
Vested	(200	)	50.18
Forfeited	(32	)	53.67
Nonvested at September 30, 2018	470		$	61.38

XML 50 R40.htm IDEA: XBRL DOCUMENT

Goodwill and Intangible Assets, Net (Tables)

9 Months Ended

Sep. 30, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Changes in the Carrying Amount of Goodwill

The changes in the carrying amount of goodwill for the nine months ended September 30, 2018 were as follows:



	Discovery & Analytical Solutions			Diagnostics			Consolidated
	(In thousands)
Balance at December 31, 2017	$	1,344,235		$	1,657,963		$	3,002,198
Foreign currency translation	(26,167		)	(31,613		)	(57,780		)
Acquisitions and other	(7,980		)	(15,749		)	(23,729		)
Balance at September 30, 2018	$	1,310,088		$	1,610,601		$	2,920,689

Identifiable Intangible Asset Balances

Identifiable intangible asset balances at September 30, 2018 and December 31, 2017 by category were as follows:



	September 30, 2018			December 31, 2017
	(In thousands)
Patents	$	42,951		$	39,959
Less: Accumulated amortization	(37,046		)	(35,085		)
Net patents	5,905			4,874
Trade names and trademarks	78,628			80,974
Less: Accumulated amortization	(32,251		)	(28,250		)
Net trade names and trademarks	46,377			52,724
Licenses	52,261			53,300
Less: Accumulated amortization	(44,889		)	(42,635		)
Net licenses	7,372			10,665
Core technology	476,403			471,740
Less: Accumulated amortization	(272,475		)	(244,916		)
Net core technology	203,928			226,824
Customer relationships	1,108,220			1,141,511
Less: Accumulated amortization	(290,616		)	(242,840		)
Net customer relationships	817,604			898,671
IPR&D	81,813			88,025
Less: Accumulated amortization	(9,808		)	(5,427		)
Net IPR&D	72,005			82,598
Net amortizable intangible assets	1,153,191			1,276,356
Non-amortizing intangible asset:
Trade name	70,584			70,584
Total	$	1,223,775		$	1,346,940

XML 51 R41.htm IDEA: XBRL DOCUMENT

Warranty Reserves (Tables)

9 Months Ended

Sep. 30, 2018

Product Warranties Disclosures [Abstract]

Warranty Reserve Activity

A summary of warranty reserve activity for the three and nine months ended September 30, 2018 and October 1, 2017 is as follows:



	Three Months Ended						Nine Months Ended
	September 30, 2018			October 1, 2017			September 30, 2018			October 1, 2017
	(In thousands)
Balance at beginning of period	$	8,943		$	9,088		$	9,050		$	9,012
Provision charged to income	3,327			3,326			10,012			9,706
Payments	(3,547		)	(3,488		)	(10,514		)	(10,625		)
Adjustments to previously provided warranties, net	(226		)	(730		)	110			(215		)
Foreign currency translation and acquisitions	(49		)	117			(210		)	435
Balance at end of period	$	8,448		$	8,313		$	8,448		$	8,313

XML 52 R42.htm IDEA: XBRL DOCUMENT

Employee Benefit Plans (Tables)

9 Months Ended

Sep. 30, 2018

Retirement Benefits [Abstract]

Components of Net Periodic Benefit Cost (Credit)



	Defined Benefit Pension Benefits						Postretirement Medical Benefits
	Three Months Ended
	September 30, 2018			October 1, 2017			September 30, 2018			October 1, 2017
	(In thousands)
Service and administrative costs	$	1,712		$	1,231		$	27		$	23
Interest cost	4,051			4,160			30			32
Expected return on plan assets	(7,270		)	(6,568		)	(314		)	(279		)
Amortization of prior service costs	(41		)	(49		)	—			—
Net periodic pension credit	$	(1,548	)	$	(1,226	)	$	(257	)	$	(224	)

	Defined Benefit Pension Benefits						Postretirement Medical Benefits
	Nine Months Ended
	September 30, 2018			October 1, 2017			September 30, 2018			October 1, 2017
	(In thousands)
Service and administrative costs	$	5,180		$	3,667		$	80		$	69
Interest cost	12,212			12,420			90			94
Expected return on plan assets	(21,926		)	(19,609		)	(941		)	(836		)
Amortization of prior service costs	(123		)	(144		)	—			—
Net periodic benefit credit	$	(4,657	)	$	(3,666	)	$	(771	)	$	(673	)

XML 53 R43.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2018

Fair Value Disclosures [Abstract]

Assets and Liabilities Carried at Fair Value Measured on a Recurring Basis



				Fair Value Measurements at September 30, 2018 Using:
	Total Carrying Value at September 30, 2018			Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)
	(In thousands)
Marketable securities	$	2,405		$	2,405	$	—		$	—
Foreign exchange derivative assets	1,273			—		1,273			—
Foreign exchange derivative liabilities	(4,694		)	—		(4,694		)	—
Contingent consideration	(67,126		)	—		—			(67,126		)



				Fair Value Measurements at December 31, 2017 Using:
	Total Carrying Value at December 31, 2017			Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)
	(In thousands)
Marketable securities	$	2,208		$	2,208	$	—		$	—
Foreign exchange derivative assets	1,431			—		1,431			—
Foreign exchange derivative liabilities	(23,638		)	—		(23,638		)	—
Contingent consideration	(65,328		)	—		—			(65,328		)

Reconciliation of Beginning and Ending Level 3 Net Liabilities

A reconciliation of the beginning and ending Level 3 net liabilities for contingent consideration is as follows:



	Three Months Ended						Nine Months Ended
	September 30, 2018			October 1, 2017			September 30, 2018			October 1, 2017
	(In thousands)
Balance at beginning of period	$	(74,093	)	$	(64,076	)	$	(65,328	)	$	(63,201	)
Additions	(5,800		)	—			(7,500		)	—
Amounts paid and foreign currency translation	16,507			—			16,507			34
Change in fair value (included within selling, general and administrative expenses)	(3,740		)	(651		)	(10,805		)	(1,560		)
Balance at end of period	$	(67,126	)	$	(64,727	)	$	(67,126	)	$	(64,727	)

XML 54 R44.htm IDEA: XBRL DOCUMENT

Basis of Presentation (Basis of Presentation) (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2018	Oct. 01, 2017	Sep. 30, 2018	Oct. 01, 2017	Dec. 30, 2018	Dec. 31, 2017	Jan. 01, 2018	Jan. 01, 2017
Basis of Presentation [Line Items]
Defined Benefit Plan, Other Cost (Credit)	$ (2,500,000)	$ (1,800,000)	$ (7,500,000)	$ (5,400,000)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents			(7,410,000)	19,945,000
Restricted Cash	$ 3,204,000	236,000	$ 3,204,000	236,000
Operating Cycle						52
Accounting Standards Update 2014-09 [Member]
Basis of Presentation [Line Items]
Cumulative Effect of New Accounting Principle in Period of Adoption							$ 10,200,000
Impact of New Accounting Principle, Deferred Revenue							(11,500,000)
Tax impact of Cumulative Adjustments, Deferred Income Tax							3,000,000
Accounting Standards Update 2016-16 [Member]
Basis of Presentation [Line Items]
Cumulative Effect of New Accounting Principle in Period of Adoption							2,000,000
Impact of New Accounting Principles, Deferred Tax Assets							10,700,000
Impact of New Accounting Principles, Prepaid Taxes							$ (12,800,000)
Accounting Standards Update 2016-18 [Member]
Basis of Presentation [Line Items]
Increase (Decrease) in Restricted Cash				(17,218,000)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents				(200,000)
Restricted Cash		236,000		236,000				$ 17,302,000
Accounting Standards Update 2017-07 [Member]
Basis of Presentation [Line Items]
Defined Benefit Plan, Other Cost (Credit)		$ 1,800,000		$ 5,400,000
Scenario, Forecast [Member]
Basis of Presentation [Line Items]
Operating Cycle					52

XML 55 R45.htm IDEA: XBRL DOCUMENT

Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Revenue (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Oct. 01, 2017	Sep. 30, 2018	Oct. 01, 2017	Jan. 01, 2018
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 674,313	$ 554,275	$ 2,021,647	$ 1,615,352
Contract with Customer, Asset and Liability [Abstract]
Contract with Customer, Asset, Net, Current	31,200		31,200		$ 22,700
Contract with Customer, Liability, Current	26,300		26,300		$ 29,000
Contract with Customer, Liability, Revenue Recognized			(20,400)
Increase (Decrease) in Unbilled Receivables			29,500
Unbilled Receivables Transferred To Accounts Receivables			(21,100)
Contract with Customer, Liability, Increase (Decrease)			17,600
Transferred at Point in Time [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	538,118		1,600,575
Transferred over Time [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	136,195		421,072
Americas [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	264,973		780,369
Europe [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	179,227		563,658
Asia [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	230,113		677,620
Discovery & Analytical Solutions [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	406,166	385,382	1,233,319	1,130,270
Discovery & Analytical Solutions [Member] \| Transferred at Point in Time [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	290,929		874,517
Discovery & Analytical Solutions [Member] \| Transferred over Time [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	115,237		358,802
Discovery & Analytical Solutions [Member] \| Americas [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	169,366		497,833
Discovery & Analytical Solutions [Member] \| Europe [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	110,747		357,766
Discovery & Analytical Solutions [Member] \| Asia [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	126,053		377,720
Diagnostics [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	268,147	$ 168,893	788,328	$ 485,082
Diagnostics [Member] \| Transferred at Point in Time [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	247,189		726,058
Diagnostics [Member] \| Transferred over Time [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	20,958		62,270
Diagnostics [Member] \| Americas [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	95,607		282,536
Diagnostics [Member] \| Europe [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	68,480		205,892
Diagnostics [Member] \| Asia [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	104,060		299,900
Diagnostics [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	268,147		788,328
Diagnostics [Member] \| Discovery & Analytical Solutions [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	0		0
Diagnostics [Member] \| Diagnostics [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	268,147		788,328
Life Sciences [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	222,191		675,807
Life Sciences [Member] \| Discovery & Analytical Solutions [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	222,191		675,807
Life Sciences [Member] \| Diagnostics [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	0		0
Applied Markets [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	183,975		557,512
Applied Markets [Member] \| Discovery & Analytical Solutions [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	183,975		557,512
Applied Markets [Member] \| Diagnostics [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 0		$ 0

XML 56 R46.htm IDEA: XBRL DOCUMENT

Changes in Accounting Policies (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Oct. 01, 2017	Sep. 30, 2018	Oct. 01, 2017	Dec. 31, 2017
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	$ (674,313)	$ (554,275)	$ (2,021,647)	$ (1,615,352)
Cost of Revenue	341,986	285,308	1,056,958	849,027
Selling, general and administrative expenses	196,769	152,775	601,374	449,642
Research and development expenses	48,848	34,885	142,028	101,731
Restructuring and contract termination charges, net	6,508	3,269	13,086	12,920
Operating income (loss) from continuing operations	80,202	78,038	208,201	202,032
Nonoperating Income (Expense)	2,161	(27,016)	29,947	(13,797)
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest	78,041	105,054	178,254	215,829
Provision for income taxes	2,596	8,508	12,101	20,495
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent	75,445	96,546	166,153	195,334
Income from discontinued operations before income taxes	0	0	0	650
(Loss) gain on disposition of discontinued operations before income taxes	(308)	(206)	(859)	180,171
Cash and cash equivalents	149,513	709,488	149,513	709,488	$ 202,134
Accounts receivable, net	(551,385)		(551,385)		(552,304)
Inventories	354,244		354,244		351,675
Other current assets	(110,353)		(110,353)		(93,842)
Property, Plant and Equipment, Net	317,049		317,049		298,066
Intangible assets, net	1,223,775		1,223,775		1,346,940
Goodwill	2,920,689		2,920,689		3,002,198
Other assets, net	235,347		235,347		244,304
Assets	(5,862,355)		(5,862,355)		(6,091,463)
Current portion of long-term debt	20,072		20,072		217,306
Accounts payable	180,693		180,693		222,093
Accrued expenses and other current liabilities	8,079		8,079		8,759
Accrued expenses and other current liabilities	475,743		475,743		500,642
Current liabilities of discontinued operations	2,165		2,165		2,102
Long-term debt	1,882,502		1,882,502		1,788,803
Long-term liabilities	720,632		720,632		848,570
Liabilities	3,289,886		3,289,886		3,588,275
Preferred Stock, Value, Issued	0		0		0
Common Stock, Value, Issued	111,087		111,087		110,361
Capital in excess of par value	89,970		89,970		58,828
Retained earnings	2,532,060		2,532,060		2,380,517
Accumulated other comprehensive loss	(160,648)		(160,648)		(46,518)
Stockholders' Equity Attributable to Parent	2,572,469		2,572,469		2,503,188
Liabilities and Equity	(5,862,355)		(5,862,355)		$ (6,091,463)
Discontinued Operation, Tax Effect of Discontinued Operation	(1,411)	5,262	(1,341)	42,405
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	1,103	(5,468)	482	138,416
Net income	76,548	91,078	166,635	333,750
Difference between Revenue Guidance in Effect before and after Topic 606 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	(3,198)		(25,562)
Cost of Revenue	98		7,780
Selling, general and administrative expenses	47		300
Research and development expenses	0		0
Restructuring and contract termination charges, net	0		0
Operating income (loss) from continuing operations	(3,147)		(18,082)
Nonoperating Income (Expense)	0		0
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest	(3,147)		(18,082)
Provision for income taxes	(814)		(4,753)
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent	(2,333)		(13,329)
(Loss) gain on disposition of discontinued operations before income taxes	0		0
Cash and cash equivalents	0		0
Accounts receivable, net	(11,554)		(11,554)
Inventories	7,451		7,451
Other current assets	(522)		(522)
Property, Plant and Equipment, Net	0		0
Intangible assets, net	0		0
Goodwill	0		0
Other assets, net	0		0
Assets	(4,625)		(4,625)
Current portion of long-term debt	0		0
Accounts payable	0		0
Accrued expenses and other current liabilities	0		0
Accrued expenses and other current liabilities	18,912		18,912
Current liabilities of discontinued operations	0		0
Long-term debt	0		0
Long-term liabilities	0		0
Liabilities	18,912		18,912
Preferred Stock, Value, Issued	0		0
Common Stock, Value, Issued	0		0
Capital in excess of par value	0		0
Retained earnings	(23,537)		(23,537)
Accumulated other comprehensive loss	0		0
Stockholders' Equity Attributable to Parent	(23,537)		(23,537)
Liabilities and Equity	(4,625)		(4,625)
Discontinued Operation, Tax Effect of Discontinued Operation	0		0
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	0		0
Net income	(2,333)		(13,329)
Calculated under Revenue Guidance in Effect before Topic 606 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	(671,115)		(1,996,085)
Cost of Revenue	341,888		1,049,178
Selling, general and administrative expenses	196,816		601,674
Research and development expenses	48,848		142,028
Restructuring and contract termination charges, net	6,508		13,086
Operating income (loss) from continuing operations	77,055		190,119
Nonoperating Income (Expense)	2,161		29,947
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest	74,894		160,172
Provision for income taxes	1,782		7,348
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent	73,112		152,824
(Loss) gain on disposition of discontinued operations before income taxes	(308)		(859)
Cash and cash equivalents	149,513		149,513
Accounts receivable, net	(539,831)		(539,831)
Inventories	361,695		361,695
Other current assets	(109,831)		(109,831)
Property, Plant and Equipment, Net	317,049		317,049
Intangible assets, net	1,223,775		1,223,775
Goodwill	2,920,689		2,920,689
Other assets, net	235,347		235,347
Assets	(5,857,730)		(5,857,730)
Current portion of long-term debt	20,072		20,072
Accounts payable	180,693		180,693
Accrued expenses and other current liabilities	8,079		8,079
Accrued expenses and other current liabilities	494,655		494,655
Current liabilities of discontinued operations	2,165		2,165
Long-term debt	1,882,502		1,882,502
Long-term liabilities	720,632		720,632
Liabilities	3,308,798		3,308,798
Preferred Stock, Value, Issued	0		0
Common Stock, Value, Issued	111,087		111,087
Capital in excess of par value	89,970		89,970
Retained earnings	2,508,523		2,508,523
Accumulated other comprehensive loss	(160,648)		(160,648)
Stockholders' Equity Attributable to Parent	2,548,932		2,548,932
Liabilities and Equity	(5,857,730)		(5,857,730)
Discontinued Operation, Tax Effect of Discontinued Operation	(1,411)		(1,341)
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	1,103		482
Net income	74,215		153,306
Accounting Standards Update 2014-09 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Impact of New Accounting Principle, Comprehensive income	(2,300)		(13,300)
Product [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	(474,523)	(354,819)	(1,417,739)	(1,043,534)
Cost of Goods and Services Sold	(213,672)	(165,015)	(663,651)	(501,079)
Product [Member] \| Difference between Revenue Guidance in Effect before and after Topic 606 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	(3,198)		(25,562)
Cost of Goods and Services Sold	(98)		(7,780)
Product [Member] \| Calculated under Revenue Guidance in Effect before Topic 606 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	(471,325)		(1,392,177)
Cost of Goods and Services Sold	(213,574)		(655,871)
Service [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	(199,790)	(199,456)	(603,908)	(571,818)
Cost of Goods and Services Sold	(128,314)	$ (120,293)	(393,307)	$ (347,948)
Service [Member] \| Difference between Revenue Guidance in Effect before and after Topic 606 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	0		0
Cost of Goods and Services Sold	0		0
Service [Member] \| Calculated under Revenue Guidance in Effect before Topic 606 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	(199,790)		(603,908)
Cost of Goods and Services Sold	$ (128,314)		$ (393,307)

XML 57 R47.htm IDEA: XBRL DOCUMENT

Business Combinations (Narrative) (Details)	3 Months Ended				9 Months Ended		12 Months Ended
Business Combinations (Narrative) (Details)	Dec. 30, 2018 USD ($)	Sep. 30, 2018 USD ($)	Apr. 01, 2018 USD ($)	Oct. 01, 2017 USD ($) $ / shares	Sep. 30, 2018 USD ($)	Oct. 01, 2017 USD ($) $ / shares	Dec. 31, 2017 USD ($) employees	Jan. 03, 2016 USD ($)	Jul. 01, 2018 USD ($)	Jul. 02, 2017 USD ($)	Jan. 01, 2017 USD ($)
Business Acquisition [Line Items]
Number of Years in Measurement Period from Acquisition Date to Change Underlying Assumptions					1 year
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High		$ 76,500,000			$ 76,500,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value		67,126,000		$ 64,727,000	$ 67,126,000	$ 64,727,000	$ 65,328,000		$ 74,093,000	$ 64,076,000	$ 63,201,000
Business Combination, Contingent Consideration Arrangements, Maximum Period					2 years
Business Combination, Contingent Consideration Arrangements, Weighted Average Period					7 months
Total transaction costs		1,700,000		(30,800,000)	$ 5,500,000	(30,100,000)
Business Combination, Contingent Consideration Arrangements, Description					Contingent consideration is measured at fair value at the acquisition date, based on the probability that revenue thresholds or product development milestones will be achieved during the earnout period, with changes in the fair value after the acquisition date affecting earnings to the extent it is to be settled in cash.
Goodwill		2,920,689,000			$ 2,920,689,000		3,002,198,000
Business Combination, Contingent Consideration, Liability, Current		61,300,000			61,300,000		52,200,000
Business Combination, Contingent Consideration, Liability, Noncurrent		5,800,000			5,800,000		13,100,000
Foreign Currency Transaction Gain (Loss), before Tax		(4,300,000)		2,700,000	8,800,000	5,400,000
EUROIMMUM [Member]
Business Acquisition [Line Items]
Business Acquisition, Pro Forma Revenue				640,154,000		1,846,233,000
Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual							13,500,000
Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual							$ (1,000,000)
Business Acquisition, Percentage of Voting Interests Acquired							99.98%
Business Acquisition, Cost Of Acquired Entity, Working Capital Adjustments							$ 0
Business Combination, Consideration Transferred							1,388,762,000.000
Cash Acquired							(25,018,000)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets							121,174,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment							$ 130,512,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets		49,679,000			$ 49,679,000
Entity Number of Employees \| employees							2,400
Cash paid to the shareholders							$ 1,413,780,000.000
Business Combination, Consideration Transferred, Liabilities Incurred							0
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life					16 years 1 month
Goodwill		581,172,000			$ 581,172,000
Intangible Assets, Gross (Excluding Goodwill)		907,400,000			907,400,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt							61,357,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net							1,388,762,000
Business Acquisition, Pro Forma Income (Loss) from Continuing Operations, Net of Tax				$ 94,055,000		$ 172,672,000
Business Acquisition, Pro Forma Earnings Per Share, Basic \| $ / shares				$ 0.86		$ 1.57
Business Acquisition, Pro Forma Earnings Per Share, Diluted \| $ / shares				$ 0.85		$ 1.56
Fiscal Year 2018 Acquisitions [Member]
Business Acquisition [Line Items]
Business Acquisition, Cost Of Acquired Entity, Working Capital Adjustments					(599,000)
Business Combination, Consideration Transferred					54,257,000.000
Cash Acquired					1,138,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets		3,469,000			3,469,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment		937,000			937,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets		430,000			430,000
Cash paid to the shareholders					43,942,000
Business Combination, Consideration Transferred, Liabilities Incurred					$ 3,354,000
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life					14 years 7 months
Business Acquisition, Cost of Acquired Entity, Liabilities Incurred, Contingent Consideration at Fair Value					$ 7,500,000
Goodwill		28,423,000			28,423,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt		208,000			208,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net		54,257,000			54,257,000
Fiscal Year 2017 Other Acquisitions [Member]
Business Acquisition [Line Items]
Business Acquisition, Cost Of Acquired Entity, Working Capital Adjustments							93,000
Business Combination, Consideration Transferred							139,602,000.000
Cash Acquired							2,439,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets							16,268,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment							11,356,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets							1,691,000
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments							142,041,000
Cash paid to the shareholders							140,861,000
Business Combination, Consideration Transferred, Liabilities Incurred							1,273,000
Goodwill							75,250,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt							0
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net							139,602,000
Vanadis Diagnostics AB [Member]
Business Acquisition [Line Items]
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High								$ 93,000,000
Business Acquisition, Cost of Acquired Entity, Liabilities Incurred, Contingent Consideration at Fair Value					59,599,000			$ 56,878,000
Tulip Diagnostics Private Limited [Member]
Business Acquisition [Line Items]
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments							$ 127,280,000
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life							11 years 9 months
Foreign Currency Transaction Gain (Loss), before Tax		100,000			1,000,000
Euroimmun [Member]
Business Acquisition [Line Items]
Goodwill, Purchase Accounting Adjustments		(1,520,000)
Business Combination, Increase (Decrease) in Property and Equipment		500,000
Business Combination, Increase (Decrease) in Other Assets		(265,000)
Business Combination, Increase (Decrease) in Liabilities Assumed		1,200,000
Business Combination, Increase (Decrease) in Deferred Tax Liabilities		66,000
Foreign Currency Transaction Gain (Loss), before Tax				$ 36,300,000		$ 42,000,000
Fiscal Year 2017 Other Acquisitions, Excluding Tulip [Member]
Business Acquisition [Line Items]
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments							$ 14,700,000
Diagnostics [Member]
Business Acquisition [Line Items]
Goodwill		1,610,601,000			1,610,601,000		1,657,963,000
Discovery & Analytical Solutions [Member]
Business Acquisition [Line Items]
Goodwill		1,310,088,000			1,310,088,000		1,344,235,000
Core Technology [Member] \| EUROIMMUM [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles							160,000,000
Core Technology [Member] \| Fiscal Year 2018 Acquisitions [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles		15,957,000			15,957,000
Core Technology [Member] \| Fiscal Year 2017 Other Acquisitions [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles							12,400,000
Customer Relationships [Member] \| EUROIMMUM [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles		710,000,000			710,000,000
Customer Relationships [Member] \| Fiscal Year 2018 Acquisitions [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles		10,800,000			10,800,000
Customer Relationships [Member] \| Fiscal Year 2017 Other Acquisitions [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles							43,700,000
Trade Names [Member] \| EUROIMMUM [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles							36,000,000
Trade Names [Member] \| Fiscal Year 2018 Acquisitions [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles		1,010,000			1,010,000
Trade Names [Member] \| Fiscal Year 2017 Other Acquisitions [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles							3,000,000
In-process Research and Development [Member] \| EUROIMMUM [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles							1,400,000
In-process Research and Development [Member] \| Fiscal Year 2017 Other Acquisitions [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles							0
Euro Member Countries, Euro \| EUROIMMUM [Member]
Business Acquisition [Line Items]
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments							1,200,000,000
Euro Member Countries, Euro \| Subsequent Event [Member] \| Dani Analitica S.r.l. [Member]
Business Acquisition [Line Items]
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments	$ 43,060,000
India, Rupees \| Tulip Diagnostics Private Limited [Member]
Business Acquisition [Line Items]
Business Combination, Payment of Stay Bonus			$ 716,286,000
Business Combination, Remaining Stay Bonus To Be Paid		803,600,000			803,600,000
Business Combination, Stay Bonus Which May Be Paid, Maximum							1,600,000,000
United States of America, Dollars \| EUROIMMUM [Member]
Business Acquisition [Line Items]
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments							1,413,780,000
United States of America, Dollars \| Fiscal Year 2018 Acquisitions [Member]
Business Acquisition [Line Items]
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments					55,395,000
United States of America, Dollars \| Tulip Diagnostics Private Limited [Member]
Business Acquisition [Line Items]
Business Combination, Payment of Stay Bonus			$ 11,254,000
Business Combination, Remaining Stay Bonus To Be Paid		11,100,000			11,100,000
Business Combination, Stay Bonus Which May Be Paid, Maximum							25,200,000
United States of America, Dollars \| Shanghai Spectrum Instruments Co., Ltd. [Member]
Business Acquisition [Line Items]
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments					15,398,000
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High		2,000,000			2,000,000
Business Acquisition, Cost of Acquired Entity, Liabilities Incurred, Contingent Consideration at Fair Value					1,700,000
Business Combination, Additional Consideration, Liability		2,500,000			2,500,000
Business Combination, Additional Consideration, Liability, at Fair Value		2,400,000			2,400,000
United States of America, Dollars \| RHS Limited [Member]
Business Acquisition [Line Items]
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments					19,442,000
United States of America, Dollars \| DNA Labs [Member]
Business Acquisition [Line Items]
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments					9,000,000
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High		8,000,000			8,000,000
Business Acquisition, Cost of Acquired Entity, Liabilities Incurred, Contingent Consideration at Fair Value					5,800,000
Business Combination, Working Capital Adjustments To Be Paid		700,000			700,000
Business Combination, Additional Consideration, Liability		$ 1,000,000			$ 1,000,000
Cash and Cash Equivalents [Member] \| United States of America, Dollars \| EUROIMMUM [Member]
Business Acquisition [Line Items]
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments							503,780,000
Term Loan Credit Facility, 12 Months Maturity [Member] \| United States of America, Dollars \| EUROIMMUM [Member]
Business Acquisition [Line Items]
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments							200,000,000
Line of Credit, Maturing August 11, 2021 [Member] \| United States of America, Dollars \| EUROIMMUM [Member]
Business Acquisition [Line Items]
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments							$ 710,000,000

XML 58 R48.htm IDEA: XBRL DOCUMENT

Business Combinations (Fair Values of the Business Combinations and Allocations for the Acquisitions Completed) (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2018	Dec. 31, 2017
Business Acquisition [Line Items]
Goodwill	$ 2,920,689,000	$ 3,002,198,000
EUROIMMUM [Member]
Business Acquisition [Line Items]
Business Acquisition, Cost of Acquired Entity, Cash Paid		1,413,780,000.000
Business Combination, Consideration Transferred, Liabilities Incurred		0
Business Acquisition, Cost Of Acquired Entity, Working Capital Adjustments		0
Cash Acquired		(25,018,000)
Business Combination, Consideration Transferred		1,388,762,000.000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets		121,174,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment		130,512,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets	49,679,000
Goodwill	581,172,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities, Total	(253,288,000)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities	(86,530,000)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net		1,388,762,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt		(61,357,000)
Fiscal Year 2017 Other Acquisitions [Member]
Business Acquisition [Line Items]
Business Acquisition, Cost of Acquired Entity, Cash Paid		140,861,000
Business Combination, Consideration Transferred, Liabilities Incurred		1,273,000
Business Acquisition, Cost Of Acquired Entity, Working Capital Adjustments		93,000
Cash Acquired		2,439,000
Business Combination, Consideration Transferred		139,602,000.000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets		16,268,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment		11,356,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets		1,691,000
Goodwill		75,250,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities, Total		(15,735,000)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities		(8,328,000)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net		139,602,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt		0
Fiscal Year 2018 Acquisitions [Member]
Business Acquisition [Line Items]
Business Acquisition, Cost of Acquired Entity, Cash Paid	43,942,000
Business Combination, Consideration Transferred, Liabilities Incurred	3,354,000
Business Acquisition, Cost of Acquired Entity, Liabilities Incurred, Contingent Consideration at Fair Value	(7,500,000)
Business Acquisition, Cost Of Acquired Entity, Working Capital Adjustments	(599,000)
Cash Acquired	1,138,000
Business Combination, Consideration Transferred	54,257,000.000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets	3,469,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	937,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets	430,000
Goodwill	28,423,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities, Total	(2,524,000)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities	(4,037,000)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net	54,257,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt	(208,000)
Core Technology [Member] \| EUROIMMUM [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles		160,000,000
Core Technology [Member] \| Fiscal Year 2017 Other Acquisitions [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles		12,400,000
Core Technology [Member] \| Fiscal Year 2018 Acquisitions [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	15,957,000
Trade Names [Member] \| EUROIMMUM [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles		36,000,000
Trade Names [Member] \| Fiscal Year 2017 Other Acquisitions [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles		3,000,000
Trade Names [Member] \| Fiscal Year 2018 Acquisitions [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	1,010,000
Customer Relationships [Member] \| EUROIMMUM [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	710,000,000
Customer Relationships [Member] \| Fiscal Year 2017 Other Acquisitions [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles		43,700,000
Customer Relationships [Member] \| Fiscal Year 2018 Acquisitions [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	10,800,000
In-process Research and Development [Member] \| EUROIMMUM [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles		1,400,000
In-process Research and Development [Member] \| Fiscal Year 2017 Other Acquisitions [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles		0
Diagnostics [Member]
Business Acquisition [Line Items]
Goodwill	1,610,601,000	1,657,963,000
Discovery & Analytical Solutions [Member]
Business Acquisition [Line Items]
Goodwill	1,310,088,000	$ 1,344,235,000
United States of America, Dollars \| Shanghai Spectrum Instruments Co., Ltd. [Member]
Business Acquisition [Line Items]
Business Acquisition, Cost of Acquired Entity, Liabilities Incurred, Contingent Consideration at Fair Value	$ (1,700,000)

XML 59 R49.htm IDEA: XBRL DOCUMENT

Discontinued Operations (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2018	Oct. 01, 2017	Sep. 30, 2018	Oct. 01, 2017	Dec. 31, 2017
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operation, Revenue	$ 0	$ 0	$ 0	$ 44,343
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	1,103	(5,468)	482	138,416
Income from discontinued operations before income taxes	0	0	0	650
Pre-tax gain (loss) on disposal of business unit	(308)	(206)	(859)	180,171
Discontinued Operation, Tax Effect of Discontinued Operation	(1,411)	5,262	(1,341)	42,405
Current liabilities of discontinued operations	2,165		2,165		$ 2,102
Disposal Group, Including Discontinued Operation, Costs of Goods Sold	0	0	0	32,933
Disposal Group, Including Discontinued Operation, General and Administrative Expense	0	0	0	5,869
Disposal Group, Including Discontinued Operations, Research and development expenses	0	0	0	4,891
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax	0	$ 0	$ 0	$ 650
Medical Imaging Business [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operation, Consideration					277,400
Disposal Group, Including Discontinued Operation, Working Capital Adjustment					4,200
Pre-tax gain (loss) on disposal of business unit					179,615
Discontinued Operation, Tax Effect of Gain (Loss) from Disposal of Discontinued Operation					43,131
Discontinued Operation, Period of Continuing Involvement after Disposal			12 months
Suzhou PerkinElmer Medical Laboratory Co. Ltd [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operation, Consideration					2,300
Pre-tax gain (loss) on disposal of business unit					$ (1,108)
Multispectral Imaging Business [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operation, Consideration	37,300		$ 37,300
Pre-tax gain (loss) on disposal of business unit	$ 13,031

XML 60 R50.htm IDEA: XBRL DOCUMENT

Restructuring and Lease Charges, Net (Narrative) (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2018	Dec. 31, 2017
Restructuring Cost and Reserve [Line Items]
Accrued restructuring and integration costs	$ 9,421	$ 13,969
Accrued expenses and other current liabilities	8,079	8,759
Restructuring Reserve, Noncurrent	1,300	2,300
Restructuring Reserve, Current other		$ 2,900
Restructuring Reserve, Accrual Adjustment	$ 580

XML 61 R51.htm IDEA: XBRL DOCUMENT

Restructuring and Lease Charges, Net (Schedule of Initial Charges) (Details) $ in Thousands	3 Months Ended					9 Months Ended
	Sep. 30, 2018 USD ($) employees	Apr. 01, 2018 USD ($) employees	Dec. 31, 2017 USD ($) employees	Oct. 01, 2017 USD ($) employees	Apr. 02, 2017 USD ($) employees	Sep. 30, 2018 USD ($)
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	$ 9,421		$ 13,969			$ 9,421
Restructuring and contract termination charges, net						12,506
Restructuring Reserve, Accrual Adjustment						580
Restructuring reserve Settled with Cash and Translation Adjustment						(17,634)
Q3 2018 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Number of Positions Eliminated \| employees	61
Restructuring and contract termination charges, net	$ 1,764
Q1 2018 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Number of Positions Eliminated \| employees		47
Restructuring and contract termination charges, net		$ 5,998
Q4 2017 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Number of Positions Eliminated \| employees			29
Restructuring and contract termination charges, net			$ 1,935
Q3 2017 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Number of Positions Eliminated \| employees				27
Restructuring and contract termination charges, net				$ 2,342
Q1 2017 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Number of Positions Eliminated \| employees					90
Restructuring and contract termination charges, net					$ 6,697
Employee Severance [Member] \| Q3 2018 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	1,764		0			1,764
Restructuring and contract termination charges, net						1,764
Restructuring Reserve, Accrual Adjustment						0
Restructuring reserve Settled with Cash and Translation Adjustment						0
Employee Severance [Member] \| Q1 2018 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	1,725		0			1,725
Restructuring and contract termination charges, net						5,998
Restructuring Reserve, Accrual Adjustment						0
Restructuring reserve Settled with Cash and Translation Adjustment						(4,273)
Employee Severance [Member] \| Q4 2017 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	381		1,919			381
Restructuring and contract termination charges, net						0
Restructuring Reserve, Accrual Adjustment						0
Restructuring reserve Settled with Cash and Translation Adjustment						(1,538)
Employee Severance [Member] \| Q3 2017 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	1,204		2,072			1,204
Restructuring and contract termination charges, net						0
Restructuring Reserve, Accrual Adjustment						0
Restructuring reserve Settled with Cash and Translation Adjustment						(868)
Employee Severance [Member] \| Q1 2017 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	1,324		2,498			1,324
Restructuring and contract termination charges, net						0
Restructuring Reserve, Accrual Adjustment						0
Restructuring reserve Settled with Cash and Translation Adjustment						1,174
Facility Closing [Member] \| Q1 2017 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	11		33			11
Restructuring and contract termination charges, net						0
Restructuring Reserve, Accrual Adjustment						0
Restructuring reserve Settled with Cash and Translation Adjustment						$ (22)
Diagnostics [Member] \| Employee Severance [Member] \| Q3 2018 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and contract termination charges, net	618
Diagnostics [Member] \| Employee Severance [Member] \| Q1 2018 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and contract termination charges, net		902
Diagnostics [Member] \| Employee Severance [Member] \| Q4 2017 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and contract termination charges, net			255
Diagnostics [Member] \| Employee Severance [Member] \| Q3 2017 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and contract termination charges, net				1,021
Diagnostics [Member] \| Employee Severance [Member] \| Q1 2017 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and contract termination charges, net					1,631
Diagnostics [Member] \| Facility Closing [Member] \| Q3 2018 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and contract termination charges, net	0
Diagnostics [Member] \| Facility Closing [Member] \| Q1 2018 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and contract termination charges, net		0
Diagnostics [Member] \| Facility Closing [Member] \| Q4 2017 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and contract termination charges, net			0
Diagnostics [Member] \| Facility Closing [Member] \| Q3 2017 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and contract termination charges, net				0
Diagnostics [Member] \| Facility Closing [Member] \| Q1 2017 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and contract termination charges, net					33
Discovery & Analytical Solutions [Member] \| Employee Severance [Member] \| Q3 2018 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and contract termination charges, net	1,146
Discovery & Analytical Solutions [Member] \| Employee Severance [Member] \| Q1 2018 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and contract termination charges, net		5,096
Discovery & Analytical Solutions [Member] \| Employee Severance [Member] \| Q4 2017 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and contract termination charges, net			1,680
Discovery & Analytical Solutions [Member] \| Employee Severance [Member] \| Q3 2017 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and contract termination charges, net				1,321
Discovery & Analytical Solutions [Member] \| Employee Severance [Member] \| Q1 2017 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and contract termination charges, net					5,000
Discovery & Analytical Solutions [Member] \| Facility Closing [Member] \| Q3 2018 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and contract termination charges, net	$ 0
Discovery & Analytical Solutions [Member] \| Facility Closing [Member] \| Q1 2018 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and contract termination charges, net		$ 0
Discovery & Analytical Solutions [Member] \| Facility Closing [Member] \| Q4 2017 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and contract termination charges, net			$ 0
Discovery & Analytical Solutions [Member] \| Facility Closing [Member] \| Q3 2017 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and contract termination charges, net				$ 0
Discovery & Analytical Solutions [Member] \| Facility Closing [Member] \| Q1 2017 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and contract termination charges, net					$ 33

XML 62 R52.htm IDEA: XBRL DOCUMENT

Restructuring and Lease Charges, Net (Schedule of Restructuring Plan Activity) (Details) - USD ($) $ in Thousands	3 Months Ended					9 Months Ended
	Sep. 30, 2018	Apr. 01, 2018	Dec. 31, 2017	Oct. 01, 2017	Apr. 02, 2017	Sep. 30, 2018
Restructuring Reserve [Roll Forward]
Balance at beginning of period		$ 13,969				$ 13,969
Restructuring and contract termination charges, net						12,506
Restructuring Reserve, Accrual Adjustment						580
Restructuring reserve Settled with Cash and Translation Adjustment						(17,634)
Balance at end of period	$ 9,421		$ 13,969			9,421
Employee Severance and Facility Closing [Member]
Restructuring Reserve [Roll Forward]
Balance at beginning of period		10,921				10,921
Restructuring and contract termination charges, net						7,762
Restructuring Reserve, Accrual Adjustment						353
Restructuring reserve Settled with Cash and Translation Adjustment						(9,981)
Balance at end of period	9,055		10,921			9,055
Contract Termination [Member]
Restructuring Reserve [Roll Forward]
Balance at beginning of period		3,048				3,048
Restructuring and contract termination charges, net						4,744
Restructuring Reserve, Accrual Adjustment						227
Restructuring reserve Settled with Cash and Translation Adjustment						(7,653)
Balance at end of period	366		3,048			366
Q3 2018 Restructuring Plan [Member]
Restructuring Reserve [Roll Forward]
Restructuring and contract termination charges, net	1,764
Q3 2018 Restructuring Plan [Member] \| Employee Severance [Member]
Restructuring Reserve [Roll Forward]
Balance at beginning of period		0				0
Restructuring and contract termination charges, net						1,764
Restructuring Reserve, Accrual Adjustment						0
Restructuring reserve Settled with Cash and Translation Adjustment						0
Balance at end of period	1,764		0			1,764
Q1 2018 Restructuring Plan [Member]
Restructuring Reserve [Roll Forward]
Restructuring and contract termination charges, net		5,998
Q1 2018 Restructuring Plan [Member] \| Employee Severance [Member]
Restructuring Reserve [Roll Forward]
Balance at beginning of period		0				0
Restructuring and contract termination charges, net						5,998
Restructuring Reserve, Accrual Adjustment						0
Restructuring reserve Settled with Cash and Translation Adjustment						(4,273)
Balance at end of period	1,725		0			1,725
Q4 2017 Restructuring Plan [Member]
Restructuring Reserve [Roll Forward]
Restructuring and contract termination charges, net			1,935
Q4 2017 Restructuring Plan [Member] \| Employee Severance [Member]
Restructuring Reserve [Roll Forward]
Balance at beginning of period		1,919				1,919
Restructuring and contract termination charges, net						0
Restructuring Reserve, Accrual Adjustment						0
Restructuring reserve Settled with Cash and Translation Adjustment						(1,538)
Balance at end of period	381		1,919			381
Q3 2017 Restructuring Plan [Member]
Restructuring Reserve [Roll Forward]
Restructuring and contract termination charges, net				$ 2,342
Q3 2017 Restructuring Plan [Member] \| Employee Severance [Member]
Restructuring Reserve [Roll Forward]
Balance at beginning of period		2,072				2,072
Restructuring and contract termination charges, net						0
Restructuring Reserve, Accrual Adjustment						0
Restructuring reserve Settled with Cash and Translation Adjustment						(868)
Balance at end of period	1,204		2,072			1,204
Q1 2017 Restructuring Plan [Member]
Restructuring Reserve [Roll Forward]
Restructuring and contract termination charges, net					$ 6,697
Q1 2017 Restructuring Plan [Member] \| Employee Severance [Member]
Restructuring Reserve [Roll Forward]
Balance at beginning of period		2,498				2,498
Restructuring and contract termination charges, net						0
Restructuring Reserve, Accrual Adjustment						0
Restructuring reserve Settled with Cash and Translation Adjustment						1,174
Balance at end of period	1,324		2,498			1,324
Q1 2017 Restructuring Plan [Member] \| Facility Closing [Member]
Restructuring Reserve [Roll Forward]
Balance at beginning of period		33				33
Restructuring and contract termination charges, net						0
Restructuring Reserve, Accrual Adjustment						0
Restructuring reserve Settled with Cash and Translation Adjustment						(22)
Balance at end of period	11		33			11
Previous restructuring and integration plans [Member] \| Employee Severance and Facility Closing [Member]
Restructuring Reserve [Roll Forward]
Balance at beginning of period		4,399				4,399
Restructuring and contract termination charges, net						0
Restructuring Reserve, Accrual Adjustment						353
Restructuring reserve Settled with Cash and Translation Adjustment						(2,106)
Balance at end of period	2,646		4,399			2,646
Diagnostics [Member] \| Q3 2018 Restructuring Plan [Member] \| Employee Severance [Member]
Restructuring Reserve [Roll Forward]
Restructuring and contract termination charges, net	618
Diagnostics [Member] \| Q3 2018 Restructuring Plan [Member] \| Facility Closing [Member]
Restructuring Reserve [Roll Forward]
Restructuring and contract termination charges, net	0
Diagnostics [Member] \| Q1 2018 Restructuring Plan [Member] \| Employee Severance [Member]
Restructuring Reserve [Roll Forward]
Restructuring and contract termination charges, net		902
Diagnostics [Member] \| Q1 2018 Restructuring Plan [Member] \| Facility Closing [Member]
Restructuring Reserve [Roll Forward]
Restructuring and contract termination charges, net		0
Diagnostics [Member] \| Q4 2017 Restructuring Plan [Member] \| Employee Severance [Member]
Restructuring Reserve [Roll Forward]
Restructuring and contract termination charges, net			255
Diagnostics [Member] \| Q4 2017 Restructuring Plan [Member] \| Facility Closing [Member]
Restructuring Reserve [Roll Forward]
Restructuring and contract termination charges, net			0
Diagnostics [Member] \| Q3 2017 Restructuring Plan [Member] \| Employee Severance [Member]
Restructuring Reserve [Roll Forward]
Restructuring and contract termination charges, net				1,021
Diagnostics [Member] \| Q3 2017 Restructuring Plan [Member] \| Facility Closing [Member]
Restructuring Reserve [Roll Forward]
Restructuring and contract termination charges, net				0
Diagnostics [Member] \| Q1 2017 Restructuring Plan [Member] \| Employee Severance [Member]
Restructuring Reserve [Roll Forward]
Restructuring and contract termination charges, net					1,631
Diagnostics [Member] \| Q1 2017 Restructuring Plan [Member] \| Facility Closing [Member]
Restructuring Reserve [Roll Forward]
Restructuring and contract termination charges, net					33
Discovery & Analytical Solutions [Member] \| Contract Termination [Member]
Restructuring Reserve [Roll Forward]
Restructuring and contract termination charges, net	4,744					$ 4,971
Discovery & Analytical Solutions [Member] \| Q3 2018 Restructuring Plan [Member] \| Employee Severance [Member]
Restructuring Reserve [Roll Forward]
Restructuring and contract termination charges, net	1,146
Discovery & Analytical Solutions [Member] \| Q3 2018 Restructuring Plan [Member] \| Facility Closing [Member]
Restructuring Reserve [Roll Forward]
Restructuring and contract termination charges, net	$ 0
Discovery & Analytical Solutions [Member] \| Q1 2018 Restructuring Plan [Member] \| Employee Severance [Member]
Restructuring Reserve [Roll Forward]
Restructuring and contract termination charges, net		5,096
Discovery & Analytical Solutions [Member] \| Q1 2018 Restructuring Plan [Member] \| Facility Closing [Member]
Restructuring Reserve [Roll Forward]
Restructuring and contract termination charges, net		$ 0
Discovery & Analytical Solutions [Member] \| Q4 2017 Restructuring Plan [Member] \| Employee Severance [Member]
Restructuring Reserve [Roll Forward]
Restructuring and contract termination charges, net			1,680
Discovery & Analytical Solutions [Member] \| Q4 2017 Restructuring Plan [Member] \| Facility Closing [Member]
Restructuring Reserve [Roll Forward]
Restructuring and contract termination charges, net			$ 0
Discovery & Analytical Solutions [Member] \| Q3 2017 Restructuring Plan [Member] \| Employee Severance [Member]
Restructuring Reserve [Roll Forward]
Restructuring and contract termination charges, net				1,321
Discovery & Analytical Solutions [Member] \| Q3 2017 Restructuring Plan [Member] \| Facility Closing [Member]
Restructuring Reserve [Roll Forward]
Restructuring and contract termination charges, net				$ 0
Discovery & Analytical Solutions [Member] \| Q1 2017 Restructuring Plan [Member] \| Employee Severance [Member]
Restructuring Reserve [Roll Forward]
Restructuring and contract termination charges, net					5,000
Discovery & Analytical Solutions [Member] \| Q1 2017 Restructuring Plan [Member] \| Facility Closing [Member]
Restructuring Reserve [Roll Forward]
Restructuring and contract termination charges, net					$ 33

XML 63 R53.htm IDEA: XBRL DOCUMENT

Interest and Other Expense (Income), Net (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Oct. 01, 2017	Sep. 30, 2018	Oct. 01, 2017
Other Income and Expenses [Abstract]
Interest income	$ (316)	$ (802)	$ (754)	$ (1,512)
Interest expense	16,684	10,974	50,745	32,510
Gain on disposition of businesses and assets, net	(13,031)	0	(13,031)	301
Other expense, net	(1,176)	(37,188)	(7,013)	(45,096)
Total interest and other expense, net	2,161	(27,016)	29,947	(13,797)
Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments	(2,500)	(32,700)	9,800	(34,400)
Foreign Currency Transaction Gain (Loss), before Tax	(4,300)	2,700	8,800	5,400
Defined Benefit Plan, Other Cost (Credit)	$ (2,500)	$ (1,800)	$ (7,500)	$ (5,400)

XML 64 R54.htm IDEA: XBRL DOCUMENT

Inventories, Net (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Inventory Disclosure [Abstract]
Raw materials	$ 117,266	$ 122,100
Work in progress	21,389	18,452
Finished goods	215,589	211,123
Total inventories, net	$ 354,244	$ 351,675

XML 65 R55.htm IDEA: XBRL DOCUMENT

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Oct. 01, 2017	Sep. 30, 2018	Oct. 01, 2017	Dec. 31, 2017
Income Tax Contingency [Line Items]
Provision for income taxes	$ 2,596	$ 8,508	$ 12,101	$ 20,495
Unrecognized tax benefits, gross	30,500		30,500
Uncertain tax benefits if recognized that could affect the continuing operations effective tax rate	28,800		28,800
Uncertain tax positions including accrued interest, net of tax benefits and penalties, to be resolved within the next year	6,400		$ 6,400
Open Tax Years by Major Tax Jurisdiction, Begin Date			2010
Tax Adjustments, Settlements, and Unusual Provisions			$ (7,100)	(7,000)
Discontinued Operation, Tax Effect of Discontinued Operation	(1,411)	5,262	(1,341)	42,405
Income Tax Expense (Benefit), Intraperiod Tax Allocation	1,185	$ 13,770	10,760	62,900
Discrete Income Tax Expense (Benefit), Sale of Business			7,100
Excess Income Tax Benefit on Stock Compensation			(5,400)	$ (3,600)
2017 Tax Cuts and Jobs Act [Member]
Income Tax Contingency [Line Items]
Tax Adjustments, Settlements, and Unusual Provisions	(1,800)		(300)		$ 21,500
Income Tax Expense on Repatriated Earnings	$ (5,100)				$ 85,000
Discrete Income Tax Expense (Benefit), Tax Reform True-up			$ (5,400)

XML 66 R56.htm IDEA: XBRL DOCUMENT

Debt (Details) € in Millions			1 Months Ended	9 Months Ended	12 Months Ended
Debt (Details) € in Millions	Apr. 11, 2018 USD ($)	Jul. 19, 2016 EUR (€)	Oct. 25, 2011 USD ($)	Sep. 30, 2018 USD ($)	Dec. 30, 2012 USD ($)	Sep. 30, 2018 EUR (€)	Dec. 31, 2017 USD ($)	Dec. 31, 2017 EUR (€)
Other Secured Bank Loan [Member]
Interest rate terms under amended senior unsecured revolving credit facility				The secured bank loan of $0.3 million bears a fixed annual interest rate of 1.95% and is repaid in monthly installments until 2027.
Secured Debt \| €						€ 0.2
Debt Instrument, Interest Rate, Stated Percentage				1.95%		1.95%
Line of Credit, Maturing August 11, 2021 [Member]
Line of Credit Facility, Maximum Borrowing Capacity				$ 1,000,000,000
Unsecured revolving credit facility, expiry date				Aug. 11, 2021
Letters of credit issued and outstanding				$ 11,400,000
Line of Credit Facility, Remaining Borrowing Capacity				577,600,000
Aggregate borrowings under the amended facility				411,000,000			$ 625,000,000
Unamortized Debt Issuance Expense				$ 2,600,000			3,300,000
Term Loan Credit Facility, 12 Months Maturity [Member]
Interest rate terms under amended senior unsecured revolving credit facility				The interest rates under the senior unsecured term loan credit facility were based on the Eurocurrency rate or the base rate at the time of the borrowing, plus a margin. The base rate is the higher of (i) the rate of interest in effect for such day as publicly announced from time to time by JP Morgan Chase Bank, N.A. as its "prime rate," (ii) the Federal Funds rate plus 50 basis points or (iii) an adjusted one-month Libor plus 1.00%.
Term Loan Credit Facility, Maximum Borrowing Capacity				$ 200,000,000
Short-term Debt, Terms				twelve months
Short-term Debt, Maximum Amount Outstanding During Period				$ 200,000,000
2021 Notes [Member]
Interest rate terms under amended senior unsecured revolving credit facility				Interest on the November 2021 Notes is payable semi-annually on May 15th and November 15th each year. Prior to August 15, 2021 (three months prior to their maturity date), the Company may redeem the November 2021 Notes in whole or in part, at its option, at a redemption price equal to the greater of (i) 100% of the principal amount of the November 2021 Notes to be redeemed, plus accrued and unpaid interest, or (ii) the sum of the present values of the remaining scheduled payments of principal and interest in respect to the November 2021 Notes being redeemed, discounted on a semi-annual basis, at the Treasury Rate plus 45 basis points, plus accrued and unpaid interest.
Debt Instrument, Interest Rate, Stated Percentage			5.00%
Unsecured senior notes, face value			$ 500,000,000
Gross proceeds from the issuance of debt instrument			$ 493,600,000
Senior unsecured notes issuance as percentage of principal amount			99.372%
Debt Instrument, Unamortized Discount			$ 3,100,000	$ 1,200,000			1,400,000
Debt instrument maturity date			Nov. 25, 2021
Percentage of redemption of senior notes on or after August 15, 2021			100.00%
Percentage of redemption upon a change of control and a contemporaneous downgrade of the Notes			101.00%
Unamortized Debt Issuance Expense				$ 1,700,000			2,000,000
2021 Notes [Member] \| Treasury Rate [Member]
Basis spread on variable rate				0.45%
Financing Lease Obligations [Member]
Initial Fair Value of Other Long-term Debt Related to Financing Lease Obligations					$ 29,300,000
Additional Financing Lease Obligations, funded by lessors					$ 11,500,000
Other Long-term Debt, Current				$ 1,500,000			1,400,000
Other Long-term Debt, Noncurrent				33,400,000			34,500,000
1.875 Percent Ten Year Senior Unsecured Notes [Member]
Debt Instrument, Interest Rate, Stated Percentage		1.875%
Unsecured senior notes, face value \| €		€ 500.0
Gross proceeds from the issuance of debt instrument \| €		€ 492.3
Senior unsecured notes issuance as percentage of principal amount		99.118%
Debt Instrument, Unamortized Discount		€ 4.4		4,200,000			4,700,000
Debt instrument maturity date		Jul. 19, 2026
Percentage of redemption upon a change of control and a contemporaneous downgrade of the Notes		101.00%
Unamortized Debt Issuance Expense				$ 3,900,000			4,300,000
0.6 Percent Senior Unsecured Notes due in April 2021 [Member]
Interest rate terms under amended senior unsecured revolving credit facility				Interest on the April 2021 Notes is payable annually on April 9th each year.
Debt Instrument, Interest Rate, Stated Percentage	0.60%
Unsecured senior notes, face value	$ 300,000,000
Gross proceeds from the issuance of debt instrument	$ 298,700,000
Senior unsecured notes issuance as percentage of principal amount	99.95%
Debt Instrument, Unamortized Discount	$ 200,000			$ 200,000
Debt instrument maturity date	Apr. 09, 2021
Percentage of redemption upon a change of control and a contemporaneous downgrade of the Notes	101.00%
Unamortized Debt Issuance Expense				$ 2,300,000
0.6 Percent Senior Unsecured Notes due in April 2021 [Member] \| Treasury Rate [Member]
Basis spread on variable rate				0.15%
Other Debt Facilities - EUROIMMUN [Member]
Interest rate terms under amended senior unsecured revolving credit facility				Of these bank loans, loans in the aggregate amount of $35.1 million bear fixed interest rates between 1.1% and 5.5% and a loan in the amount of $0.2 million bears a variable interest rate based on the Euribor rate plus a margin of 1.5%.
Long-term Debt, Percentage Bearing Variable Interest, Amount \| €						€ 0.2
Long-term Debt, Percentage Bearing Fixed Interest, Amount \| €						43.3
Other Debt Facilities - EUROIMMUN [Member] \| Euribor Rate [Member]
Basis spread on variable rate				1.50%
Other Unsecured Revolving Debt Facilities [Member]
Other Unsecured Revolving Credit Facilities				$ 8,100,000
Interest rate terms under amended senior unsecured revolving credit facility				The unsecured revolving debt facilities bear fixed interest rates between 0.05% and 2.30% and will mature in 2018.
Unsecured Revolving Credit Facility [Member] \| Base Rate Option Two [Member]
Description of variable rate basis				Federal Funds
Unsecured Revolving Credit Facility [Member] \| Eurocurrency Rate [Member]
Description of variable rate basis				Eurocurrency
Unsecured Revolving Credit Facility [Member] \| Line of Credit, Maturing August 11, 2021 [Member]
Interest rate terms under amended senior unsecured revolving credit facility				The interest rates under the senior unsecured revolving credit facility are based on the Eurocurrency rate or the base rate at the time of borrowing, plus a margin. The base rate is the higher of (i) the rate of interest in effect for such day as publicly announced from time to time by JP Morgan Chase Bank, N.A. as its "prime rate," (ii) the Federal Funds rate plus 50 basis points or (iii) an adjusted one-month Libor plus 1.00%. The Eurocurrency margin as of September 30, 2018 was 110 basis points.
Weighted average interest rates under amended senior unsecured revolving credit facility				The weighted average Eurocurrency interest rate as of September 30, 2018 was 2.19%, resulting in a weighted average effective Eurocurrency rate, including the margin, of 3.29%,
Unsecured Revolving Credit Facility [Member] \| Line of Credit, Maturing August 11, 2021 [Member] \| Base Rate Option Two [Member]
Basis spread on variable rate				0.50%
Unsecured Revolving Credit Facility [Member] \| Line of Credit, Maturing August 11, 2021 [Member] \| Base Rate Option Three [Member]
Basis spread on variable rate				1.00%
Unsecured Revolving Credit Facility [Member] \| Line of Credit, Maturing August 11, 2021 [Member] \| Eurocurrency Rate [Member]
Basis spread on variable rate				1.10%
United States of America, Dollars \| Other Debt Facilities - EUROIMMUN [Member]
Unsecured Debt \| €						29.9
Secured Debt \| €						5.4
Other Long-term Debt \| €						35.3		€ 57.2
Long-term Debt, Percentage Bearing Fixed Interest, Amount \| €						35.1
Euro Member Countries, Euro \| Other Debt Facilities - EUROIMMUN [Member]
Other Long-term Debt \| €						€ 30.4		47.6
Minimum [Member] \| Other Debt Facilities - EUROIMMUN [Member]
Debt Instrument, Interest Rate, Stated Percentage				0.10%		0.10%
Minimum [Member] \| Other Unsecured Revolving Debt Facilities [Member]
Debt Instrument, Interest Rate, Stated Percentage				0.05%		0.05%
Minimum [Member] \| United States of America, Dollars \| Other Debt Facilities - EUROIMMUN [Member]
Debt Instrument, Interest Rate, Stated Percentage				1.10%		1.10%
Maximum [Member] \| Other Debt Facilities - EUROIMMUN [Member]
Debt Instrument, Interest Rate, Stated Percentage				5.50%		5.50%
Maximum [Member] \| Other Unsecured Revolving Debt Facilities [Member]
Debt Instrument, Interest Rate, Stated Percentage				2.30%		2.30%
Maximum [Member] \| United States of America, Dollars \| Other Debt Facilities - EUROIMMUN [Member]
Debt Instrument, Interest Rate, Stated Percentage				5.50%		5.50%
Significant Other Observable Inputs (Level 2) [Member] \| Line of Credit, Maturing August 11, 2021 [Member]
Long-term Debt				$ 408,400,000			621,700,000
Significant Other Observable Inputs (Level 2) [Member] \| 2021 Notes [Member]
Long-term Debt				497,200,000			496,600,000
Significant Other Observable Inputs (Level 2) [Member] \| Financing Lease Obligations [Member]
Other Long-term Debt				34,900,000			35,900,000
Significant Other Observable Inputs (Level 2) [Member] \| 1.875 Percent Ten Year Senior Unsecured Notes [Member]
Long-term Debt				572,300,000			$ 591,700,000
Significant Other Observable Inputs (Level 2) [Member] \| 0.6 Percent Senior Unsecured Notes due in April 2021 [Member]
Long-term Debt				$ 345,800,000
Significant Other Observable Inputs (Level 2) [Member] \| Other Debt Facilities - EUROIMMUN [Member]
Other Long-term Debt \| €						€ 43.5		€ 60.2

XML 67 R57.htm IDEA: XBRL DOCUMENT

Earnings Per Share (Schedule of Reconciliation of Number of Shares Utilized in Earnings Per Share Calculations) (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Oct. 01, 2017	Sep. 30, 2018	Oct. 01, 2017
Earnings Per Share [Abstract]
Number of common shares-basic	110,724	110,003	110,499	109,788
Effect of dilutive securities, Stock options	791	735	813	669
Effect of dilutive securities, Restricted stock	232	255	198	196
Number of common shares-diluted	111,747	110,993	111,510	110,653
Number of potentially dilutive securities excluded from calculation due to antidilutive impact	358	14	346	377

XML 68 R58.htm IDEA: XBRL DOCUMENT

Industry Segment Information Industry Segment Information Narrative (Details)	9 Months Ended
	Sep. 30, 2018 segments
Segment Reporting Information [Line Items]
Number of Operating Segment	2

XML 69 R59.htm IDEA: XBRL DOCUMENT

Industry Segment Information (Schedule of Sales and Operating Income by Operating Segment, Excluding Discontinued Operations) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Oct. 01, 2017	Sep. 30, 2018	Oct. 01, 2017
Segment Reporting Information [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 674,313	$ 554,275	$ 2,021,647	$ 1,615,352
Operating income (loss) from continuing operations	80,202	78,038	208,201	202,032
Interest and other expense, net	2,161	(27,016)	29,947	(13,797)
Income from continuing operations before income taxes	78,041	105,054	178,254	215,829
Corporate [Member]
Segment Reporting Information [Line Items]
Operating income (loss) from continuing operations	(15,590)	(12,581)	(45,627)	(39,596)
Diagnostics [Member]
Segment Reporting Information [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	268,147	168,893	788,328	485,082
Operating income (loss) from continuing operations	47,411	43,361	104,585	113,024
Discovery & Analytical Solutions [Member]
Segment Reporting Information [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	406,166	385,382	1,233,319	1,130,270
Operating income (loss) from continuing operations	48,381	47,258	149,243	128,604
Product [Member]
Segment Reporting Information [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	474,523	354,819	1,417,739	1,043,534
Product [Member] \| Diagnostics [Member]
Segment Reporting Information [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	227,273	132,201	669,469	378,466
Product [Member] \| Discovery & Analytical Solutions [Member]
Segment Reporting Information [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	247,250	222,618	748,270	665,068
Service [Member]
Segment Reporting Information [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	199,790	199,456	603,908	571,818
Service [Member] \| Diagnostics [Member]
Segment Reporting Information [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	40,874	36,692	118,859	106,616
Service [Member] \| Discovery & Analytical Solutions [Member]
Segment Reporting Information [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 158,916	$ 162,764	$ 485,049	$ 465,202

XML 70 R60.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended							9 Months Ended	12 Months Ended
	Mar. 31, 2019	Dec. 30, 2018	Sep. 30, 2018	Jul. 01, 2018	Apr. 01, 2018	Dec. 31, 2017	Oct. 01, 2017	Sep. 30, 2018	Dec. 30, 2018	Jul. 23, 2018	Jul. 27, 2016
Schedule of Shareholders' Equity [Line Items]
Stock repurchase program, number of shares authorized to be repurchased											8,000,000
Stock repurchase program, number of shares remained available for repurchase			250,000,000					250,000,000
Stock Repurchase Program, Authorized Amount										$ 250.0
Repurchased Common Shares For Activity Pursuant to Equity Incentive Plans			3,807					63,506
Aggregate Cost of Repurchased Common Shares for Activity Pursuant to Equity Incentive Plans			$ 0.3					$ 5.0
Cash dividends (per share)			$ 0.07	$ 0.07	$ 0.07	$ 0.07	$ 0.07
Dividends Payable, Amount			$ 7.8					$ 7.8
Dividends Payable, Date Declared			Jul. 23, 2018
Dividends Payable, Date to be Paid								Nov. 09, 2018
Subsequent Event [Member]
Schedule of Shareholders' Equity [Line Items]
Cash dividends (per share)		$ 0.07
Dividends Payable, Date Declared									Oct. 24, 2018
Dividends Payable, Date to be Paid	Feb. 08, 2019

XML 71 R61.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Components Of Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Stockholders' Equity Note [Abstract]
Foreign currency translation adjustments, net of income taxes	$ (160,780)	$ (46,582)
Unrecognized losses and prior service costs, net of income taxes	322	322
Unrealized net losses on securities, net of income taxes	(190)	(258)
Accumulated other comprehensive loss	$ (160,648)	$ (46,518)

XML 72 R62.htm IDEA: XBRL DOCUMENT

Stock Plans (Narrative) (Details) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018 USD ($) $ / shares shares	Oct. 01, 2017 USD ($) $ / shares	Sep. 30, 2018 USD ($) plan $ / shares shares	Oct. 01, 2017 USD ($) $ / shares shares	Dec. 31, 2017 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Former Stock-based Compensation Plans \| plan			1
Total income tax benefit recognized for stock-based compensation	$ 6,100	$ 1,900	$ 10,600	$ 9,900
Stock-based compensation costs capitalized as part of inventory			400
Proceeds from issuance of common stock under stock plans			19,484	14,004
Share-based Compensation	$ 11,127	$ 4,412	$ 23,275	$ 16,179
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average grant-date fair value of options \| $ / shares	$ 18.65	$ 14.32	$ 17.56	$ 11.79
Total intrinsic value of options exercised	$ 18,900	$ 700	$ 25,300	$ 12,800
Proceeds from issuance of common stock under stock plans			19,500	14,000
Total pre-tax stock-based compensation expense	1,400	1,100	4,000	3,500
Total unrecognized compensation cost, net of estimated forfeitures, related to nonvested stock, granted	8,000		$ 8,000
Weighted-average period for recognition of unrecognized compensation cost, years			2 years
Restricted Stock Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total pre-tax stock-based compensation expense	3,000	2,300	$ 8,700	7,800
Total unrecognized compensation cost, net of estimated forfeitures, related to nonvested stock, granted	$ 18,900		$ 18,900
Weighted-average period for recognition of unrecognized compensation cost, years			1 year 6 months 9 days
Awards/units outstanding \| shares	470,000		470,000		496,000
Number of Shares, Granted \| shares			206,000
Weighted-average grant-date fair value of stock granted (per share) \| $ / shares			$ 75.78
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period \| shares			32,000
Fair value of restricted stock awards vested	$ 1,100	500	$ 10,000	9,800
Performance Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total pre-tax stock-based compensation expense	$ 5,300	800	$ 7,600	3,600
Awards/units outstanding \| shares	201,762		201,762
Number of Shares, Granted \| shares			37,281
Weighted-average grant-date fair value of stock granted (per share) \| $ / shares			$ 73.23
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period \| shares			0
Deferred Compensation Share-based Arrangements, Liability, Current and Noncurrent	$ 13,900		$ 13,900
Stock Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total pre-tax stock-based compensation expense			$ 800	$ 700
Number of Shares, Granted \| shares			1,386
Weighted-average grant-date fair value of stock granted (per share) \| $ / shares			$ 72.17
Employee Stock Purchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized under plan \| shares	5,000,000		5,000,000
Number of Shares, Granted \| shares			21,321	18,483
Weighted-average grant-date fair value of stock granted (per share) \| $ / shares			$ 69.57	$ 64.73
Shares available for grant under employee stock purchase plan \| shares	800,000		800,000
Performance Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total pre-tax stock-based compensation expense	$ 1,300	$ 200	$ 2,200	$ 600
Awards/units outstanding \| shares	87,673		87,673
Number of Shares, Granted \| shares			39,133
Weighted-average grant-date fair value of stock granted (per share) \| $ / shares			$ 80.31
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period \| shares				5,797
2009 Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized under plan \| shares	10,000,000		10,000,000

XML 73 R63.htm IDEA: XBRL DOCUMENT

Stock Plans (Summary of Total Compensation Recognized Related to Outstanding Stock Options) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Oct. 01, 2017	Sep. 30, 2018	Oct. 01, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation	$ 11,127	$ 4,412	$ 23,275	$ 16,179
Cost of sales [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total pre-tax stock-based compensation expense	430	357	1,093	898
Research and development expenses [Member ]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total pre-tax stock-based compensation expense	335	373	1,029	1,077
Selling, general and administrative and other expenses [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total pre-tax stock-based compensation expense	$ 10,362	$ 3,682	$ 21,153	$ 14,204

XML 74 R64.htm IDEA: XBRL DOCUMENT

Stock Plans (Weighted-Average Assumptions Used in the Black-Scholes Option Pricing Model) (Details)	9 Months Ended
	Sep. 30, 2018	Oct. 01, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Risk-free interest rate	2.90%	1.50%
Expected dividend yield	0.40%	0.40%
Expected lives, years	5 years	5 years
Expected stock volatility	20.70%	22.40%

XML 75 R65.htm IDEA: XBRL DOCUMENT

Stock Plans (Summary of Stock Option Activity) (Details) $ / shares in Units, shares in Thousands, $ in Millions	9 Months Ended
	Sep. 30, 2018 USD ($) $ / shares shares
Stock option activity
Number of Shares, Outstanding at beginning of period \| shares	2,154
Number of Shares, Granted \| shares	363
Number of Shares, Exercised \| shares	(554)
Number of Shares, Forfeited \| shares	(43)
Number of Shares, Outstanding at end of period \| shares	1,920
Number of Shares, Exercisable at end of period \| shares	1,113
Weighted-Average Price, Outstanding at beginning of period \| $ / shares	$ 42.77
Weighted-Average Price, Granted \| $ / shares	77.81
Weighted-Average Price, Exercised \| $ / shares	35.19
Weighted-Average Price, Forfeited \| $ / shares	51.62
Weighted-Average Price, Outstanding at end of period \| $ / shares	51.38
Weighted-Average Price, Exercisable at end of period \| $ / shares	$ 43.10
Weighted-Average Remaining Contractual Term in Years, Outstanding at end of period	4 years 4 months
Weighted-Average Remaining Contractual Term in Years, Exercisable at end of period	3 years 2 months
Total Intrinsic Value, Outstanding at end of period \| $	$ 88.1
Total Intrinsic Value, Exercisable at end of period \| $	$ 60.3

XML 76 R66.htm IDEA: XBRL DOCUMENT

Stock Plans (Summary of Restricted Stock Award Activity) (Details) - Restricted Stock Awards [Member] shares in Thousands	9 Months Ended
	Sep. 30, 2018 $ / shares shares
Restricted stock award activity
Number of Shares, Nonvested at beginning of period \| shares	496
Number of Shares, Granted \| shares	206
Number of Shares, Vested \| shares	(200)
Number of Shares, Forfeited \| shares	(32)
Number of Shares, Nonvested at end of period \| shares	470
Weighted-Average Grant-Date Fair Value, Nonvested at beginning of period \| $ / shares	$ 50.30
Weighted-Average Grant-Date Fair Value, Granted \| $ / shares	75.78
Weighted-Average Grant-Date Fair Value, Vested \| $ / shares	50.18
Weighted-Average Grant-Date Fair Value, Forfeited \| $ / shares	53.67
Weighted-Average Grant-Date Fair Value, Nonvested at end of period \| $ / shares	$ 61.38

XML 77 R67.htm IDEA: XBRL DOCUMENT

Goodwill and Intangible Assets, Net (Narrative) (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
	Jan. 01, 2018	Sep. 30, 2018	Oct. 01, 2017	Sep. 30, 2018	Oct. 01, 2017	Dec. 31, 2017
Goodwill and Intangible Assets Net [Line Items]
Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount	20.00%
Change in any one of the input assumptions for the various reporting units	10.00%
Goodwill		$ 2,920,689		$ 2,920,689		$ 3,002,198
Total amortization expense related to finite-lived intangible assets		35,300	$ 17,700	100,700	$ 52,300
Future Amortization Expense, Year One		37,600		37,600
Future Amortization Expense, Year Two		148,300		148,300
Future Amortization Expense, Year Three		150,400		150,400
Future Amortization Expense, Year Four		135,200		135,200
Future Amortization Expense, Year Five		123,800		123,800
Finite-Lived Intangible Assets, Net		1,153,191		1,153,191		1,276,356
Intangible assets, net		1,223,775		1,223,775		1,346,940
Minimum [Member]
Goodwill and Intangible Assets Net [Line Items]
Long-term terminal growth rates for reporting units	3.00%
Discount rates for reporting units	9.00%
Maximum [Member]
Goodwill and Intangible Assets Net [Line Items]
Long-term terminal growth rates for reporting units	5.00%
Discount rates for reporting units	15.00%
Patents [Member]
Goodwill and Intangible Assets Net [Line Items]
Gross amortizable intangible assets		42,951		42,951		39,959
Less: Accumulated amortization		37,046		37,046		35,085
Finite-Lived Intangible Assets, Net		5,905		5,905		4,874
Trade Names And Trademarks [Member]
Goodwill and Intangible Assets Net [Line Items]
Gross amortizable intangible assets		78,628		78,628		80,974
Less: Accumulated amortization		32,251		32,251		28,250
Finite-Lived Intangible Assets, Net		46,377		46,377		52,724
Licensing Agreements [Member]
Goodwill and Intangible Assets Net [Line Items]
Gross amortizable intangible assets		52,261		52,261		53,300
Less: Accumulated amortization		44,889		44,889		42,635
Finite-Lived Intangible Assets, Net		7,372		7,372		10,665
Core Technology [Member]
Goodwill and Intangible Assets Net [Line Items]
Gross amortizable intangible assets		476,403		476,403		471,740
Less: Accumulated amortization		272,475		272,475		244,916
Finite-Lived Intangible Assets, Net		203,928		203,928		226,824
Customer Relationships [Member]
Goodwill and Intangible Assets Net [Line Items]
Gross amortizable intangible assets		1,108,220		1,108,220		1,141,511
Less: Accumulated amortization		290,616		290,616		242,840
Finite-Lived Intangible Assets, Net		817,604		817,604		898,671
In-process Research and Development [Member]
Goodwill and Intangible Assets Net [Line Items]
Gross amortizable intangible assets		81,813		81,813		88,025
Less: Accumulated amortization		9,808		9,808		5,427
Finite-Lived Intangible Assets, Net		$ 72,005		$ 72,005		82,598
Informatics [Member]
Goodwill and Intangible Assets Net [Line Items]
Goodwill	$ 217,200
Medical Imaging Business [Member]
Goodwill and Intangible Assets Net [Line Items]
Disposal Group, Including Discontinued Operation, Consideration						$ 277,400

XML 78 R68.htm IDEA: XBRL DOCUMENT

Goodwill and Intangible Assets, Net (Changes in the Carrying Amount of Goodwill) (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2018 USD ($)
Changes in the carrying amount of goodwill
Balance at beginning of period	$ 3,002,198
Foreign currency translation	(57,780)
Goodwill, Acquisition, Earn Outs and Other Adjustments	(23,729)
Balance at end of period	2,920,689
Diagnostics [Member]
Changes in the carrying amount of goodwill
Balance at beginning of period	1,657,963
Foreign currency translation	(31,613)
Goodwill, Acquisition, Earn Outs and Other Adjustments	(15,749)
Balance at end of period	1,610,601
Discovery & Analytical Solutions [Member]
Changes in the carrying amount of goodwill
Balance at beginning of period	1,344,235
Foreign currency translation	(26,167)
Goodwill, Acquisition, Earn Outs and Other Adjustments	(7,980)
Balance at end of period	$ 1,310,088

XML 79 R69.htm IDEA: XBRL DOCUMENT

Goodwill and Intangible Assets, Net (Identifiable Intangible Asset Balances) (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]
Net amortizable intangible assets	$ 1,153,191	$ 1,276,356
Intangible assets, net	1,223,775	1,346,940
Patents [Member]
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]
Gross amortizable intangible assets	42,951	39,959
Less: Accumulated amortization	(37,046)	(35,085)
Net amortizable intangible assets	5,905	4,874
Trade Names And Trademarks [Member]
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]
Gross amortizable intangible assets	78,628	80,974
Less: Accumulated amortization	(32,251)	(28,250)
Net amortizable intangible assets	46,377	52,724
Trade names and trademarks	70,584	70,584
Licensing Agreements [Member]
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]
Gross amortizable intangible assets	52,261	53,300
Less: Accumulated amortization	(44,889)	(42,635)
Net amortizable intangible assets	7,372	10,665
Core Technology [Member]
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]
Gross amortizable intangible assets	476,403	471,740
Less: Accumulated amortization	(272,475)	(244,916)
Net amortizable intangible assets	203,928	226,824
Customer Relationships [Member]
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]
Gross amortizable intangible assets	1,108,220	1,141,511
Less: Accumulated amortization	(290,616)	(242,840)
Net amortizable intangible assets	817,604	898,671
In-process Research and Development [Member]
Finite and Indefinite Lived Intangible Assets by Major Class [Line Items]
Gross amortizable intangible assets	81,813	88,025
Less: Accumulated amortization	(9,808)	(5,427)
Net amortizable intangible assets	$ 72,005	$ 82,598

XML 80 R70.htm IDEA: XBRL DOCUMENT

Warranty Reserves (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Warranty Reserves (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Oct. 01, 2017	Sep. 30, 2018	Oct. 01, 2017
Warranty reserve activity
Balance beginning of period	$ 8,943	$ 9,088	$ 9,050	$ 9,012
Provision charged to income	3,327	3,326	10,012	9,706
Payments	(3,547)	(3,488)	(10,514)	(10,625)
Adjustments to previously provided warranties, net	(226)	(730)	110	(215)
Foreign currency translation and acquisitions	(49)	117	(210)	435
Balance end of period	$ 8,448	$ 8,313	$ 8,448	$ 8,313

XML 81 R71.htm IDEA: XBRL DOCUMENT

Employee Benefit Plans (Components of Net Periodic Benefit Cost (Credit)) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Oct. 01, 2017	Sep. 30, 2018	Oct. 01, 2017
Defined Benefit Pension Benefits [Member]
Components of net periodic benefit cost (credit)
Service cost	$ 1,712	$ 1,231	$ 5,180	$ 3,667
Interest cost	4,051	4,160	12,212	12,420
Expected return on plan assets	(7,270)	(6,568)	(21,926)	(19,609)
Amortization of prior service	(41)	(49)	(123)	(144)
Net periodic benefit cost (credit)	(1,548)	(1,226)	(4,657)	(3,666)
Postretirement Medical Benefits [Member]
Components of net periodic benefit cost (credit)
Service cost	27	23	80	69
Interest cost	30	32	90	94
Expected return on plan assets	(314)	(279)	(941)	(836)
Amortization of prior service	0	0	0	0
Net periodic benefit cost (credit)	$ (257)	$ (224)	(771)	(673)
UNITED STATES
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Contributions by Employer			15,000
Foreign Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Contributions by Employer			$ 6,400	$ 6,200

XML 82 R72.htm IDEA: XBRL DOCUMENT

Derivatives And Hedging Activities (Details) $ in Thousands, € in Millions		3 Months Ended			9 Months Ended
	Apr. 11, 2018 USD ($)	Sep. 30, 2018 USD ($)	Apr. 01, 2018 USD ($)	Oct. 01, 2017 USD ($)	Sep. 30, 2018 USD ($)	Oct. 01, 2017 USD ($)	Sep. 30, 2018 EUR (€)	Apr. 27, 2018 EUR (€)	Dec. 31, 2017 USD ($)	Dec. 31, 2017 EUR (€)	Oct. 01, 2017 EUR (€)
Derivative [Line Items]
Company's business conducted outside United States					70.00%
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, before Tax					$ 2,600
Payments for Hedge, Financing Activities					30,285
Payments for (Proceeds from) Hedge, Financing Activities					30,285	$ 11,539
Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net		$ 0			0
Foreign Currency Transaction Gain (Loss), before Tax		(4,300)		$ 2,700	$ 8,800	5,400
European And Asian Currencies [Member]
Derivative [Line Items]
Maximum maturity period for foreign exchange contracts, in months					12 months
Duration Of Foreign Currency Derivatives					30 days
Fair Value Hedging [Member]
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments		180,400		140,000	$ 180,400	140,000			$ 212,100
Notional Amount of Euro Derivatives [Member]
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments \| €							€ 48.7	€ 298.7		€ 57.2	€ 19.0
Notional Amount of US Dollar Derivatives [Member] \| Cash Flow Hedging [Member]
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments		28,000		$ 12,300	28,000	$ 12,300			$ 1,253,000
Net Investment Hedging [Member] \| 1.875 Percent Ten Year Senior Unsecured Notes [Member]
Derivative [Line Items]
Notional Amount of Nonderivative Instruments					135,100
Unrealized Gain (Loss) on Net Investment Hedge in AOCI		(800)	$ (2,100)		(7,700)
Net Investment Hedging [Member] \| 0.6 Percent Senior Unsecured Notes due in April 2021 [Member]
Derivative [Line Items]
Notional Amount of Nonderivative Instruments	$ 298,700				298,700
Unrealized Gain (Loss) on Net Investment Hedge in AOCI		$ (1,800)			$ (22,600)

XML 83 R73.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Narrative) (Details) $ in Thousands, € in Millions	3 Months Ended	9 Months Ended		12 Months Ended
	Sep. 30, 2018 USD ($)	Sep. 30, 2018 USD ($)	Oct. 01, 2017 USD ($)	Jan. 03, 2016 USD ($)	Sep. 30, 2018 EUR (€)	Jul. 01, 2018 USD ($)	Apr. 11, 2018 USD ($)	Dec. 31, 2017 USD ($)	Dec. 31, 2017 EUR (€)	Jul. 02, 2017 USD ($)	Jan. 01, 2017 USD ($)	Jul. 19, 2016 EUR (€)	Oct. 25, 2011 USD ($)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High	$ 76,500	$ 76,500
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	67,126	$ 67,126	$ 64,727			$ 74,093		$ 65,328		$ 64,076	$ 63,201
Business Combination, Contingent Consideration Arrangements, Description		Contingent consideration is measured at fair value at the acquisition date, based on the probability that revenue thresholds or product development milestones will be achieved during the earnout period, with changes in the fair value after the acquisition date affecting earnings to the extent it is to be settled in cash.
Business Combination, Contingent Consideration Arrangements, Maximum Period		2 years
Business Combination, Contingent Consideration Arrangements, Weighted Average Period		7 months
Payments for acquisition-related contingent consideration		$ (12,800)	$ (8,940)
2021 Notes [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Unamortized Debt Issuance Expense	1,700	1,700						2,000
Unsecured senior notes, face value													$ 500,000
Debt Instrument, Unamortized Discount	(1,200)	(1,200)						(1,400)					$ (3,100)
Unsecured senior notes, fair value	515,600	515,600						536,600
Line of Credit, Maturing August 11, 2021 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	1,000,000	1,000,000
Revolving credit facility outstanding balance	411,000	411,000						625,000
Unamortized Debt Issuance Expense	2,600	2,600						3,300
1.875 Percent Ten Year Senior Unsecured Notes [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Unamortized Debt Issuance Expense	3,900	3,900						4,300
Unsecured senior notes, face value \| €												€ 500.0
Debt Instrument, Unamortized Discount	(4,200)	(4,200)						(4,700)				€ (4.4)
1.875 Percent Ten Year Senior Unsecured Notes [Member] \| Euro Member Countries, Euro
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Unsecured senior notes, fair value	502,900	502,900						508,900
0.6 Percent Senior Unsecured Notes due in April 2021 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Unamortized Debt Issuance Expense	2,300	2,300
Unsecured senior notes, face value							$ 300,000
Debt Instrument, Unamortized Discount	(200)	(200)					$ (200)
Unsecured senior notes, fair value	301,200	301,200
Other Debt Facilities - EUROIMMUN [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term Debt, Percentage Bearing Fixed Interest, Amount \| €					€ 43.3
Other Debt Facilities - EUROIMMUN [Member] \| Euro Member Countries, Euro
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Other Long-term Debt \| €					€ 30.4				€ 47.6
Vanadis Diagnostics AB [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Payments to Acquire Businesses, Net of Cash Acquired				$ 32,000
Business Acquisition, Cost of Acquired Entity, Liabilities Incurred, Contingent Consideration at Fair Value		$ 59,599		56,878
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High				$ 93,000
Payments for acquisition-related contingent consideration	16,500
Payment for Contingent Consideration Liability, Financing Activities	12,800
Payment for Contingent Consideration Liability, Operating Activities	$ 3,700
Minimum [Member] \| Vanadis Diagnostics AB [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Projected milestone date		2018
Conditional probability of success	95.00%	95.00%			95.00%
Cumulative probability of success	84.00%	84.00%			84.00%
Minimum [Member] \| Vanadis Diagnostics AB [Member] \| Measurement Input, Discount Rate [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Measurement Inputs, Discount Rate		3.40%
Maximum [Member] \| Vanadis Diagnostics AB [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Projected milestone date		2019
Conditional probability of success	98.00%	98.00%			98.00%
Cumulative probability of success	98.00%	98.00%			98.00%
Maximum [Member] \| Vanadis Diagnostics AB [Member] \| Measurement Input, Discount Rate [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Measurement Inputs, Discount Rate		6.50%
Significant Other Observable Inputs (Level 2) [Member] \| 2021 Notes [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term Debt	$ 497,200	$ 497,200						496,600
Significant Other Observable Inputs (Level 2) [Member] \| Line of Credit, Maturing August 11, 2021 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term Debt	408,400	408,400						621,700
Significant Other Observable Inputs (Level 2) [Member] \| 1.875 Percent Ten Year Senior Unsecured Notes [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term Debt	572,300	572,300						591,700
Significant Other Observable Inputs (Level 2) [Member] \| 0.6 Percent Senior Unsecured Notes due in April 2021 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term Debt	345,800	345,800
Significant Other Observable Inputs (Level 2) [Member] \| Financing Lease Obligations [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Other Long-term Debt	$ 34,900	$ 34,900						$ 35,900
Significant Other Observable Inputs (Level 2) [Member] \| Other Debt Facilities - EUROIMMUN [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Other Long-term Debt \| €					€ 43.5				€ 60.2

XML 84 R74.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Assets and Liabilities Carried at Fair Value Measured on a Recurring Basis) (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Jul. 01, 2018	Dec. 31, 2017	Oct. 01, 2017	Jul. 02, 2017	Jan. 01, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	$ 67,126	$ 74,093	$ 65,328	$ 64,727	$ 64,076	$ 63,201
Fair Value, Measurements, Recurring [Member] \| Carrying (Reported) Amount, Fair Value Disclosure [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	2,405		2,208
Foreign exchange derivative assets, net	(1,273)		(1,431)
Foreign exchange derivative liabilities, net	(4,694)		(23,638)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	67,126		65,328
Fair Value, Measurements, Recurring [Member] \| Quoted Prices In Active Markets (Level 1) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	2,405		2,208
Foreign exchange derivative assets, net	0		0
Foreign exchange derivative liabilities, net	0		0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	0		0
Fair Value, Measurements, Recurring [Member] \| Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0		0
Foreign exchange derivative assets, net	(1,273)		(1,431)
Foreign exchange derivative liabilities, net	(4,694)		(23,638)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	0		0
Fair Value, Measurements, Recurring [Member] \| Significant Unobservable Inputs (Level 3) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0		0
Foreign exchange derivative assets, net	0		0
Foreign exchange derivative liabilities, net	0		0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	$ 67,126		$ 65,328

XML 85 R75.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Reconciliation of Beginning and Ending Level 3 Net Liabilities) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Oct. 01, 2017	Sep. 30, 2018	Oct. 01, 2017
Fair Value Disclosures [Abstract]
Balance beginning of period	$ (74,093,000)	$ (64,076,000)	$ (65,328,000)	$ (63,201,000)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases	5,800,000	0.000	7,500,000	0.000
Payments	16,507,000	0	16,507,000	34,000
Change in fair value (included within selling, general and administrative expenses)	(3,740,000)	(651,000)	(10,805,000)	(1,560,000)
Balance end of period	$ (67,126,000)	$ (64,727,000)	$ (67,126,000)	$ (64,727,000)

XML 86 R76.htm IDEA: XBRL DOCUMENT

Contingencies (Details) $ in Millions	9 Months Ended
Contingencies (Details) $ in Millions	Sep. 30, 2018 USD ($) years	Dec. 31, 2017 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Management's estimate of total cost of ultimate disposition \| $	$ 8.5	$ 9.4
Number of years over which estimated environmental cost will be paid \| years	10

EXCEL 87 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 88 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 89 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 91 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 404 396 1 false 106 0 false 9 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.perkinelmer.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - Condensed Consolidated Income Statements Sheet http://www.perkinelmer.com/role/CondensedConsolidatedIncomeStatements Condensed Consolidated Income Statements Statements 2 false false R3.htm 1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income Sheet http://www.perkinelmer.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome Condensed Consolidated Statements of Comprehensive Income Statements 3 false false R4.htm 1003000 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.perkinelmer.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 4 false false R5.htm 1003501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.perkinelmer.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 5 false false R6.htm 1004000 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.perkinelmer.com/role/CondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 2101100 - Disclosure - Basis of Presentation Sheet http://www.perkinelmer.com/role/BasisOfPresentation Basis of Presentation Notes 7 false false R8.htm 2102100 - Disclosure - Revenue (Notes) Notes http://www.perkinelmer.com/role/RevenueNotes Revenue (Notes) Notes 8 false false R9.htm 2103100 - Disclosure - Changes in Accounting Policies (Notes) Notes http://www.perkinelmer.com/role/ChangesInAccountingPoliciesNotes Changes in Accounting Policies (Notes) Notes 9 false false R10.htm 2104100 - Disclosure - Business Combinations Sheet http://www.perkinelmer.com/role/BusinessCombinations Business Combinations Notes 10 false false R11.htm 2105100 - Disclosure - Discontinued Operations Sheet http://www.perkinelmer.com/role/DiscontinuedOperations Discontinued Operations Notes 11 false false R12.htm 2106100 - Disclosure - Restructuring and Lease Charges, Net Sheet http://www.perkinelmer.com/role/RestructuringAndLeaseChargesNet Restructuring and Lease Charges, Net Notes 12 false false R13.htm 2107100 - Disclosure - Interest and Other Expense (Income), Net Sheet http://www.perkinelmer.com/role/InterestAndOtherExpenseIncomeNet Interest and Other Expense (Income), Net Notes 13 false false R14.htm 2108100 - Disclosure - Inventories, Net Sheet http://www.perkinelmer.com/role/InventoriesNet Inventories, Net Notes 14 false false R15.htm 2109100 - Disclosure - Income Taxes Sheet http://www.perkinelmer.com/role/IncomeTaxes Income Taxes Notes 15 false false R16.htm 2110100 - Disclosure - Debt Sheet http://www.perkinelmer.com/role/Debt Debt Notes 16 false false R17.htm 2111100 - Disclosure - Earnings Per Share Sheet http://www.perkinelmer.com/role/EarningsPerShare Earnings Per Share Notes 17 false false R18.htm 2112100 - Disclosure - Industry Segment Information Sheet http://www.perkinelmer.com/role/IndustrySegmentInformation Industry Segment Information Notes 18 false false R19.htm 2113100 - Disclosure - Stockholders' Equity Sheet http://www.perkinelmer.com/role/StockholdersEquity Stockholders' Equity Notes 19 false false R20.htm 2114100 - Disclosure - Stock Plans Sheet http://www.perkinelmer.com/role/StockPlans Stock Plans Notes 20 false false R21.htm 2115100 - Disclosure - Goodwill and Intangible Assets, Net Sheet http://www.perkinelmer.com/role/GoodwillAndIntangibleAssetsNet Goodwill and Intangible Assets, Net Notes 21 false false R22.htm 2116100 - Disclosure - Warranty Reserves Sheet http://www.perkinelmer.com/role/WarrantyReserves Warranty Reserves Notes 22 false false R23.htm 2117100 - Disclosure - Employee Benefit Plans Sheet http://www.perkinelmer.com/role/EmployeeBenefitPlans Employee Benefit Plans Notes 23 false false R24.htm 2119100 - Disclosure - Derivatives And Hedging Activities Sheet http://www.perkinelmer.com/role/DerivativesAndHedgingActivities Derivatives And Hedging Activities Notes 24 false false R25.htm 2120100 - Disclosure - Fair Value Measurements Sheet http://www.perkinelmer.com/role/FairValueMeasurements Fair Value Measurements Notes 25 false false R26.htm 2121100 - Disclosure - Contingencies Sheet http://www.perkinelmer.com/role/Contingencies Contingencies Notes 26 false false R27.htm 2201201 - Disclosure - Basis of Presentation (Policies) Sheet http://www.perkinelmer.com/role/BasisOfPresentationPolicies Basis of Presentation (Policies) Policies http://www.perkinelmer.com/role/ChangesInAccountingPoliciesNotes 27 false false R28.htm 2302302 - Disclosure - Revenue (Tables) Sheet http://www.perkinelmer.com/role/RevenueTables Revenue (Tables) Tables http://www.perkinelmer.com/role/RevenueNotes 28 false false R29.htm 2303302 - Disclosure - Changes in Accounting Policies (Tables) Sheet http://www.perkinelmer.com/role/ChangesInAccountingPoliciesTables Changes in Accounting Policies (Tables) Tables http://www.perkinelmer.com/role/ChangesInAccountingPoliciesNotes 29 false false R30.htm 2304301 - Disclosure - Business Combinations (Tables) Sheet http://www.perkinelmer.com/role/BusinessCombinationsTables Business Combinations (Tables) Tables http://www.perkinelmer.com/role/BusinessCombinations 30 false false R31.htm 2305301 - Disclosure - Discontinued Operations (Tables) Sheet http://www.perkinelmer.com/role/DiscontinuedOperationsTables Discontinued Operations (Tables) Tables http://www.perkinelmer.com/role/DiscontinuedOperations 31 false false R32.htm 2306301 - Disclosure - Restructuring and Lease Charges, Net (Tables) Sheet http://www.perkinelmer.com/role/RestructuringAndLeaseChargesNetTables Restructuring and Lease Charges, Net (Tables) Tables http://www.perkinelmer.com/role/RestructuringAndLeaseChargesNet 32 false false R33.htm 2307301 - Disclosure - Interest and Other Expense (Income), Net (Tables) Sheet http://www.perkinelmer.com/role/InterestAndOtherExpenseIncomeNetTables Interest and Other Expense (Income), Net (Tables) Tables http://www.perkinelmer.com/role/InterestAndOtherExpenseIncomeNet 33 false false R34.htm 2308301 - Disclosure - Inventories, Net (Tables) Sheet http://www.perkinelmer.com/role/InventoriesNetTables Inventories, Net (Tables) Tables http://www.perkinelmer.com/role/InventoriesNet 34 false false R35.htm 2309301 - Disclosure - Income Taxes (Tables) Sheet http://www.perkinelmer.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.perkinelmer.com/role/IncomeTaxes 35 false false R36.htm 2311301 - Disclosure - Earnings Per Share (Tables) Sheet http://www.perkinelmer.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.perkinelmer.com/role/EarningsPerShare 36 false false R37.htm 2312301 - Disclosure - Industry Segment Information (Tables) Sheet http://www.perkinelmer.com/role/IndustrySegmentInformationTables Industry Segment Information (Tables) Tables http://www.perkinelmer.com/role/IndustrySegmentInformation 37 false false R38.htm 2313301 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.perkinelmer.com/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.perkinelmer.com/role/StockholdersEquity 38 false false R39.htm 2314301 - Disclosure - Stock Plans (Tables) Sheet http://www.perkinelmer.com/role/StockPlansTables Stock Plans (Tables) Tables http://www.perkinelmer.com/role/StockPlans 39 false false R40.htm 2315301 - Disclosure - Goodwill and Intangible Assets, Net (Tables) Sheet http://www.perkinelmer.com/role/GoodwillAndIntangibleAssetsNetTables Goodwill and Intangible Assets, Net (Tables) Tables http://www.perkinelmer.com/role/GoodwillAndIntangibleAssetsNet 40 false false R41.htm 2316301 - Disclosure - Warranty Reserves (Tables) Sheet http://www.perkinelmer.com/role/WarrantyReservesTables Warranty Reserves (Tables) Tables http://www.perkinelmer.com/role/WarrantyReserves 41 false false R42.htm 2317301 - Disclosure - Employee Benefit Plans (Tables) Sheet http://www.perkinelmer.com/role/EmployeeBenefitPlansTables Employee Benefit Plans (Tables) Tables http://www.perkinelmer.com/role/EmployeeBenefitPlans 42 false false R43.htm 2320301 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.perkinelmer.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.perkinelmer.com/role/FairValueMeasurements 43 false false R44.htm 2401402 - Disclosure - Basis of Presentation (Basis of Presentation) (Details) Sheet http://www.perkinelmer.com/role/BasisOfPresentationBasisOfPresentationDetails Basis of Presentation (Basis of Presentation) (Details) Details http://www.perkinelmer.com/role/BasisOfPresentationPolicies 44 false false R45.htm 2402403 - Disclosure - Revenue (Details) Sheet http://www.perkinelmer.com/role/RevenueDetails Revenue (Details) Details http://www.perkinelmer.com/role/RevenueTables 45 false false R46.htm 2403403 - Disclosure - Changes in Accounting Policies (Details) Sheet http://www.perkinelmer.com/role/ChangesInAccountingPoliciesDetails Changes in Accounting Policies (Details) Details http://www.perkinelmer.com/role/ChangesInAccountingPoliciesTables 46 false false R47.htm 2404402 - Disclosure - Business Combinations (Narrative) (Details) Sheet http://www.perkinelmer.com/role/BusinessCombinationsNarrativeDetails Business Combinations (Narrative) (Details) Details http://www.perkinelmer.com/role/BusinessCombinationsTables 47 false false R48.htm 2404403 - Disclosure - Business Combinations (Fair Values of the Business Combinations and Allocations for the Acquisitions Completed) (Details) Sheet http://www.perkinelmer.com/role/BusinessCombinationsFairValuesOfBusinessCombinationsAndAllocationsForAcquisitionsCompletedDetails Business Combinations (Fair Values of the Business Combinations and Allocations for the Acquisitions Completed) (Details) Details http://www.perkinelmer.com/role/BusinessCombinationsTables 48 false false R49.htm 2405402 - Disclosure - Discontinued Operations (Narrative) (Details) Sheet http://www.perkinelmer.com/role/DiscontinuedOperationsNarrativeDetails Discontinued Operations (Narrative) (Details) Details http://www.perkinelmer.com/role/DiscontinuedOperationsTables 49 false false R50.htm 2406402 - Disclosure - Restructuring and Lease Charges, Net (Narrative) (Details) Sheet http://www.perkinelmer.com/role/RestructuringAndLeaseChargesNetNarrativeDetails Restructuring and Lease Charges, Net (Narrative) (Details) Details http://www.perkinelmer.com/role/RestructuringAndLeaseChargesNetTables 50 false false R51.htm 2406403 - Disclosure - Restructuring and Lease Charges, Net (Schedule of Initial Charges) (Details) Sheet http://www.perkinelmer.com/role/RestructuringAndLeaseChargesNetScheduleOfInitialChargesDetails Restructuring and Lease Charges, Net (Schedule of Initial Charges) (Details) Details http://www.perkinelmer.com/role/RestructuringAndLeaseChargesNetTables 51 false false R52.htm 2406404 - Disclosure - Restructuring and Lease Charges, Net (Schedule of Restructuring Plan Activity) (Details) Sheet http://www.perkinelmer.com/role/RestructuringAndLeaseChargesNetScheduleOfRestructuringPlanActivityDetails Restructuring and Lease Charges, Net (Schedule of Restructuring Plan Activity) (Details) Details http://www.perkinelmer.com/role/RestructuringAndLeaseChargesNetTables 52 false false R53.htm 2407402 - Disclosure - Interest and Other Expense (Income), Net (Details) Sheet http://www.perkinelmer.com/role/InterestAndOtherExpenseIncomeNetDetails Interest and Other Expense (Income), Net (Details) Details http://www.perkinelmer.com/role/InterestAndOtherExpenseIncomeNetTables 53 false false R54.htm 2408402 - Disclosure - Inventories, Net (Details) Sheet http://www.perkinelmer.com/role/InventoriesNetDetails Inventories, Net (Details) Details http://www.perkinelmer.com/role/InventoriesNetTables 54 false false R55.htm 2409402 - Disclosure - Income Taxes (Details) Sheet http://www.perkinelmer.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.perkinelmer.com/role/IncomeTaxesTables 55 false false R56.htm 2410401 - Disclosure - Debt (Details) Sheet http://www.perkinelmer.com/role/DebtDetails Debt (Details) Details http://www.perkinelmer.com/role/Debt 56 false false R57.htm 2411402 - Disclosure - Earnings Per Share (Schedule of Reconciliation of Number of Shares Utilized in Earnings Per Share Calculations) (Details) Sheet http://www.perkinelmer.com/role/EarningsPerShareScheduleOfReconciliationOfNumberOfSharesUtilizedInEarningsPerShareCalculationsDetails Earnings Per Share (Schedule of Reconciliation of Number of Shares Utilized in Earnings Per Share Calculations) (Details) Details http://www.perkinelmer.com/role/EarningsPerShareTables 57 false false R58.htm 2412402 - Disclosure - Industry Segment Information Industry Segment Information Narrative (Details) Sheet http://www.perkinelmer.com/role/IndustrySegmentInformationIndustrySegmentInformationNarrativeDetails Industry Segment Information Industry Segment Information Narrative (Details) Details 58 false false R59.htm 2412403 - Disclosure - Industry Segment Information (Schedule of Sales and Operating Income by Operating Segment, Excluding Discontinued Operations) (Details) Sheet http://www.perkinelmer.com/role/IndustrySegmentInformationScheduleOfSalesAndOperatingIncomeByOperatingSegmentExcludingDiscontinuedOperationsDetails Industry Segment Information (Schedule of Sales and Operating Income by Operating Segment, Excluding Discontinued Operations) (Details) Details http://www.perkinelmer.com/role/IndustrySegmentInformationTables 59 false false R60.htm 2413402 - Disclosure - Stockholders' Equity (Narrative) (Details) Sheet http://www.perkinelmer.com/role/StockholdersEquityNarrativeDetails Stockholders' Equity (Narrative) (Details) Details http://www.perkinelmer.com/role/StockholdersEquityTables 60 false false R61.htm 2413403 - Disclosure - Stockholders' Equity (Components Of Accumulated Other Comprehensive Loss) (Details) Sheet http://www.perkinelmer.com/role/StockholdersEquityComponentsOfAccumulatedOtherComprehensiveLossDetails Stockholders' Equity (Components Of Accumulated Other Comprehensive Loss) (Details) Details http://www.perkinelmer.com/role/StockholdersEquityTables 61 false false R62.htm 2414402 - Disclosure - Stock Plans (Narrative) (Details) Sheet http://www.perkinelmer.com/role/StockPlansNarrativeDetails Stock Plans (Narrative) (Details) Details http://www.perkinelmer.com/role/StockPlansTables 62 false false R63.htm 2414403 - Disclosure - Stock Plans (Summary of Total Compensation Recognized Related to Outstanding Stock Options) (Details) Sheet http://www.perkinelmer.com/role/StockPlansSummaryOfTotalCompensationRecognizedRelatedToOutstandingStockOptionsDetails Stock Plans (Summary of Total Compensation Recognized Related to Outstanding Stock Options) (Details) Details http://www.perkinelmer.com/role/StockPlansTables 63 false false R64.htm 2414404 - Disclosure - Stock Plans (Weighted-Average Assumptions Used in the Black-Scholes Option Pricing Model) (Details) Sheet http://www.perkinelmer.com/role/StockPlansWeightedAverageAssumptionsUsedInBlackScholesOptionPricingModelDetails Stock Plans (Weighted-Average Assumptions Used in the Black-Scholes Option Pricing Model) (Details) Details http://www.perkinelmer.com/role/StockPlansTables 64 false false R65.htm 2414405 - Disclosure - Stock Plans (Summary of Stock Option Activity) (Details) Sheet http://www.perkinelmer.com/role/StockPlansSummaryOfStockOptionActivityDetails Stock Plans (Summary of Stock Option Activity) (Details) Details http://www.perkinelmer.com/role/StockPlansTables 65 false false R66.htm 2414406 - Disclosure - Stock Plans (Summary of Restricted Stock Award Activity) (Details) Sheet http://www.perkinelmer.com/role/StockPlansSummaryOfRestrictedStockAwardActivityDetails Stock Plans (Summary of Restricted Stock Award Activity) (Details) Details http://www.perkinelmer.com/role/StockPlansTables 66 false false R67.htm 2415402 - Disclosure - Goodwill and Intangible Assets, Net (Narrative) (Details) Sheet http://www.perkinelmer.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails Goodwill and Intangible Assets, Net (Narrative) (Details) Details http://www.perkinelmer.com/role/GoodwillAndIntangibleAssetsNetTables 67 false false R68.htm 2415403 - Disclosure - Goodwill and Intangible Assets, Net (Changes in the Carrying Amount of Goodwill) (Details) Sheet http://www.perkinelmer.com/role/GoodwillAndIntangibleAssetsNetChangesInCarryingAmountOfGoodwillDetails Goodwill and Intangible Assets, Net (Changes in the Carrying Amount of Goodwill) (Details) Details http://www.perkinelmer.com/role/GoodwillAndIntangibleAssetsNetTables 68 false false R69.htm 2415404 - Disclosure - Goodwill and Intangible Assets, Net (Identifiable Intangible Asset Balances) (Details) Sheet http://www.perkinelmer.com/role/GoodwillAndIntangibleAssetsNetIdentifiableIntangibleAssetBalancesDetails Goodwill and Intangible Assets, Net (Identifiable Intangible Asset Balances) (Details) Details http://www.perkinelmer.com/role/GoodwillAndIntangibleAssetsNetTables 69 false false R70.htm 2416402 - Disclosure - Warranty Reserves (Details) Sheet http://www.perkinelmer.com/role/WarrantyReservesDetails Warranty Reserves (Details) Details http://www.perkinelmer.com/role/WarrantyReservesTables 70 false false R71.htm 2417402 - Disclosure - Employee Benefit Plans (Components of Net Periodic Benefit Cost (Credit)) (Details) Sheet http://www.perkinelmer.com/role/EmployeeBenefitPlansComponentsOfNetPeriodicBenefitCostCreditDetails Employee Benefit Plans (Components of Net Periodic Benefit Cost (Credit)) (Details) Details http://www.perkinelmer.com/role/EmployeeBenefitPlansTables 71 false false R72.htm 2419401 - Disclosure - Derivatives And Hedging Activities (Details) Sheet http://www.perkinelmer.com/role/DerivativesAndHedgingActivitiesDetails Derivatives And Hedging Activities (Details) Details http://www.perkinelmer.com/role/DerivativesAndHedgingActivities 72 false false R73.htm 2420402 - Disclosure - Fair Value Measurements (Narrative) (Details) Sheet http://www.perkinelmer.com/role/FairValueMeasurementsNarrativeDetails Fair Value Measurements (Narrative) (Details) Details http://www.perkinelmer.com/role/FairValueMeasurementsTables 73 false false R74.htm 2420403 - Disclosure - Fair Value Measurements (Assets and Liabilities Carried at Fair Value Measured on a Recurring Basis) (Details) Sheet http://www.perkinelmer.com/role/FairValueMeasurementsAssetsAndLiabilitiesCarriedAtFairValueMeasuredOnRecurringBasisDetails Fair Value Measurements (Assets and Liabilities Carried at Fair Value Measured on a Recurring Basis) (Details) Details http://www.perkinelmer.com/role/FairValueMeasurementsTables 74 false false R75.htm 2420404 - Disclosure - Fair Value Measurements (Reconciliation of Beginning and Ending Level 3 Net Liabilities) (Details) Sheet http://www.perkinelmer.com/role/FairValueMeasurementsReconciliationOfBeginningAndEndingLevel3NetLiabilitiesDetails Fair Value Measurements (Reconciliation of Beginning and Ending Level 3 Net Liabilities) (Details) Details http://www.perkinelmer.com/role/FairValueMeasurementsTables 75 false false R76.htm 2421401 - Disclosure - Contingencies (Details) Sheet http://www.perkinelmer.com/role/ContingenciesDetails Contingencies (Details) Details http://www.perkinelmer.com/role/Contingencies 76 false false All Reports Book All Reports pki-20180930.xml pki-20180930.xsd pki-20180930_cal.xml pki-20180930_def.xml pki-20180930_lab.xml pki-20180930_pre.xml http://fasb.org/srt/2018-01-31 http://xbrl.sec.gov/country/2017-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/us-gaap/2018-01-31 http://xbrl.sec.gov/currency/2017-01-31 http://xbrl.sec.gov/invest/2013-01-31 true true ZIP 93 0000031791-18-000018-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000031791-18-000018-xbrl.zip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�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ƾ'W?M_%__K%?[9I: *D3<2%[E89& ,@R',^]I1-GP M1&Z (/_YUL<% Z2@P_0FZ%"]"=YNM_O&\;4N9^BY.A10)]./3J'EP8O"7Y<- M\:M;'A[:]8D91#-8)'$5AJ1(TSPE.::CF33-H-SM+9(?;KE[]'@\Z!O/B;G2 M,90Y]*-7J,-_<7>)%@_"UY=P U_:%:-EVV\9GF4Q'UV'),,H2A %%8G&CA?' ME=PQ?86/M]PG3A']?^-9 Q^V?;ZDZDHOT>#5CWZBX\#S&R]TN5 80O![QEZ: MY3>*1:1,JB3& $4P!^5PPV^:H*20.2ENS*:;,?0)S,/D[.[[9*.0LU2)#4WT M6/:C[-[=\FE$D4 MTTP7_,G)HQ)U=H9HY[FY-D[39-,/?=+VXOF(S0@KHJHSVOCU\#(3*2.8QJ2$ MH*1Y20FL$!KL5#$($\&N(O_!]CK)L6/\.M7;9R_HN-(OU*GSHT=HX&]--2*U M7O"!U8*TW?Q5;Q:S- ,I#*LL8?TN#'/6X>C!4@:IU%E1E<^W/?U]O+AK]Z4) MYO5F\[V[P^Z![W/EZ>1^ "V7@96HE),46RRJB@K'$PR )I*5$TH$A$6%0+^D M1DB+,7YU G'8%UJ^I-^R MS9UUJF9YO^ZW@,^_=\^ KIX<9YJ!LKMAFPVC<57$++/G(!D @ J66"7)&C!K M.?<."(?##?/OP>Z(42W;FJ!:+@D[9EDM-[\)1JI'G,$)T-/CH--HTVT2!=3+ M8"3\TC>3CEU00./LW]W=?6A6W?IB^['F@W^XW[)!SW;[C_5R M-\LJB!*8H3B+*:011D5RP !D#K*8M:R9:4\=N0!+JLF^,M"'6 ^B<\A\PIC M!!UPU&H::B@4 M-# <"I&G#>0X.I.H+!(]_2,'MAQKK3=2Q2$X%WOI@^:G $8/*1&##^M$KF (4)]0N]XN%\.&FFZPW9]L =^6?*"=1 4I"E1$(8 9*0C.$,55 M6%'6"\-(M!JS9=]R67880)W@?A/TR'D'>H(]. $?_,GA"VZ4L1J@VY6:#[&1 M*]E^@+"(5W$^A$>MG+,6)I'"3I&V"Q6>[2!,7^I9][!UUZ2MYD79.&5]U$N=2HP*7T]0;_D+R/P__$3= MUWK%IVE^:QX^-YM9F&95_ M<0(O^+,'*'EB0H]4L<5.9WS*)2X-*NUN<$R\F]Q]R*2[]SCM7TWP37(FE A(X+N< HD],G!+/NM)9:G'AJ^&>]KA?+ M+5[6]^MVNUO.MP >Y@72$)8@3_(2A3%B7^?@D(1)A\7;@N^(0#F9]X([<4%WQ*&:C*MR*2+=EQV_(-@&F)I>IDTXT1IM/7+5 M>G8V$XPP^A4FBDF<98#B@B8)CLH"D\,XH4A3H7MX3=JS7[-G%VN= >G/"NOI MQN@6J]Q=,RU=O/M-LEP)[YILY2K>!.FBA;P *5=J>9.43I\GC'O4VFN XAGD MTWZU?#Q)5N\WRZ_UKOEU^;#<-8LA<3%T*,])43$K,*K2,+U.*B-O M]1N!W+Q*<;8>)__X\.[M;[_]X_?!=HHPJ&B2HRK.0@C+) G+T3:)4J%M:V8M MVI];*2Z.0 ]851?N#)$N-K_BGF_I&1;_J9:;97%/N?(\BQGJ16=:A(BY,M=B MEMCI\X0%GUJ;35$\MWSXCX]/BW>,:)2E(,DRFB(4Q@D@Z6%9(*-";\0K?;#E M3,'P: SLY6FZ+?I6&9+3=M?DB,NT59+4U%B*+!'%?>[C!6%5IF)Z_52'WAIH M"N)JB'\'3%7&\R413F&!2XK+B "-$7/CL<:.F>N($^\NZ)T: ].+G2+N5C?V$C)7KY=@ M7?/W+N?UQ[]M_K;ZVUA@ HA1AN.D*"$D95Z$,$.4$% !D(6Y\ 2"N@7;\L> M!0=D00]-I=^K4RB@BT[8D]3(Z8F3$$\G!"H*J1J10JIZR>U+"JM-DP=JJ^]# M:[+AB*LP76[G]>H_FWK#Q__]#98GDP!DG 3HUMP&% F-$=]Q@4 1)5699K@Z ME+QQ5@F7I#9L6U;N'G+ ,0?=A-APP>L)[#?! 7C0KSG+ZY.5J-R6_*D#(I<, M7G,LQ+/(U#%1RR]V8B.2?A3XNI"8;#(_?QB")8U"0T3*,,B!S"9 )>Y;3V>'^KB=7F#.0 M08M3::YYJ6G=R M\]IH^.WZCO^'?VO \.ZN [AIFH]+QMD)6ESOV#]W^WHUPQ1F90( H@@00K,P MH^ADGINH**,[=*YT],D]B,>>?N+5F[';\_L11\^"+7?M5"<"[AQ_6H*[IZ:_ M#F,OI]9^AEU1VQU'W&I.,!88@0SBOA'XE6\F\/]"=IHJ$F9S&7^'A0TCMN\V M_-%%(;@DCS#%.8@1",,R3K(<'-8TDBR4>J!],I ^9;;1/=:+ N[@Q"G.1I,P MF>DF;@T6$YZ-AC!AYI,/E'8"M-@V7E,>M$F#4CJT'A>-V:SW#>NZZUU]S[+U M/]L=@_EVS22_V>ZV \S%K$QHC&D2E7$)V3@3593"$4Q&"JHYP64"PC1S7@?@ M7*MZZ,$!^RA>EY\?I>V*9)JEW0^%-.S3A3<[ M33(F\W#9B1"C=KL[5,\+PD#LOO,'%M[7R\7;]; F_$>[^1?[#ZH?E[MZ=>Z% M78K3,*EHDN$L Q')RC [W!\6Q3B5?=C,/<))JEWNV\F8?!'T[KWI'S+A'@8' M%X/!QV!P,@!Z3XQ/V!AN[X!Z'>W 1%G];]H$Y!]I\[LI:#YV.E63D'G?S7@ M+NSWFC[@T^\*\X"#,^_'31V16S7.HEG.>BB_[_D&MG=WY.%QU7YOFNTLSRC! M:0EP&(&R1+@"^#":C%,DM&]"Y_,MUQ<]K*#'Q<7C@$PL'6A1=SV?NV)-+ALK M$'9F]+5]_A@4<[8?>;$OG@^XKA!Q1@I-T#:MD!GQH#77B/0G]H?QVOO-5<.?VJ&>'D$WV[]OVNUV!DA6I1#D M("-Y7(4PI-GA%KDD*XO9UV;SN15-']KF9#3D%)FPE'3CW$<^SMVU 1LR!-LO M]:;YTJY8DW4\.7Z+K"N=WQC/?O1G<^ZTEMJC7*\;QZYTN5[R2VN_-FS@NF/- ML.OOS/IN^T>SO/_"I "P5ES?-__8-G?[U:_+NX8)09K@D%1E$N$HAB0OT\.X MM8"QU/J@52"6J[?#%%4/_I<51Q\:Q6?UG:_-;K?[A\?N\-B,0A3'E)2 IE&> M1@!A$HX0*PJ0Z'JG:W7>Q8<70M. M?!-?UW(?[MLKFEY'6BZ-_+L&67S-TNM@JRU53A)TD>5)TUQ?6)6<+*33+T9. MYWKK09?2/B2'VFYK%T/*OMHN&9;NVV"SX>"ZH>\'_M6[NW?[W;Q]:+;_K%?[ MYC]8>30K< %I7O 5C3C+*H(P/H D(-4][6T3FJMU@R?GH(X.!4\\"DY=>A-T M3G$M&]UZ$W2.O0FX:]IGX*Q&7&Y5P<-@*RXK.(RSJR-N&A$16'1P''H_1KM3 M.7_[$)N[&!C<"OSKLOZ\Y!<@-BSGSO<;]H-+?NQHO=QTD&]JKG8O=?THQT-L :#?LTY?= M?M @OPW015QD)$Y.@W^KORT?]@_]H&+&+]7.84A15E2T"C.8'H47)7$EJV0V ML?A<< ^>#-,$\CO4K<;P]N2=;^%S6$)['3GY4P2^1%#SO(#%2,H4!1ILWLC] M+N+D3XIWXNV93.Z.97L)^]DZXH N*_,J3V$9 A3'19JG-#L\.UQ5F?00Q 4F MGQ/XBQT!;O*!8G!M973[<768V5]72&VG>ONAG2#ERX;87NX_2Z_1&D O@*^U M%M#T6KLF,,&ZQMK:R53$AV95[_A4PW:WG44I2=,PSN(DS2-4X3S-T;$X@4!N MQ[1!P];W3G]J^2G@'8O0MIYWDC#GP+37M)295EZO MJ2[.H-S:D6X8O%T7TG;L]IJ/&>[L[CW S7:^67:;(F8E3,HHIS"$!0449%4< M'ZZ_MNO[3\WF 3>?=S,<1ZA*((( @IAF M49AEA]P5YU6LF2+)YM_!Z]/->STYTSFF.N_ M,)@/ 7=^=C\X'1^^9 M0#?=40[FD[EWNZ=K-G)C":^P.QB"N&@LSI\AMQ4P@<3M9?OQ*W_[29'$R^O3 M@]6^#WCP9'R,\'VS^K_:Y9S$@6%@7E_X^P_P.H"NGQ:A>,@"7E%37OH?8.T*VI MKW!DC.NOC:#85^!;\9A:@P=\9E18-D2O3H>E'5178C4N%4_GL0I^T]3;!C?] M?Y<<%JO>=]]K5J SK(]\;],,1"5"<81+0ICQ$N.H2 [W>9)*2([M(IAD!6#$ M'OPTHO^9WZHW.M#-_!]%$YT+9_0,^Y0BA_]7DLZ47)/-8NK\&4M>SY]UF)59B! IRKB$(4Q3BN(D[W%$(:X2 MX:<1[%CW*8V]>'C%L)+*A\900K,:%8M9S;^ &,YO5@/C(,F)!\A8IGM.F4ZZ M4Z;_E>0\=?]D$Y\FD\:RW\O-AC,8AB@%20E3&E9Y55!2%2.2*B_CV;JYYS^HGOAC69M78&4J;-N-E/W5Z'B/#.=1! MK!SD4>F8&4NFY_G32:B:$7DE25772]G$:H158\GUCW;SK^7Z'M6/RUV] HO_ MVF]W_6HFR2B*4$G9L#B)$7]*%XQXRI!8&8@J@_$PP0Z^!(,SP=$;P_*M'D%# M2=9NU.RGV5<0*<.IUDG$'"1;A<@92[>7.-1)N-IQ>24I5]]/V:1KB%G%M/N^ M_LZ-M7+0+RU#GA0D%:Y.L:PXX^<%5 MCC3HH&I)K@K/2DG0,L4FDIT?[&HE+LLLFTQ0 5BMW*8 MMSI)TCC@/>EGP:==*,([X-YEH5..@F'(N M,R2>>@RP[&4*,N'7]51DC#G%E'1IU'2$D6(:1\5L=TBR?WQ9SK_\QO[1&1_>K9V1*$9A&69IDJ"HBE,:9]6( M(:^@SMDZ3%K[RM-!(9]JV)TEH1]07GW[0$E+]B"@E-*?!,)'2_(^#5DIS M&@^324TG+HHI[197XDG-&.M>IC5SWEU/;(99M)3:ZAVMEYM_UJM],T,)8 T- MQUD4 YS!)"GBZ+"K$J748I:3@>%KPGL3U+N NQ%T?EC57:FP64F%MB+F*"MZ M&RRK^=)6T!RG3M'@6NMA>MV28FUU^&AR?6]\>7*6899=TO8[T0XC+/ MXB@)23Y8@F6(S# M;0\ZP]65WJ/#K!\]1\N#UEP[4\DPMY]PZ7_O4_VMV?ZV7+<;EO[>KMDPJ-GN MP'KQ]%/X=9R[[[\UNR\M^\G79EA)G%4A8B/0,,-9E&1IF.,J2T8/\K@ ,CW1 M)]R6>_C;6_TZ^-RY.@K CCL[1;9T$HV;&=BO-N&'-GG)S-E*P3.,AK5T5H R MC2&.$E+A!*1Y&$5X-%R$$34K@3?-3:UFN+,F5: _$ MR^W0SIK%P1B3"G)WU\QW[^[._GQ&ZK/\%FW=PM=UUO_3EXW+1?EUN&+&":^Z2R"-CW%B<^G!8B M_))^]K/'=G@HT&W_5F+^2I>W&TD_5,"RCZW+OJ&3K<]:/CY(F58%+4D*7/'I]SZV\6WA"=;B+O* MU!4%,L.P'XIDR)?61ALT/47&T'1 .DBS'*4DBRO(:OXO6!^7#!-II 7Y^!>"G@]K]+*=VQ@,BL_-@FD@H[4CXZ==C"(YP@R/>-YUD M]EK98?9M;O,)H5H3G6JA\4-*K7DG/06JPZ*-.8ZG>$!1D 2'$0)90M*T*O-\ M6"%!603R6*9XM(?"MI2HV-QDM%EZ<*E;9"GP(_T>@N4KB+5+WB M]X1=^+TW 1]?LY\S+[W2=8F &)KF4@NRCUIOQ4^-"3 =9K4F"&:DR'$"F1T: MI\Q.580I&&UE44)D9L74+#B;'5.78D7J-(;_1EDS-.SW8*PO.\87IM$/D=+T M061,+\F(JKC@Y6J_:Q:'&01&!DA954NB),MI4I$X(:/5&/')=_7Y1UE;E@O% M 8ZU.4AI:M5DR":K^H(TDNS+3.0SMB1T2I5G/Q5+V9L;VJ7'DM$9R0%*7ZHA M7, PSH(E%>E%%6H1$1*D*A^^!< MX/@WGZ>4BYF5F4IKX?)OKM(;I9<*BKGY2J50^ZC^ECS5F[/48%=S8F&69;BJ M4(FKN(2(E+!$>3%:*P N=.8M16V\PIE+8?JT)@V,,F=LLL"+&0+YF0%A,OV0 M+6TOQ&8")%D1E9L_FN7]%S[1P ;#]7WS^_[A<[-Y=]=9WK[;[[8[EHH9G,-$ M1(YRP! D,,M)@J,(%\5AK:8(B=3$IG'CEDO-$6]0]X![A=KR H2IU@.K/K>[ M=OZOH#U"EYS[-!\.,5V;-!)R@G<(PH UZ,%V+U_UX3C!._W$J2RS5_326I#\ M$%)[[K6.&KL=Z>V7L7#)*DV2%3G"(,L036F1'3#0$MG073'+3C:X_\0&^;W: M7BX()^V_MY9K[7#^NGJNI&^*W5:%0SHN/(4RPW$**A:=N.EH5]Z[F7^)+ON]K,>]U[];T3Z[^&6!3MP:@KU#_R.ATOORX7 MS7IQ&&JA>ONE>^XE2D(,*;,1TRAA @++XVHKB2*ITV-&#%KNJQQ'L!C1=3LW MQ@'-U7E4BPR+C5NG^5>M=O]IOG4?-M!1L&_9H2&A,*B M+ E*0Y1$%2FJ""!0%+0@F$K5*2;L6=:[M^O%GHWMO@<#UN#M^J[=/'3S_7)B M9X1<,:USS:N'R0Z^NT71SEX FNWXHE!E7SJ[S&^%'5)-^:[]VMWZ_Y<^QK1?U M9@'6"_)MQRJ_9O%^TR[V\]T?]693K_D=GO--4V\;W/3__="N5K3=_,7^:!;3 M-*<11A7*0U2R,7$611VZ*LP@2(F,?+G"9'L=;H 8L-]I-E^;H)[O6%$M^BZ7 M\PB)*:2/P9$3T],G'O+T/W5:NT8M@<",X1!#,YYM]O7H3C!X%/XT^_1S\ MR=T*!K\<"[&A:%S1;-?Q]D/>G7O=3MO+Y)+&,P!#[YA%B.91@0 MRJ)DGY_G MS/9@#(4HG3TVFV6[8!YM=F*90-&0C'8\QR2QXL?^.6^"S\W]NV 0LDAN)3DNI73\V1=44=-=OT0.UTG6J,MSH04#?]<-MNWV^V^ M6"?[P^W0\R_UYIYUL5U[ZSY* MJPSKR)55[9O%)5QV%+0IUW*KON"_ B8OC M ,>$$HJ3J:. 9@ETHGSC>*13OIN,.Q2\$8NTT$D'P6>!DW=&2-@4.=(4M$W3 M?%MNA^?8GHR&9UE5(9Q5 *01ZR=Y&F*_]L.+2KS^ M>]PT7Y?M?KOZWK\>PCOP7X=,]"98-SLCDJ@3#BV5=!0)1R7CR21CIZ%'[TXJ M22\4]3+O\B)K((9>ZZX)_\2DV!B3PIMX;DY6#M!HNVF6]VNTWVR:]?S[)_:S M[:K;V,(/RG?W\1WGGB9/GJ"NXD\#9S=!##&>/0F.'$GZ&^2Z&XG<+Q)R5PLKFUF MFB#B?J2+23Q_OCEJ,O8UUYX !C0/446KJ$ LM14H/.2S*(WAL/9$U@NME:=; M9N17GD9$TNM.+#@"*TY>+Y.(LNE'_]1U0FR91(X3B<)LURTHO[OC^[CIJOUK M>S@XFN$\3$+$NF0:Q3A&152D.(1I$:.2ED4IGJO5;5A-OCTLWENZ8PP=LLF. M6E^CZ7I>U&?7CXYDQI67FA@6.1'EEQ[U1\#&:/-TA.%P^:$2=ES3>=I8CC_1'G^RW/:I_=!P=I:K MYLD[LY]:0<$ZB%,:YC@MXX+BHJP (B!,X @5H5SR,O-)(,H4)DKWG3];Y]R, M?G7B,"C#E5O0V9_P7YSS"N?QI,(Y^]N2E>@T;4*L+O6^,F?(N.YED7Z\:_@58 M+\ #/VK]/]WW9R"$<9*78480#9GI*@1D,(T0()',=(<1@Y8G,TXQ]@NT)^#D M4HD9?L52@W-JY:3^%![?:C@ [ @&(@1;D6H1TJY(KU'._9!2LRZU%MNHG-3Q M@>J[]<=ZU;R[>[O^V@P*/4L A''%!A20#3"2!&41P;TU'*>TQ K#>%53#D?L M_/8HAH\/PT\0RHF;,J-B>F:5124)4V'.BFI=H.:*4.F2Z8MO+7<8/V*5Y$I$X3-(\SM.X'(T!2%*I;7-J)BP75-WU9+]\ MYK#X_7\'7(Z7<<]R!^NUPWVRTS]7FY[BSU MBP+WK)>RK[9L\-1/\0"^)>.^6TW>HB_\R[=K5E/LN\7E\W_RZ[+^O%PM=]^C M61:'!8)E@L*J1#!&)4P.W9UU>*GU7%\P6^[2HYO!B9_C^B&''3S!'9SZRGZM M\Y;?YM'[V^WSN/"G;X*#TW+5B2^!$*QV?(%KKWKRJLE8R3".8G@E9?G6BOS( M@=ZQTOK=]R67T$[&[N_N*'-@/6FI@B'Y&+3LSA@3C\_S-_MSD8']@]8':\:"3)X;27(=!#\ MT&_S;CU?L;'#VRT%??S7\IEIP(^";?A:T%>FX^WF^X?F:[W:]X.LHBAH5<60 M4(PQQ7D8I]G!. 149)ABV*3E4<;S'EL/6%D=.( --D>T8@)IFO3K\C@AWWKB MZ"/5BW:^YZ5/_^L>4OX$H##UG[XT3Y88.?T[]KWMKGG\9?_(!SUW]7(3<,Q- MOW%N#,G90(FF+494EXO"*@F[3"3'W)D\9(GZ:;.0+:=:J\U5>N/KD]/F)WL1 M4/VXW-6KPT8$'(4@"DN0E2P3QB@'!!8#@!27-)>\]MR46]XX- M4"?;.";.XO5=R:9#X<20D3(=.1=)U D=(L%7Y]%2LE M7VZJE#I#^J78^_I[)XO,0@G#.$PHY1O&TCQ%![L8%II#85EKMN=BQ\+@L<=C MJO 2)E.WZK+!H]F2Z_T-9AW76P,I[#E=R4M^-D#OC#4G7J^6[5_]=_G M@/76?,XS>VF!1S,.'JSFZ'K0FFN5+B^PFH&"Q%F.0T)048 ,@#*-!E 5["< M[=I=O1(K6"U#D4H2!]3"7?;W9N MLWI-5UA=J;P=1=*/LMR5LT:OJI+D6#0#""(Z?YG.K(0X3K,$L"C +(4HH]$X MD0MIF@.9&0N[2"P/$@[ZO^\UY*+V7[C52D[]+0=-3/S]B9><]DOK_JD'DRF_ M%MM7A-]-%/W0?4>^ME/T$UMU_PP7$41%B&,8QIA4(1MZ9 < 98[MU/@WS?I2 MS]LJVV_S;KI$-TJY]7+7B0;E0DV,"UWCKF+5?$!VC&K_#6XEQ+-5W1;50]CX'PX"I# M>6+E!=5$E+P65B,.B@FL.2Z%G_<9G@_]U [G%A@DIO*[[^]9H]_Q9XG8=Q_Y MK\RR)(=552%*\C@MDZC(#[>$P#!+J-R6+H.&K>_O&C>6=VM!B^5NOY&M1$W2 M+*:IKOE5TM(1)+\>=H 9C#C?!!W2-_TC;B-8QP\O"9-X130+R,;M6RY%1\C]V:@CZ."(^LW9,DGZ*63SD1'4UHF#(BFRQN-AZY$[ M65*OB:[%$'FBOC8]?/EVGF4V5?3XU^4=Q[#?\!M WK>KY9S;16F1P0CB/"(I M3J,T05D\VBT E7K'6-^:4ZW==J^#+OCVI+M@Q?"R$>D .'@<$*N+K"+=\I)J MGVD= >7H@@.\H,/G^*:RFV0)"J,>T?[)H*8_5T3/!%-*)6=W@KP;<;Z[&R\: M8Y9I%*PCRCP@7_Y^;$E"_YU^-7<:;1.*?&YA8GN_+_&D/.2+.^S;_#]\AO)KO>(_ M&J^&FD6P#,,(A5&($ !Q55&^U;2#A@D4O0+$*23KBRS#U &_J&[5'9=A_;8^ M<>GP\&BW48@O"G1?-$=?#I>IB1]\NW3P)7A>OY=&-5QY, M\6-O7@95[9RV9!#Q)Z*8_6N?>Y7;"KF)K2]K9\R0)I55!4A## M+"PJD,(2C]LW,"U(:&!CKRDHKC;[CH^,,<*QS<.\,H@O'2D@*"<%5A M;P?!85%J']PSA\3R1/[9@QZ7]-_:X3V#@1-+ /[$3$[_I;7?V\-[PFQ?$7\W M4?1#^QWY*G!XSQ;#YNO^60J2,LI(% *:91FEN"CP(?54T,3A/16SKNKYG_:C M.-Q2=UM%_.T(F"[8C9)OO3CWM0HW4G$+A\(/A;7AF'(E+GF@Z<\PE M+2)2TB@,*4J+@M TATD/A"2@RHF!8WPZYBW7QP=HQH_Q:7&NI9JNZ#:JGL= M^'N,[PJQ\H)J(DI>"ZL1!\4$UAR7HD+[H7D<9L_?W?W*M^R\NT.;9K'CO:8TL=RI_;4[5A?/SXL3[7KX'.[V;1_L0!(5IH:-(I) MI&7^E)3PB(E/NG2HNO>9.UQNA>XB/5?T3)]2/V3+@!^MZ<:FAY&>3S:*T-4JI_)D+'B=).RJ@1ID"@F06[XD]PW\NR$Q802=)$> MP=W&:I3Z(4$&_+AZAD*=&14)&M^&?G?WL5DOV\VO[?K^4[-YX ]'SZJ$D+BL M8%X4_+KV%!;A<#J-I&P4+/7X@S&C3@5J6Z^Z#?[;#F?WFKFZ4NEQ+2]-/4.B,A, _W3/CUA49-,B;["F+=W?< MR B@>Q]]AB#.V>>'I"Q2$!<4(%B.%C-(%6]U4;'D<(1XU\E=<'>8Y)ESA&I' M*Y1(%50\VVSJ;?)E-')<1YU#5UFT>K#B#$77=,P L9Y(EPE/+IRJT&='5J!H MNSF5RO]H%O?-F9E6I$S*+ ?AL-)+LBHI*HV38:8@**B9PF&Q MC\UNM^J>$#GLM^Y>%OG"84_4%049%.B>IF/A5YF$5%?N M)(A615* L.#7-N&,&1\'@1DN2N51F+0A!]O>'D_FI_LWA.;=2#BXJ^?#V_/J MXR]Y9N7'7%9)U1EG_?1D!OOGB8=6SVD2'$XIL^N)J!EQY.='_KC MB/U>XWOV<_;5=KD8=IW-H@)SP0QCG*1E3&F2Q_D((T)Q)/H4+IP( M^V4\PCD_X.9?'H'KGNG3C1"'R/A.Y)2H<1,7MJ4CTRZDH?7AHUQ]W[?Q?LSR- MBBR),22 \#%_"@X3D8"$)%*;%M0P:']V<( U'#WDR((MAZ8V+:C#K=SLH&U2 M]1/2$5ZWJMMS^_$JM[9G*"XP)C8IH4NW)R6[08_1,$6D] *'-0:U MUSC>;1;+=;WY'APPOO% P\Y3)K;FH<.U7]JEZ\SEE0]]CLP?DCA[WCDM:4Z* M.*H2@N.\ J3"X J!(F!0V>FH$A-1Z@=1)/U#L(V M\:D,,Y=,F(ZD'TKNREGEDQL&.-:Y9.(,H@O'GZ,RCM*JHCB/89:5898FX_H= MPC 1FHEV@\3RM+2TF,C>6C!%\,22@#]QD\L!UD/F[*()8;:O) W4?1#_QWY M*G#1A"V&S8\#9@4&$<1%1:,D#FE!DI!$(X 29=1.S7_3K(/Z_LG%< ?FBVN\URSI?3 M^@M"GW[CY#??-YMER^#.-TV];7#3_Y?]>[5?,/#DV_P+ZP[-AWK7D+N[9KZ; M11E,RZB"E)"L !E$H,@/DI^"2$9Q/8/N0+67 ]S@I\4 ^&>NWUS,W[RX'/A- ML#DX?[Q"^/GWCG\@7Z9[1+Y$7>\1:KL#@3=][B&G3>+H7/]#WB2>?^_)'_1. M!V\/+6_T^V?^V.'@>C#Z'G#G@]Y[]V,(=Y&],>CPL(GYD5%])>?,L,9'F.XR M^PP5688!@5D4)SF*8)6A\6H#]@6EL\?.S8^[>K-SD*YOXI&1TN?07:MJ4.^" MS\W]GQ%*X#LHI%/#B/P*5)#PW[E=E+X M-Y(8T?#^"!(C[*M1B9%C6%1B/NX?'_M3M?6*6Z2K]J^WZ[MV\] M !SN\LO" M M($Q"0IDBI**X*.UB, H%R MQ9X9KJWHK2!Y5Y35-/U^:*AQKUJ[C=9AZ77 %F6 YF%05*8VU,;MH)'\ 91'W MU>B878YAB7N&%OOY[H]ZLZG7N^]\Y]ZJW>XWS:?FVPZN^/$=FD911#,04QB! M,$9E6$810*"HXJ@D:25YVY"N.5^WWIOG8?&TV M_/K%WYJ'S\UFEJ&BC ".XA25),J2$D6XLU:6D+(:34;#5&U8%JX15G# %?S9 M(Y,->+M^M=<]^?>WC/VMIV!%#%B$: %6Q10N*4Q$6(!@ HK4@B?.N9 M6;.6E6E$VV]&'>%VHZKE$7#PR!%+:I:-&%R7L8GIERW#7A7S$K>:31JF'QN;^/G_?;8R'WX^_,MSG"_ZJ M-PN^!6GW_>V:8^\O^>5J_>E+O7[WV%WKQ0KTK\RS9O&A7:UHN^%_- ,HRE(, M25ZB"&41*HJJ+]6KE"0X1%)'?/R"[D*7^WV&W3,*0GL+T M+5'W"C C>9&G$:DJ@I,( E9LA,6('Z8TE+_RQ1_L,IJM?#W, MJ[CV%$RKJY)-XM]&4F5Y<:^F2I&;7DC_V8%_N^YO_IH!&)8X+2C%(4%1515Q M60[P:4:C5.%5=6^P"^FH]G/L+X6TA^G+8$1"5&41KS:XM(@9@W*1T] M2-.R]"K1RL.?*M<>D/XHFOF"^DED4[T!_.C*J<&,,_'4C=[T^OE\E)44)1/] M,DZ3'(4XS5"8Q"/^&$(L>X6C/\CE)WNDKWN\,=4SX16._UZ3/*)-X4>74&5> M)IODD8N<1_+Y1[.\_\+^"_A9TOOF[_Q$.V;%%ZV7FW_6JWTS*U- <1Z&B$1A M7(28@AR,KF%2Y%Y.I.N[Y62.?83YRX SZ(#^PI$&'&K08=68>7_%S6KJ:::) MVI*O4U G:^PC(<&35AL\:[4_7*%PLQU,6T.8:Z;_-N6%0)MH M*X;IR$]?G0RKI7LFA;>=2\JTQ%59Q6%1L#$W\Q5GHW,1JCPI38RZY$E=O1.R0YGI3DXV83U^#2$S[ M9R&D ":4Q&$2QSC'(#NX5F"8>;@52M\I![NDE!;K?^R]4WZ*OX5F]:-+OPW* M?%P2E8NWR"5[_S?AW>_)[2?\WN/AVN,BQF7!4TU>Q&%&\QS$%2JJ*,L!1;@2 M6J+4MV)Y@/9_DX"C"YY>!\3Q*=RZKLGG]5&26RKE!BX^L2A^IYX[-M4NU--A M5>0^O:O^G\E^YCB;_B8]0WZTIEN3A'A'U^RQ9)&3$* R#W,<$I8X(FXO1!6) M(2E38?'6LF);O".3LJ/'IX!X.Z-24KP]8E%"O)VQJ2C>&JP*B?E!>WXIM M\4YY!RD,R8X>GP+B[8Q*2?'VB$4)\7;&IJ)X:[ J)-[7_+\DWD8X\T"\S?C1 MFFY-DM,F%^UE$8WS!"8@0BBL,IHF"3[80Z%XY:UEQ-3<-K$"94J MTR9^L"@Y;>*$39UIDZNL!G_B]J%>K@W,G\BJN!'R/%!Q,WX\GS\QQ(SP_,E% M>YA46965($OC*,^J,"=PS!H="JGY$V4K3N9/3.F/'I^"\R=.J%29/_3!4H)(@4-TS#/0'>S M6C;:(TDB5X(K6W%2@N<&BT=U/@5+<"=4JI3@?K H68([85.G!%=C5;CRON3_ MMLE>!$D>8YB0(HTA+4D:5=%HKZH*H0=J]*TX M$>_4H.RH\RDHWDZH5!%O/UB4%&\G;.J(]SE6]37[DMO7-%N;*D\T6]^/YYIM MB!DAS8ZOY8@<@22$19)&)2DP))@@,-A+XQR*:[:6%=N:'9LL%?7X%-!L9U1* M:K9'+$IHMC,V%35;@U4A\;[F_R7Q-L*9!^)MQH_6=&N2%._LDCU*,Y"Q9))7 M!<&H*E%>C;,S*8)BIW[UK3@1[\R@[*CS*2C>3JA4$6\_6)04;R=LZHBW&JO" MXGW)_VOBK'O$HN1602=LZFP5M"C>U_R_ME50FS,/Q-N, M'\^W"AIB1KCROCA- Y,X*KBI"I91%!6P)/E@+R-I2:0J;V4K3BIO4Y.T>GP* M5MY.J%2IO/U@4;+R=L*F3N6MQJIPY2T[YVV$,P_$VXP?SRMO0\R(WHI"Z_ER MM=Q]1ZMVR^P-ME@Z*!&)01K1/&:)@:)RG*+)211#F8O2U"Q8%NT15#"@DA09 M3?:NR[0[XN0D6IXS*U>GG*7EC-:8H=&/RT4T?6A--BSQXI \/*[:[TWSL>%W M?C!'Z_7BO.TH)##+JA3D,:Q*R,O3L3#-"XB%"T5S%BWKSP@T." -&-1 4Y8, MDWZ[FIR&;SG9>A54BY>2K)"I7]6M6,XA([#@ M!)EB':O!I%@MZX9$N<2@QI^5FO8B/5?J6GU*_:AM#?C1FFYLH&UQ=Z5:F6/:C()'E>@ISF10+3?@'KQ:=-O=ZN^BNF%_^UW^[XS-*L3$ 8IV5:5'$(0DH0I?&( M)@>@FJV;^WK7+#Z)307;A"+4TZJ^I[U K=CK-D-5/?@0_,6<"+@7G;:=^!$< M'1&?RK0:N-OSR),'RX LON( B<\^^Q(HM?GH\P';G@9L/@9L=Q*P^G; 1&:H M-.#_$M3<.+(O#[T'0^?FF:W=\W M[?Z1&?]4?UXU,TAR&F5940%28A)%(< QHIB91815Q$*/?Q@U:'W#T_$1I,_? M@[%/=4"#$6GP9X=5>A.4";[%!L;.J9:K",VP;&G;U&WFKNZB,DB\'_IFUJ47 M>ZR,\R6J?[\U]7:_Z9YM>KM^W.\^L;\&WY;;69YG10Q"P+0VHI1DN,!A;XX9 M+\5NGM$V8EGG3G %';" (PO^Y-@D=4V=1S$MFO(YZ1-"0D)A G<01*$H8XKD:#!!.ATYP&S$RD0;?N9#;. MIKH.62#2C!))WFMM3XMZ())J)$FKOWHDZXB (BEQHZI)>+F=M_OU[D.]:\;# MD1@654$ !E55T@AF$)6C892#4$>;%,RYUJ@WP0@RX"@5-Q*:X%E-M2Q3K*E> MTNPZT;&7G$GHF0;A?NJ:CD,W]$V;*_FYKS.#3KI1?/#\';[]E,+YO^]7VX:N-\RD]MML_V]V;V[Z]8V^Y\L9BB/JS*K4)(6 M84BBA. \'B&4K"J7R05O6_1%KL&N# 5-PA/LF8(#Y*F2WMV/$+"?O9L,@ M)N6314!.MHV2;T6=98B\HL16XN&'ZMIQK770GL6W.K[?M/_5S'?-XF&Y:K:[ M=MTLF);/2IQG.:4@#LN$I%$4\GOQ1D,Y$+ZO3O'C;2OCB"HXP HX+O%];*JT M7=<0%C$N(Y+Q M.^Y@%J>88T($9A@40K<]NT'BIHH-[MI-<(0?/,$?'!PXC(77]\'1!Z6JUE;@ MI,I<#V*F5/?:"9?-.EB-Z=N%L>4(>E4IV_;U?.GLA&'SJO_NL?O.$TPTR8_,I M35BM@=8DUQ-P\WGW=LT/R?!.^H]U_=!N=LO_:1;CWH%954 0 MDCRL $EI3C-8@/Q@E])0XH"T.:-"74?[*#3'&1R!O@E.H!YVUKCM.3>IN]*= MS-'N1Q\SZ$]KJX'J],;#8NXL8I^?HR(+XY3 (BMH&4:C-5IA().B5&U8SE;_ M6&^;^9Y)7;!MUDM6EZ[;'5]XN^/[*;YRA'+C V4JQ2I_%RS*U?0OQ.JX$Z73 MJE7+]X9-J58'EH0U2IY7'Y5)P8NK>J3*BLCZ(JO,6;'!JO)Z];AI/P^5>7NW MW<_GS78["TN80QJ"#,8IC G-*GJPB!+QA49=.Y;5Z 1><(*/;P$8$(HOIVE3 M>GL1TB6;9B&^+B0"DLJ_$2MIAG;6GY IZ] FGP**+D[ M*B6%W!\6)63<'9N**J[,JI"(7W7_DH:;X!B I:A!@M@W:SL[#8F$HMI(*ZTI9R\FV_WXI68R5-G9$D9>BNXL!.DF3 M6N?<0]W#CTN2(I9F21J'6192G/DIBX9CZ^.8)F32CA> QP(G]@-:9P37&? Z M1\ .1^QPR#/NR=(MPNOI?\'XR_G!I85^NFLL*,$\&]$LQ11OD8O1";,!"O3R M[@-%K %OI-/]Z=W^4[GK/;"KR'DH-T/I35.WPS,SYN<9"5P4!-3WL._%XL[V M. E#/'EHH?XD8!?J 3ICA,X1XHS4IR&TKQN-V:C*>8N% 9UN'V8#.\\Q% ,\ MQ2%>#<,)4] 7ON5]0".7!J*!24PB59QTL=L57V^*MMQLJN*N;MI]M=Z7;5=N MN7VRG:KF\/ZLJWVYZ<\($)AC'HB M\&O/P#E2< 8.SI&$4]4.I^$<>!P.^YB3 @T(.&%NRRKM).>_?E39)*;3K))O MYI2;G(Q:K% Y;JS,:82+F4VMC-M2#'&DVSGU4"<\A5]$;3 .#22:4!:V?34SP=] M]TU;;/O3V*[J]?:AVW_UXE#PKZ:;&;RCQ7VU+[:C:YZ\$$5A&,4T#W.2,A:F MB9@)3/TXF[Q09 (+L'D("H=C%=\X3RQ.S(R\<08FSD!EUGUX1D1\W8)LTT_. MHWY@Z:8[G6T2SK-"(U).\4L-X3QAJ":%6MYQC;)MEGD=)/?D34?VOGPL^5^L MLBBC@1^YW=C1122E+G$'()AFH=0)I@"/M\Z9!^"2&_P =#GOO)9( FVVKZD! MLU-0.J8OI&L# EFROQ"0X+=;#Z%C"9"'\;HO[FO?=EN(<;WYHRGJ]GVY+JO' M[@*\M^5^E?MQ%#/DYRAFB9<':4Q]@9$$* 9*T1J069>]!:&>1[)F([BHX!= MI$/G_-SA^\5I:F<$L=O;=@ I9P>JH9V6WPU&52YA*P44)/.>#]695*HIQG;D M1EUD&I!V*-W#_CZ7"B0YIRY2\+O;%W^5E+?-KN2IN?EBQW-XU$+]LH.IEW>4QD\BM]O2M_W1=?G+O^U=Z*5WLC MNF;\O;X1:XH/=66^8Z4SW.>[5HL(:T<"68S]]]VK!560[V!]*+;ENUNQ:KN* M69:2/,%)E@0,Y6GN!=[P.$JB4.K\_=D/6;13)5#.[5;)!E2V0P482YU=J5?# M"-R9>AZF2=VHF9&U(_^ITSC9=5**"\"TY%7]6-;][JZ'W:Y;L H2YK.(I@%U MNZE1@HA'!"*/$A]H$E(:AW53CD\,WC@#!["Y17G1M,\D@NH%/6\H(=72$X3? MQEG/=.!L]>S(ST:8SI_J4XRNYL(]/J2[+RK^XZX7S,=V92M@13GQ618E)&)> MXF8AI2@0L!"B"4#EWGPPUN7[@8ISX.+T9"13OSDEM9;OF1$1V@0N2C^0&CXS M.IHJXGM)3UE[5RWC.QE1]3H^=;$NJI!/ ]UYE7RZX@PP5NOW:0]H#K/N*R_/ M,\9R%, M\J +@PH"3*(\\,+,=S/DQYC$ \B,D90!F8$.:-:Y@R#%O^IH]:5E3\2Z>C-! M#6F?F:"('N/1*?W%.9%6\O.M2;\&(&M*>_Y25C?; M\N">(VQIEL:A2U(4>R'!,8<:Y0*;CY$+MKHT&Y%USG3D\M05-N!&*IH"+#X9 MD1-^&6J.DDO[S>G@ZUJ;4A;WXMQ%!V>5]2I-$0?PDM^;9O.?:KL=^UO&:.@S M$N8)][Q3FF;4=7'DY[Y//+$(PY#K0R7_>6"L MR__/9] ->,!,$6%6/D#U,[OX<0%N\&+(-2Z!S%;SXCQ!D:[B0HABG*WP 8-\U0^948JTYOTG'-..?\_?K_WN8;U_V/%?+.I-]XN[8KWGV?1S5?>_ MN?Y4[.Z.];:9%TY0M,"USL/^A]@&RO<:*=F)J]PU4>]&\06>N)NK[=\!; MPT5M[X&/QKS=/X94@AF&=\C_J(J;:EOMJQ$T[(9>Y&8D3'R:A8A@(FK7*Y*66F$ MKB7> Z2E;%^<]^IC/MR#-T8H)KH#N+)R*8,):B%(N M&%V(C?YES;_:XGJ#-Y^KNFKWW=\_ENS+?5FWY0IYQ&=QF*5>DGMN1FF4#I-2 MB>?R+Z%V_2O"LLX%!D)]:Y %6)M7N$276A+4-!V*4=Y!49]!B* M+JTOSE^T$5S3/,IR M%/+_0!U*&K0K+,==HWCB#4IZ<1)4=P JD85I;VO.-8K"JLVURN MH""5WB:%-5/0K22PYIKM5Z*K7IJM2[Z+JL#61GI>H;7>F"O=)GS57_4PNE+T M^U_Y]B+1.$B#(/#] *$<>S@)L4L%NB .9(\Q-8()OD_PXK#D %#<;=DUUY,C MF)N>D?@7G)/T2-2,N).'H=;I*MTK,">IN0NCY34X/P UJK(UHT^SK*=<# T> M=267X8]CM[?E>O_N]CN@O6F>N,-ZY3(:)P@AEQ&4X#!$##TY8> F1-EKP) M MY#A=W>V!4+^ ,KI96:2J0U>8__#EC]!@.W!J*YB/%4+KL2 XC^Q1G,J2 DC]=E[NJV;R[I8>?\'';5?W8;!_+;EB&;WE^%F!781[Y M:1(GD4^CV&4LB:BH"?'#U)>]9P@4RT(>=�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end